N-cycloalkyl-N-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives

ABSTRACT

The present invention relates to fungicidal N-cycloalkyl-N-{[2-(1-substitutedcycloalkyl)phenyl]methylene} carboxamide derivatives and their thiocarbonyl derivatives, their process of preparation and intermediate compounds for their preparation, their use as fungicides, particularly in the form of fungicidal compositions and methods for the control of phytopathogenic fungi of plants using these compounds or their compositions.

CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a divisional application of U.S. patentapplication Ser. No. 15/100,966 filed on Jun. 1, 2016, which is anational phase application under 35 U.S.C. § 371 of PCT/EP2014/076512filed on Dec. 4, 2014, which claims priority to European Application No.13356016.9 filed on Dec. 5, 2013.

FIELD OF THE INVENTION Description

The present invention relates to fungicidalN-cycloalkyl-N-{[2-(1-substitutedcycloalkyl)phenyl]methylene}carboxamidederivatives and their thiocarbonyl derivatives, their process ofpreparation and intermediate compounds for their preparation, their useas fungicides, particularly in the form of fungicidal compositions andmethods for the control of phytopathogenic fungi of plants, using thesecompounds or their compositions.

Background of the Invention

In international patent application WO-2007/087906 certainN-cycloalkyl-N-benzyl-carboxamides are generically embraced in a broaddisclosure of numerous compounds of the following formula:

wherein A represents a carbo-linked, partially saturated or unsaturated,5-membered heterocyclyl group, Z¹ represents a substituted ornon-substituted C₃-C₇-cycloalkyl group, n is equal to 1 to 5 and X canrepresent various substituents among which a unsubstitutedC₃-C₇-cycloalkyl. However, there is no explicit disclosure or suggestionto select in this document of any such derivative wherein X canrepresent a substituted C₃-C₇-cycloalkyl.

In international patent application WO-2009/016220 certainN-cycloalkyl-N-benzyl-thiocarboxamides are generically embraced in abroad disclosure of numerous compounds of the following formula:

wherein A represents a carbo-linked, partially saturated or unsaturated,5-membered heterocyclyl group, T can represent S, Z¹ represents asubstituted or non-substituted C₃-C₇-cycloalkyl group, n is equal to 1to 5 and X can represent various substituents among which aunsubstituted C₃-C₇-cycloalkyl. However, there is no explicit disclosureor suggestion to select in this document of any such derivative whereinX can represent a substituted C₃-C₇-cycloalkyl.

In international patent application WO-2010/130767 certainN-cycloalkyl-N-benzyl-carboxamides or thiocarboxamides are genericallyembraced in a broad disclosure of numerous compounds of the followingformula:

wherein X¹ and X² represent a fluorine of a chlorine atom, T canrepresent O or S, Z¹ represents a substituted or non-substitutedcyclopropyl group, Y can represent CR⁵ and each substituent R^(i), ibeing an integer from 1 to 5, can, independently, represent varioussubstituents among which a substituted or non-substitutedC₃-C₇-cycloalkyl. However, there is no explicit disclosure in thisdocument of any such derivative wherein R^(i), i being an integer from 1to 5, can represent a substituted C₃-C₇-cycloalkyl.

In international patent application WO-2012/052490 certainN-cycloalkyl-N-benzyl-carboxamides or thiocarboxamides are genericallyembraced in a broad disclosure of numerous compounds of the followingformula:

wherein X¹ and X² represent a fluorine of a chlorine atom, T canrepresent O or S, Z¹ can represents a substituted or non-substitutedC₄-C₇-cycloalkyl group, Y can represent CR⁵ and each substituent R^(i),i being an integer from 1 to 5, can, independently, represent varioussubstituents among which a substituted or non-substitutedC₃-C₇-cycloalkyl. However, there is no explicit disclosure in thisdocument of any such derivative wherein R^(i), i being an integer from 1to 5, can represent a substituted C₄-C₇-cycloalkyl. In internationalpatent application WO-2013/156559 certainN-cycloalkyl-N-[(heterocyclylphenyl)-methylene] carboxamides orthiocarboxamides are generically embraced in a broad disclosure ofnumerous compounds of the following formula:

wherein A represents a carbo-linked, partially saturated or unsaturated,5-membered heterocyclyl group, T can represent O or S, Z¹ can representsa substituted or non-substituted C₃-C₇-cycloalkyl group, L can representa direct bond and B can represent various saturated heterocyclic ringsamong which substituted or non-substituted cyclic ether groups such asan oxiranyl group. However, there is no explicit disclosure orsuggestion to select in this document of any such derivative wherein Bcan represent a carba analogue of a substituted cyclic ether group suchas a C₃-C₇-cycloalkyl group.

SUMMARY OF THE INVENTION

Accordingly, the present invention provides aN-cycloalkyl-N-{[2-(1-substitutedcycloalkyl)phenyl]-methylene}(thio)carboxamide of formula (I)

wherein

-   -   X¹ and X² which can be the same or different, represent a        chlorine or a fluorine atom,    -   T represents O or S;    -   n represents 0, 1, 2, 3 or 4;    -   m represents 0, 1, 2, 3, 4, 5 or 6;    -   p represents 1, 2, 3, 4 or 5;    -   Z¹ represents a non-substituted C₃-C₇-cycloalkyl or a        C₃-C₇-cycloalkyl substituted by up to 10 atoms or groups that        can be the same or different and that can be selected in the        list consisting of halogen atoms, cyano, C₁-C₈-alkyl,        C₁-C₈-halogenoalkyl comprising up to 9 halogen atoms that can be        the same or different, C₁-C₈-alkoxy, C₁-C₈-halogenoalkoxy        comprising up to 9 halogen atoms that can be the same or        different, C₁-C₈-alkoxycarbonyl, C₁-C₈-halogenoalkoxycarbonyl        comprising up to 9 halogen atoms that can be the same or        different, C₁-C₈-alkylaminocarbonyl and        di-C₁-C₈-alkylaminocarbonyl;    -   Z² and Z³, which can be the same or different, represent a        hydrogen atom; substituted or non-substituted C₁-C₈-alkyl;        substituted or non-substituted C₂-C₈-alkenyl; substituted or        non-substituted C₂-C₈-alkynyl; cyano; isonitrile; nitro; a        halogen atom; substituted or non-substituted C₁-C₈-alkoxy;        substituted or non-substituted C₂-C₈-alkenyloxy; substituted or        non-substituted C₂-C₈-alkynyloxy; substituted or non-substituted        C₃-C₇-cycloalkyl; substituted or non-substituted        C₁-C₈-alkylsulfanyl; substituted or non-substituted        C₁-C₈-alkylsulfonyl; substituted or non-substituted        C₁-C₈-alkylsulfinyl; amino; substituted or non-substituted        C₁-C₈-alkylamino; substituted or non-substituted        di-C₁-C₈-alkylamino; substituted or non-substituted        C₁-C₈-alkoxycarbonyl; substituted or non-substituted        C₁-C₈-alkylcarbamoyl; substituted or non-substituted        di-C₁-C₈-alkylcarbamoyl; or substituted or non-substituted        N—C₁-C₈-alkyl-C₁-C₈-alkoxy-carbamoyl; or    -   Z² and Z³ together with the carbon atom to which they are linked        can form a substituted or non-substituted C₃-C₇-cycloalkyl;    -   Z⁴ represents a halogen atom; hydroxy; cyano; substituted or        non-substituted C₁-C₈-alkyl; C₁-C₈-halogenoalkyl having 1 to 5        halogen atoms; substituted or non-substituted C₂-C₈-alkenyl;        C₂-C₈-halogenoalkenyl having 1 to 5 halogen atoms; substituted        or non-substituted C₂-C₈-alkynyl; C₂-C₈-halogenoalkynyl having 1        to 5 halogen atoms; substituted or non-substituted C₁-C₈-alkoxy;        C₁-C₈-halogenoalkoxy having 1 to 5 halogen atoms; substituted or        non-substituted C₁-C₈-alkylsulfanyl; formyl; substituted or        non-substituted C₁-C₈-alkylcarbonyl; carboxy; or substituted or        non-substituted C₁-C₈-alkoxycarbonyl;    -   W independently represents a halogen atom; nitro; cyano;        isonitrile; hydroxy; amino; sulfanyl; pentafluoro-λ⁶-sulfanyl;        formyl; formyloxy; formylamino; substituted or non-substituted        (hydroxyimino)-C₁-C₈-alkyl; substituted or non-substituted        (C₁-C₈-alkoxyimino)-C₁-C₈-alkyl; substituted or non-substituted        (C₂-C₈-alkenyloxyimino)-C₁-C₈-alkyl; substituted or        non-substituted (C₂-C₈-alkynyloxyimino)-C₁-C₈-alkyl; substituted        or non-substituted (benzyloxyimino)-C₁-C₈-alkyl; carboxy;        carbamoyl; N-hydroxycarbamoyl; carbamate; substituted or        non-substituted C₁-C₈-alkyl; C₁-C₈-halogenoalkyl having 1 to 9        halogen atoms; substituted or non-substituted C₂-C₈-alkenyl;        C₂-C₈-halogenoalkenyl having 1 to 9 halogen atoms; substituted        or non-substituted C₂-C₈-alkynyl; C₂-C₈-halogenoalkynyl having 1        to 9 halogen atoms; substituted or non-substituted C₁-C₈-alkoxy;        C₁-C₈-halogenoalkoxy having 1 to 9 halogen atoms; substituted or        non-substituted C₁-C₈-alkylsulfanyl; C₁-C₈-halogenoalkylsulfanyl        having 1 to 9 halogen atoms; substituted or non-substituted        C₁-C₈-alkylsulfinyl; C₁-C₈-halogenoalkylsulfinyl having 1 to 9        halogen atoms; substituted or non-substituted        C₁-C₈-alkylsulfonyl; C₁-C₈-halogenoalkylsulfonyl having 1 to 9        halogen atoms; substituted or non-substituted C₁-C₈-alkylamino;        substituted or non-substituted di-C₁-C₈-alkylamino; substituted        or non-substituted C₂-C₈-alkenyloxy; C₂-C₈-halogenoalkenyloxy        having 1 to 9 halogen atoms; substituted or non-substituted        C₃-C₈-alkynyloxy; C₂-C₈-halogenoalkynyloxy having 1 to 9 halogen        atoms; substituted or non-substituted C₃-C₇-cycloalkyl;        C₃-C₇-halogenocycloalkyl having 1 to 9 halogen atoms;        substituted or non-substituted (C₃-C₇-cycloalkyl)-C₁-C₈-alkyl;        substituted or non-substituted C₄-C₇-cycloalkenyl;        C₄-C₇-halogenocycloalkenyl having 1 to 9 halogen atoms;        substituted or non-substituted (C₃-C₇-cycloalkyl)-C₂-C₈-alkenyl;        substituted or non-substituted (C₃-C₇-cycloalkyl)-C₂-C₈-alkynyl        substituted or non-substituted bicyclo[2.2.1]heptanyl;        substituted or non-substituted bicyclo[2.2.1]heptenyl;        substituted or non-substituted tri(C₁-C₈)alkylsilyl; substituted        or non-substituted tri(C₁-C₈)alkylsilyl-C₁-C₈-alkyl; substituted        or non-substituted C₁-C₈-alkylcarbonyl;        C₁-C₈-halogenoalkylcarbonyl having 1 to 9 halogen atoms;        substituted or non-substituted C₁-C₈-alkylcarbonyloxy;        C₁-C₈-halogenoalkylcarbonyloxy having 1 to 9 halogen atoms;        substituted or non-substituted C₁-C₈-alkylcarbonylamino;        C₁-C₈-halogenoalkylcarbonylamino having 1 to 9 halogen atoms;        substituted or non-substituted C₁-C₈-alkoxycarbonyl;        C₁-C₈-halogenoalkoxycarbonyl having 1 to 9 halogen atoms;        substituted or non-substituted C₁-C₈-alkyloxycarbonyloxy;        C₁-C₈-halogenoalkoxycarbonyloxy having 1 to 9 halogen atoms;        substituted or non-substituted C₁-C₈-alkylcarbamoyl; substituted        or non-substituted di-C₁-C₈-alkylcarbamoyl; substituted or        non-substituted C₁-C₈-alkylaminocarbonyloxy; substituted or        non-substituted di-C₁-C₈-alkylaminocarbonyloxy; substituted or        non-substituted N—(C₁-C₈-alkyl)hydroxy carbamoyl; substituted or        non-substituted C₁-C₈-alkoxycarbamoyl; substituted or        non-substituted N—(C₁-C₈-alkyl)-C₁-C₈-alkoxycarbamoyl; aryl that        can be substituted by up to 6 groups Q which can be the same or        different; C₁-C₈-arylalkyl that can be substituted by up to 6        groups Q which can be the same or different; C₂-C₈-arylalkenyl        that can be substituted by up to 6 groups Q which can be the        same or different; C₂-C₈-arylalkynyl that can be substituted by        up to 6 groups Q which can be the same or different; aryloxy        that can be substituted by up to 6 groups Q which can be the        same or different; arylsulfanyl that can be substituted by up to        6 groups Q which can be the same or different; arylamino that        can be substituted by up to 6 groups Q which can be the same or        different; C₁-C₈-arylalkyloxy that can be substituted by up to 6        groups Q which can be the same or different;        C₁-C₈-arylalkylsulfanyl that can be substituted by up to 6        groups Q which can be the same or different;        C₁-C₈-arylalkylamino that can be substituted by up to 6 groups Q        which can be the same or different; C₁-C₈-heteroarylalkyl that        can be substituted by up to 6 groups Q which can be the same or        different; heteroaryl which can be substituted by up to 4 groups        Q; or heteroaryloxy which can be substituted by up to 4 groups        Q; or    -   Z⁴ and its vicinal substituent W, together with the carbon atom        to which they are linked, can form a substituted or        non-substituted C₄-C₇-cycloalkyl;    -   Y independently represents a halogen atom; C₁-C₈-alkyl;        C₁-C₈-halogenoalkyl having 1 to 9 halogen atoms; substituted or        non-substituted C₁-C₈-alkoxy; C₁-C₈-halogenoalkoxy having 1 to 9        halogen atoms; substituted or non-substituted        C₁-C₈-alkylsulfanyl; C₁-C₈-halogenoalkylsulfanyl having 1 to 9        halogen atoms; or substituted or non-substituted        C₁-C₈-alkoxycarbonyl; Q independently represents a halogen atom,        cyano, nitro, substituted or non-substituted C₁-C₈-alkyl,        C₁-C₈-halogenoalkyl comprising up to 9 halogen atoms that can be        the same or different, substituted or non-substituted        C₁-C₈-alkoxy, C₁-C₈-halogenoalkoxy comprising up to 9 halogen        atoms that can be the same or different, substituted or        non-substituted C₁-C₈-alkylsulfanyl, C₁-C₈-halogenoalkylsulfanyl        comprising up to 9 halogen atoms that can be the same or        different, substituted or non-substituted tri(C₁-C₈)alkylsilyl,        substituted or non-substituted tri(C₁-C₈)alkylsilyl-C₁-C₈-alkyl,        substituted or non-substituted (C₁-C₈-alkoxyimino)-C₁-C₈-alkyl,        or substituted or non-substituted (benzyloxyimino)-C₁-C₈-alkyl;        as well as its salts, N-oxides, metal complexes, metalloid        complexes and optically active isomers or geometric isomers        thereof.

DETAILED DESCRIPTION OF THE INVENTION

Unless indicated otherwise, a group or a substituent that is substitutedaccording to the invention can be substituted by one or more of thefollowing groups or atoms: a halogen atom; nitro; hydroxyl; cyano;isonitrile; amino; sulfanyl; a pentafluoro-λ⁶-sulfanyl group; formyl;formyloxy; formylamino; carbamoyl; N-hydroxycarbamoyl; carbamate;(hydroxyimino)-C₁-C₈-alkyl; C₁-C₈-alkyl; a tri(C₁-C₈-alkyl)silyl;C₃-C₈-cycloalkyl; C₁-C₈-halogenoalkyl having 1 to 5 halogen atoms; aC₃-C₈-halogenocycloalkyl having 1 to 5 halogen atoms; C₂-C₈-alkenyl;C₂-C₈-alkynyl; C₂-C₈-alkenyloxy; C₂-C₈-alkynyloxy; C₁-C₈-alkylamino;di-C₁-C₈-alkylamino; C₁-C₈-alkoxy; C₁-C₈-halogenoalkoxy having 1 to 5halogen atoms; C₁-C₈-alkylsulfanyl; C₁-C₈-halogenoalkylsulfanyl having 1to 5 halogen atoms; C₂-C₈-alkenyloxy; C₂-C₈-halogenoalkenyloxy having 1to 5 halogen atoms; C₃-C₈-alkynyloxy; C₃-C₈-halogenoalkynyloxy having 1to 5 halogen atoms; C₁-C₈-alkylcarbonyl; C₁-C₈-halogenoalkylcarbonylhaving 1 to 5 halogen atoms; C₁-C₈-alkylcarbamoyl;di-C₁-C₈-alkylcarbamoyl; N—C₁-C₈-alkyloxycarbamoyl;C₁-C₈-alkoxycarbamoyl; N—C₁-C₈-alkyl-C₁-C₈-alkoxycarbamoyl;C₁-C₈-alkoxycarbonyl; C₁-C₈-halogenoalkoxycarbonyl having 1 to 5 halogenatoms; C₁-C₈-alkylcarbonyloxy; C₁-C₈-halogenoalkylcarbonyloxy having 1to 5 halogen atoms; C₁-C₈-alkylcarbonylamino;C₁-C₈-halogenoalkylcarbonylamino having 1 to 5 halogen atoms;C₁-C₈-alkylaminocarbonyloxy; di-C₁-C₈-alkylaminocarbonyloxy;C₁-C₈-alkyloxycarbonyloxy; C₁-C₈-alkylsulfanyl;C₁-C₈-halogenoalkylsulfanyl having 1 to 5 halogen atoms;C₁-C₈-alkylsulfinyl; C₁-C₈-halogenoalkylsulfinyl having 1 to 5 halogenatoms; C₁-C₈-alkylsulfonyl; C₁-C₈-halogenoalkylsulfonyl having 1 to 5halogen atoms; C₁-C₈-alkylaminosulfamoyl; di-C₁-C₈-alkylaminosulfamoyl;(C₁-C₈-alkoxyimino)-C₁-C₆-alkyl; (C₁-C₆-alkenyloxyimino)-C₁-C₈-alkyl;(C₁-C₈-alkynyloxyimino)-C₁-C₈-alkyl; 2-oxopyrrolidin-1-yl;(benzyloxyimino)-C₁-C₈-alkyl; C₁-C₈-alkoxyalkyl;C₁-C₈-halogenoalkoxyalkyl having 1 to 5 halogen atoms; benzyloxy;benzylsulfanyl; benzylamino; aryloxy; arylsulfanyl or arylamino.

According to the invention, the following generic terms are generallyused with the following meanings:

-   -   halogen means fluorine, chlorine, bromine or iodine,    -   carboxy means —C(═O)OH;    -   carbonyl means —C(O)—;    -   carbamoyl means —C(═O)NH₂;    -   N-hydroxycarbamoyl means —C(═O)NHOH;    -   SO represents a sulfoxide group;    -   SO₂ represents a sulfone group;    -   heteroatom means sulfur, nitrogen or oxygen;    -   methylene means the diradical —CH₂—;    -   an alkyl group, an alkenyl group and an alkynyl group as well as        moieties containing these terms, can be linear or branched;    -   halogenated groups, notably haloalkyl, haloalkoxy and cycloalkyl        groups, can comprise up to nine identical or different halogen        atoms;    -   the term “aryl” means phenyl or naphthyl;    -   the term “heteroaryl” means a saturated, partially saturated or        unsaturated, monocyclic or fused bicyclic 3-, 4-, 5-, 6-, 7-,        8-, 9-, 10-membered ring comprising from 1 up to 4 heteroatoms        selected in the list consisting of N, O and S.    -   In the case of an amino group or the amino moiety of any other        amino-containing group, substituted by two substituents that can        be the same or different, the two substituents together with the        nitrogen atom to which they are linked can form a heterocyclyl        group, preferably a 5- to 7-membered heterocyclyl group, that        can be substituted or that can include other hetero atoms, for        example a morpholino group or piperidinyl group.    -   Where a compound of the invention can be present in tautomeric        form, such a compound is understood hereinabove and hereinbelow        also to include, where applicable, corresponding tautomeric        forms, even when these are not specifically mentioned in each        case.

Any of the compounds of the present invention can exist in one or moreoptical or chiral isomer forms depending on the number of asymmetriccentres in the compound. The invention thus relates equally to all theoptical isomers and to their racemic or scalemic mixtures (the term“scalemic” denotes a mixture of enantiomers in different proportions)and to the mixtures of all the possible stereoisomers, in allproportions. The diastereoisomers and/or the optical isomers can beseparated according to the methods which are known per se by the manordinary skilled in the art.

Any of the compounds of the present invention can also exist in one ormore geometric isomer forms depending on the number of double bonds inthe compound. The invention thus relates equally to all geometricisomers and to all possible mixtures, in all proportions. The geometricisomers can be separated according to general methods, which are knownper se by the man ordinary skilled in the art.

Any of the compounds of the present invention can also exist in one ormore geometric isomer forms depending on the relative position (syn/antior cis/trans or endo/exo) of the substituents of the chain or ring. Theinvention thus relates equally to all syn/anti (or cis/trans orendo/exo) isomers and to all possible syn/anti (or cis/trans orendo/exo) mixtures, in all proportions. The syn/anti (or cis/trans orendo/exo) isomers can be separated according to general methods, whichare known per se by the man ordinary skilled in the art.

Preferred compounds of formula (I) according to the invention are thosewherein X¹ represents a fluorine atom.

Other preferred compounds of formula (I) according to the invention arethose wherein X² represents a fluorine atom.

Other preferred compounds according to the invention are compounds offormula (I) wherein T represents O.

Other preferred compounds according to the invention are compounds offormula (I) wherein Z¹ represents a substituted or non-substitutedcyclopropyl.

Other more preferred compounds according to the invention are compoundsof formula (I) wherein Z¹ represents a non-substituted cyclopropyl or aC₁-C₅-alkylcyclopropyl.

Other even more preferred compounds according to the invention arecompounds of formula (I) wherein Z¹ represents a non-substitutedcyclopropyl.

Other even more preferred compounds according to the invention arecompounds of formula (I) wherein Z¹ represents a methylcyclopropyl.

Other preferred compounds according to the invention are compounds offormula (I) wherein Z² and Z³ independently represent a hydrogen atom ora methyl.

Other more preferred compounds according to the invention are compoundsof formula (I) wherein Z² represents a hydrogen atom and Z³ represents ahydrogen atom or a methyl.

Other preferred compounds according to the invention are compounds offormula (I) wherein n represents 0, 1 or 2.

Other preferred compounds according to the invention are compounds offormula (I) wherein m represents 0, 1, 2, 3 or 4, even preferred 0, 1 or2.

Other preferred compounds according to the invention are compounds offormula (I) wherein p represents 1, 3 or 4.

Other more preferred compounds according to the invention are compoundsof formula (I) wherein p represents 1.

Other preferred compounds according to the invention are compounds offormula (I) wherein Z⁴ represents a halogen, substituted ornon-substituted C₁-C₄-alkyl, C₁-C₄-halogenoalkyl having 1 to 3 halogenatoms, substituted or non-substituted C₁-C₄-alkyloxy, substituted ornon-substituted cyclopropyl, substituted or non-substitutedC₂-C₄-alkenyl or substituted or non-substituted C₂-C₄-alkynyl.

Other more preferred compounds according to the invention are compoundsof formula (I) wherein Z⁴ represents chloro, methyl, ethyl, propyl,isopropyl, isobutyl, cyclopropyl, methoxy, methoxymethyl,difluoromethyl, trifluoromethyl or ethynyl.

Other preferred compounds according to the invention are compounds offormula (I) wherein W independently, represents a halogen atom;substituted or non-substituted C₁-C₈-alkyl; C₁-C₈-halogenoalkylcomprising up to 9 halogen atoms which can be the same or different;substituted or non-substituted C₂-C₈-alkenyl; substituted ornon-substituted C₅-C₇-cycloalkenyl; substituted or non-substitutedC₃-C₇-cycloalkyl; tri(C₁-C₈-alkyl)silyl; substituted or non-substitutedC₁-C₈-alkoxy; substituted or non-substituted C₁-C₈-alkylsulfanyl;substituted or non-substituted phenyl; substituted or non-substitutedthienyl or substituted or non-substituted furyl.

Other preferred compounds according to the invention are compounds offormula (I) wherein Y independently, represents a halogen or asubstituted or non-substituted C₁-C₈-alkyl.

The above mentioned preferences with regard to the substituents of thecompounds according to the invention can be combined in various manners.These combinations of preferred features thus provide sub-classes ofcompounds according to the invention. Examples of such sub-classes ofpreferred compounds according to the invention are:

-   -   preferred features of X¹ with preferred features of X², Z¹ to        Z⁴, n, m, p, W and Y;    -   preferred features of X² with preferred features of X¹, Z¹ to        Z⁴, n, m, p, W and Y;    -   preferred features of T with preferred features of X¹, X², Z¹ to        Z⁴, n, m, p, W and Y;    -   preferred features of Z¹ with preferred features of X¹, X², T,        Z² to Z⁴, n, m, p, W and Y;    -   preferred features of Z² with preferred features of X¹, X², T,        Z¹, Z³ to Z⁴, n, m, p, W and Y;    -   preferred features of Z³ with preferred features of X¹, X², T,        Z¹ to Z², Z⁴, n, m, p, W and Y;    -   preferred features of Z⁴ with preferred features of X¹, X², T,        Z¹ to Z³, n, m, p, W and Y;    -   preferred features of n with preferred features of X¹, X², T, Z¹        to n, m, p, W and Y;    -   preferred features of m with preferred features of X¹, X², T, Z¹        to Z⁴, n, p, W and Y;    -   preferred features of p with preferred features of X¹, X², T, Z¹        to Z⁴, n, m, W and Y;    -   preferred features of W with preferred features of X¹, X², T, Z¹        to Z⁴, n, m, p and Y;    -   preferred features of Y with preferred features of X¹, X², T, Z¹        to Z⁴, n, m, p and W.

In these combinations of preferred features of the substituents of thecompounds according to the invention, the said preferred features canalso be selected among the more preferred features of each of X¹, X², T,Z¹ to Z⁴, n, m, p, W and Y so as to form most preferred subclasses ofcompounds according to the invention.

The present invention also relates to a process for the preparation ofthe compound of formula (I).

Thus, according to a further aspect of the present invention there isprovided a process P1 for the preparation of a compound of formula (I)as herein-defined and wherein T represents O and that comprises reactionof an amine of formula (II) or one of its salts:

wherein Z¹, Z², Z³, Z⁴, n, m, p, W and Y are as herein-defined; with acarboxylic acid derivative of formula (III):

wherein X¹ and X² are as herein-defined and U¹ represents a leavinggroup selected in the list consisting of a halogen atom, a hydroxylgroup, —OR^(a), —OC(═O)R^(a), R^(a) being a substituted ornon-substituted C₁-C₆-alkyl, a substituted or non-substitutedC₁-C₆-haloalkyl, a benzyl, 4-methoxybenzyl or pentafluorophenyl group;in the presence, if necessary, of a catalyst and in the presence of acondensing agent in case U¹ represents a hydroxyl group, and in thepresence of an acid binder in case U¹ represents a halogen atom.N-substituted amine derivatives of formula (II) are known or can beprepared by known processes such as reductive amination of aldehydes offormula (IV):

wherein Z⁴, n, m, p, W and Y are as herein-defined, or ketones(Bioorganics and Medicinal Chemistry Letters (2006), 16, 2014), orreduction of imines (Tetrahedron (2005), 61, 11689), or nucleophilicsubstitution of a halogen of halogenobenzylic derivatives of formula(V):

wherein U² is a halogen, preferentially chloro, bromo and iodo, and Z⁴,n, m, p, W and Y are as herein-defined, or substitution of a mesylate ortosylate (Journal of Medicinal Chemistry (2002), 45, 3887).

Carboxylic acid derivatives of formula (III) can be prepared accordingto WO-2010/130767.

In case U¹ represents a hydroxy group, process P1 according to thepresent invention is conducted in the presence of condensing agent.Suitable condensing agent may be selected in the non limited listconsisting of acid halide former, such as phosgene, phosphoroustribromide, phosphorous trichloride, phosphorous pentachloride,phosphorous trichloride oxide or thionyl chloride; anhydride former,such as ethyl chloroformate, methyl chloroformate, isopropylchloroformate, isobutyl chloroformate or methanesulfonyl chloride;carbodiimides, such as N,N′-dicyclohexylcarbodiimide (DCC) or othercustomary condensing agents, such as phosphorous pentoxide,polyphosphoric acid, N,N′-carbonyl-diimidazole,2-ethoxy-N-ethoxycarbonyl-1,2-dihydroquinoline (EEDQ),triphenylphosphine/tetrachloro-methane,4-(4,6-dimethoxy[1.3.5]-triazin-2-yl)-4-methylmorpholinium chloridehydrate, bromo-tripyrrolidinophosphoniumhexafluorophosphate orpropanephosphonic anhydride (T3P).

Process P1 according to the present invention may be conducted in thepresence of a catalyst. Suitable catalyst may be selected in the listconsisting of N,N-dimethylpyridin-4-amine, 1-hydroxy-benzotriazole orN,N-dimethylformamide.

In case U¹ represents a halogen atom, process P1 according to thepresent invention is conducted in the presence of an acid binder.Suitable acid binders for carrying out process P1 according to theinvention are in each case all inorganic and organic bases that arecustomary for such reactions. Preference is given to using alkalineearth metal, alkali metal hydride, alkali metal hydroxides or alkalimetal alkoxides, such as sodium hydroxide, sodium hydride, calciumhydroxide, potassium hydroxide, potassium tert-butoxide or otherammonium hydroxide, alkali metal carbonates, such as caesium carbonate,sodium carbonate, potassium carbonate, potassium bicarbonate, sodiumbicarbonate, alkali metal or alkaline earth metal acetates, such assodium acetate, potassium acetate, calcium acetate and also tertiaryamines, such as trimethylamine, triethylamine, diisopropylethylamine,tributylamine, N,N-dimethylaniline, pyridine, N-methylpiperidine,N,N-dimethylpyridin-4-amine, diazabicyclooctane (DABCO),diazabicyclo-nonene (DBN) or diazabicycloundecene (DBU).

It is also possible to work in the absence of an additional condensingagent or to employ an excess of the amine component, so that itsimultaneously acts as acid binder agent.

Suitable solvents for carrying out process P1 according to the inventioncan be customary inert organic solvents. Preference is given to usingoptionally halogenated aliphatic, alicyclic or aromatic hydrocarbons,such as petroleum ether, hexane, heptane, cyclohexane,methylcyclohexane, benzene, toluene, xylene or decalin; chlorobenzene,dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride,dichlorethane or trichlorethane; ethers, such as diethyl ether,diisopropyl ether, methyl t-butyl ether, methyl t-amyl ether, dioxane,tetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane or anisole;nitriles, such as acetonitrile, propionitrile, n- or i-butyronitrile orbenzonitrile; amides, such as N,N-dimethylformamide,N,N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone, orhexamethylphosphoric triamide; alcohols such as methanol, ethanol,propanol, iso-propanol; esters, such as methyl acetate or ethyl acetate,sulfoxides, such as dimethyl sulfoxide, or sulfones, such as sulfolane.

When carrying out process P1 according to the invention, the aminederivative of formula (II) can be employed as its salt, such aschlorhydrate or any other convenient salt.

When carrying out process P1 according to the invention, 1 mole or anexcess of the amine derivative of formula (II) and from 1 to 3 moles ofthe acid binder can be employed per mole of the reagent of formula(III).

It is also possible to employ the reaction components in other ratios.Work-up is carried out by known methods.

According to a further aspect according to the invention, there isprovided a second process P2 for the preparation of a compound offormula (I) wherein T represents S, starting from a compound of formula(I) wherein T represents O and illustrated according to the followingreaction scheme:

wherein X¹, X², Z¹, Z², Z³, Z⁴, n, m, p, W and Y are as herein-defined.

Process P2 according to the invention is performed in the presence of athionating agent.

Starting amide derivatives of formula (I) wherein T represents O can beprepared according to process P1.

Suitable thionating agents for carrying out process P2 according to theinvention can be sulfur (S), sulfhydric acid (H₂S), sodium sulfide(Na₂S), sodium hydrosulfide (NaHS), boron trisulfide (B₂S₃),bis(diethylaluminium) sulfide ((AlEt₂)₂S), ammonium sulfide ((NH₄)₂S),phosphorous pentasulfide (P₂S₅), Lawesson's reagent(2,4-bis(4-methoxyphenyl)-1,2,3,4-dithiadiphosphetane 2,4-disulfide) ora polymer-supported thionating reagent such as described in Journal ofthe Chemical Society, Perkin 1 (2001), 358, in the optionally presenceof a catalytic or stoichiometric or excess amount, quantity of a basesuch as an inorganic and organic base. Preference is given to usingalkali metal carbonates, such as sodium carbonate, potassium carbonate,potassium bicarbonate, sodium bicarbonate; heterocyclic aromatic bases,such as pyridine, picoline, lutidine, collidine; and also tertiaryamines, such as trimethylamine, triethylamine, tributylamine,N,N-dimethylaniline, N,N-dimethylpyridin-4-amine or N-methyl-piperidine.

Suitable solvents for carrying out process P2 according to the inventioncan be customary inert organic solvents. Preference is given to usingoptionally halogenated aliphatic, alicyclic or aromatic hydrocarbons,such as petroleum ether, hexane, heptane, cyclohexane,methylcyclohexane, benzene, toluene, xylene or decalin, chlorobenzene,dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride,dichlorethane or trichlorethane, ethers, such as diethyl ether,diisopropyl ether, methyl t-butyl ether, methyl t-amyl ether, dioxane,tetrahydrofuran, 1,2-dimethoxyethane or 1,2-diethoxyethane, nitriles,such as acetonitrile, propionitrile, n- or i-butyronitrile orbenzonitrile, sulfurous solvents, such as sulfolane or carbon disulfide.

When carrying out process P2 according to the invention, 1 mole or anexcess of the sulfur equivalent of the thionating agent and from 1 to 3moles of the base can be employed per mole of the amide reactant (I).

It is also possible to employ the reaction components in other ratios.Work-up is carried out by known methods.

When carrying out processes P1 and P2 according to the invention, thereaction temperatures can be varied within a relatively wide range. Ingeneral, these processes are carried out at temperatures from 0° C. to200° C., preferably from 10° C. to 150° C. A way to control thetemperature for the processes according to the invention is to usemicrowave technology.

The present invention also relates to a process for the preparation ofthe compound of formula IV (Process P3).

wherein U³ is defined as bromo or iodo, and Z⁴, n, m, p, X and Y are asherein-defined.

A compound of the general formula (IV) is obtained from a compound ofthe general formula (VI) by a formylation reaction, such as a reactionsequence of halogen-metal exchange with an organolithium or anorganomagnesium reagent, followed by subsequent addition of anelectrophile (e.g. N,N-dimethylformamide (DMF)); see, for example,Journal of the American Chemical Society, (2008), 130(26), 8481-8490.Alternatively, magnesium can be used to form a Grignard reagent from(VI), which can then be treated with an appropriate electrophile such asDMF to form a compound of the general formula (IV) (see for example:Chemistry Letters, (2007), 36(1), 72-73).

Process P3 is performed in the presence of a suitable organometalliccompound or magnesium. Preferred organometallic compounds areorganolithium compounds (for example butyllithium) or organomagnesiumcompounds (for example, iso-propylmegnesium chloride or bromide).

Process P3 is preferably performed using one or more diluents. Usefulsolvents in the performance of process P3 are preferably aproticsolvents (for example dioxane, glyme, alkanes, cycloalkanes, diethylether or tetrahydrofuran). Particular preference is given to diethylether or tetrahydropyran.

In the performance of process P3, the reaction temperatures can bevaried within a relatively wide range. In the case of the halogen-metalexchange reactions, the temperatures employed are generally from −120°C. to 150° C., preferably temperatures from −120° C. to 60° C., mostpreferably −120° C. to 70 t. After the addition of an electrophile suchas DMF, preference is given to working at −80° C. to 50° C.

To perform process P3, generally 1 to 2 mol, preferably 1 mol, of theorganometallic compound and of the electrophile are used per mole ofcompound of the formula (VI).

The present invention also relates to processes for the preparation ofthe compound of formula V (Process P4).

s wherein U² is defined as a halogen, preferentially chloro, bromo oriodo, and Z⁴, n, m, p, X and Y are as herein-defined.

A compound of the general formula (V) is obtained from a compound of thegeneral formula (VII) by a radical halogenation of the methyl group;see, for example, WO2008/016239, WO2013/051632.

Process P4 is performed in the presence of a suitable halogenatingreagent (for example, n-chlorosuccinimide, n-bromosuccinimide, chlorine,bromine, iodine), and with a catalytic amount of a radical initiatorsuch as 2,2′-Azobis(2-methylpropionitrile) (AIBN).

Process P3 is preferably performed using one or more diluents. Usefulsolvents in the performance of process P3 are preferably inert solventsunder radical halogenation conditions (for example carbontetrachloride). Particular preference is given to carbon tetrachloride.

In the performance of process P4, the reaction temperatures can bevaried within a relatively wide range. In the case of the halogen-metalexchange reactions, the temperatures employed are generally from −120°C. to 200° C., preferably temperatures from −80° C. to 150° C.

To perform process P4, 1 to 2 mol, preferably 1 mol, of a halogenatingreagent are generally used per mole of compound of the formula (VII).

The present invention also relates to processes for the preparation ofthe compound of formula VI and VII (Process P5).

wherein U⁴ is defined as methyl, chloro, bromo or iodo, and Z⁴, n, m, p,X and Y.

A compound of the general formula (VI) or (VII) is obtained from acompound of the general formula (VIII), where Z⁴ is an electronwithdrawing group (for example, nitrile, carboxylic acid ester), by acyclization reaction with a substituted or non-substituted alkyl chainwhich bears an appropriate leaving group, for example, chloro, bromo,iodo, mesylate, tosylate or triflate, on each terminal carbon (forexample, 1,2-dibromoethane), in the presence of a suitable base, forexample, mineral carbonates, such as potassium, sodium or caesiumcarbonate; metal hydroxides such as sodium or potassium hydroxide;alkoxides, such as potassium or sodium tert-butoxide; metal hydrides,such as sodium hydride; amides, such as lithium diisopropylamide; seefor example, Organic & Biomolecular Chemistry, (2012), 10(31),6404-6409; WO2011/041694. Process P5 can also be performed in thepresence of an additive such as tetra-n-butylammonium bromide orN,N′-Dimethyl-N,N′-trimethyleneurea (DMPU).

To perform process P5, generally a stoichiometric or an excess amount ofthe substituted or non-substituted alkyl chain which bears anappropriate leaving group on each terminal carbon is used per mole ofcompound of the formula (VIII).

The solvents used may be all customary solvents which are inert underthe reaction conditions, or the reaction can be performed in mixtures oftwo or more of these solvents.

In the performance of process P5, the reaction temperatures can bevaried within a relatively wide range.

In general, the temperatures employed are from −10° C. to 150° C.,preferably temperatures from 0° C. to 100° C.

The present invention also relates to processes for the preparation ofthe compound of formula VI and VII (Process P6).

wherein U⁴ is defined as methyl, chloro, bromo or iodo, U⁵ is defined ashydrogen or Y, p is 1, and Z⁴, n, m, X and Y are as herein-defined.

A compound of the general formula (VI) or (VII) is obtained from acompound of the general formula (IX) by a cyclopropanation; see, forexample, Simmons-Smith reaction: WO2012/165648; cyclopropanation with afree carbene: Chemical Reviews, (2003), 103(4): 1099-1132;cyclopropanation with a metal carbinoid: Chemical Reviews, (1987),87(2): 411-432. The akenes (IX) are commercially available or can beprepared from commercially available precursors by methods described inthe literature (for example from ketones by a Wittig orHorner-Wadsworth-Emmons olefination: Chemical Reviews, (1989), 89,863-927 and Julia olefination: Tetrahedron Letters, (1973), 14,4833-4836; Peterson olefination: Journal of Organic Chemistry, (1968),33, 780; or trapping of an electrophile by an enolate or an enol as inWO1991/11445).

The solvents used may be all customary solvents which are inert underthe reaction conditions, or the reaction can be performed in mixtures oftwo or more of these solvents.

In the performance of process P6, the reaction temperatures can bevaried within a relatively wide range. In general, the temperaturesemployed are from −120° C. to 150° C., preferably temperatures from 80°C. to 100° C.

It is recognized that at any appropriate stage of synthesis, thesubstituent Z⁴ can be converted from one substituent definition toanother as specified above, in one or more steps, by synthetic methodscommonly used by the person skilled in the art of chemical synthesis,for example, from a nitrile to a corresponding carboxylic acid byhydrolysis or to an aldehyde by reduction; from a carboxylic acid to ahydroxyalkyl by reduction, or to a halogen by decarboxylativehalogenation; from an aldehyde to a corresponding alkene or alkyne by aWittig olefination or a Seyferth-Gilbert homologation.

Furthermore, it is also recognized that some reagents and reactionconditions described above for preparation of compounds of the formula(I) may not be compatible with particular functionalities present in theintermediate compounds. In these cases, the introduction ofprotection/deprotection sequences or of mutual conversions of functionalgroups into the synthesis helps to obtain the desired products. The useand selection of the protecting groups is obvious to the person skilledin the art of chemical synthesis (see, for example, “Protective Groupsin Organic Synthesis”; Third Edition; 494-653, and literature citedtherein). The person skilled in the art will recognize that, in somecases, after the introduction of a given reagent as shown in anindividual scheme, it may be necessary to perform additional routinesynthesis steps not described individually in order to complete thesynthesis of compounds of the formula (I). The person skilled in the artwill likewise recognize that it may be necessary to perform acombination of the steps illustrated in the above schemes in a sequenceother than the implied sequence shown specifically, in order to preparethe compounds of the formula (I).

Processes P1 and P6 according to the invention are generally carried outunder atmospheric pressure. It is also possible to operate underelevated or reduced pressure.

In general, the reaction mixture is concentrated under reduced pressure.The residue that remains can be freed by known methods, such aschromatography or crystallization, from any impurities that can still bepresent.

Work-up is carried out by customary methods. Generally, the reactionmixture is treated with water and the organic phase is separated offand, after drying, concentrated under reduced pressure. If appropriate,the remaining residue can, be freed by customary methods, such aschromatography, crystallization or distillation, from any impuritiesthat may still be present.

The compound according to the present invention can be preparedaccording to the general processes of preparation described above. Itwill nevertheless be understood that, on the basis of his generalknowledge and of available publications, the skilled worker will be ableto adapt this method according to the specifics of each of thecompounds, which it is desired to synthesize.

The present invention thus provides compounds of formula (II) as well astheir acceptable salts:

wherein Z¹, Z², Z³, Z⁴, n, m, p, W and Y are as herein-defined.

Preferred compounds of formula (II) according to the invention are:

-   N-[2-(1-methylcyclopropyl)benzyl]cyclopropanamnine-   N-[3-fluoro-2-(1-methylcyclopropyl)benzyl]cyclopropanamine-   N-{[4-(1-methylcyclopropyl)-1,3-benzodioxol-5-yl]methyl}cyclopropanamine-   N-[4-chloro-2-(1-methylcyclopropyl)benzyl]cyclopropanamine-   N-[4-methyl-2-(1-methylcyclopropyl)benzyl]cyclopropanamine-   N-[4,5-dimethyl-2-(1-methylcyclopropyl)benzyl]cyclopropanamine-   N-[4,5-dichloro-2-(1-methylcyclopropyl)benzyl]cyclopropanamine-   N-[4,5-dimethoxy-2-(1-methylcyclopropyl)benzyl]cyclopropanamine-   N-[5-bromo-2-(1-methylcyclopropyl)benzyl]cyclopropanamnine-   N-[5-chloro-2-(1-methylcyclopropyl)benzyl]cyclopropanamine-   N-[5-fluoro-2-(1-methylcyclopropyl)benzyl]cyclopropanamine-   N-[5-methyl-2-(1-methylcyclopropyl)benzyl]cyclopropanamine-   1-methyl-N-[5-methyl-2-(1-methylcyclopropyl)benzyl]cyclopropanamine-   1-{[5-methyl-2-(1-methylcyclopropyl)benzyl]amino}cyclopropanecarbonitrile-   N-[3-chloro-2-(1-methylcyclopropyl)benzyl]cyclopropanamine-   N-[5-chloro-2-(1-ethynylcyclopropyl)benzyl]cyclopropanamine-   N-[2-(1-ethynylcyclopropyl)-5-methybenzyl]cyclopropanamnine-   N-(5-chloro-2-{1-[(trimethylsilyl)ethynyl]cyclopropyl}benzyl)cyclopropanamine-   N-(5-methyl-2-{1-[(trimethylsilyl)ethynyl]cyclopropyl}benzyl)cyclopropanamine-   1-{4-chloro-2-[(cyclopropylamino)methyl]phenyl}cyclopropanecarbonitrile-   1-{2-[(cyclopropylamino)methyl]-4-methylphenyl}cyclopropanecarbonitrile-   N-{2-[1-(methoxymethyl)cyclopropyl]-5-methylbenzyl}cyclopropanamine-   N-[2-(1-ethylcyclopropyl)benzyl]cyclopropanamine-   N-[2-(1-ethylcyclopropyl)-4-(trifluoromethyl)benzyl]cyclopropanamine-   N-[4-chloro-2-(1-ethylcyclopropyl)benzyl]cyclopropanamine-   N-[2-(1-ethylcyclopropyl)-4-methylbenzyl]cyclopropanamine-   N-[2-(1-ethylcyclopropyl)-5-fluoro-4-methylbenzyl]cyclopropanamine-   N-[2-(1-ethylcyclopropyl)-5-(trifluoromethyl)benzyl]cyclopropanamine-   N-[5-chloro-2-(1-ethylcyclopropyl)benzyl]cyclopropanamine-   N-[2-(1-ethylcyclopropyl)-5-methylbenzyl]cyclopropanamine-   N-[2-(1-ethylcyclopropyl)-6-fluorobenzyl]cyclopropanamine-   N-[4-chloro-2-(1-propylcyclopropyl)benzyl]cyclopropanamine-   N-[5-methyl-2-(1-propylcyclopropyl)benzyl]cyclopropanamine-   N-[2-(1-chlorocyclopropyl)-5-methylbenzyl]cyclopropanamine-   N-{2-[1,1′-bi(cyclopropyl)-1-yl]-5-methylbenzyl}cyclopropanamnine-   N-{2-[1-(difluoromethyl)cyclopropyl]benzyl}cyclopropanamine-   N-{5-bromo-2-[1-(difluoromethyl)cyclopropyl]benzyl}cyclopropanamine-   N-{5-chloro-2-[1-(difluoromethyl)cyclopropyl]benzyl}cyclopropanamine-   N-{2-[1-(difluoromethyl)cyclopropyl]-5-fluorobenzyl}cyclopropanamine-   N-{2-[1-(difluoromethyl)cyclopropyl]-5-methylbenzyl}cyclopropanamine-   N-{2-bromo-6-[1-(difluoromethyl)cyclopropyl]benzyl}cyclopropanamine-   N-[4-chloro-2-(1-isobutylcyclopropyl)benzyl]cyclopropanamine-   N-[2-(1-isobutylcyclopropyl)-5-methylbenzyl]cyclopropanamine-   N-{5-chloro-2-[1-(trifluoromethyl)cyclopropyl]benzyl}cyclopropanamine-   N-{2-[1-(trifluoromethyl)cyclopropyl]benzyl}cyclopropanamine-   N-{5-fluoro-2-[1-(trifluoromethyl)cyclopropyl]benzyl}cyclopropanamine,    as well as their acceptable salts.

Other interesting compounds of formula (II) according to the inventionare:

-   N-[2-(1-methoxycyclopropyl)benzyl]cyclopropanamnine-   N-[5-chloro-2-(1-methoxycyclopropyl)benzyl]cyclopropanamine-   N-[2-(1-methoxycyclopropyl)-5-methylbenzyl]cyclopropanamine-   N-[2-fluoro-3-methyl-6-(1-methylcyclopropyl)benzyl]cyclopropanamine-   N-(2′,3′-dihydrospiro[cyclopropane-1,1′-inden]-7′-ylmethyl)cyclopropanamine-   N-[(2,2-dichloro-3′,4′-dihydro-2′H-spiro[cyclopropane-1,1′-naphthalen]-8′-yl)methyl]cyclopropanamine-   N-(3′,4′-dihydro-2′H-spiro[cyclopropane-1,1′-naphthalen]-8′-ylmethyl)cyclopropanamine-   N-[(2,2-dichloro-2′,3′-dihydrospiro[cyclopropane-1,1′-inden]-7′-yl)methyl]cyclopropanamine-   N-[(6′-methyl-3′,4′-dihydro-2′H-spiro[cyclopropane-1,1′-naphthalen]-8′-yl)methyl]cyclopropanamine,    as well as their acceptable salts.

The present invention thus also provides compounds of formula (IV):

wherein Z⁴, n, m, p, W and Y are as herein-defined, providing that (IV)does not represent:

-   2-(1-methoxycycloheptyl)-5-(trifluoromethyl)benzaldehyde-   methyl (1 S,2S)-2-ethoxy-2-(2-formylphenyl)cyclopropanecarboxylate,    and-   methyl (1 S,2R)-2-ethoxy-2-(2-formylphenyl)cyclopropanecarboxylate.

Preferred compounds of formula (IV) according to the invention are:

-   2-(1-methylcyclopropyl)benzaldehyde-   4-chloro-2-(1-methylcyclopropyl)benzaldehyde-   4-fluoro-2-(1-methylcyclopropyl)benzaldehyde-   4-methyl-2-(1-methylcyclopropyl)benzaldehyde-   4-methoxy-2-(1-methylcyclopropyl)benzaldehyde-   4,5-difluoro-2-(1-methylcyclopropyl)benzaldehyde-   4,5-dimethyl-2-(1-methylcyclopropyl)benzaldehyde-   4,5-dimethoxy-2-(1-methylcyclopropyl)benzaldehyde-   4-methyl-2,5-bis(1-methylcyclopropyl)benzaldehyde-   5-chloro-2-(1-methylcyclopropyl)benzaldehyde-   5-fluoro-2-(1-methylcyclopropyl)benzaldehyde-   5-methyl-2-(1-methylcyclopropyl)benzaldehyde-   2,5-bis(1-methylcyclopropyl)benzaldehyde-   3-fluoro-2-(1-methylcyclopropyl)benzaldehyde-   1-(4-chloro-2-formylphenyl)cyclopropanecarbonitrile-   1-(2-formyl-4-methylphenyl)cyclopropanecarbonitrile-   2-(1-ethylcyclopropyl)-4-(trifluoromethyl)benzaldehyde-   2-(1-ethylcyclopropyl)-5-methylbenzaldehyde-   4-chloro-2-(1-propylcyclopropyl)benzaldehyde-   5-chloro-2-[1-(difluoromethyl)cyclopropyl]benzaldehyde-   2-[1-(difluoromethyl)cyclopropyl]-5-methylbenzaldehyde-   4-chloro-2-(1-isobutylcyclopropyl)benzaldehyde-   2-(1-isobutylcyclopropyl)-5-methylbenzaldehyde-   1-(4-chloro-2-formylphenyl)cyclopropanecarboxylic acid, and-   methyl 1-(4-chloro-2-formylphenyl)cyclopropanecarboxylate.

Other interesting compounds of formula (IV) according to the inventionare:

-   2-(1-ethylcyclopropyl)-4-methylbenzaldehyde-   2-(1-ethylcyclopropyl)-6-fluorobenzaldehyde-   4-chloro-2-(1-ethylcyclopropyl)benzaldehyde-   5-methyl-2-(1-propylcyclopropyl)benzaldehyde-   2-(1-ethylcyclopropyl)-5-(trifluoromethyl)benzaldehyde-   2-(1-ethylcyclopropyl)-5-fluoro-4-methylbenzaldehyde-   5-chloro-2-(1-ethylcyclopropyl)benzaldehyde-   2-[1,1′-bi(cyclopropyl)-1-yl]-5-methylbenzaldehyde-   5-bromo-2-(1-methylcyclopropyl)benzaldehyde, and-   5-bromo-4-methyl-2-(1-methylcyclopropyl)benzaldehyde.

The present invention thus also provides compounds of formula (V):

wherein U² is a halogen and Z⁴, n, m, p, W and Y are as herein-defined,providing that compound (V) does not represent:

-   1-[2-(bromomethyl)-3-chlorophenyl]cyclobutanol-   1-[2-(bromomethyl)phenyl]cyclopropanecarbonitrile-   1-[2-(bromomethyl)-4-(trifluoromethyl)phenyl]cycloheptyl methyl    ether-   2-(bromomethyl)-1-(1-methoxycyclopentyl)-4-(trifluoromethyl)benzene-   2-(bromomethyl)-1-(1-methoxycyclohexyl)-4-(trifluoromethyl)benzene,    and-   1-[2-(bromomethyl)phenyl]cyclopentanecarbonitrile.

The following compound of formula (V) wherein U² is a halogen and Z⁴, n,m, p, W and Y are as herein-defined, is also mentioned in chemicaldatabases and/or suppliers' databases but without any references orinformation which enables it to be prepared and separated:

-   1-[2-(chloromethyl)-4,5-dimethoxyphenyl]cyclopentanecarbonitrile.

Preferred compounds of formula (V) according to the invention are:

-   1-(bromomethyl)-3-chloro-2-(1-methylcyclopropyl)benzene.

Other interesting compounds of formula (V) according to the inventionare:

-   1-(bromomethyl)-2-[1-(trifluoromethyl)cyclopropyl]benzene-   2-(bromomethyl)-4-chloro-1-[1-(trifluoromethyl)cyclopropyl]benzene-   2-(bromomethyl)-4-fluoro-1-[1-(trifluoromethyl)cyclopropyl]benzene-   1-(bromomethyl)-2-[1-(difluoromethyl)cyclopropyl]-4-fluorobenzene-   2-(bromomethyl)-1-[1-(difluoromethyl)cyclopropyl]-4-fluorobenzene-   1-(bromomethyl)-2-[1-(difluoromethyl)cyclopropyl]benzene-   2-(bromomethyl)-4-chloro-1-[1-(difluoromethyl)cyclopropyl]benzene-   1-bromo-2-(bromomethyl)-3-[1-(difluoromethyl)cyclopropyl]benzene,    and-   4-bromo-2-(bromomethyl)-1-[1-(difluoromethyl)cyclopropyl]benzene.

In a further aspect, the present invention also relates to a fungicidecomposition comprising an effective and non-phytotoxic amount of anactive compound of formula (I).

The expression “effective and non-phytotoxic amount” means an amount ofcomposition according to the invention that is sufficient to control ordestroy the fungi present or liable to appear on the cropland, that doesnot entail any appreciable symptom of phytotoxicity for the said crops.Such an amount can vary within a wide range depending on the fungus tobe controlled, the type of crop, the climatic conditions and thecompounds included in the fungicide composition according to theinvention. This amount can be determined by systematic field trials thatare within the capabilities of a person skilled in the art.

Thus, according to the invention, there is provided a fungicidecomposition comprising, as an active ingredient, an effective amount ofa compound of formula (I) as herein defined and an agriculturallyacceptable support, carrier or filler.

According to the invention, the term “support” denotes a natural orsynthetic, organic or inorganic compound with that the active compoundof formula (I) is combined or associated to make it easier to apply,notably to the parts of the plant. This support is thus generally inertand should be agriculturally acceptable. The support can be a solid or aliquid. Examples of suitable supports include clays, natural orsynthetic silicates, silica, resins, waxes, solid fertilisers, water,alcohols, in particular butanol, organic solvents, mineral and plantoils and derivatives thereof. Mixtures of such supports can also beused.

The composition according to the invention can also comprise additionalcomponents. In particular, the composition can further comprise asurfactant. The surfactant can be an emulsifier, a dispersing agent or awetting agent of ionic or non-ionic type or a mixture of suchsurfactants. Mention can be made, for example, of polyacrylic acidsalts, lignosulfonic acid salts, phenolsulfonic or naphthalenesulfonicacid salts, polycondensates of ethylene oxide with fatty alcohols orwith fatty acids or with fatty amines, substituted phenols (inparticular alkylphenols or arylphenols), salts of sulfosuccinic acidesters, taurine derivatives (in particular alkyl taurates), phosphoricesters of polyoxyethylated alcohols or phenols, fatty acid esters ofpolyols and derivatives of the above compounds containing sulfate,sulfonate and phosphate functions. The presence of at least onesurfactant is generally essential when the active compound and/or theinert support are water-insoluble and when the vector agent for theapplication is water. Preferably, surfactant content can be comprisedfrom 5% to 40% by weight of the composition.

Optionally, additional components can also be included, e.g. protectivecolloids, adhesives, thickeners, thixotropic agents, penetration agents,stabilisers, sequestering agents. More generally, the active compoundscan be combined with any solid or liquid additive, that complies withthe usual formulation techniques.

In general, the composition according to the invention can contain from0.05 to 99% by weight of active compound, preferably 10 to 70% byweight.

Compositions according to the invention can be used in various forms andformulations such as aerosol dispenser, capsule suspension, cold foggingconcentrate, dustable powder, emulsifiable concentrate, emulsion oil inwater, emulsion water in oil, encapsulated granule, fine granule,flowable concentrate for seed treatment, gas (under pressure), gasgenerating product, granule, hot fogging concentrate, macrogranule,microgranule, oil dispersible powder, oil miscible flowable concentrate,oil miscible liquid, paste, plant rodlet, powder for dry seed treatment,seed coated with a pesticide, soluble concentrate, soluble powder,solution for seed treatment, suspension concentrate (flowableconcentrate), ultra low volume (ULV) liquid, ultra low volume (ULV)suspension, water dispersible granules or tablets, water dispersiblepowder for slurry treatment, water soluble granules or tablets, watersoluble powder for seed treatment and wettable powder. Thesecompositions include not only compositions that are ready to be appliedto the plant or seed to be treated by means of a suitable device, suchas a spraying or dusting device, but also concentrated commercialcompositions that must be diluted before application to the crop.

The formulations can be prepared in a manner known per se, for exampleby mixing the active ingredients with at least one customary extender,solvent or diluent, adjuvant, emulsifier, dispersant, and/or binder orfixative, wetting agent, water repellent, if appropriate desiccants andUV stabilizers and, if appropriate, dyes and pigments, antioams,preservatives, inorganic and organic thickeners, adhesives, gibberellinsand also further processing auxiliaries and also water. Depending on theformulation type to be prepared further processing steps are necessary,e.g. wet grinding, dry grinding and granulation.

The inventive active ingredients may be present as such or in their(commercial) formulations and in the use forms prepared from theseformulations as a mixture with other (known) active ingredients, such asinsecticides, attractants, sterilants, bactericides, acaricides,nematicides, fungicides, growth regulators, herbicides, fertilizers,safeners, biologicals and/or semiochemicals.

The compounds of formula (I) and the fungicide composition according tothe invention can be used to curatively or preventively control thephytopathogenic fungi of plants or crops, particularly rust diseases.Thus, according to a further aspect of the invention, there is provideda method for curatively or preventively controlling the phytopathogenicfungi of plants or crops, particularly rust diseases, characterised inthat a compound of formula (I) or a fungicide composition according tothe invention is applied to the seed, the plant or to the fruit of theplant or to the soil wherein the plant is growing or wherein it isdesired to grow.

The method of treatment according to the invention can also be useful totreat propagation material such as tubers or rhizomes, but also seeds,seedlings or seedlings pricking out and plants or plants pricking out.This method of treatment can also be useful to treat roots. The methodof treatment according to the invention can also be useful to treat theoverground parts of the plant such as trunks, stems or stalks, leaves,flowers and fruit of the concerned plant.

According to the invention all plants and plant parts can be treated. Byplants is meant all plants and plant populations such as desirable andundesirable wild plants, cultivars and plant varieties (whether or notprotectable by plant variety or plant breeder's rights). Cultivars andplant varieties can be plants obtained by conventional propagation andbreeding methods which can be assisted or supplemented by one or morebiotechnological methods such as by use of double haploids, protoplastfusion, random and directed mutagenesis, molecular or genetic markers orby bioengineering and genetic engineering methods. By plant parts ismeant all above ground and below ground parts and organs of plants suchas shoot, leaf, blossom and root, whereby for example leaves, needles,stems, branches, blossoms, fruiting bodies, fruits and seed as well asroots, corms and rhizomes are listed. Crops and vegetative andgenerative propagating material, for example cuttings, corms, rhizomes,runners and seeds also belong to plant parts.

Among the plants that can be protected by the method according to theinvention, mention may be made of major field crops like corn, soybean,cotton, Brassica oilseeds such as Brassica napus (e.g. canola), Brassicarapa, B. juncea (e.g. mustard) and Brassica carinata, rice, wheat,sugarbeet, sugarcane, oats, rye, barley, millet, triticale, flax, vineand various fruits and vegetables of various botanical taxa such asRosaceae sp. (for instance pip fruit such as apples and pears, but alsostone fruit such as apricots, cherries, almonds and peaches, berryfruits such as strawberries), Ribesioidae sp., Juglandaceae sp.,Betulaceae sp., Anacardiaceae sp., Fagaceae sp., Moraceae sp., Oleaceaesp., Actinidaceae sp., Lauraceae sp., Musaceae sp. (for instance bananatrees and plantings), Rubiaceae sp. (for instance coffee), Theaceae sp.,Sterculceae sp., Rutaceae sp. (for instance lemons, oranges andgrapefruit); Solanaceae sp. (for instance tomatoes, potatoes, peppers,eggplant), Liliaceae sp., Compositiae sp. (for instance lettuce,artichoke and chicory—including root chicory, endive or common chicory),Umbelliferae sp. (for instance carrot, parsley, celery and celeriac),Cucurbitaceae sp. (for instance cucumber—including pickling cucumber,squash, watermelon, gourds and melons), Alliaceae sp. (for instanceonions and leek), Cruciferae sp. (for instance white cabbage, redcabbage, broccoli, cauliflower, brussel sprouts, pak choi, kohlrabi,radish, horseradish, cress, Chinese cabbage), Leguminosae sp. (forinstance peanuts, peas and beans—such as climbing beans and broadbeans), Chenopodiaceae sp. (for instance mangold, spinach beet, spinach,beetroots), Malvaceae (for instance okra), Asparagaceae (for instanceasparagus); horticultural and forest crops; ornamental plants; as wellas genetically modified homologues of these crops.

The method of treatment according to the invention can be used in thetreatment of genetically modified organisms (GMOs), e.g. plants orseeds. Genetically modified plants (or transgenic plants) are plants ofwhich a heterologous gene has been stably integrated into genome. Theexpression “heterologous gene” essentially means a gene which isprovided or assembled outside the plant and when introduced in thenuclear, chloroplastic or mitochondrial genome gives the transformedplant new or improved agronomic or other properties by expressing aprotein or polypeptide of interest or by downregulating or silencingother gene(s) which are present in the plant (using for example,antisense technology, cosuppression technology or RNAinterference—RNAi—technology). A heterologous gene that is located inthe genome is also called a transgene. A transgene that is defined byits particular location in the plant genome is called a transformationor transgenic event.

Depending on the plant species or plant cultivars, their location andgrowth conditions (soils, climate, vegetation period, diet), thetreatment according to the invention may also result in superadditive(“synergistic”) effects. Thus, for example, reduced application ratesand/or a widening of the activity spectrum and/or an increase in theactivity of the active compounds and compositions which can be usedaccording to the invention, better plant growth, increased tolerance tohigh or low temperatures, increased tolerance to drought or to water orsoil salt content, increased flowering performance, easier harvesting,accelerated maturation, higher harvest yields, bigger fruits, largerplant height, greener leaf color, earlier flowering, higher qualityand/or a higher nutritional value of the harvested products, highersugar concentration within the fruits, better storage stability and/orprocessability of the harvested products are possible, which exceed theeffects which were actually to be expected.

At certain application rates, the active compound combinations accordingto the invention may also have a strengthening effect in plants.Accordingly, they are also suitable for mobilizing the defense system ofthe plant against attack by unwanted microorganisms. This may, ifappropriate, be one of the reasons of the enhanced activity of thecombinations according to the invention, for example against fungi.Plant-strengthening (resistance-inducing) substances are to beunderstood as meaning, in the present context, those substances orcombinations of substances which are capable of stimulating the defensesystem of plants in such a way that, when subsequently inoculated withunwanted microorganisms, the treated plants display a substantial degreeof resistance to these microorganisms. In the present case, unwantedmicroorganisms are to be understood as meaning phytopathogenic fungi,bacteria and viruses. Thus, the substances according to the inventioncan be employed for protecting plants against attack by theabovementioned pathogens within a certain period of time after thetreatment. The period of time within which protection is effectedgenerally extends from 1 to 10 days, preferably 1 to 7 days, after thetreatment of the plants with the active compounds.

Plants and plant cultivars which are preferably to be treated accordingto the invention include all plants which have genetic material whichimpart particularly advantageous, useful traits to these plants (whetherobtained by breeding and/or biotechnological means).

Plants and plant cultivars which are also preferably to be treatedaccording to the invention are resistant against one or more bioticstresses, i.e. said plants show a better defense against animal andmicrobial pests, such as against nematodes, insects, mites,phytopathogenic fungi, bacteria, viruses and/or viroids.

Examples of nematode resistant plants are described in e.g. U.S. patentapplication Ser. Nos. 11/765,491, 11/765,494, 10/926,819, 10/782,020,12/032,479, 10/783,417, 10/782,096, 11/657,964, 12/192,904, 11/396,808,12/166,253, 12/166,239, 12/166,124, 12/166,209, 11/762,886, 12/364,335,11/763,947, 12/252,453, 12/209,354, 12/491,396 or 12/497,221.

Plants and plant cultivars which may also be treated according to theinvention are those plants which are resistant to one or more abioticstresses. Abiotic stress conditions may include, for example, drought,cold temperature exposure, heat exposure, osmotic stress, flooding,increased soil salinity, increased mineral exposure, ozone exposure,high light exposure, limited availability of nitrogen nutrients, limitedavailability of phosphorus nutrients, shade avoidance.

Plants and plant cultivars which may also be treated according to theinvention, are those plants characterized by enhanced yieldcharacteristics. Increased yield in said plants can be the result of,for example, improved plant physiology, growth and development, such aswater use efficiency, water retention efficiency, improved nitrogen use,enhanced carbon assimilation, improved photosynthesis, increasedgermination efficiency and accelerated maturation. Yield can furthermorebe affected by improved plant architecture (under stress and non-stressconditions), including but not limited to, early flowering, floweringcontrol for hybrid seed production, seedling vigor, plant size,internode number and distance, root growth, seed size, fruit size, podsize, pod or ear number, seed number per pod or ear, seed mass, enhancedseed filling, reduced seed dispersal, reduced pod dehiscence and lodgingresistance. Further yield traits include seed composition, such ascarbohydrate content, protein content, oil content and composition,nutritional value, reduction in anti-nutritional compounds, improvedprocessability and better storage stability.

Examples of plants with the above-mentioned traits are non-exhaustivelylisted in Table A.

Plants that may be treated according to the invention are hybrid plantsthat already express the characteristic of heterosis or hybrid vigorwhich results in generally higher yield, vigor, health and resistancetowards biotic and abiotic stresses). Such plants are typically made bycrossing an inbred male-sterile parent line (the female parent) withanother inbred male-fertile parent line (the male parent). Hybrid seedis typically harvested from the male sterile plants and sold to growers.Male sterile plants can sometimes (e.g. in corn) be produced bydetasseling, i.e. the mechanical removal of the male reproductive organs(or males flowers) but, more typically, male sterility is the result ofgenetic determinants in the plant genome. In that case, and especiallywhen seed is the desired product to be harvested from the hybrid plantsit is typically useful to ensure that male fertility in the hybridplants is fully restored. This can be accomplished by ensuring that themale parents have appropriate fertility restorer genes which are capableof restoring the male fertility in hybrid plants that contain thegenetic determinants responsible for male-sterility. Geneticdeterminants for male sterility may be located in the cytoplasm.Examples of cytoplasmic male sterility (CMS) were for instance describedin Brassica species (WO 92/05251, WO 95/09910, WO 98/27806, WO05/002324, WO 06/021972 and U.S. Pat. No. 6,229,072). However, geneticdeterminants for male sterility can also be located in the nucleargenome. Male sterile plants can also be obtained by plant biotechnologymethods such as genetic engineering. A particularly useful means ofobtaining male-sterile plants is described in WO 89/10396 in which, forexample, a ribonuclease such as barnase is selectively expressed in thetapetum cells in the stamens. Fertility can then be restored byexpression in the tapetum cells of a ribonuclease inhibitor such asbarstar (e.g. WO 91/02069).

Plants or plant cultivars (obtained by plant biotechnology methods suchas genetic engineering) which may be treated according to the inventionare herbicide-tolerant plants, i.e. plants made tolerant to one or moregiven herbicides. Such plants can be obtained either by genetictransformation, or by selection of plants containing a mutationimparting such herbicide tolerance.

Herbicide-resistant plants are for example glyphosate-tolerant plants,i.e. plants made tolerant to the herbicide glyphosate or salts thereof.Plants can be made tolerant to glyphosate through different means.

For example, glyphosate-tolerant plants can be obtained by transformingthe plant with a gene encoding the enzyme5-enolpyruvylshikimate-3-phosphate synthase (EPSPS). Examples of suchEPSPS genes are the AroA gene (mutant CT7) of the bacterium Salmonellatyphimurium (Comai et al., 1983, Science 221, 370-371), the CP4 gene ofthe bacterium Agrobacterium sp. (Barry et al., 1992, Curr. Topics PlantPhysiol. 7, 139-145), the genes encoding a Petunia EPSPS (Shah et al.,1986, Science 233, 478-481), a Tomato EPSPS (Gasser et al., 1988, J.Biol. Chem. 263, 4280-4289), or an Eleusine EPSPS (WO 01/66704). It canalso be a mutated EPSPS as described in for example EP 0837944, WO00/66746, WO 00/66747 or WO02/26995. Glyphosate-tolerant plants can alsobe obtained by expressing a gene that encodes a glyphosateoxido-reductase enzyme as described in U.S. Pat. Nos. 5,776,760 and5,463,175. Glyphosate-tolerant plants can also be obtained by expressinga gene that encodes a glyphosate acetyl transferase enzyme as describedin for example WO 02/36782, WO 03/092360, WO 05/012515 and WO 07/024782.Glyphosate-tolerant plants can also be obtained by selecting plantscontaining naturally-occurring mutations of the above-mentioned genes,as described in for example WO 01/024615 or WO 03/013226. Plantsexpressing EPSPS genes that confer glyphosate tolerance are described ine.g. U.S. patent application Ser. Nos. 11/517,991, 10/739,610,12/139,408, 12/352,532, 11/312,866, 11/315,678, 12/421,292, 11/400,598,11/651,752, 11/681,285, 11/605,824, 12/468,205, 11/760,570, 11/762,526,11/769,327, 11/769,255, 11/943,801 or 12/362,774. Plants comprisingother genes that confer glyphosate tolerance, such as decarboxylasegenes, are described in e.g. U.S. patent application Ser. Nos.11/588,811, 11/185,342, 12/364,724, 11/185,560 or 12/423,926.

Other herbicide resistant plants are for example plants that are madetolerant to herbicides inhibiting the enzyme glutamine synthase, such asbialaphos, phosphinothricin or glufosinate. Such plants can be obtainedby expressing an enzyme detoxifying the herbicide or a mutant glutaminesynthase enzyme that is resistant to inhibition, e.g. described in U.S.patent application Ser. No. 11/760,602. One such efficient detoxifyingenzyme is an enzyme encoding a phosphinothricin acetyltransferase (suchas the bar or pat protein from Streptomyces species). Plants expressingan exogenous phosphinothricin acetyltransferase are for exampledescribed in U.S. Pat. Nos. 5,561,236; 5,648,477; 5,646,024; 5,273,894;5,637,489; 5,276,268; 5,739,082; 5,908,810 and 7,112,665.

Further herbicide-tolerant plants are also plants that are made tolerantto the herbicides inhibiting the enzyme hydroxyphenylpyruvatedioxygenase(HPPD). Hydroxyphenylpyruvatedioxygenases are enzymes that catalyze thereaction in which para-hydroxyphenylpyruvate (HPP) is transformed intohomogentisate. Plants tolerant to HPPD-inhibitors can be transformedwith a gene encoding a naturally-occurring resistant HPPD enzyme, or agene encoding a mutated or chimeric HPPD enzyme as described in WO96/38567, WO 99/24585, WO 99/24586, WO 2009/144079, WO 2002/046387, orU.S. Pat. No. 6,768,044. Tolerance to HPPD-inhibitors can also beobtained by transforming plants with genes encoding certain enzymesenabling the formation of homogentisate despite the inhibition of thenative HPPD enzyme by the HPPD-inhibitor. Such plants and genes aredescribed in WO 99/34008 and WO 02/36787. Tolerance of plants to HPPDinhibitors can also be improved by transforming plants with a geneencoding an enzyme having prephenate deshydrogenase (PDH) activity inaddition to a gene encoding an HPPD-tolerant enzyme, as described in WO2004/024928. Further, plants can be made more tolerant to HPPD-inhibitorherbicides by adding into their genome a gene encoding an enzyme capableof metabolizing or degrading HPPD inhibitors, such as the CYP450 enzymesshown in WO 2007/103567 and WO 2008/150473.

Still further herbicide resistant plants are plants that are madetolerant to acetolactate synthase (ALS) inhibitors. Known ALS-inhibitorsinclude, for example, sulfonylurea, imidazolinone, triazolopyrimidines,pryimidinyoxy(thio)benzoates, and/or sulfonylaminocarbonyltriazolinoneherbicides. Different mutations in the ALS enzyme (also known asacetohydroxyacid synthase, AHAS) are known to confer tolerance todifferent herbicides and groups of herbicides, as described for examplein Tranel and Wright (2002, Weed Science 50:700-712), but also, in U.S.Pat. Nos. 5,605,011, 5,378,824, 5,141,870, and 5,013,659. The productionof sulfonylurea-tolerant plants and imidazolinone-tolerant plants isdescribed in U.S. Pat. Nos. 5,605,011; 5,013,659; 5,141,870; 5,767,361;5,731,180; 5,304,732; 4,761,373; 5,331,107; 5,928,937; and 5,378,824;and international publication WO 96/33270. Other imidazolinone-tolerantplants are also described in for example WO 2004/040012, WO 2004/106529,WO 2005/020673, WO 2005/093093, WO 2006/007373, WO 2006/015376, WO2006/024351, and WO 2006/060634. Further sulfonylurea- andimidazolinone-tolerant plants are also described in for example WO07/024782 and U.S. Patent Application No. 61/288,958.

Other plants tolerant to imidazolinone and/or sulfonylurea can beobtained by induced mutagenesis, selection in cell cultures in thepresence of the herbicide or mutation breeding as described for examplefor soybeans in U.S. Pat. No. 5,084,082, for rice in WO 97/41218, forsugar beet in U.S. Pat. No. 5,773,702 and WO 99/057965, for lettuce inU.S. Pat. No. 5,198,599, or for sunflower in WO 01/065922.

Plants or plant cultivars (obtained by plant biotechnology methods suchas genetic engineering) which may also be treated according to theinvention are insect-resistant transgenic plants, i.e. plants maderesistant to attack by certain target insects. Such plants can beobtained by genetic transformation, or by selection of plants containinga mutation imparting such insect resistance.

An “insect-resistant transgenic plant”, as used herein, includes anyplant containing at least one transgene comprising a coding sequenceencoding:

-   -   1) an insecticidal crystal protein from Bacillus thuringiensis        or an insecticidal portion thereof, such as the insecticidal        crystal proteins listed by Crickmore et al. (1998, Microbiology        and Molecular Biology Reviews, 62: 807-813), updated by        Crickmore et al. (2005) at the Bacillus thuringiensis toxin        nomenclature, online at:    -   http://www.lifesci.sussex.ac.uk/Home/Neil_Crickmore/Bt/), or        insecticidal portions thereof, e.g., proteins of the Cry protein        classes Cry1Ab, Cry1Ac, Cry1B, Cry1C, Cry1D, Cry1F, Cry2Ab,        Cry3Aa, or Cry3Bb or insecticidal portions thereof (e.g. EP        1999141 and WO 2007/107302), or such proteins encoded by        synthetic genes as e.g. described in and U.S. patent application        Ser. No. 12/249,016; or    -   2) a crystal protein from Bacillus thuringiensis or a portion        thereof which is insecticidal in the presence of a second other        crystal protein from Bacillus thuringiensis or a portion        thereof, such as the binary toxin made up of the Cry34 and Cry35        crystal proteins (Moellenbeck et al. 2001, Nat. Biotechnol. 19:        668-72; Schnepf et al. 2006, Applied Environm. Microbiol. 71,        1765-1774) or the binary toxin made up of the Cry1A or Cry1F        proteins and the Cry2Aa or Cry2Ab or Cry2Ae proteins (U.S.        patent application Ser. No. 12/214,022 and EP 08010791.5); or    -   3) a hybrid insecticidal protein comprising parts of different        insecticidal crystal proteins from Bacillus thuringiensis, such        as a hybrid of the proteins of 1) above or a hybrid of the        proteins of 2) above, e.g., the Cry1A. 105 protein produced by        corn event MON89034 (WO 2007/027777); or 4) a protein of any one        of 1) to 3) above wherein some, particularly 1 to 10, amino        acids have been replaced by another amino acid to obtain a        higher insecticidal activity to a target insect species, and/or        to expand the range of target insect species affected, and/or        because of changes introduced into the encoding DNA during        cloning or transformation, such as the Cry3Bb1 protein in corn        events MON863 or MON88017, or the Cry3A protein in corn event        MIR604; or    -   5) an insecticidal secreted protein from Bacillus thuringiensis        or Bacillus cereus, or an insecticidal portion thereof, such as        the vegetative insecticidal (VIP) proteins listed at:    -   http:/www.lifesci.sussex.ac.uk/home/Neil_Crickmore/Bt/vip.html,        e.g., proteins from the VIP3Aa protein class; or    -   6) a secreted protein from Bacillus thuringiensis or Bacillus        cereus which is insecticidal in the presence of a second        secreted protein from Bacillus thuringiensis or B. cereus, such        as the binary toxin made up of the VIP1A and VIP2A proteins (WO        94/21795); or    -   7) a hybrid insecticidal protein comprising parts from different        secreted proteins from Bacillus thuringiensis or Bacillus        cereus, such as a hybrid of the proteins in 1) above or a hybrid        of the proteins in 2) above; or    -   8) a protein of any one of 5) to 7) above wherein some,        particularly 1 to 10, amino acids have been replaced by another        amino acid to obtain a higher insecticidal activity to a target        insect species, and/or to expand the range of target insect        species affected, and/or because of changes introduced into the        encoding DNA during cloning or transformation (while still        encoding an insecticidal protein), such as the VIP3Aa protein in        cotton event COT102; or    -   9) a secreted protein from Bacillus thuringiensis or Bacillus        cereus which is insecticidal in the presence of a crystal        protein from Bacillus thuringiensis, such as the binary toxin        made up of VIP3 and Cry1A or Cry1F (U.S. Patent Appl. No.        61/126,083 and 61/195,019), or the binary toxin made up of the        VIP3 protein and the Cry2Aa or Cry2Ab or Cry2Ae proteins (U.S.        patent application Ser. No. 12/214,022 and EP 08010791.5).    -   10) a protein of 9) above wherein some, particularly 1 to 10,        amino acids have been replaced by another amino acid to obtain a        higher insecticidal activity to a target insect species, and/or        to expand the range of target insect species affected, and/or        because of changes introduced into the encoding DNA during        cloning or transformation (while still encoding an insecticidal        protein)

Of course, an insect-resistant transgenic plant, as used herein, alsoincludes any plant comprising a combination of genes encoding theproteins of any one of the above classes 1 to 10. In one embodiment, aninsect-resistant plant contains more than one transgene encoding aprotein of any one of the above classes 1 to 10, to expand the range oftarget insect species affected when using different proteins directed atdifferent target insect species, or to delay insect resistancedevelopment to the plants by using different proteins insecticidal tothe same target insect species but having a different mode of action,such as binding to different receptor binding sites in the insect.

An “insect-resistant transgenic plant”, as used herein, further includesany plant containing at least one transgene comprising a sequenceproducing upon expression a double-stranded RNA which upon ingestion bya plant insect pest inhibits the growth of this insect pest, asdescribed e.g. in WO 2007/080126, WO 2006/129204, WO 2007/074405, WO2007/080127 and WO 2007/035650.

Plants or plant cultivars (obtained by plant biotechnology methods suchas genetic engineering) which may also be treated according to theinvention are tolerant to abiotic stresses. Such plants can be obtainedby genetic transformation, or by selection of plants containing amutation imparting such stress resistance. Particularly useful stresstolerance plants include:

-   -   1) plants which contain a transgene capable of reducing the        expression and/or the activity of poly(ADP-ribose) polymerase        (PARP) gene in the plant cells or plants as described in WO        00/04173, WO/2006/045633, EP 04077984.5, or EP 06009836.5.    -   2) plants which contain a stress tolerance enhancing transgene        capable of reducing the expression and/or the activity of the        PARG encoding genes of the plants or plants cells, as described        e.g. in WO 2004/090140.    -   3) plants which contain a stress tolerance enhancing transgene        coding for a plant-functional enzyme of the nicotineamide        adenine dinucleotide salvage synthesis pathway including        nicotinamidase, nicotinate phosphoribosyltransferase, nicotinic        acid mononucleotide adenyl transferase, nicotinamide adenine        dinucleotide synthetase or nicotine amide        phosphorybosyltransferase as described e.g. in EP 04077624.7, WO        2006/133827, PCT/EP07/002433, EP 1999263, or WO 2007/107326.

Plants or plant cultivars (obtained by plant biotechnology methods suchas genetic engineering) which may also be treated according to theinvention show altered quantity, quality and/or storage-stability of theharvested product and/or altered properties of specific ingredients ofthe harvested product such as:

-   -   1) transgenic plants which synthesize a modified starch, which        in its physical-chemical characteristics, in particular the        amylose content or the amylose/amylopectin ratio, the degree of        branching, the average chain length, the side chain        distribution, the viscosity behaviour, the gelling strength, the        starch grain size and/or the starch grain morphology, is changed        in comparison with the synthesised starch in wild type plant        cells or plants, so that this is better suited for special        applications. Said transgenic plants synthesizing a modified        starch are disclosed, for example, in EP 0571427, WO 95/04826,        EP 0719338, WO 96/15248, WO 96/19581, WO 96/27674, WO 97/11188,        WO 97/26362, WO 97/32985, WO 97/42328, WO 97/44472, WO 97/45545,        WO 98/27212, WO 98/40503, WO99/58688, WO 99/58690, WO 99/58654,        WO 00/08184, WO 00/08185, WO 00/08175, WO 00/28052, WO 00/77229,        WO 01/12782, WO 01/12826, WO 02/101059, WO 03/071860, WO        2004/056999, WO 2005/030942, WO 2005/030941, WO 2005/095632, WO        2005/095617, WO 2005/095619, WO 2005/095618, WO 2005/123927, WO        2006/018319, WO 2006/103107, WO 2006/108702, WO 2007/009823, WO        00/22140, WO 2006/063862, WO 2006/072603, WO 02/034923, EP        06090134.5, EP 06090228.5, EP 06090227.7, EP 07090007.1, EP        07090009.7, WO 01/14569, WO 02/79410, WO 03/33540, WO        2004/078983, WO 01/19975, WO 95/26407, WO 96/34968, WO 98/20145,        WO 99/12950, WO 99/66050, WO 99/53072, U.S. Pat. No. 6,734,341,        WO 00/11192, WO 98/22604, WO 98/32326, WO 01/98509, WO 01/98509,        WO 2005/002359, U.S. Pat. No. 5,824,790, U.S. Pat. No.        6,013,861, WO 94/04693, WO 94/09144, WO 94/11520, WO 95/35026,        WO 97/20936    -   2) transgenic plants which synthesize non starch carbohydrate        polymers or which synthesize non starch carbohydrate polymers        with altered properties in comparison to wild type plants        without genetic modification. Examples are plants producing        polyfructose, especially of the inulin and levan-type, as        disclosed in EP 0663956, WO 96/01904, WO 96/21023, WO 98/39460,        and WO 99/24593, plants producing alpha-1,4-glucans as disclosed        in WO 95/31553, US 2002031826, U.S. Pat. No. 6,284,479, U.S.        Pat. No. 5,712,107, WO 97/47806, WO 97/47807, WO 97/47808 and WO        00/14249, plants producing alpha-1,6 branched alpha-1,4-glucans,        as disclosed in WO 00/73422, plants producing alternan, as        disclosed in e.g. WO 00/47727, WO 00/73422, EP 06077301.7, U.S.        Pat. No. 5,908,975 and EP 0728213,    -   3) transgenic plants which produce hyaluronan, as for example        disclosed in WO 2006/032538, WO 2007/039314, WO 2007/039315, WO        2007/039316, JP 2006304779, and WO 2005/012529.    -   4) transgenic plants or hybrid plants, such as onions with        characteristics such as ‘high soluble solids content’, ‘low        pungency’ (LP) and/or ‘long storage’ (LS), as described in U.S.        patent application Ser. No. 12/020,360 and 61/054,026.

Plants or plant cultivars (that can be obtained by plant biotechnologymethods such as genetic engineering) which may also be treated accordingto the invention are plants, such as cotton plants, with altered fibercharacteristics. Such plants can be obtained by genetic transformation,or by selection of plants contain a mutation imparting such alteredfiber characteristics and include:

-   -   a) Plants, such as cotton plants, containing an altered form of        cellulose synthase genes as described in WO 98/00549    -   b) Plants, such as cotton plants, containing an altered form of        rsw2 or rsw3 homologous nucleic acids as described in WO        2004/053219    -   c) Plants, such as cotton plants, with increased expression of        sucrose phosphate synthase as described in WO 01/17333    -   d) Plants, such as cotton plants, with increased expression of        sucrose synthase as described in WO 02/45485    -   e) Plants, such as cotton plants, wherein the timing of the        plasmodesmatal gating at the basis of the fiber cell is altered,        e.g. through downregulation of fiber-selective β-1,3-glucanase        as described in WO 2005/017157, or as described in EP 08075514.3        or U.S. Patent Appl. No. 61/128,938    -   f) Plants, such as cotton plants, having fibers with altered        reactivity, e.g. through the expression of        N-acetylglucosaminetransferase gene including nodC and chitin        synthase genes as described in WO 2006/136351

Plants or plant cultivars (that can be obtained by plant biotechnologymethods such as genetic engineering) which may also be treated accordingto the invention are plants, such as oilseed rape or related Brassicaplants, with altered oil profile characteristics. Such plants can beobtained by genetic transformation, or by selection of plants contain amutation imparting such altered oil profile characteristics and include:

-   -   a) Plants, such as oilseed rape plants, producing oil having a        high oleic acid content as described e.g. in U.S. Pat. No.        5,969,169, U.S. Pat. No. 5,840,946 or U.S. Pat. No. 6,323,392 or        U.S. Pat. No. 6,063,947    -   b) Plants such as oilseed rape plants, producing oil having a        low linolenic acid content as described in U.S. Pat. No.        6,270,828, U.S. Pat. No. 6,169,190, or U.S. Pat. No. 5,965,755    -   c) Plant such as oilseed rape plants, producing oil having a low        level of saturated fatty acids as described e.g. in U.S. Pat.        No. 5,434,283 or U.S. patent application Ser. No. 12/668,303

Plants or plant cultivars (that can be obtained by plant biotechnologymethods such as genetic engineering) which may also be treated accordingto the invention are plants, such as oilseed rape or related Brassicaplants, with altered seed shattering characteristics. Such plants can beobtained by genetic transformation, or by selection of plants contain amutation imparting such altered seed shattering characteristics andinclude plants such as oilseed rape plants with delayed or reduced seedshattering as described in U.S. Patent Appl. No. 61/135,230 WO09/068313and WO10/006732.

Particularly useful transgenic plants which may be treated according tothe invention are plants containing transformation events, orcombination of transformation events, that are the subject of petitionsfor non-regulated status, in the United States of America, to the Animaland Plant Health Inspection Service (APHIS) of the United StatesDepartment of Agriculture (USDA) whether such petitions are granted orare still pending. At any time this information is readily availablefrom APHIS (4700 River Road Riverdale, Md. 20737, USA), for instance onits internet site (URL http://www.aphis.usda.gov/brs/not_reg.html). Onthe filing date of this application the petitions for nonregulatedstatus that were pending with APHIS or granted by APHIS were thoselisted in table B which contains the following information:

-   -   Petition: the identification number of the petition. Technical        descriptions of the transformation events can be found in the        individual petition documents which are obtainable from APHIS,        for example on the APHIS website, by reference to this petition        number. These descriptions are herein incorporated by reference.    -   Extension of Petition: reference to a previous petition for        which an extension is requested.    -   Institution: the name of the entity submitting the petition.    -   Regulated article: the plant species concerned.    -   Transgenic phenotype: the trait conferred to the plants by the        transformation event.    -   Transformation event or line: the name of the event or events        (sometimes also designated as lines or lines) for which        nonregulated status is requested.    -   APHIS documents: various documents published by APHIS in        relation to the Petition and which can be requested with APHIS.

Additional particularly useful plants containing single transformationevents or combinations of transformation events are listed for examplein the databases from various national or regional regulatory agencies(see for example http://gmoinfo.jrc.it/gmp_browse.aspx andhttp://www.agbios.com/dbase.php). Particularly useful transgenic plantswhich may be treated according to the invention are plants containingtransformation events, or a combination of transformation events, andthat are listed for example in the databases for various national orregional regulatory agencies including Event 1143-14A (cotton, insectcontrol, not deposited, described in WO 2006/128569); Event 1143-51B(cotton, insect control, not deposited, described in WO 2006/128570);Event 1445 (cotton, herbicide tolerance, not deposited, described inUS-A 2002-120964 or WO 02/034946); Event 17053 (rice, herbicidetolerance, deposited as PTA-9843, described in WO 2010/117737); Event17314 (rice, herbicide tolerance, deposited as PTA-9844, described in WO2010/117735); Event 281-24-236 (cotton, insect control—herbicidetolerance, deposited as PTA-6233, described in WO 2005/103266 or US-A2005-216969); Event 3006-210-23 (cotton, insect control—herbicidetolerance, deposited as PTA-6233, described in US-A 2007-143876 or WO2005/103266); Event 3272 (corn, quality trait, deposited as PTA-9972,described in WO 2006/098952 or US-A 2006-230473); Event 40416 (corn,insect control—herbicide tolerance, deposited as ATCC PTA-11508,described in WO 2011/075593); Event 43A47 (corn, insectcontrol—herbicide tolerance, deposited as ATCC PTA-11509, described inWO 2011/075595); Event 5307 (corn, insect control, deposited as ATCCPTA-9561, described in WO 2010/077816); Event ASR-368 (bent grass,herbicide tolerance, deposited as ATCC PTA-4816, described in US-A2006-162007 or WO 2004/053062); Event B16 (corn, herbicide tolerance,not deposited, described in US-A 2003-126634); Event BPS-CV127-9(soybean, herbicide tolerance, deposited as NCIMB No. 41603, describedin WO 2010/080829); Event CE43-67B (cotton, insect control, deposited asDSM ACC2724, described in US-A 2009-217423 or WO2006/128573); EventCE44-69D (cotton, insect control, not deposited, described in US-A2010-0024077); Event CE44-69D (cotton, insect control, not deposited,described in WO 2006/128571); Event CE46-02A (cotton, insect control,not deposited, described in WO 2006/128572); Event COT102 (cotton,insect control, not deposited, described in US-A 2006-130175 or WO2004/039986); Event COT202 (cotton, insect control, not deposited,described in US-A 2007-067868 or WO 2005/054479); Event COT203 (cotton,insect control, not deposited, described in WO 2005/054480); EventDAS40278 (corn, herbicide tolerance, deposited as ATCC PTA-10244,described in WO 2011/022469); Event DAS-59122-7 (corn, insectcontrol—herbicide tolerance, deposited as ATCC PTA 11384, described inUS-A 2006-070139); Event DAS-59132 (corn, insect control—herbicidetolerance, not deposited, described in WO 2009/100188); Event DAS68416(soybean, herbicide tolerance, deposited as ATCC PTA-10442, described inWO 2011/066384 or WO 2011/066360); Event DP-098140-6 (corn, herbicidetolerance, deposited as ATCC PTA-8296, described in US-A 2009-137395 orWO 2008/112019); Event DP-305423-1 (soybean, quality trait, notdeposited, described in US-A 2008-312082 or WO 2008/054747); EventDP-32138-1 (corn, hybridization system, deposited as ATCC PTA-9158,described in US-A 2009-0210970 or WO 2009/103049); Event DP-356043-5(soybean, herbicide tolerance, deposited as ATCC PTA-8287, described inUS-A 2010-0184079 or WO 2008/002872); Event EE-1 (brinjal, insectcontrol, not deposited, described in WO 2007/091277); Event FI117 (corn,herbicide tolerance, deposited as ATCC 209031, described in US-A2006-059581 or WO 98/044140); Event GA21 (corn, herbicide tolerance,deposited as ATCC 209033, described in US-A 2005-086719 or WO98/044140); Event GG25 (corn, herbicide tolerance, deposited as ATCC209032, described in US-A 2005-188434 or WO 98/044140); Event GHB119(cotton, insect control—herbicide tolerance, deposited as ATCC PTA-8398,described in WO 2008/151780); Event GHB614 (cotton, herbicide tolerance,deposited as ATCC PTA-6878, described in US-A 2010-050282 or WO2007/017186); Event GJ11 (corn, herbicide tolerance, deposited as ATCC209030, described in US-A 2005-188434 or WO 98/044140); Event GM RZ13(sugar beet, virus resistance, deposited as NCIMB-41601, described in WO2010/076212); Event H7-1 (sugar beet, herbicide tolerance, deposited asNCIMB 41158 or NCIMB 41159, described in US-A 2004-172669 or WO2004/074492); Event JOPLIN1 (wheat, disease tolerance, not deposited,described in US-A 2008-064032); Event LL27 (soybean, herbicidetolerance, deposited as NCIMB41658, described in WO 2006/108674 or US-A2008-320616); Event LL55 (soybean, herbicide tolerance, deposited asNCIMB 41660, described in WO 2006/108675 or US-A 2008-196127); EventLLcotton25 (cotton, herbicide tolerance, deposited as ATCC PTA-3343,described in WO 03/013224 or US-A 2003-097687); Event LLRICE06 (rice,herbicide tolerance, deposited as ATCC-23352, described in U.S. Pat. No.6,468,747 or WO 00/026345); Event LLRICE601 (rice, herbicide tolerance,deposited as ATCC PTA-2600, described in US-A 2008-2289060 or WO00/026356); Event LY038 (corn, quality trait, deposited as ATCCPTA-5623, described in US-A 2007-028322 or WO 2005/061720); Event MIR162(corn, insect control, deposited as PTA-8166, described in US-A2009-300784 or WO 2007/142840); Event MIR604 (corn, insect control, notdeposited, described in US-A 2008-167456 or WO 2005/103301); EventMON15985 (cotton, insect control, deposited as ATCC PTA-2516, describedin US-A 2004-250317 or WO 02/100163); Event MON810 (corn, insectcontrol, not deposited, described in US-A 2002-102582); Event MON863(corn, insect control, deposited as ATCC PTA-2605, described in WO2004/011601 or US-A 2006-095986); Event MON87427 (corn, pollinationcontrol, deposited as ATCC PTA-7899, described in WO 2011/062904); EventMON87460 (corn, stress tolerance, deposited as ATCC PTA-8910, describedin WO 2009/111263 or US-A 2011-0138504); Event MON87701 (soybean, insectcontrol, deposited as ATCC PTA-8194, described in US-A 2009-130071 or WO2009/064652); Event MON87705 (soybean, quality trait—herbicidetolerance, deposited as ATCC PTA-9241, described in US-A 2010-0080887 orWO 2010/037016); Event MON87708 (soybean, herbicide tolerance, depositedas ATCC PTA9670, described in WO 2011/034704); Event MON87754 (soybean,quality trait, deposited as ATCC PTA-9385, described in WO 2010/024976);Event MON87769 (soybean, quality trait, deposited as ATCC PTA-8911,described in US-A 2011-0067141 or WO 2009/102873); Event MON88017 (corn,insect control—herbicide tolerance, deposited as ATCC PTA-5582,described in US-A 2008-028482 or WO 2005/059103); Event MON88913(cotton, herbicide tolerance, deposited as ATCC PTA-4854, described inWO 2004/072235 or US-A 2006-059590); Event MON89034 (corn, insectcontrol, deposited as ATCC PTA-7455, described in WO 2007/140256 or US-A2008-260932); Event MON89788 (soybean, herbicide tolerance, deposited asATCC PTA-6708, described in US-A 2006-282915 or WO 2006/130436); EventMS11 (oilseed rape, pollination control—herbicide tolerance, depositedas ATCC PTA-850 or PTA-2485, described in WO 01/031042); Event MS8(oilseed rape, pollination control—herbicide tolerance, deposited asATCC PTA-730, described in WO 01/041558 or US-A 2003-188347); EventNK603 (corn, herbicide tolerance, deposited as ATCC PTA-2478, describedin US-A 2007-292854); Event PE-7 (rice, insect control, not deposited,described in WO 2008/114282); Event RF3 (oilseed rape, pollinationcontrol—herbicide tolerance, deposited as ATCC PTA-730, described in WO01/041558 or US-A 2003-188347); Event RT73 (oilseed rape, herbicidetolerance, not deposited, described in WO 02/036831 or US-A2008-070260); Event T227-1 (sugar beet, herbicide tolerance, notdeposited, described in WO 02/44407 or US-A 2009-265817); Event T25(corn, herbicide tolerance, not deposited, described in US-A 2001-029014or WO 01/051654); Event T304-40 (cotton, insect control—herbicidetolerance, deposited as ATCC PTA-8171, described in US-A 2010-077501 orWO 2008/122406); Event T342-142 (cotton, insect control, not deposited,described in WO 2006/128568); Event TC1507 (corn, insectcontrol—herbicide tolerance, not deposited, described in US-A2005-039226 or WO 2004/099447); Event VIP1034 (corn, insectcontrol—herbicide tolerance, deposited as ATCC PTA-3925, described in WO03/052073), Event 32316 (corn, insect control-herbicide tolerance,deposited as PTA-11507, described in WO 2011/084632), Event 4114 (corn,insect control-herbicide tolerance, deposited as PTA-11506, described inWO 2011/084621).

Among the diseases of plants or crops that can be controlled by themethod according to the invention, mention can be made of:

Powdery mildew diseases such as:

-   -   Blumeria diseases, caused for example by Blumena graminis;    -   Podosphaera diseases, caused for example by Podosphaera        leucotricha;    -   Sphaerotheca diseases, caused for example by Sphaerotheca        fuliginea;    -   Uncinula diseases, caused for example by Uncinula necator;

Rust diseases such as:

-   -   Gymnosporangium diseases, caused for example by Gymnosporangium        sabinae;    -   Hemileia diseases, caused for example by Hemileia vastatrix;    -   Phakopsora diseases, caused for example by Phakopsora pachyrhizi        or Phakopsora meibomiae;    -   Puccinia diseases, caused for example by Puccinia recondite,        Puccinia graminis or Puccinia striiformis;

Uromyces diseases, caused for example by Uromyces appendiculatus;

Oomycele diseases such as:

-   -   Albugo diseases caused for example by Albugo candida;    -   Bremia diseases, caused for example by Bremia lactucae;    -   Peronospora diseases, caused for example by Peronospora pisi        or P. brassicae;    -   Phytophthora diseases, caused for example by Phytophthora        infestans;    -   Plasmopara diseases, caused for example by Plasmopara viticola;    -   Pseudoperonospora diseases, caused for example by        Pseudoperonospora humuli or        Pseudaperonospora cubensis;    -   Pythium diseases, caused for example by Pythium ultimum;        Leafspot, leaf blotch and leaf blight diseases such as:    -   Alternaria diseases, caused for example by Alternaria solani;    -   Cercospora diseases, caused for example by Cercospora beticola;    -   Cladiosporum diseases, caused for example by Cladiosporium        cucumerinum;    -   Cochliobolus diseases, caused for example by Cochiobolus sativus        (Conidiaform: Drechslera, Syn: Helminthosporium) or Cochliobolus        miyabeanus;    -   Colletotrichum diseases, caused for example by Colletotrichum        indemuthanium;    -   Cycloconium diseases, caused for example by Cycloconium        oleaginum;    -   Diaporthe diseases, caused for example by Diaporthe citri;    -   Elsinoe diseases, caused for example by Elsinoe fawcettii;    -   Gloeosporium diseases, caused for example by Gloeosporium        laeticolor;    -   Glomerella diseases, caused for example by Glomerella cigulata;    -   Guignardia diseases, caused for example by Guignardia bidwelli;    -   Leptosphaeria diseases, caused for example by Leptosphaeria        maculans; Leptosphaeria nodorum;    -   Magnaporthe diseases, caused for example by Magnaporthe grisea;    -   Mycosphaerella diseases, caused for example by Mycosphaerella        graminicola; Mycosphaerella arachidicola; Mycosphaerella        fijiensis;    -   Phaeosphaeria diseases, caused for example by Phaeosphaeria        nodorum;    -   Pyrenophora diseases, caused for example by Pyrenophora teres,        or Pyrenophora tritici repentis;    -   Ramularia diseases, caused for example by Ramularia collocygni,        or Ramularia areola;    -   Rhynchosporium diseases, caused for example by Rhynchosporium        secalis;    -   Septoria diseases, caused for example by Septoria apii or        Septoria lycopercisi;    -   Typhula diseases, caused for example by Typhula incarnata;    -   Venturia diseases, caused for example by Venturia inaequalis;        Root, Sheath and stem diseases such as:    -   Corticium diseases, caused for example by Corticium graminearum;    -   Fusarium diseases, caused for example by Fusarium oxysporum;    -   Gaeumannomyces diseases, caused for example by Gaeumannomyces        graminis;    -   Rhizoctonia diseases, caused for example by Rhizoctonia solani;    -   Sarocladium diseases caused for example by Sarocladium oryzae;    -   Sclerotium diseases caused for example by Sclerotium oryzae;    -   Tapesia diseases, caused for example by Tapesia acuformis;    -   Thielaviopsis diseases, caused for example by Thielaviopsis        basicola;        Ear and panicle diseases such as:    -   Alternaria diseases, caused for example by Alternaria spp.;    -   Aspergillus diseases, caused for example by Aspergillus flavus;    -   Cladosporium diseases, caused for example by Cladosporium spp.;    -   Claviceps diseases, caused for example by Claviceps purpurea;    -   Fusarium diseases, caused for example by Fusarium culmorum;    -   Gibberella diseases, caused for example by Gibberella zeae;    -   Monographella diseases, caused for example by Monographella        nivalis;        Smut and bunt diseases such as:    -   Sphacelotheca diseases, caused for example by Sphacelotheca        reiliana;    -   Tilletia diseases, caused for example by Tilletia caries;    -   Urocystis diseases, caused for example by Urocystis occulta;    -   Ustilago diseases, caused for example by Ustilago nuda;        Fruit rot and mould diseases such as:    -   Aspergillus diseases, caused for example by Aspergillus flavus;    -   Botrytis diseases, caused for example by Botrytis cinerea;    -   Penicillium diseases, caused for example by Penicillium        expansum;    -   Rhizopus diseases caused by example by Rhizopus stolonifer    -   Sclerotinia diseases, caused for example by Sclerotinia        sclerotiorum;    -   Verticilium diseases, caused for example by Verticilium        alboatrum;        Seed and soilborne decay, mould, wilt, rot and damping-off        diseases:    -   Alternaria diseases, caused for example by Alternaria        brassicicola;    -   Aphanomyces diseases, caused for example by Aphanomyces        euteiches;    -   Ascochyta diseases, caused for example by Ascochyta lentis;    -   Aspergillus diseases, caused for example by Aspergillus flavus;    -   Cladosporium diseases, caused for example by Cladosporium        herbarum;    -   Cochliobolus diseases, caused for example by Cochliobolus        sativus;    -   (Conidiaform: Drechslera, Bipolaris Syn: Helminthosporium);    -   Colletotrichum diseases, caused for example by Colletotrichum        coccodes;    -   Fusarium diseases, caused for example by Fusarium culmorum;    -   Gibberella diseases, caused for example by Gibberella zeae;    -   Macrophomina diseases, caused for example by Macrophomina        phaseolina;    -   Monographella diseases, caused for example by Monographella        nivalis;    -   Penicillium diseases, caused for example by Penicillium        expansum;    -   Phoma diseases, caused for example by Phoma lingam;    -   Phomopsis diseases, caused for example by Phomopsis sojae;    -   Phytophthora diseases, caused for example by Phytophthora        cactorum;    -   Pyrenophora diseases, caused for example by Pyrenophora        graminea;    -   Pyricularia diseases, caused for example by Pyricularia oryzae;    -   Pythium diseases, caused for example by Pythium ultimum;    -   Rhizoctonia diseases, caused for example by Rhizoctonia solani;    -   Rhizopus diseases, caused for example by Rhizopus oryzae;    -   Sclerotium diseases, caused for example by Sclerotium rolfsii;    -   Septoria diseases, caused for example by Septoria nodorum;    -   Typhula diseases, caused for example by Typhula incarnata;    -   Verticillium diseases, caused for example by Verticillium        dahliae;        Canker, broom and dieback diseases such as:    -   Nectria diseases, caused for example by Nectria galligena;        Blight diseases such as:    -   Monilinia diseases, caused for example by Monilinia laxa;        Leaf blister or leaf curl diseases such as:    -   Exobasidium diseases caused for example by Exobasidium vexans;    -   Taphrina diseases, caused for example by Taphrina deformans;        Decline diseases of wooden plants such as:    -   Esca diseases, caused for example by Phaemoniella clamydospora;    -   Eutypa dyeback, caused for example by Eutypa lata;    -   Ganoderma diseases caused for example by Ganoderma boninense;    -   Rigidoporus diseases caused for example by Rigidoporus lignosus;        Diseases of Flowers and Seeds such as:    -   Botrytis diseases caused for example by Botrytis cinerea;        Diseases of Tubers such as:    -   Rhizoctonia diseases caused for example by Rhizoctonia solani;    -   Helminthosporium diseases caused for example by Helminthosporium        solani;        Club root diseases such as:    -   Plasmodiophora diseases, cause for example by Plamodiophora        brassicae;        Diseases caused by Bacterial Organisms such as:    -   Xanthomonas species for example Xanthomonas campestris pv.        oryzae;    -   Pseudomonas species for example Pseudomonas syringae pv.        lachrymans;    -   Erwinia species for example Erwinia amylovora.

The composition according to the invention may also be used againstfungal diseases liable to grow on or inside timber. The term “timber”means all types of species of wood, and all types of working of thiswood intended for construction, for example solid wood, high-densitywood, laminated wood, and plywood. The method for treating timberaccording to the invention mainly consists in contacting one or morecompounds according to the invention or a composition according to theinvention; this includes for example direct application, spraying,dipping, injection or any other suitable means.

The dose of active compound usually applied in the method of treatmentaccording to the invention is generally and advantageously from 10 to800 g/ha, preferably from 50 to 300 g/ha for applications in foliartreatment. The dose of active substance applied is generally andadvantageously from 2 to 200 g per 100 kg of seed, preferably from 3 to150 g per 100 kg of seed in the case of seed treatment.

It is clearly understood that the doses indicated herein are given asillustrative examples of the method according to the invention. A personskilled in the art will know how to adapt the application doses, notablyaccording to the nature of the plant or crop to be treated.

The compounds or mixtures according to the invention can also be usedfor the preparation of composition useful to curatively or preventivelytreat human or animal fungal diseases such as, for example, mycoses,dermatoses, trichophyton diseases and candidiases or diseases caused byAspergillus spp., for example Aspergillus fumigatus.

The present invention further relates to the use of compounds of theformula (I) as herein defined for the control of phytopathogenic fungi.

The present invention further relates to the use of compounds of theformula (I) as herein defined for the treatment of transgenic plants.

The present invention further relates to the use of compounds of theformula (I) as herein defined for the treatment of seed and of seed oftransgenic plants.

The present invention further relates to a process for producingcompositions for controlling phytopathogenic harmful fungi,characterized in that derivatives of the formula (I) as herein definedare mixed with extenders and/or surfactants.

The various aspects of the invention will now be illustrated withreference to the following table of compound examples and the followingpreparation or efficacy examples.

Table 1 illustrates in a non-limiting manner examples of compounds offormula (I) according to the invention:

In table 1, unless otherwise specified, M+H (Apcl+) means the molecularion peak plus 1 a.m.u. (atomic mass unit) as observed in massspectroscopy via positive atmospheric pressure chemical ionisation.

In table 1, the log P values were determined in accordance with EECDirective 79/831 Annex V.A8 by HPLC (High Performance LiquidChromatography) on a reversed-phase column (C 18), using the methoddescribed below:

Temperature: 40° C.; Mobile phases: 0.1% aqueous formic acid andacetonitrile; linear gradient from 10% acetonitrile to 90% acetonitrile.

Calibration was carried out using unbranched alkan-2-ones (comprising 3to 16 carbon atoms) with known log P values (determination of the log Pvalues by the retention times using linear interpolation between twosuccessive alkanones). lambda-max-values were determined usingUV-spectra from 200 nm to 400 nm and the peak values of thechromatographic signals.

TABLE 1 Example X¹ X² T Z¹ Z² Z³ (W)_(n)

M + H logP 1.001 F F O cyclopropyl H H — 1-methylcyclopropyl 378 3.851.002 F Cl O cyclopropyl H H — 1-methylcyclopropyl 394 4.01 1.003 F F Scyclopropyl H H — 1-methylcyclopropyl 394 4.46 1.004 F Cl S cyclopropylH H — 1-methylcyclopropyl 410 4.63 1.005 F F O cyclopropyl H H 3-Cl1-methylcyclopropyl 412 4.30 1.006 F Cl O cyclopropyl H H 3-Cl1-methylcyclopropyl 428 4.44 1.007 F F O cyclopropyl H H 3-cyclohexyl1-methylcyclopropyl 460 5.74 1.008 F F O cyclopropyl H H 3-F1-methylcyclopropyl 396 3.89 1.009 F Cl O cyclopropyl H H 3-F1-methylcyclopropyl 412 3.99 1.010 F F S cyclopropyl H H 3-F1-methylcyclopropyl 412 4.49 1.011 F Cl S cyclopropyl H H 3-F1-methylcyclopropyl 428 4.64 1.012 F F O cyclopropyl H H 3-phenyl1-methylcyclopropyl 454 4.73 1.013 F F O cyclopropyl H H3-(bicyclo[2.2.1]hept- 1-methylcyclopropyl 469 5.78 2-en-2-yl) 1.014 F FO cyclopropyl H H 3-(cyclohex-1-en-1-yl) 1-methylcyclopropyl 458 5.591.015 F F O cyclopropyl H H 3-(prop-1-en-2-yl) 1-methylcyclopropyl 4184.64 1.016 F F O cyclopropyl H H 3,4-methylene 1-methylcyclopropyl 4223.53 dioxy⁽¹⁾ 1.017 F Cl O cyclopropyl H H 3,4-methylene1-methylcyclopropyl 438 3.67 dioxy⁽¹⁾ 1.018 F F O cyclopropyl H H 4-Cl1-methylcyclopropyl 412 4.43 1.019 F Cl O cyclopropyl H H 4-Cl1-methylcyclopropyl 428 4.54 1.020 F F O cyclopropyl H H 4-cyclopropyl1-methylcyclopropyl 418 4.51 1.021 F F O cyclopropyl H H 4-F1-methylcyclopropyl 396 3.92 1.022 F Cl O cyclopropyl H H 4-F1-methylcyclopropyl 412 4.06 1.023 F F S cyclopropyl H H 4-F1-methylcyclopropyl 412 4.56 1.024 F Cl S cyclopropyl H H 4-F1-methylcyclopropyl 428 4.74 1.025 F F O cyclopropyl H H 4-i-Pr1-methylcyclopropyl 420 4.90 1.026 F F O cyclopropyl H H 4-Me1-methylcyclopropyl 392 4.21 1.027 F Cl O cyclopropyl H H 4-Me1-methylcyclopropyl 408 4.36 1.028 F F O cyclopropyl H H 4-OMe1-methylcyclopropyl 408 3.69 1.029 F Cl O cyclopropyl H H 4-OMe1-methylcyclopropyl 424 3.83 1.030 F F S cyclopropyl H H 4-OMe1-methylcyclopropyl 424 4.34 1.031 F Cl S cyclopropyl H H 4-OMe1-methylcyclopropyl 440 4.51 1.032 F F O cyclopropyl H H 4-phenoxy1-methylcyclopropyl 470 4.91 1.033 F F O cyclopropyl H H 4-phenyl1-methylcyclopropyl 454 4.93 1.034 F F O cyclopropyl H H 4-(1-methy1-1H-1-methylcyclopropyl 457 4.15 pyrrol-3-yl) 1.035 F F O cyclopropyl H H4-(2-methylphenyl) 1-methylcyclopropyl 468 5.26 1.036 F F O cyclopropylH H 4-(3,4-difluorophenyl) 1-methylcyclopropyl 490 5.03 1.037 F F Ocyclopropyl H H 4-(3,6-dihydro-2H- 1-methylcyclopropyl 460 3.94pyran-4-yl) 1.038 F F O cyclopropyl H H 4-(3-fluorophenyl)1-methylcyclopropyl 472 4.96 1.039 F F O cyclopropyl H H 4-(3-furyl)1-methylcyclopropyl 444 4.23 1.040 F F O cyclopropyl H H 4-(3-thienyl)1-methylcyclopropyl 460 4.61 1.041 F F O cyclopropyl H H4-(4-fluorophenyl) 1-methylcyclopropyl 472 4.96 1.042 F F O cyclopropylH H 4-(5-fluoro-2- 1-methylcyclopropyl 486 5.31 methylphenyl) 1.043 F FO cyclopropyl H H 4-(prop-1-en-2-yl) 1-methylcyclopropyl 418 4.73 1.044F F O cyclopropyl H H 4-(pyridin-3-yl) 1-methylcyclopropyl 455 2.351.045 F F O cyclopropyl H H 4-(pyridin-4-yl 1-methylcyclopropyl 455 2.001.046 F F O cyclopropyl H H 4-(quinolin-6-yl) 1-methylcyclopropyl 5053.09 1.047 F F O cyclopropyl H H 4-(tetrahydro-2H- 1-methylcyclopropyl462 3.87 pyran-4-yl) 1.048 F F O cyclopropyl H H 4,5-diF1-methylcyclopropyl 414 4.01 1.049 F Cl O cyclopropyl H H 4,5-diF1-methylcyclopropyl 430 4.16 1.050 F Cl S cyclopropyl H H 4,5-diF1-methylcyclopropyl 446 4.90 1.051 F F O cyclopropyl H H 4,5-diMe1-methylcyclopropyl 406 4.36 1.052 F Cl O cyclopropyl H H 4,5-diMe1-methylcyclopropyl 422 4.53 1.053 F F O cyclopropyl H H 4,5-diOMe1-methylcyclopropyl 438 3.33 1.054 F Cl O cyclopropyl H H 4,5-diOMe1-methylcyclopropyl 454 3.46 1.055 F F S cyclopropyl H H 4,5-diOMe1-methylcyclopropyl 454 3.96 1.056 F Cl S cyclopropyl H H 4,5-diOMe1-methylcyclopropyl 470 4.09 1.057 F Cl O cyclopropyl H H 5-Br1-methylcyclopropyl 472 4.56 1.058 F F O cyclopropyl H H 5-Br1-methylcyclopropyl 456 4.36 1.059 F F O cyclopropyl H H 5-CF₃1-methylcyclopropyl 446 4.34 1.060 F F O cyclopropyl H H 5-Cl1-methylcyclopropyl 412 4.26 1.061 F Cl O cyclopropyl H H 5-Cl1-methylcyclopropyl 428 4.44 1.062 F F S cyclopropyl H H 5-Cl1-methylcyclopropyl 428 4.82 1.063 F Cl S cyclopropyl H H 5-Cl1-methylcyclopropyl 444 5.03 1.064 F F O cyclopropyl H H 5-cyclopropyl1-methylcyclopropyl 418 4.56 1.065 F F O cyclopropyl H H 5-Et1-methylcyclopropyl 406 4.56 1.066 F F O cyclopropyl H H 5-F1-methylcyclopropyl 396 3.89 1.067 F Cl O cyclopropyl H H 5-F1-methylcyclopropyl 412 4.04 1.068 F F S cyclopropyl H H 5-F1-methylcyclopropyl 412 4.49 1.069 F Cl S cyclopropyl H H 5-F1-methylcyclopropyl 428 4.64 1.070 F F O cyclopropyl H H 5-i-Pr1-methylcyclopropyl 420 4.61 1.071 F F O cyclopropyl H H 5-Me1-methylcyclopropyl 392 4.19 1.072 F Cl O cyclopropyl H H 5-Me1-methylcyclopropyl 408 4.36 1.073 F F S cyclopropyl H H 5-Me1-methylcyclopropyl 408 4.80 1.074 F Cl S cyclopropyl H H 5-Me1-methylcyclopropyl 424 4.98 1.075 F F O 1-methyl H H 5-Me1-methylcyclopropyl 406 4.51 cyclopropyl 1.076 F F O 1-cyano H H 5-Me1-methylcyclopropyl 417 3.73 cyclopropyl 1.077 F Cl O 1-methyl H H 5-Me1-methylcyclopropyl 422 4.63 cyclopropyl 1.078 F Cl O 1-cyano H H 5-Me1-methylcyclopropyl 433 3.87 cyclopropyl 1.079 F F O cyclopropyl OMe H5-Me 1-methylcyclopropyl 390 4.41 1.080 F F O cyclopropyl H H 5-vinyl1-methylcyclopropyl 404 4.34 1.081 F F O cyclopropyl H H 5-(1-benzo1-methylcyclopropyl 510 5.48 thiophen-3-yl) 1.082 F F O cyclopropyl H H5-(1-methyl- 1-methylcyclopropyl 507 5.00 1H-indol-3-yl) 1.083 F F Ocyclopropyl H H 5-(prop-1-en-2-yl) 1-methylcyclopropyl 418 4.67 1.084 FF O cyclopropyl H H 5-Cl-6-F 1-methylcyclopropyl none 4.24 1.085 F F Ocyclopropyl H H 5,6-diCl 1-methylcyclopropyl 446 4.51 1.086 F F Ocyclopropyl H H 5-Me-6-Cl 1-methylcyclopropyl 426 4.51 1.087 F F Ocyclopropyl H H 5-Me-6-F 1-methylcyclopropyl none 4.21 1.088 F F Ocyclopropyl H H 6-CF₃ 1-methylcyclopropyl 446 4.46 1.089 F F Ocyclopropyl H H 6-F 1-methylcyclopropyl 396 3.79 1.090 F F O cyclopropylH H 5-Cl 1-ethynylcyclopropyl 422 3.73 1.091 F Cl O cyclopropyl H H 5-Cl1-ethynylcyclopropyl 438 3.89 1.092 F F O cyclopropyl H H 5-Me1-ethynylcyclopropyl 402 3.68 1.093 F Cl O cyclopropyl H H 5-Me1-ethynylcyclopropyl 418 3.78 1.094 F F O cyclopropyl H H 5-Cl1-cyanocyclopropyl 423 3.13 1.095 F Cl O cyclopropyl H H 5-Cl1-cyanocyclopropyl 439 3.31 1.096 F F O cyclopropyl H H —1-ethylcyclopropyl 392 4.21 1.097 F Cl O cyclopropyl H H —1-ethylcyclopropyl 408 4.34 1.098 F F S cyclopropyl H H —1-ethylcyclopropyl 408 4.85 1.099 F Cl S cyclopropyl H H —1-ethylcyclopropyl 424 5.00 1.100 F F O cyclopropyl H H 4-CF31-ethylcyclopropyl 460 4.75 1.101 F Cl O cyclopropyl H H 4-CF₃1-ethylcyclopropyl 476 4.86 1.102 F F O cyclopropyl H H 4-Cl1-ethylcyclopropyl 426 4.67 1.103 F Cl O cyclopropyl H H 4-Cl1-ethylcyclopropyl 442 4.82 1.104 F F O cyclopropyl H H 4-Me1-ethylcyclopropyl 406 4.59 1.105 F Cl O cyclopropyl H H 4-Me1-ethylcyclopropyl 422 4.74 1.106 F F O cyclopropyl H H 4-Me-5-F1-ethylcyclopropyl 424 4.67 1.107 F Cl O cyclopropyl H H 4-Me-5-F1-ethylcyclopropyl 440 4.85 1.108 F F O cyclopropyl H H 5-CF₃1-ethylcyclopropyl 460 4.67 1.109 F Cl O cyclopropyl H H 5-CF₃1-ethylcyclopropyl 476 4.85 1.110 F F O cyclopropyl H H 5-Cl1-ethylcyclopropyl 426 4.59 1.111 F Cl O cyclopropyl H H 5-Cl1-ethylcyclopropyl 442 4.77 1.112 F Cl O cyclopropyl H H 5-Me1-ethylcyclopropyl 422 4.77 1.113 F F O cyclopropyl H H 5-Me1-ethylcyclopropyl 406 4.61 1.114 F F O cyclopropyl H H 6-F1-ethylcyclopropyl 410 4.19 1.115 F Cl O cyclopropyl H H 6-F1-ethylcyclopropyl 426 4.34 1.116 F F O cyclopropyl H H —1-methoxycyclopropyl 394 3.27 1.117 F Cl O cyclopropyl H H —1-methoxycyclopropyl 410 3.42 1.118 F F O cyclopropyl H H 5-Cl1-methoxycyclopropyl 428 3.67 1.119 F Cl O cyclopropyl H H 5-Cl1-methoxycyclopropyl 444 3.87 1.120 F F O cyclopropyl H H 5-cyclopropyl1-methoxycyclopropyl 402 3.97 1.121 F F O cyclopropyl H H 5-i-Pr1-methoxycyclopropyl 436 4.29 1.122 F F O cyclopropyl H H 5-Me1-methoxycyclopropyl 408 3.57 1.123 F Cl O cyclopropyl H H 5-Me1-methoxycyclopropyl 424 3.74 1.124 F F O cyclopropyl H H5-(3,6-dihydro-2H- 1-methoxycyclopropyl 476 3.55 pyran-4-yl) 1.125 F F Ocyclopropyl H H 5-(3-furyl) 1-methoxycyclopropyl 460 3.80 1.126 F F Ocyclopropyl H H 5-(cyclopent- 1-methoxycyclopropyl 460 4.76 1-en-1-yl)1.127 F F O cyclopropyl H H 5-(prop-1-en-2-yl) 1-methoxycyclopropyl 4344.12 1.128 F F O cyclopropyl H H 4-Cl 1-propylcyclopropyl 440 5.14 1.129F Cl O cyclopropyl H H 4-Cl 1-propylcyclopropyl 456 5.31 1.130 F F Ocyclopropyl H H 5-Me 1-propylcyclopropyl 420 5.03 1.131 F Cl Ocyclopropyl H H 5-Me 1-propylcyclopropyl 436 5.19 1.132 F F Ocyclopropyl H H 5-Me 1-chlorocyclopropyl 412 3.89 1.133 F Cl Ocyclopropyl H H 5-Me 1-chlorocyclopropyl 428 4.06 1.134 F F Ocyclopropyl H H 5-Me 1,1′-bi(cyclopropyl)-1-yl 418 4.59 1.135 F Cl Ocyclopropyl H H 5-Me 1,1′-bi(cyclopropyl)-1-yl 434 4.72 1.136 F Cl Ocyclopropyl H H 5-Me 1-isopropylcyclopropyl 436 5.11 1.137 F F Ocyclopropyl H H 5-Me 1-isopropylcyclopropyl 420 4.95 1.138 F Cl Ocyclopropyl H H 5-Me 1-ethoxycyclopropyl 438 4.21 1.139 F F Ocyclopropyl H H 5-Me 1-ethoxycyclopropyl 422 4.06 1.140 F F Ocyclopropyl H H 5-Me-6-Cl 2-chloro- 460 4.58 1-methylcyclopropyl 1.141 FF O cyclopropyl H H 6-CF₃ 2-chloro- 480 4.46 1-methylcyclopropyl 1.142 FF O cyclopropyl H H — 1-(difluoromethyl) 414 3.33 cyclopropyl 1.143 F ClO cyclopropyl H H — 1-(difluoromethyl) 430 3.46 cyclopropyl 1.144 F F Ocyclopropyl H H 4-F 1-(difluoromethyl) 432 3.41 cyclopropyl 1.145 F Cl Ocyclopropyl H H 4-F 1-(difluoromethyl) 448 3.55 cyclopropyl 1.146 F F Ocyclopropyl H H 5-Br 1-(difluoromethyl) 492 3.76 cyclopropyl 1.147 F ClO cyclopropyl H H 5-Br 1-(difluoromethyl) 508 3.92 cyclopropyl 1.148 FCl O cyclopropyl H H 5-Cl 1-(difluoromethyl) 464 3.85 cyclopropyl 1.149F F O cyclopropyl H H 5-Cl 1-(difluoromethyl) 448 3.70 cyclopropyl 1.150F F O cyclopropyl H H 5-cyclopropyl 1-(difluoromethyl) 454 3.94cyclopropyl 1.151 F F O cyclopropyl H H 5-F 1-(difluoromethyl) 432 3.39cyclopropyl 1.152 F Cl O cyclopropyl H H 5-F 1-(difluoromethyl) 448 3.53cyclopropyl 1.153 F F O cyclopropyl H H 5-Me 1-(difluoromethyl) 428 3.64cyclopropyl 1.154 F Cl O cyclopropyl H H 5-Me 1-(difluoromethyl) 4443.76 cyclopropyl 1.155 F F O cyclopropyl H H 6-Br 1-(difluoromethyl) 4923.76 cyclopropyl 1.156 F Cl O cyclopropyl H H 6-Br 1-(difluoromethyl)508 3.87 cyclopropyl 1.157 F F O cyclopropyl H H 4-Cl1-isobutylcyclopropyl 454 5.42 1.158 F Cl O cyclopropyl H H 4-Cl1-isobutylcyclopropyl 470 5.59 1.159 F F O cyclopropyl H H 5-Me1-isobutylcyclopropyl 434 5.36 1.160 F Cl O cyclopropyl H H 5-Me1-isobutylcyclopropyl 450 5.54 1.161 F F O cyclopropyl H H —1-(trifluoromethyl) 432 2.34 cyclopropyl 1.162 F Cl O cyclopropyl H H —1-(trifluoromethyl) 448 3.87 cyclopropyl 1.163 F F O cyclopropyl H H5-Cl 1-(trifluoromethyl) 466 4.13 cyclopropyl 1.164 F Cl O cyclopropyl HH 5-Cl 1-(trifluoromethyl) 482 4.30 cyclopropyl 1.165 F F O cyclopropylH H 5-F 1-(trifluoromethyl) 450 3.83 cyclopropyl 1.166 F Cl Ocyclopropyl H H 5-F 1-(trifluoromethyl) 466 3.96 cyclopropyl 1.167 F F Ocyclopropyl H H 5-Me 1-(trifluoromethyl) 446 4.11 cyclopropyl 1.168 F FO cyclopropyl H H 5-Cl 2,2-dichloro- 480 4.39 1-methylcyclopropyl 1.169F F O cyclopropyl H H 5-cyclopropyl 2,2-dichloro- 486 4.591-methylcyclopropyl 1.170 F F O cyclopropyl H H 5-F 2,2-dichloro- 4644.09 1-methylcyclopropyl 1.171 F Cl O cyclopropyl H H 5-F 2,2-dichloro-480 4.21 1-methylcyclopropyl 1.172 F F O cyclopropyl H H 5-Me2,2-dichloro- 460 4.24 1-methylcyclopropyl 1.173 F F O cyclopropyl H H5,6-diCl 2,2-dichloro- 514 4.71 1-methylcyclopropyl 1.174 F Cl Ocyclopropyl H H 5,6-diCl 2,2-dichloro- 530 4.81 1-methylcyclopropyl1.175 F Cl O cyclopropyl H H 5-Cl-6-F 2,2-dichloro- 514 4.611-methylcyclopropyl 1.176 F F O cyclopropyl H H 5-Cl-6-F 2,2-dichloro-498 4.46 1-methylcyclopropyl 1.177 F Cl O cyclopropyl H H 5-Me-6-Cl2,2-dichloro- 510 4.78 1-methylcyclopropyl 1.178 F F O cyclopropyl H H5-Me-6-Cl 2,2-dichloro- 494 4.67 1-methylcyclopropyl 1.179 F F Ocyclopropyl H H 5-Me-6-F 2,2-dichloro- 478 4.41 1-methylcyclopropyl1.180 F F O cyclopropyl H H 4,5-diCl 1-methylcyclopropyl 446 4.73 1.181F Cl O cyclopropyl H H 4,5-diCl 1-methylcyclopropyl 462 4.93 1.182 F F Ocyclopropyl H H 5-Me 1-(methoxymethyl) 422 3.52 cyclopropyl 1.183 F Cl Ocyclopropyl H H 5-Me 1-(methoxymethyl) 438 3.68 cyclopropyl Note:⁽¹⁾forming with the phenyl ring, a 4-substituted-1,3-benzodioxol-5-ylmoiety Note: Me: methyl; i-Pr: isopropyl

Table 2 illustrates in a non-limiting manner examples of compounds offormula (I) according to the invention:

wherein Z⁴ and its vicinal substituent W, together with the carbon atomto which they are linked, can form a substituted or non-substitutedC₄-C₇-cycloalkyl.

In table 2, M+H (Apcl+) and log P are defined as for table 1.

TABLE 2 Example X¹ X² T Z¹ Z² Z³

M + H logP Ia.01  F Cl O cyclopropyl H H

406 4.06 Ia.02  F F O cyclopropyl H H

390 3.92 Ia.03  F F S cyclopropyl H H

404 4.16 Ia.04  F Cl S cyclopropyl H H

420 4.34 Ia.05  F F O cyclopropyl H H

418 4.59 Ia.06  F Cl O cyclopropyl H H

434 4.77 Ia.07  F Cl O cyclopropyl H H

474 4.23 Ia.08  F F O cyclopropyl H H

458 4.10 Ia.09  F F O cyclopropyl H H

472 4.46 Ia.10 F Cl O cyclopropyl H H

488 4.59 Ia.11 F F O cyclopropyl H H

418 4.78 Ia.12 F Cl O cyclopropyl H H

434 4.98 Ia.13 F Cl S cyclopropyl H H

450 5.74

Table 3 illustrates in a non limiting manner examples of compounds offormula (II) according to the invention,

In table 3, M+H (Apcl+) and log P are defined as for table 1.

TABLE 3 Example Z¹ Z² Z³ (W)_(n)

M + H logP II.01 cyclopropyl H H — 1-methylcyclopropyl 202 1.10 II.02cyclopropyl H H 3-F 1-methylcyclopropyl 220 1.36 II.03 cyclopropyl H H3,4-methylenedioxy⁽¹⁾ 1-methylcyclopropyl 246 1.43 II.04 cyclopropyl H H4-Cl 1-methylcyclopropyl 236 1.54 II.05 cyclopropyl H H 4-Me1-methylcyclopropyl 216 1.43 II.06 cyclopropyl H H 4,5-diMe1-methylcyclopropyl 230 1.68 II.07 cyclopropyl H H 4,5-diMe1-methylcyclopropyl 270 1.79 II.08 cyclopropyl H H 4,5-diOMe1-methylcyclopropyl 262 1.26 II.09 cyclopropyl H H 5-Br1-methylcyclopropyl 280 1.43 II.10 cyclopropyl H H 5-Cl1-methylcyclopropyl 236 1.70 II.11 cyclopropyl H H 5-F1-methylcyclopropyl 220 1.37 II.12 cyclopropyl H H 5-Me1-methylcyclopropyl 216 1.38 II.13 1-methylcyclopropyl H H 5-Me1-methylcyclopropyl 230 1.45 II.14 1-cyanocyclopropyl H H 5-Me1-methylcyclopropyl 241 4.07 II.15 cyclopropyl H H 6-Cl1-methylcyclopropyl 236 1.48 II.16 cyclopropyl H H 5-Cl1-ethynylcyclopropyl 1.22 II.17 cyclopropyl H H 5-Me1-ethynylcyclopropyl 1.15 II.18 cyclopropyl H H 5-Cl1-[(trimethylsilyl)ethynyl] 2.07 cyclopropyl II.19 cyclopropyl H H 5-Me1-[(trimethylsilyl)ethynyl] 2.05 cyclopropyl II.20 cyclopropyl H H 5-Cl1-cyanocyclopropyl 0.77 II.21 cyclopropyl H H 5-Me 1-cyanocyclopropyl1.19 II.22 cyclopropyl H H 5-Me 1-(methoxymethyl) 246 1.49 cyclopropylII.23 cyclopropyl H H — 1-ethylcyclopropyl 216 1.52 II.24 cyclopropyl HH 4-CF₃ 1-ethylcyclopropyl 284 1.95 II.25 cyclopropyl H H 4-Cl1-ethylcyclopropyl 250 1.65 II.26 cyclopropyl H H 4-Me1-ethylcyclopropyl 230 1.47 II.27 cyclopropyl H H 4-Me-5-F1-ethylcyclopropyl 248 1.69 II.28 cyclopropyl H H 5-CF₃1-ethylcyclopropyl 284 1.82 II.29 cyclopropyl H H 5-Cl1-ethylcyclopropyl 250 1.66⁽²⁾ II.30 cyclopropyl H H 5-Me1-ethylcyclopropyl 230 1.63 II.31 cyclopropyl H H 6-F 1-ethylcyclopropyl234 1.14 II.32 cyclopropyl H H 5-Cl 1-propylcyclopropyl 264 1.94 II.33cyclopropyl H H 5-Me 1-propylcyclopropyl 244 1.81⁽²⁾ II.34 cyclopropyl HH 5-Me 1-chlorocyclopropyl 236 1.34⁽²⁾ II.35 cyclopropyl H H 5-Me1,1′-bi(cyclopropyl)-1-yl 242 1.67⁽²⁾ II.36 cyclopropyl H H —1-(difluoromethyl) 238 0.92 cyclopropyl II.37 cyclopropyl H H 5-Br1-(difluoromethyl) 316 1.30 cyclopropyl II.38 cyclopropyl H H 5-Cl1-(difluoromethyl) 1.16 cyclopropyl II.39 cyclopropyl H H 5-F1-(difluoromethyl) 256 1.08 cyclopropyl II.40 cyclopropyl H H 5-Me1-(difluoromethyl) 1.09 cyclopropyl II.41 cyclopropyl H H 6-Br1-(difluoromethyl) 316 1.10 cyclopropyl II.42 cyclopropyl H H 5-Cl1-isobutylcyclopropyl 278 2.09 II.43 cyclopropyl H H 5-Me1-isobutylcyclopropyl 258 2.15 II.44 cyclopropyl H H 5-Cl1-(trifluoromethyl) 290 1.47 cyclopropyl II.45 cyclopropyl H H —1-(trifluoromethyl) 256 1.25 cyclopropyl II.46 cyclopropyl H H 5-F1-(trifluoromethyl) 274 1.32 cyclopropyl Note ⁽¹⁾forming with the phenylring, a 4-substituted-1,3-benzodioxol-5-yl moiety Note ⁽²⁾isolated astheir hydrochloride salt Note: Me: methyl

Table 4 illustrates in a non limiting manner examples of compounds offormula (IV) according to the invention,

In table 4, M+H (Apcl+) and log P are defined as for table 1.

TABLE 4 Example (W)_(n)

M + H logP IV.01 — 1-methylcyclopropyl 161 3.02 IV.02 4-Cl1-methylcyclopropyl 166⁽¹⁾ IV.03 4-F 1-methylcyclopropyl 179 3.15 IV.044-Me 1-methylcyclopropyl 175 3.44 IV.05 4-OMe 1-methylcyclopropyl 1912.92 IV.06 4,5-diF 1-methylcyclopropyl 196⁽²⁾ 3.44 IV.07 4,5-diMe1-methylcyclopropyl 189 3.85 IV.08 4,5-diOMe 1-methylcyclopropyl 2212.56 IV.09 4-Me-5-(1-methyl- 1-methylcyclopropyl cyclopropyl) IV.10 5-Cl1-methylcyclopropyl 166⁽¹⁾ 3.76 IV.11 5-F 1-methylcyclopropyl 150⁽¹⁾3.22 IV.12 5-Me 1-methylcyclopropyl 175 3.55 IV.13 5-(1-methyl-1-methylcyclopropyl cyclopropyl) IV.14 6-F 1-methylcyclopropyl 150⁽¹⁾3.13 IV.15 5-Cl 1-cyanocyclopropyl 2.35 IV.16 5-Me 1-cyanocyclopropyl166 2.08 IV.17 4-CF₃ 1-ethylcyclopropyl 214⁽¹⁾ 4.29 IV.18 5-Me1-ethylcyclopropyl 189 4.29 IV.19 4-Me 1-propylcyclopropyl 223 4.69IV.20 5-Cl 1-(difluoromethyl) 3.04 cyclopropyl IV.21 5-Me1-(difluoromethyl) 3.01 cyclopropyl IV.22 4-Cl 1-isobutylcyclopropyl208⁽¹⁾ IV.23 5-Me 1-isobutylcyclopropyl 188⁽¹⁾ IV.24 5-Cl1-carboxycyclopropyl 1.91 IV.25 5-Cl 1-(methoxycarbonyl) 2.68cyclopropyl Note ⁽¹⁾M-CO fragment (GC-mass) Note ⁽²⁾M (GC-mass) Note:Me: methyl

Table 5 illustrates in a non limiting manner examples of compounds offormula (V) according to the invention,

wherein U² represents a halogen atom.

In table 5, M+H (Apcl+) and log P are defined as for table 1.

TABLE 5             Example             U²             (W)_(n)

            M + H             logP V.01 Br 3-Cl 1-methylcyclopropyl 4.86

Table 6 provides the NMR data (¹H) of a selected number of compoundsfrom table 1 to table 4.

The ¹H-NMR data of selected examples are stated in the form of ¹H-NMRpeak lists. For each signal peak, the δ value in ppm and the signalintensity in brackets are listed.

Intensity of sharp signals correlates with the height of the signals ina printed example of a NMR spectrum in cm and shows the real relationsof signal intensities. From broad signals several peaks or the middle ofthe signal and their relative intensity in comparison to the mostintensive signal in the spectrum can be shown.

The ¹H-NMR peak lists are similar to classical ¹H-NMR prints and containtherefore usually all peaks, which are listed at classicalNMR-interpretation. Additionally they can show like classical ¹H-NMRprints signals of solvents, stereoisomers of the target compounds, whichare also object of the invention, and/or peaks of impurities. To showcompound signals in the delta-range of solvents and/or water the usualpeaks of solvents, for example peaks of DMSO in d6-DMSO and the peak ofwater are shown in our ¹H-NMR peak lists and have usually on average ahigh intensity.

The peaks of stereoisomers of the target compounds and/or peaks ofimpurities have usually on average a lower intensity than the peaks oftarget compounds (for example with a purity >90%). Such stereoisomersand/or impurities can be typical for the specific preparation process.Therefore their peaks can help to recognize the reproduction of ourpreparation process via “side-products-fingerprints”.

An expert, who calculates the peaks of the target compounds with knownmethods (MestreC, ACD-simulation, but also with empirically evaluatedexpectation values), can isolate the peaks of the target compounds asneeded optionally using additional intensity filters. This isolationwould be similar to relevant peak picking at classical ¹H-NMRinterpretation.

Further details of NMR-data description with peak lists can be found inthe publication “Citation of NMR Peaklist Data within PatentApplications” of the Research Disclosure Database Number 564025.

TABLE 6 NMR peak lists Example I.001: ¹H-NMR (400.1 MHz, d₆-DMSO): 7.342(2.0); 7.337 (1.5); 7.329 (1.9); 7.327 (1.9); 7.320 (2.8); 7.310 (0.4);7.233 (0.6); 7.220 (2.9); 7.216 (4.0); 7.207 (5.8); 7.198 (4.0); 7.194(3.0); 7.182 (0.6); 7.140 (2.3); 7.093 (0.3); 7.084 (2.4); 7.075 (2.0);7.066 (1.3); 7.061 (1.9); 7.005 (5.0); 6.871 (2.5); 4.918 (4.8); 3.825(7.7); 3.315 (6.2); 2.851 (0.7); 2.516 (7.9); 2.512 (15.9); 2.508(21.4); 2.503 (15.3); 2.499 (7.3); 1.995 (1.1); 1.304 (10.6); 1.274(1.1); 1.254 (3.3); 1.200 (0.4); 1.182 (0.6); 0.882 (1.4); 0.866 (4.2);0.848 (1.8); 0.786 (16.0); 0.702 (0.8); 0.685 (3.0); 0.672 (3.0); 0.554(3.2) Example I.002: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.335(1.8); 7.318(2.4);7.240(0.7); 7.217(3.8); 7.210(6.6); 7.199(4.7); 7.195(4.4); 7.180(3.2);7.064(2.5); 6.930(1.2); 4.934(2.8); 3.924(12.4); 3.878(0.5); 3.810(0.5);3.315(11.9); 2.875(1.6); 2.530(0.6); 2.516(13.6); 2.512(27.6);2.508(37.1); 2.503(26.3); 2.499(12.4); 1.995(0.7); 1.319(12.8);1.288(1.2); 1.274(1.3); 1.255(3.7); 1.212(0.5); 1.200(0.4); 1.182(0.7);1.164(0.7); 0.882(1.6); 0.866(5.0); 0.848(2.1); 0.801(16.0); 0.709(0.6);0.671(0.6); 0.649(0.6); 0.562(3.1); 0.546(3.3); 0.499(3.7) ExampleI.003: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.360(1.7); 7.356(1.6); 7.341(2.2);7.318(0.5); 7.298(0.5); 7.266(1.7); 7.248(0.7); 7.233(1.1); 7.214(3.3);7.204(3.3); 7.195(3.2); 7.176(1.0); 7.131(2.8); 7.112(0.4); 7.007(2.6);6.995(3.0); 5.619(0.4); 5.553(0.5); 5.544(0.5); 5.498(0.4); 5.022(0.9);3.827(13.0); 3.671(1.8); 3.312(20.5); 3.096(1.5); 2.500(24.0);2.072(3.4); 1.935(0.4); 1.318(14.9); 1.146(2.0); 0.969(0.4); 0.955(0.5);0.803(16.0); 0.729(3.4); 0.712(4.3); 0.639(1.3); 0.000(1.5) ExampleI.004: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.350(1.9); 7.335(2.5); 7.294(0.5);7.275(0.8); 7.259(0.6); 7.227(2.2); 7.215(4.1); 7.206(3.9); 7.197(4.4);7.114(2.5); 7.093(4.5); 7.054(0.6); 7.036(0.5); 6.984(0.6); 6.958(1.5);5.689(2.0); 5.650(2.7); 5.420(2.7); 5.380(2.1); 4.971(0.6); 4.921(0.6);3.912(15.2); 3.773(2.8); 3.311(20.4); 3.150(0.4); 3.108(1.3);3.097(1.8); 3.084(1.5); 2.500(27.6); 2.072(9.8); 1.323(16.0);1.111(2.8); 1.003(0.4); 0.983(0.4); 0.964(0.4); 0.844(0.9); 0.807(13.8);0.720(0.9); 0.692(1.8); 0.675(1.6); 0.634(4.7); 0.628(4.6); 0.617(6.2);0.000(1.7) Example I.005: ¹H-NMR(300.2 MHz, CDCl₃): 7.273(1.3);7.262(2.7); 7.259(2.8); 7.236(4.0); 7.232(4.1); 7.148(2.7); 7.122(5.4);7.096(3.1); 7.057(1.1); 7.036(4.0); 7.011(2.4); 6.875(2.1); 6.693(1.1);5.312(0.7); 5.293(0.6); 5.260(0.9); 4.805(4.9); 4.751(3.9); 3.831(12.2);2.884(1.1); 1.773(1.2); 1.770(1.2); 1.383(16.0); 1.329(0.5); 1.323(0.5);1.306(0.7); 1.267(3.7); 0.966(0.8); 0.954(1.5); 0.942(2.1); 0.929(3.5);0.913(8.4); 0.880(6.3); 0.857(3.2); 0.784(0.4); 0.663(3.4); 0.641(4.7);0.633(4.6); 0.000(1.2) Example I.006: ¹H-NMR(300.2 MHz, CDCl₃):7.266(4.7); 7.253(2.5); 7.245(2.8); 7.235(4.6); 7.217(0.6); 7.143(11.4);7.123(4.1); 7.096(0.7); 6.969(1.4); 6.787(2.9); 6.604(1.4); 5.387(1.5);5.333(1.8); 4.784(2.4); 4.732(2.0); 3.923(15.9); 3.820(0.9); 2.920(1.3);2.905(1.8); 2.888(1.5); 2.044(0.4); 1.671(1.8); 1.666(1.7); 1.398(16.0);1.329(0.9); 1.305(1.5); 1.266(7.5); 0.948(2.1); 0.917(9.6); 0.881(9.8);0.858(4.7); 0.561(7.8); 0.546(6.2); 0.000(2.8) Example I.007:¹H-NMR(300.2 MHz, CDCl₃): 7.369(0.4); 7.352(0.5); 7.338(0.6);7.262(30.2); 7.232(0.5); 7.211(1.0); 7.198(2.0); 7.174(4.1); 7.150(9.5);7.143(7.1); 7.123(2.4); 7.084(0.9); 7.054(0.6); 7.019(0.3); 6.981(0.5);6.949(3.4); 6.927(2.9); 6.899(1.7); 6.717(0.8); 5.339(1.1); 5.301(8.7);5.040(0.6); 4.934(0.4); 4.823(0.4); 4.792(5.0); 4.738(3.9); 3.833(11.1);3.380(1.7); 2.893(1.5); 2.174(0.5); 2.009(0.6); 1.848(3.8); 1.810(3.9);1.777(4.1); 1.721(2.0); 1.702(2.5); 1.615(0.4); 1.573(91.0); 1.540(1.1);1.502(2.0); 1.464(5.2); 1.429(7.1); 1.398(5.2); 1.354(14.9); 1.335(7.1);1.307(3.8); 1.266(15.7); 1.026(0.4); 0.903(5.6); 0.882(16.0);0.857(12.0); 0.807(5.2); 0.774(3.7); 0.647(8.5); 0.000(20.2) ExampleI.008: ¹H-NMR(300.2 MHz, CDCl₃): 7.263(16.0); 7.254(0.3); 7.192(1.2);7.174(1.4); 7.166(2.6); 7.147(2.7); 7.139(2.0); 7.121(1.8); 7.060(0.9);6.941(2.3); 6.912(6.4); 6.883(5.3); 6.696(0.9); 5.300(1.8); 5.001(1.1);3.835(11.8); 2.895(1.0); 1.584(6.2); 1.353(16.0); 1.326(1.0);0.838(13.2); 0.647(6.3); 0.011(0.4); 0.000(12.2); −0.008(0.4);−0.009(0.4); −0.011(0.5) Example I.009: ¹H-NMR(499.9 MHz, d₆-DMSO):7.272(1.5); 7.257(3.3); 7.245(3.3); 7.230(1.7); 7.151(1.6); 7.049(5.5);7.044(3.9); 7.031(5.5); 7.012(4.4); 7.002(4.5); 6.987(4.1); 6.935(1.7);5.744(1.6); 4.909(1.3); 3.913(16.0); 3.811(0.5); 3.282(90.9);2.884(2.4); 2.506(8.0); 2.502(16.4); 2.499(22.3); 2.495(15.9);2.492(7.6); 1.321(15.5); 1.237(0.6); 1.192(0.4); 1.170(0.5); 1.149(0.5);0.859(6.6); 0.823(1.5); 0.788(7.1); 0.645(0.7); 0.569(4.9); 0.561(4.9);0.498(5.4); 0.006(0.3); 0.000(8.5); −0.007(0.4) Example I.010:¹H-NMR(300.2 MHz, CDCl₃): 7.266(2.3); 7.242(1.7); 7.187(0.7);7.169(0.8); 7.161(1.4); 7.142(1.4); 7.134(1.0); 7.116(0.9); 7.059(3.5);6.960(1.0); 6.930(1.3); 6.900(1.0); 6.876(3.2); 6.846(1.5); 5.296(4.6);3.825(9.8); 3.682(1.3); 3.116(0.5); 3.109(0.7); 3.093(0.9); 3.087(0.9);3.078(0.6); 3.071(0.7); 3.063(0.4); 1.619(1.3); 1.380(16.0); 1.228(0.9);0.922(0.5); 0.908(0.6); 0.857(5.7); 0.799(0.6); 0.773(1.8); 0.760(2.8);0.744(1.5); 0.727(1.7); 0.715(2.2); 0.707(1.9); 0.691(2.1); 0.665(0.4);0.000(1.1) Example I.011: ¹H-NMR(300.2 MHz, CDCl₃): 7.265(2.2);7.197(0.4); 7.189(0.8); 7.171(0.9); 7.163(1.5); 7.144(1.5); 7.136(1.1);7.118(1.0); 7.076(1.7); 6.977(1.8); 6.962(1.4); 6.958(1.5); 6.953(1.6);6.942(0.8); 6.935(1.2); 6.929(1.6); 6.917(0.5); 6.894(2.9); 6.893(2.9);6.710(1.9); 5.295(4.9); 3.9114(11.6); 3.9106(11.6); 3.785(2.9);3.161(0.4); 3.147(0.8); 3.137(0.9); 3.132(0.6); 3.123(1.4); 3.109(0.8);3.099(0.7); 3.084(0.4); 1.611(1.6); 1.386(16.0); 1.205(0.5); 0.949(0.4);0.939(0.6); 0.929(0.6); 0.924(0.7); 0.908(0.4); 0.862(6.1); 0.778(0.8);0.766(1.8); 0.756(2.4); 0.751(2.1); 0.742(2.8); 0.734(1.2); 0.727(1.0);0.706(0.4); 0.685(0.5); 0.671(0.4); 0.652(1.2); 0.645(1.0); 0.637(2.2);0.628(1.9); 0.621(1.2); 0.612(2.5); 0.602(1.3); 0.589(0.6); 0.000(1.0)Example I.012: ¹H-NMR(300.2 MHz, CDCl₃): 7.433(1.8); 7.427(2.8);7.403(5.9); 7.399(5.9); 7.381(12.2); 7.359(7.5); 7.345(16.0);7.322(6.8); 7.289(0.9); 7.273(2.6); 7.259(8.1); 7.247(6.0); 7.222(5.1);7.212(1.3); 7.195(1.0); 7.188(0.8); 7.179(1.1); 7.157(4.7); 7.132(3.4);7.121(7.6); 7.096(5.5); 7.092(4.8); 7.059(0.4); 7.050(0.6); 7.034(0.6);7.007(0.3); 6.917(2.0); 6.877(0.5); 6.871(0.5); 6.735(1.0); 5.294(0.4);5.268(1.4); 5.214(2.2); 5.119(0.5); 5.067(2.2); 5.015(1.5); 4.978(0.6);4.957(0.4); 4.800(0.5); 4.746(0.4); 3.852(13.1); 2.983(1.6); 2.889(0.4);1.637(8.2); 1.633(6.3); 1.494(16.1); 1.432(0.6); 1.382(1.9); 1.341(2.0);1.306(1.8); 1.266(10.5); 0.931(0.6); 0.903(4.2); 0.881(12.1);0.858(5.1); 0.783(1.4); 0.772(1.9); 0.754(2.4); 0.711(12.3); 0.653(3.6);0.300(1.1); 0.282(2.6); 0.264(2.3); 0.251(2.5); 0.239(3.1); 0.219(3.6);0.209(3.0); 0.202(2.1); 0.189(3.0); 0.171(1.2); 0.000(7.6); −0.011(0.4)Example I.013: ¹H-NMR(499.9 MHz, CDCl₃): 7.261(14.6); 7.197(0.3);7.167(0.9); 7.152(2.0); 7.137(2.7); 7.122(5.6); 7.108(3.3); 7.061(2.3);7.046(1.8); 7.025(0.8); 7.000(2.3); 6.989(1.9); 6.942(3.3); 6.928(2.9);6.900(1.9); 6.842(0.7); 6.827(0.7); 6.817(0.5); 6.789(0.9); 6.059(2.8);6.055(2.9); 5.890(3.7); 5.885(3.8); 5.297(16.0); 5.259(0.7); 5.190(0.8);5.159(1.1); 5.137(0.5); 5.052(1.1); 5.022(0.8); 4.917(1.0); 4.886(0.9);3.839(10.4); 3.309(2.5); 3.204(0.4); 3.197(0.5); 3.086(2.9); 3.065(3.1);2.999(0.4); 2.970(3.2); 2.921(1.7); 2.852(0.4); 2.377(0.5); 2.234(0.6);1.871(0.4); 1.865(0.6); 1.852(1.1); 1.846(1.6); 1.829(3.4); 1.815(3.5);1.798(3.1); 1.778(1.5); 1.771(1.9); 1.757(1.1); 1.749(1.4); 1.742(0.9);1.650(4.1); 1.605(8.2); 1.543(1.0); 1.501(6.7); 1.450(2.0); 1.427(7.0);1.401(1.8); 1.340(0.9); 1.330(0.9); 1.270(5.9); 1.255(11.0); 1.205(2.9);1.189(2.7); 1.170(1.4); 1.104(1.8); 1.094(2.3); 1.070(1.7); 1.051(0.8);0.976(0.4); 0.955(0.6); 0.888(0.9); 0.880(1.1); 0.867(1.2); 0.824(3.7);0.769(3.2); 0.763(3.1); 0.752(4.7); 0.743(4.0); 0.733(4.1); 0.724(5.0);0.662(8.7); 0.000(15.5) Example I.014: ¹H-NMR(300.2 MHz, CDCl₃):7.367(0.4); 7.359(0.3); 7.351(0.5); 7.337(0.6); 7.261(5.9); 7.232(0.9);7.206(1.2); 7.195(1.4); 7.181(1.5); 7.166(2.9); 7.158(1.8); 7.140(7.0);7.115(5.3); 7.087(1.5); 7.053(1.3); 7.019(5.3); 6.993(4.0); 6.981(7.7);6.956(5.4); 6.904(2.4); 6.873(0.9); 6.721(1.2); 5.581(6.0); 5.208(1.5);5.154(2.5); 5.039(0.9); 4.995(2.5); 4.935(1.7); 4.916(1.0); 4.901(0.8);4.882(0.7); 4.801(0.4); 4.747(0.4); 3.837(16.0); 3.813(6.5); 2.931(2.0);2.568(1.6); 2.543(1.2); 2.516(2.0); 2.511(2.0); 2.194(6.8); 2.185(7.3);2.105(2.4); 2.049(1.8); 1.867(0.5); 1.840(1.2); 1.823(2.8); 1.805(3.3);1.769(2.9); 1.752(3.9); 1.740(4.7); 1.718(8.6); 1.701(8.6); 1.654(7.0);1.651(6.6); 1.491(0.4); 1.418(17.3); 1.342(2.9); 1.306(2.3);1.266(12.1); 1.041(1.9); 1.023(3.5); 1.007(2.9); 0.985(1.4); 0.903(4.5);0.881(12.2); 0.858(5.7); 0.835(2.2); 0.819(3.1); 0.802(4.1); 0.783(4.6);0.774(4.1); 0.751(1.8); 0.729(3.7); 0.711(6.6); 0.696(9.0); 0.675(15.5);0.000(6.2) Example I.015: ¹H-NMR(300.2 MHz, CDCl₃): 7.300(16.7);7.221(1.3); 7.196(3.2); 7.183(0.9); 7.171(2.6); 7.158(0.7); 7.125(0.7);7.087(2.5); 7.067(5.2); 7.042(3.0); 6.942(1.1); 6.761(0.6); 5.253(0.7);5.220(3.5); 5.215(4.6); 5.213(4.6); 5.208(4.0); 5.037(1.1); 4.985(0.8);4.922(3.9); 4.918(3.9); 4.887(0.4); 3.881(7.3); 2.974(0.9); 2.190(16.0);2.145(0.4); 2.046(0.4); 1.983(0.6); 1.977(0.6); 1.961(0.6); 1.955(0.6);1.800(0.9); 1.794(0.9); 1.776(0.9); 1.770(0.9); 1.641(0.5); 1.473(8.4);1.425(1.1); 1.369(1.2); 1.291(9.3); 1.132(1.0); 1.114(1.7); 1.099(1.3);1.075(0.6); 0.926(0.5); 0.918(0.6); 0.877(1.7); 0.861(2.2); 0.841(2.1);0.806(1.0); 0.785(1.8); 0.767(3.0); 0.753(3.5); 0.735(4.3); 0.717(6.4);0.049(0.6); 0.038(18.7); 0.027(0.8) Example I.016: ¹H-NMR(300.2 MHz,CDCl₃): 7.263(11.2); 7.068(0.3); 6.887(0.7); 6.701(0.5); 6.688(2.0);6.661(4.5); 6.623(3.3); 6.596(1.4); 5.964(16.0); 4.918(1.8); 3.827(5.4);2.869(0.5); 2.070(0.3); 1.583(14.2); 1.338(6.4); 1.257(0.5); 0.882(1.0);0.859(1.9); 0.780(3.4); 0.650(3.4); 0.000(6.6) Example I.017:¹H-NMR(300.2 MHz, CDCl₃): 7.262(13.3); 6.789(0.4); 6.714(0.7);6.689(1.6); 6.662(0.4); 5.962(3.3); 4.957(0.5); 3.920(1.9); 1.560(16.0);1.357(1.9); 1.260(0.5); 0.882(1.0); 0.790(0.9); 0.600(0.7); 0.569(0.6);0.000(8.2); −0.011(0.4) Example I.018: ¹H-NMR(300.2 MHz, CDCl₃):7.337(6.1); 7.329(6.5); 7.263(19.6); 7.187(2.5); 7.180(2.2); 7.160(3.7);7.152(3.4); 7.057(5.8); 7.030(3.3); 6.873(2.2); 6.690(1.1); 4.974(4.9);3.835(13.0); 2.859(1.1); 1.576(19.9); 1.335(16.0); 1.284(0.4);1.260(0.6); 0.882(0.8); 0.842(5.3); 0.802(5.5); 0.792(8.3); 0.769(1.8);0.637(6.0); 0.011(0.5); 0.000(12.1) Example I.019: ¹H-NMR(300.2 MHz,CDCl₃): 7.328(6.1); 7.267(7.6); 7.206(0.7); 7.172(16.4); 7.145(0.8);6.969(1.4); 6.787(2.9); 6.604(1.5); 5.014(4.9); 4.736(0.4); 3.925(15.8);3.829(0.7); 2.909(1.3); 2.896(1.8); 2.883(1.4); 1.664(1.2); 1.390(0.6);1.349(16.0); 1.307(1.4); 1.266(5.6); 1.235(1.0); 0.903(2.2); 0.881(8.1);0.858(8.7); 0.801(7.7); 0.779(2.8); 0.672(0.4); 0.566(8.7); 0.544(4.5);0.000(4.9) Example I.020: ¹H-NMR(300.2 MHz, CDCl₃): 7.261(6.8);7.256(6.0); 7.085(9.5); 7.023(3.9); 6.996(5.6); 6.877(5.8); 6.851(3.8);6.711(0.9); 5.298(0.9); 5.292(0.8); 4.984(5.8); 3.825(13.2); 2.854(1.7);1.895(0.6); 1.878(1.4); 1.867(1.7); 1.862(1.9); 1.851(3.0); 1.834(2.2);1.823(1.9); 1.806(0.9); 1.611(4.2); 1.323(16.0); 1.255(0.8); 0.970(1.7);0.965(1.6); 0.955(5.0); 0.949(7.6); 0.943(6.1); 0.935(3.8); 0.927(6.3);0.921(7.6); 0.906(2.7); 0.901(2.2); 0.879(0.8); 0.822(6.5); 0.745(12.0);0.698(3.2); 0.693(3.3); 0.678(10.7); 0.668(9.3); 0.661(13.2);0.655(11.3); 0.645(12.3); 0.640(12.4); 0.000(4.9); −0.006(4.1) ExampleI.021: ¹H-NMR(300.2 MHz, d₆-DMSO): 7.076(0.4); 7.059(0.3); 7.000(0.6);4.861(0.6); 3.813(1.0); 3.322(16.0); 2.513(2.9); 2.507(6.3); 2.501(8.8);2.495(6.4); 2.489(3.1); 1.299(1.3); 0.806(0.7); 0.793(0.8); 0.000(10.4);−0.011(0.4) Example I.022: ¹H-NMR(300.2 MHz, d₆-DMSO): 7.160(0.4);7.139(0.4); 7.125(0.4); 7.093(0.7); 7.064(0.7); 4.879(0.5); 3.914(1.8);3.323(16.0); 2.514(2.4); 2.508(5.3); 2.501(7.3); 2.495(5.4); 2.489(2.6);1.314(1.8); 0.812(1.3); 0.566(0.5); 0.545(0.5); 0.485(0.6); 0.000(9.3);−0.011(0.4) Example I.023: ¹H-NMR(300.2 MHz, d₆-DMSO): 7.310(0.4);7.167(0.5); 7.158(0.6); 7.130(1.4); 7.059(0.6); 7.051(0.4); 7.031(0.5);7.022(0.9); 7.001(0.6); 6.993(0.3); 6.950(0.5); 3.823(3.0); 3.678(0.4);3.322(16.0); 2.513(5.8); 2.507(12.8); 2.501(17.9); 2.495(13.0);2.489(6.3); 1.989(0.7); 1.320(4.5); 1.247(0.9); 1.174(0.4); 1.142(0.5);0.858(1.0); 0.835(1.9); 0.814(1.6); 0.737(0.6); 0.712(0.8); 0.675(0.5);0.011(0.6); 0.000(25.6); −0.011(1.2) Example I.024: ¹H-NMR(300.2 MHz,d₆-DMSO): 7.274(0.6); 7.163(0.6); 7.155(0.7); 7.130(0.6); 7.122(0.7);7.107(0.9); 7.093(1.2); 7.085(1.1); 7.075(0.6); 7.056(0.7); 7.048(0.6);6.915(0.7); 5.645(0.4); 5.593(0.6); 5.367(0.7); 5.314(0.5); 3.910(4.5);3.776(0.8); 3.322(16.0); 3.086(0.5); 2.513(4.5); 2.507(10.0);2.501(14.1); 2.495(10.3); 2.489(4.9); 1.989(0.5); 1.325(5.6);1.247(2.2); 1.174(0.3); 1.101(0.9); 0.880(0.7); 0.858(2.5); 0.835(2.3);0.827(1.9); 0.820(1.7); 0.689(0.5); 0.677(0.5); 0.667(0.7); 0.642(1.0);0.620(1.1); 0.612(0.8); 0.011(0.6); 0.000(20.1); −0.008(0.7);−0.011(0.9) Example I.025: ¹H-NMR(300.2 MHz, CDCl₃): 7.261(7.5);7.200(4.6); 7.127(0.5); 7.052(4.1); 6.907(1.0); 6.721(0.5); 5.007(2.9);3.937(0.4); 3.839(5.6); 2.890(2.0); 2.868(1.9); 2.845(1.3); 2.823(0.7);2.625(0.4); 2.601(0.4); 1.633(0.5); 1.595(0.6); 1.525(0.3); 1.340(8.0);1.302(2.0); 1.246(15.5); 1.223(16.0); 0.967(0.3); 0.944(0.5);0.918(0.5); 0.897(0.6); 0.838(4.1); 0.755(6.3); 0.656(7.1); 0.000(4.9)Example I.026: ¹H-NMR(300.2 MHz, CDCl₃): 7.261(17.1); 7.168(3.5);7.079(0.4); 7.018(7.8); 6.910(0.4); 6.897(0.7); 6.715(0.3); 4.997(1.9);3.829(4.8); 2.865(0.6); 2.309(16.0); 1.564(10.6); 1.328(6.2);1.265(0.7); 1.258(0.7); 0.882(0.7); 0.828(2.2); 0.763(2.3); 0.752(4.6);0.730(1.4); 0.651(3.7); 0.011(0.4); 0.000(15.1); −0.011(0.7);−0.016(0.4) Example I.027: ¹H-NMR(499.9 MHz, CDCl₃): 7.186(5.9);7.083(3.1); 7.076(2.6); 7.059(2.2); 6.955(2.0); 6.940(1.5); 6.828(0.5);6.718(1.0); 6.608(0.6); 5.219(5.9); 4.959(1.5); 4.681(0.3); 3.843(5.9);3.737(0.5); 2.822(1.0); 2.233(16.0); 1.521(7.4); 1.272(5.9); 1.195(0.4);1.164(0.4); 1.142(0.5); 0.811(0.5); 0.775(3.2); 0.723(0.6); 0.684(3.7);0.635(0.8); 0.525(2.4); 0.462(1.9); 0.453(1.9); 0.000(4.9); −0.072(4.4);−0.078(0.4) Example I.028: ¹H-NMR(300.2 MHz, d₆-DMSO): 7.000(0.8);6.972(0.4); 6.854(0.4); 6.845(0.5); 4.827(0.5); 3.812(0.9); 3.730(3.3);3.324(16.0); 2.514(0.8); 2.508(1.7); 2.501(2.4); 2.495(1.8); 2.489(0.9);1.286(1.1); 1.247(0.3); 0.778(0.6); 0.759(0.6); 0.000(1.9) ExampleI.029: ¹H-NMR(300.2 MHz, d₆-DMSO): 3.913(0.7); 3.732(1.8); 3.322(16.0);2.513(1.3); 2.507(2.8); 2.501(3.9); 2.495(2.9); 2.489(1.4); 1.301(0.7);1.247(0.4); 0.858(0.4); 0.779(0.5); 0.000(4.5) Example I.030:¹H-NMR(300.2 MHz, d₆-DMSO): 7.313(0.8); 7.133(1.8); 6.953(1.0);6.938(1.2); 6.910(1.6); 6.879(1.7); 6.870(2.0); 6.830(0.5); 6.793(1.2);6.784(1.0); 6.765(0.8); 6.756(0.7); 4.935(0.4); 3.821(5.3); 3.735(12.9);3.723(2.0); 3.689(0.9); 3.322(16.0); 3.048(0.5); 2.513(5.3);2.507(11.5); 2.501(15.9); 2.495(11.5); 2.489(5.4); 1.989(0.6);1.307(7.9); 1.247(1.8); 1.174(0.4); 1.143(1.0); 0.880(0.6); 0.858(1.9);0.835(0.9); 0.804(2.7); 0.784(2.8); 0.718(1.2); 0.694(1.5); 0.011(0.7);0.000(22.9); −0.011(0.9) Example I.031: ¹H-NMR(300.2 MHz, d₆-DMSO):7.270(0.7); 7.089(1.0); 7.042(0.9); 7.013(1.1); 6.911(0.7); 6.874(1.3);6.865(1.5); 6.814(0.6); 6.800(0.9); 6.791(0.7); 6.772(0.7); 6.762(0.6);5.629(0.6); 5.578(0.8); 5.335(0.8); 5.283(0.6); 3.908(4.9); 3.786(1.0);3.736(9.9); 3.717(2.0); 3.322(16.0); 3.081(0.3); 3.071(0.4); 3.057(0.5);2.513(3.9); 2.507(8.6); 2.501(12.0); 2.495(8.7); 2.489(4.2); 1.989(0.5);1.311(6.0); 1.282(0.4); 1.247(2.1); 1.174(0.3); 1.111(1.1); 0.880(0.7);0.858(2.3); 0.835(1.0); 0.797(2.0); 0.693(0.4); 0.680(0.4); 0.670(0.6);0.652(0.4); 0.646(0.6); 0.622(1.3); 0.613(1.0); 0.599(1.4); 0.568(0.3);0.011(0.5); 0.000(16.2); −0.011(0.6) Example I.032: ¹H-NMR(300.2 MHz,CDCl₃): 7.358(3.0); 7.331(6.0); 7.306(4.4); 7.261(9.0); 7.120(2.4);7.095(3.8); 7.078(4.1); 7.048(7.4); 7.038(5.4); 7.011(6.3); 6.985(5.1);6.949(0.4); 6.926(0.3); 6.883(1.9); 6.831(2.9); 6.822(2.6); 6.803(2.5);6.794(2.2); 6.701(1.0); 4.996(4.2); 3.826(12.9); 3.729(0.4); 2.892(1.2);2.045(0.4); 1.605(16.0); 1.337(13.7); 1.266(6.0); 1.239(1.8);0.903(1.8); 0.882(4.7); 0.858(2.5); 0.825(4.8); 0.763(4.4); 0.752(7.4);0.731(2.2); 0.649(7.6); 0.000(5.1) Example I.033: ¹H-NMR(300.2 MHz,CDCl₃): 7.595(14.4); 7.588(10.3); 7.572(10.7); 7.457(6.3); 7.452(5.6);7.445(4.6); 7.433(12.2); 7.427(8.2); 7.418(5.8); 7.407(7.3); 7.369(1.5);7.358(4.7); 7.333(5.8); 7.309(1.8); 7.260(27.9); 7.244(0.8); 7.204(5.4);7.178(4.5); 7.093(1.0); 7.057(0.4); 6.909(2.0); 6.873(0.3); 6.729(1.0);5.298(0.8); 5.074(5.2); 4.976(0.4); 4.133(0.4); 4.109(0.4); 3.843(12.7);3.755(1.1); 2.929(1.4); 2.172(0.3); 2.046(1.7); 1.582(31.3);1.389(16.0); 1.333(1.6); 1.296(3.3); 1.283(2.3); 1.266(6.5); 1.260(6.3);1.236(1.2); 0.903(7.9); 0.882(8.2); 0.858(3.4); 0.845(1.8); 0.824(5.0);0.813(10.7); 0.792(3.3); 0.690(9.5); 0.602(0.9); 0.585(0.5); 0.473(0.5);0.459(0.7); 0.439(0.4); 0.011(0.6); 0.000(16.3); −0.012(0.7) ExampleI.034: ¹H-NMR(300.2 MHz, CDCl₃): 7.475(1.2); 7.469(1.3); 7.336(0.6);7.331(0.6); 7.310(0.7); 7.304(0.7); 7.261(4.3); 7.094(1.1); 7.067(0.9);6.907(1.0); 6.902(1.4); 6.895(0.9); 6.625(0.7); 6.618(1.2); 6.609(0.7);6.425(0.9); 6.419(1.2); 6.410(0.7); 5.021(0.8); 3.833(2.0); 3.685(7.4);3.659(0.3); 1.937(1.0); 1.591(1.9); 1.356(2.5); 1.267(0.6); 1.263(0.6);1.258(0.7); 1.240(16.0); 0.882(1.1); 0.872(1.1); 0.780(0.8); 0.769(1.7);0.656(1.6); 0.000(2.7) Example I.035: ¹H-NMR(300.2 MHz, CDCl₃):7.329(3.6); 7.273(0.7); 7.258(6.2); 7.244(4.4); 7.236(4.8); 7.226(4.4);7.187(0.7); 7.179(0.6); 7.159(5.3); 7.131(0.4); 7.098(0.3); 7.059(0.8);7.031(0.5); 6.915(0.6); 6.876(0.3); 5.084(1.7); 4.976(0.7); 3.840(4.8);2.966(0.4); 2.281(16.0); 2.044(0.4); 1.654(1.2); 1.376(4.9); 1.334(2.5);1.307(0.7); 1.266(3.2); 1.234(0.4); 0.903(1.4); 0.881(4.9); 0.872(2.4);0.858(2.6); 0.842(1.4); 0.793(2.7); 0.782(3.7); 0.761(1.2); 0.701(2.9);0.688(3.0); 0.639(1.0); 0.000(1.9) Example I.036: ¹H-NMR(300.2 MHz,CDCl₃): 7.516(7.4); 7.510(8.0); 7.409(2.0); 7.402(2.3); 7.384(2.5);7.377(5.7); 7.370(5.1); 7.363(3.1); 7.350(4.7); 7.344(5.2); 7.338(3.6);7.316(1.4); 7.313(1.3); 7.309(1.2); 7.306(1.1); 7.302(1.6); 7.298(1.5);7.294(1.4); 7.287(2.5); 7.284(2.6); 7.280(2.5); 7.277(2.6); 7.273(2.5);7.269(2.6); 7.262(13.6); 7.254(1.0); 7.248(3.4); 7.222(3.8); 7.215(3.6);7.197(5.5); 7.189(4.5); 7.171(3.8); 7.160(2.2); 7.099(0.4); 7.081(1.2);7.065(0.6); 6.899(2.1); 6.716(1.1); 5.297(2.4); 5.064(5.0); 3.845(12.3);3.784(0.5); 2.936(1.2); 2.045(0.9); 1.623(7.5); 1.386(16.0); 1.334(1.4);1.306(1.5); 1.266(8.5); 1.259(7.5); 1.235(1.1); 0.896(7.3); 0.881(14.5);0.858(4.7); 0.838(5.7); 0.827(9.8); 0.805(2.7); 0.769(0.8); 0.685(7.9);0.672(8.6); 0.000(7.2) Example I.037: ¹H-NMR(300.2 MHz, CDCl₃):7.397(7.2); 7.390(7.5); 7.266(8.3); 7.250(3.2); 7.244(2.9); 7.223(4.3);7.217(4.1); 7.106(5.2); 7.079(4.5); 7.029(0.4); 6.897(1.7); 6.715(0.9);6.137(2.8); 6.132(4.0); 6.127(5.5); 6.123(4.0); 6.118(2.9); 5.025(4.6);4.858(0.5); 4.840(0.4); 4.337(3.8); 4.328(10.2); 4.319(10.3);4.310(4.2); 3.948(7.3); 3.930(16.0); 3.912(7.9); 3.836(11.3);2.892(1.3); 2.540(2.6); 2.531(3.9); 2.522(5.3); 2.517(5.3); 2.508(4.0);2.499(2.7); 2.045(0.7); 1.705(2.8); 1.351(14.5); 1.283(1.1); 1.266(2.7);1.259(2.6); 1.233(2.7); 0.903(1.2); 0.881(4.1); 0.857(5.5); 0.795(5.7);0.785(9.9); 0.763(2.7); 0.658(7.9); 0.645(7.9); 0.000(5.5) ExampleI.038: ¹H-NMR(300.2 MHz, CDCl₃): 7.574(7.9); 7.567(8.5); 7.432(3.6);7.425(4.1); 7.406(5.2); 7.399(7.6); 7.380(4.2); 7.373(7.6); 7.370(6.9);7.362(7.4); 7.359(6.6); 7.350(1.5); 7.345(1.6); 7.339(0.9); 7.329(0.6);7.302(2.5); 7.294(3.0); 7.293(2.9); 7.290(2.5); 7.267(2.7); 7.260(11.5);7.210(5.0); 7.183(4.1); 7.159(0.4); 7.152(0.4); 7.088(1.1); 7.055(1.8);7.047(2.1); 7.041(1.8); 7.031(1.9); 7.026(2.4); 7.025(2.3); 7.022(2.2);7.016(2.7); 7.007(2.3); 6.996(2.0); 6.987(1.3); 6.981(0.4); 6.906(2.0);6.723(1.0); 5.293(3.2); 5.073(5.1); 4.975(0.4); 3.842(12.5); 3.771(0.3);2.934(1.3); 1.648(1.7); 1.644(2.2); 1.389(16.0); 1.334(1.9); 1.306(1.5);1.266(8.3); 0.903(8.3); 0.881(12.9); 0.858(4.4); 0.836(5.3);0.824(10.1); 0.803(2.9); 0.768(0.7); 0.747(0.7); 0.688(8.5); 0.674(8.8);0.000(5.6) Example I.039: ¹H-NMR(300.2 MHz, CDCl₃): 7.725(4.9);7.474(6.9); 7.469(8.8); 7.342(2.2); 7.337(2.9); 7.329(1.4); 7.316(2.7);7.310(2.5); 7.262(8.8); 7.187(0.5); 7.180(0.4); 7.159(0.7); 7.144(3.2);7.117(2.5); 7.086(0.6); 7.058(1.1); 7.030(0.6); 6.903(1.1); 6.874(0.5);6.721(0.6); 6.702(4.2); 6.699(4.5); 6.696(4.5); 6.693(4.0); 5.298(0.8);5.038(2.8); 4.975(0.9); 3.837(8.8); 2.895(0.9); 2.046(0.6); 1.620(1.8);1.370(9.0); 1.334(3.5); 1.306(1.0); 1.282(1.4); 1.266(4.4); 1.237(16.0);0.903(2.3); 0.882(7.4); 0.859(3.8); 0.814(3.3); 0.802(6.7); 0.739(0.4);0.665(5.4); 0.653(5.4); 0.000(5.7) Example I.040: ¹H-NMR(300.2 MHz,CDCl₃): 7.588(4.8); 7.583(5.1); 7.447(4.7); 7.440(6.3); 7.433(4.0);7.423(3.1); 7.386(11.9); 7.379(8.8); 7.361(0.5); 7.277(0.6);7.261(19.5); 7.242(0.4); 7.165(3.5); 7.138(2.8); 7.088(0.7); 6.907(1.4);6.725(0.6); 5.049(3.6); 3.841(8.9); 2.905(1.0); 2.024(0.5); 2.008(16.0);1.990(0.3); 1.565(12.4); 1.378(10.8); 1.317(0.3); 1.254(0.6);0.890(4.0); 0.808(6.9); 0.672(6.5); 0.005(3.2); 0.000(14.5) ExampleI.041: ¹H-NMR(300.2 MHz, CDCl₃): 7.607(0.4); 7.570(0.9); 7.560(7.2);7.553(3.3); 7.539(12.4); 7.531(14.8); 7.520(3.8); 7.512(8.2);7.502(1.1); 7.397(3.6); 7.391(3.4); 7.371(4.6); 7.364(4.3); 7.337(0.8);7.330(0.9); 7.279(0.4); 7.278(0.4); 7.276(0.4); 7.275(0.5); 7.273(0.6);7.261(56.2); 7.252(1.2); 7.251(1.0); 7.249(0.9); 7.248(0.8); 7.246(0.7);7.243(0.5); 7.242(0.5); 7.236(0.4); 7.234(0.5); 7.192(5.3); 7.166(4.3);7.155(1.7); 7.145(9.0); 7.138(2.8); 7.123(3.5); 7.116(15.5); 7.109(3.3);7.094(3.4); 7.087(8.5); 7.077(1.3); 7.058(0.8); 7.029(0.5); 6.910(2.0);6.725(1.0); 5.068(5.2); 4.974(0.6); 3.845(12.8); 2.935(1.4); 1.577(3.8);1.572(10.8); 1.566(13.3); 1.386(16.0); 1.334(3.1); 1.307(1.6);1.291(2.2); 1.266(8.7); 0.903(7.9); 0.882(13.5); 0.859(4.7); 0.828(5.5);0.817(10.8); 0.795(3.6); 0.764(0.9); 0.687(9.3); 0.674(8.9); 0.011(1.2);0.000(35.8); −0.011(1.3) Example I.042: ¹H-NMR(300.2 MHz, CDCl₃):7.337(2.0); 7.330(2.1); 7.305(4.9); 7.263(9.9); 7.224(1.3); 7.213(0.8);7.204(1.7); 7.193(2.1); 7.179(1.5); 7.174(1.9); 7.151(9.5); 7.091(0.7);7.058(1.8); 7.031(1.0); 6.961(4.1); 6.952(1.9); 6.939(2.1); 6.932(2.9);6.929(3.1); 6.920(2.4); 6.911(2.8); 6.902(1.4); 6.876(0.8); 6.726(0.5);6.694(0.4); 5.079(2.9); 4.975(1.4); 3.844(8.1); 2.962(0.7); 2.871(0.4);2.227(16.0); 1.624(3.3); 1.376(8.3); 1.335(5.3); 1.307(0.9); 1.266(3.7);0.903(1.7); 0.881(6.2); 0.871(3.7); 0.858(3.9); 0.849(2.9); 0.804(4.0);0.793(7.8); 0.772(2.2); 0.684(5.1); 0.640(2.2); 0.000(5.9) ExampleI.043: ¹H-NMR(300.2 MHz, CDCl₃): 7.467(4.5); 7.460(4.9); 7.337(0.8);7.325(2.2); 7.318(2.0); 7.298(2.7); 7.292(2.6); 7.263(4.2); 7.187(0.3);7.179(0.4); 7.159(0.6); 7.152(0.5); 7.099(3.2); 7.072(2.7); 7.059(1.0);7.040(0.3); 7.031(0.5); 6.902(1.0); 6.876(0.4); 6.719(0.5); 5.365(4.6);5.363(4.6); 5.066(3.6); 5.061(5.1); 5.056(3.8); 5.030(2.9); 4.976(0.8);3.833(8.1); 2.891(0.9); 2.144(16.0); 2.142(16.0); 1.702(1.2);1.401(0.3); 1.392(0.4); 1.354(8.8); 1.336(3.2); 1.290(0.5); 1.272(1.8);1.262(1.5); 0.903(0.7); 0.881(2.5); 0.858(3.7); 0.794(3.9); 0.783(6.4);0.762(1.9); 0.734(0.5); 0.726(0.5); 0.660(5.5); 0.647(5.5); 0.000(2.0)Example I.044: ¹H-NMR(300.2 MHz, CDCl₃): 8.842(6.8); 8.836(7.1);8.590(4.9); 8.584(5.0); 8.574(5.3); 8.568(4.9); 7.891(3.0); 7.885(4.1);7.877(3.1); 7.864(3.5); 7.858(4.5); 7.851(3.3); 7.586(9.2); 7.580(9.5);7.448(4.0); 7.441(3.7); 7.431(1.3); 7.421(5.1); 7.414(4.8); 7.379(4.1);7.377(3.7); 7.363(4.1); 7.361(3.8); 7.353(3.9); 7.351(3.5); 7.337(3.6);7.335(3.3); 7.273(7.4); 7.244(5.7); 7.217(4.5); 7.086(1.3); 7.028(0.3);6.904(2.6); 6.722(1.3); 5.296(0.8); 5.085(6.3); 4.926(0.5); 4.907(0.4);3.848(15.4); 2.950(1.5); 2.044(0.9); 1.983(1.7); 1.400(20.0);1.329(1.1); 1.305(2.4); 1.266(13.5); 1.241(2.8); 1.201(0.4); 1.187(0.4);0.903(9.4); 0.881(16.0); 0.857(8.2); 0.851(7.4); 0.840(12.1);0.818(3.1); 0.695(9.7); 0.682(10.6); 0.000(3.6) Example I.045:¹H-NMR(300.2 MHz, CDCl₃): 8.656(7.6); 8.638(7.6); 7.642(6.8);7.515(8.8); 7.497(9.9); 7.479(4.5); 7.447(1.0); 7.421(0.4); 7.275(3.7);7.247(3.9); 7.220(3.3); 7.197(0.6); 7.082(1.1); 7.018(0.8); 6.899(2.2);6.838(0.4); 6.717(1.1); 5.297(0.5); 5.083(5.4); 4.926(1.1); 4.907(1.1);4.155(0.6); 4.131(1.9); 4.108(1.9); 4.084(0.7); 3.850(12.4); 3.825(4.2);2.948(1.3); 2.044(8.0); 2.029(1.1); 2.019(1.1); 1.447(0.5); 1.398(16.0);1.316(0.4); 1.301(0.4); 1.282(2.3); 1.258(4.8); 1.234(2.2); 0.909(5.8);0.848(10.0); 0.827(2.3); 0.678(8.7); 0.000(2.2) Example I.046:¹H-NMR(300.2 MHz, CDCl₃): 8.925(3.6); 8.920(5.2); 8.912(5.8);8.906(5.7); 8.230(4.6); 8.202(4.9); 8.188(4.5); 8.181(3.6); 8.155(6.1);8.002(15.8); 7.995(12.6); 7.977(4.6); 7.971(4.3); 7.727(6.3);7.721(9.4); 7.582(4.0); 7.561(3.8); 7.555(4.9); 7.453(3.9); 7.439(4.3);7.426(4.3); 7.412(4.1); 7.265(15.5); 7.258(8.7); 7.239(4.4); 7.097(1.3);6.915(2.6); 6.731(1.5); 5.298(0.6); 5.102(6.9); 4.156(1.1); 4.133(3.5);4.109(3.6); 4.085(1.4); 3.849(16.0); 3.738(0.6); 2.956(2.0);2.045(15.2); 2.038(7.0); 1.738(2.6); 1.422(18.2); 1.322(0.8);1.282(4.4); 1.276(2.3); 1.259(8.9); 1.252(4.7); 1.235(4.5); 1.228(2.2);1.126(0.5); 0.942(7.3); 0.881(2.0); 0.850(11.4); 0.697(12.5);0.572(0.4); 0.000(6.7); −0.007(3.1); −0.011(2.8) Example I.047:¹H-NMR(300.2 MHz, CDCl₃): 7.267(12.4); 7.242(0.7); 7.233(0.7);7.226(0.7); 7.208(3.0); 7.181(1.0); 7.176(1.0); 7.130(0.7); 7.101(1.0);7.091(0.9); 7.072(1.3); 7.055(4.5); 7.031(1.9); 7.001(0.5); 6.890(0.9);6.857(0.5); 6.707(0.5); 5.005(3.0); 4.843(0.6); 4.825(0.7); 4.416(0.4);4.409(0.4); 4.385(0.4); 4.378(0.4); 4.160(0.4); 4.122(0.5); 4.096(1.4);4.085(1.2); 4.061(1.4); 4.052(1.3); 3.910(0.3); 3.838(8.0); 3.816(4.2);3.704(0.5); 3.685(0.5); 3.645(0.5); 3.631(0.4); 3.610(3.2); 3.599(0.7);3.582(0.5); 3.563(1.2); 3.551(1.2); 3.527(4.8); 3.515(2.1); 3.486(1.0);3.477(1.2); 3.415(2.0); 2.957(0.8); 2.917(1.2); 2.907(1.1); 2.893(1.2);2.829(0.3); 2.773(0.4); 2.756(0.5); 2.740(0.6); 2.720(0.8); 2.704(0.7);2.684(0.6); 2.667(0.6); 2.652(0.6); 2.632(0.7); 2.627(0.6); 2.608(0.6);2.131(0.4); 2.084(0.3); 2.066(0.3); 2.045(0.4); 2.008(3.3); 1.952(0.3);1.930(0.4); 1.907(0.5); 1.886(0.6); 1.877(0.6); 1.864(0.6); 1.855(0.5);1.833(1.0); 1.818(0.9); 1.794(1.6); 1.780(2.1); 1.760(2.4); 1.747(1.8);1.733(0.9); 1.722(0.8); 1.706(0.6); 1.691(0.5); 1.674(0.4); 1.643(0.4);1.632(0.5); 1.601(0.6); 1.590(0.4); 1.336(8.0); 1.292(1.1); 1.272(0.7);1.255(0.8); 1.231(16.0); 1.204(0.8); 1.195(0.7); 0.829(3.6); 0.777(4.2);0.766(5.2); 0.654(5.8); 0.000(7.0); −0.011(0.3) Example I.048:¹H-NMR(300.2 MHz, d₆-DMSO): 7.210(0.5); 7.202(0.5); 7.185(0.5);7.177(0.6); 7.169(0.5); 7.162(0.6); 7.145(1.5); 7.137(0.5); 6.966(2.3);6.945(0.8); 6.926(0.8); 6.786(1.1); 4.685(3.3); 3.793(6.2); 3.322(16.0);2.635(0.4); 2.514(2.9); 2.508(6.3); 2.502(8.7); 2.496(6.3); 2.490(3.0);1.344(10.6); 1.291(0.4); 1.247(1.1); 0.880(0.3); 0.858(1.1); 0.845(0.6);0.819(2.7); 0.784(2.5); 0.780(2.2); 0.775(3.1); 0.769(2.3); 0.750(0.7);0.692(0.3); 0.668(1.3); 0.651(1.2); 0.644(1.2); 0.630(0.7); 0.585(0.7);0.574(1.5); 0.563(1.3); 0.000(8.8); −0.011(0.4) Example I.049:¹H-NMR(300.2 MHz, d₆-DMSO): 7.186(0.4); 7.006(0.7); 3.916(0.4);3.884(2.2); 3.322(16.0); 2.513(2.9); 2.507(6.3); 2.501(8.9); 2.495(6.5);2.489(3.1); 1.343(3.4); 1.305(0.4); 0.815(1.0); 0.809(0.9); 0.777(0.8);0.774(0.7); 0.768(1.0); 0.762(0.8); 0.557(0.7); 0.000(12.2); −0.011(0.6)Example I.050: ¹H-NMR(300.2 MHz, d₆-DMSO): 7.235(0.4); 7.222(0.8);7.210(0.4); 7.202(0.4); 7.194(0.4); 7.178(0.4); 7.170(0.4); 7.112(0.3);7.043(1.5); 7.027(0.5); 7.002(0.4); 6.863(0.8); 5.472(0.5); 5.457(0.7);5.422(0.8); 5.276(0.8); 5.226(0.5); 4.767(0.4); 3.912(1.6); 3.886(4.9);3.831(1.2); 3.322(16.0); 2.868(0.5); 2.854(0.3); 2.514(4.6);2.508(10.0); 2.501(14.0); 2.495(10.2); 2.489(4.9); 1.339(7.3);1.316(2.0); 1.247(2.6); 0.880(1.0); 0.858(3.1); 0.836(1.6); 0.811(2.4);0.793(0.7); 0.781(2.0); 0.773(2.2); 0.754(0.7); 0.739(0.6); 0.710(0.6);0.680(0.7); 0.674(0.8); 0.656(0.9); 0.637(1.1); 0.621(0.6); 0.612(0.9);0.011(0.6); 0.000(21.7); −0.009(0.7); −0.011(0.9) Example I.051:¹H-NMR(300.2 MHz, CDCl₃): 7.260(6.2); 7.067(1.1); 7.011(2.9);6.973(2.9); 6.885(2.2); 6.703(1.1); 4.696(3.8); 3.808(9.9); 3.606(0.4);2.563(0.8); 2.399(0.4); 2.336(0.6); 2.283(13.5); 2.249(0.5); 2.209(0.6);2.189(0.4); 2.151(10.6); 2.082(0.5); 2.019(0.5); 1.373(16.0);1.348(0.8); 1.289(0.5); 1.277(0.5); 1.265(0.7); 0.826(1.1); 0.804(4.2);0.792(2.0); 0.766(0.4); 0.752(0.7); 0.743(0.7); 0.727(0.5); 0.703(2.7);0.691(5.3); 0.686(4.2); 0.669(2.7); 0.652(3.8); 0.644(3.9); 0.000(4.0)Example I.052: ¹H-NMR(300.2 MHz, CDCl₃): 7.260(8.2); 7.039(1.4);7.015(2.9); 6.951(0.6); 6.768(1.0); 6.586(0.5); 3.922(0.7); 3.892(6.3);2.633(0.6); 2.335(0.6); 2.282(9.6); 2.201(3.3); 2.082(0.5); 2.019(0.5);1.370(16.0); 1.347(0.8); 1.276(0.5); 1.265(0.7); 1.219(0.4); 0.826(1.1);0.806(4.1); 0.793(1.9); 0.768(0.4); 0.742(0.9); 0.693(2.8); 0.680(5.1);0.674(4.2); 0.659(2.2); 0.634(1.6); 0.551(1.0); 0.000(5.0) ExampleI.053: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.141(1.1); 7.006(2.5); 6.868(5.3);6.602(3.4); 4.839(2.9); 3.819(5.7); 3.756(16.0); 3.677(15.2);3.316(27.0); 2.836(0.4); 2.530(0.6); 2.516(10.6); 2.512(21.3);2.508(28.5); 2.503(20.2); 2.499(9.5); 1.995(0.6); 1.285(6.8);1.182(0.3); 0.801(0.6); 0.785(2.5); 0.749(2.0); 0.742(2.9); 0.726(0.8);0.670(1.5); 0.656(1.5); 0.531(1.7) Example I.054: ¹H-NMR(400.1 MHz,d₆-DMSO): 7.194(0.8); 7.059(1.5); 6.924(0.8); 6.858(4.1); 6.647(2.7);4.858(1.3); 4.039(0.4); 4.021(0.4); 3.911(7.0); 3.859(0.5); 3.749(16.0);3.676(11.6); 3.309(49.6); 2.867(1.0); 2.523(0.9); 2.518(1.6);2.510(18.0); 2.505(37.2); 2.501(51.2); 2.496(37.3); 2.492(18.9);2.327(0.3); 1.988(1.6); 1.293(6.8); 1.267(1.4); 1.258(1.5); 1.247(3.0);1.193(0.7); 1.175(1.2); 1.157(0.7); 0.875(1.2); 0.858(4.2); 0.841(1.7);0.794(3.1); 0.754(3.6); 0.701(0.5); 0.684(0.5); 0.676(0.5); 0.551(1.9);0.537(1.9); 0.471(2.1); 0.000(2.4) Example I.055: ¹H-NMR(400.1 MHz,d₆-DMSO): 7.276(1.1); 7.140(2.5); 7.005(1.3); 6.896(5.1); 6.855(0.6);6.570(4.2); 6.526(0.5); 4.962(0.7); 3.825(8.6); 3.764(16.0); 3.746(2.1);3.711(1.3); 3.688(1.9); 3.661(14.5); 3.317(52.2); 3.104(0.6);3.091(0.8); 3.079(0.5); 2.530(0.5); 2.517(11.5); 2.512(23.2);2.508(31.2); 2.503(22.0); 2.499(10.3); 2.079(2.3); 1.305(11.9);1.164(1.5); 0.938(1.1); 0.827(1.0); 0.812(2.9); 0.766(3.1); 0.750(1.1);0.732(1.8); 0.714(1.8); 0.673(1.5) Example I.056: ¹H-NMR(400.1 MHz,d₆-DMSO): 7.246(1.2); 7.110(1.9); 7.022(0.5); 6.976(1.3); 6.893(5.1);6.838(1.0); 6.637(4.3); 6.531(0.8); 5.593(1.2); 5.554(1.8); 5.393(1.8);5.354(1.3); 4.895(0.5); 4.867(0.5); 3.913(10.5); 3.806(2.2);3.763(16.0); 3.740(3.2); 3.709(3.2); 3.664(15.5); 3.318(39.0);3.122(0.6); 3.115(0.6); 3.104(1.1); 3.093(0.6); 3.087(0.6); 3.076(0.4);2.530(0.4); 2.517(9.0); 2.512(18.4); 2.508(24.7); 2.503(17.4);2.499(8.1); 2.079(0.9); 1.312(11.8); 1.135(2.2); 0.845(0.4); 0.832(0.9);0.816(2.8); 0.813(3.0); 0.782(3.2); 0.776(2.7); 0.762(0.8); 0.702(0.5);0.688(0.7); 0.677(1.0); 0.670(0.8); 0.655(1.2); 0.650(1.4); 0.639(2.1);0.620(2.5); 0.614(1.6); 0.599(0.6); 0.594(0.5); 0.588(0.5) ExampleI.057: ¹H-NMR(300.2 MHz, CDCl₃): 7.426(4.6); 7.325(3.3); 7.318(2.9);7.297(5.5); 7.291(5.2); 7.262(19.4); 7.226(5.5); 7.199(3.3); 6.980(1.4);6.797(2.8); 6.615(1.4); 5.036(1.7); 4.757(0.4); 3.934(15.8); 3.833(0.6);2.919(1.9); 2.906(1.5); 2.047(0.5); 1.566(21.8); 1.333(16.0);1.255(3.6); 0.904(1.3); 0.882(3.2); 0.858(2.0); 0.824(7.5); 0.788(9.3);0.617(6.1); 0.602(5.9); 0.575(4.0); 0.070(1.0); 0.011(0.9); 0.000(25.2);−0.011(1.2) Example I.058: ¹H-NMR(300.2 MHz, CDCl₃): 7.328(1.6);7.321(1.8); 7.301(2.8); 7.294(3.3); 7.262(18.8); 7.252(4.9); 7.230(6.2);7.203(3.4); 7.053(1.1); 6.871(2.3); 6.689(1.2); 4.997(5.2); 3.848(12.0);2.895(1.1); 2.047(0.7); 1.555(20.7); 1.320(16.0); 1.284(1.4);1.265(3.9); 1.261(3.9); 1.237(0.7); 0.903(1.3); 0.882(3.7); 0.858(1.6);0.811(5.9); 0.781(8.3); 0.755(1.1); 0.685(3.1); 0.666(6.4); 0.069(0.9);0.000(24.3); −0.011(1.2) Example I.059: ¹H-NMR(400.1 MHz, d₆-DMSO):7.589(0.6); 7.585(0.5); 7.564(10.6); 7.543(0.5); 7.319(4.5); 7.120(2.2);6.985(4.9); 6.851(2.5); 5.751(7.3); 4.956(8.0); 3.825(10.4); 3.460(0.5);3.431(1.5); 3.418(0.4); 3.414(0.4); 3.404(0.5); 3.395(0.8); 3.389(0.9);3.382(3.3); 3.376(1.1); 3.366(1.7); 3.361(2.1); 3.332(1761.1);3.295(1.2); 3.288(1.0); 3.282(4.3); 3.232(0.4); 3.209(0.5); 2.864(0.7);2.680(0.4); 2.676(0.8); 2.671(1.1); 2.667(0.8); 2.552(0.4); 2.525(2.5);2.520(4.4); 2.511(63.3); 2.507(129.9); 2.502(176.3); 2.498(123.1);2.493(56.6); 2.453(0.8); 2.334(0.8); 2.329(1.1); 2.324(0.8); 2.320(0.4);1.386(0.4); 1.327(16.0); 0.845(11.2); 0.711(0.7); 0.693(3.1);0.680(3.2); 0.663(1.1); 0.533(3.2); 0.008(0.5); 0.000(17.4); −0.009(0.6)Example I.060: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.359(4.9); 7.339(7.6);7.277(3.7); 7.271(3.7); 7.256(2.2); 7.250(2.3); 7.141(2.6); 7.036(5.4);7.031(5.0); 7.006(5.7); 6.872(2.9); 4.895(7.8); 4.063(1.2); 4.046(3.6);4.028(3.7); 4.010(1.3); 3.832(11.0); 3.811(1.1); 3.314(19.0);2.873(0.8); 2.676(0.5); 2.672(0.3); 2.530(1.0); 2.517(25.1);2.512(51.6); 2.508(69.8); 2.503(49.3); 2.499(23.1); 2.339(0.3);2.334(0.4); 1.995(16.0); 1.359(0.7); 1.294(15.9); 1.200(4.4);1.182(8.8); 1.164(4.3); 0.795(10.9); 0.790(10.0); 0.745(0.4);0.717(0.9); 0.700(3.6); 0.687(3.6); 0.671(1.2); 0.650(0.4); 0.631(0.3);0.550(3.8) Example I.061: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.356(2.1);7.336(3.1); 7.275(3.2); 7.269(3.4); 7.254(1.9); 7.249(2.1); 7.213(0.9);7.180(0.5); 7.162(2.8); 7.078(1.9); 6.943(0.9); 4.912(2.8); 4.063(1.2);4.046(3.7); 4.028(3.7); 4.010(1.3); 3.930(9.2); 3.889(0.7); 3.314(12.7);2.897(1.0); 2.889(1.2); 2.676(0.4); 2.530(1.1); 2.516(19.9);2.512(39.5); 2.508(52.6); 2.503(36.9); 2.499(17.2); 1.995(16.0);1.354(0.6); 1.307(9.3); 1.200(4.5); 1.182(8.8); 1.164(4.4); 0.809(6.6);0.801(6.6); 0.750(0.5); 0.595(2.4); 0.580(2.4); 0.514(2.7) ExampleI.062: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.385(2.5); 7.365(3.9); 7.297(1.9);7.292(1.8); 7.277(1.2); 7.271(1.2); 7.254(1.3); 7.119(2.8); 6.984(1.7);6.977(3.0); 6.972(2.8); 5.536(0.4); 5.527(0.4); 5.019(0.4); 4.063(0.4);4.046(1.2); 4.028(1.2); 4.010(0.4); 3.840(9.8); 3.817(0.4); 3.685(0.8);3.575(0.6); 3.314(16.9); 3.149(0.6); 3.133(0.9); 3.121(0.6); 2.681(0.3);2.677(0.5); 2.672(0.3); 2.530(1.1); 2.516(29.1); 2.512(59.6);2.507(80.6); 2.503(57.2); 2.499(26.9); 2.461(0.4); 2.457(0.4);2.339(0.4); 2.334(0.5); 2.330(0.4); 1.995(5.4); 1.313(15.1); 1.288(1.0);1.254(4.2); 1.200(1.5); 1.182(2.9); 1.164(1.4); 1.143(1.0); 0.882(1.8);0.866(6.0); 0.848(2.6); 0.813(16.0); 0.765(2.0); 0.747(2.2); 0.713(1.4);0.646(0.4) Example I.063: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.382(2.9);7.361(4.4); 7.304(0.7); 7.295(2.0); 7.289(2.3); 7.274(1.2); 7.268(1.4);7.237(1.5); 7.133(0.4); 7.125(2.9); 7.120(2.7); 7.102(2.4); 7.009(0.4);7.004(0.4); 7.000(0.4); 6.967(1.7); 5.629(1.2); 5.588(1.8); 5.438(1.9);5.398(1.3); 3.924(12.8); 3.782(1.6); 3.315(44.6); 3.153(0.4);3.142(0.7); 3.136(0.7); 3.131(0.6); 3.125(1.3); 3.111(0.8); 3.096(0.3);2.677(0.4); 2.530(0.9); 2.525(1.6); 2.517(23.2); 2.512(47.9);2.508(65.4); 2.503(45.9); 2.498(21.3); 2.458(0.4); 2.334(0.4);2.330(0.3); 1.995(1.2); 1.344(0.3); 1.319(16.0); 1.286(1.0); 1.265(1.6);1.255(4.5); 1.200(0.5); 1.182(0.7); 1.164(0.4); 1.104(1.8); 0.882(2.1);0.866(7.4); 0.848(2.9); 0.819(9.8); 0.769(0.3); 0.758(0.4); 0.750(0.6);0.740(0.7); 0.735(0.8); 0.729(0.9); 0.723(0.9); 0.718(1.2); 0.708(0.4);0.700(1.3); 0.683(3.2); 0.677(2.1); 0.666(4.0); 0.659(1.7); 0.645(0.8)Example I.064: ¹H-NMR(300.2 MHz, CDCl₃): 7.261(32.6); 7.242(4.3);7.216(4.7); 7.074(0.6); 6.908(2.3); 6.902(2.8); 6.882(2.2); 6.876(2.4);6.825(3.2); 6.711(0.6); 5.300(16.0); 5.007(2.6); 3.844(6.3); 2.867(0.7);1.871(0.4); 1.855(0.9); 1.844(1.0); 1.827(1.8); 1.810(1.1); 1.799(1.1);1.782(0.5); 1.561(25.4); 1.374(0.8); 1.354(0.4); 1.313(8.7); 1.254(0.7);0.943(1.2); 0.928(3.3); 0.921(3.6); 0.915(2.0); 0.907(2.2); 0.900(3.8);0.893(3.4); 0.879(1.9); 0.857(0.5); 0.801(3.2); 0.748(3.7); 0.737(6.3);0.716(1.9); 0.658(4.7); 0.644(8.8); 0.638(8.4); 0.627(7.2); 0.621(7.2);0.605(2.6); 0.070(9.9); 0.057(0.5); 0.011(0.5); 0.000(19.6); −0.011(1.1)Example I.065: ¹H-NMR(300.2 MHz, d₆-DMSO): 7.233(3.7); 7.207(4.8);7.181(2.1); 7.041(2.5); 7.036(2.6); 7.010(2.5); 7.001(4.7); 6.892(4.2);6.822(2.2); 4.885(4.9); 3.824(7.5); 3.395(0.4); 3.329(183.1);3.256(0.5); 2.823(0.8); 2.567(1.6); 2.542(5.2); 2.514(10.6);2.508(16.7); 2.502(22.6); 2.496(17.5); 2.490(9.8); 2.075(1.8);1.274(11.5); 1.156(7.5); 1.131(16.0); 1.106(7.0); 0.748(14.8);0.671(2.7); 0.654(2.7); 0.542(3.1); 0.000(11.9); −0.011(0.6) ExampleI.066: ¹H-NMR(499.9 MHz, CDCl₃): 7.312(3.0); 7.300(3.2); 7.295(3.4);7.283(3.2); 7.257(39.6); 6.972(1.0); 6.876(1.6); 6.871(2.2); 6.860(3.9);6.854(3.6); 6.843(1.5); 6.837(1.8); 6.829(2.6); 6.824(2.1); 6.808(2.5);6.803(2.0); 6.753(1.0); 5.001(4.6); 3.835(13.2); 3.801(0.7); 2.905(1.3);1.528(25.1); 1.353(0.7); 1.322(16.0); 1.267(1.0); 1.258(0.7);0.896(0.6); 0.882(1.5); 0.868(0.8); 0.816(5.1); 0.802(2.1); 0.775(4.4);0.768(9.0); 0.755(2.4); 0.705(0.5); 0.654(6.2); 0.006(1.2); 0.000(30.7);−0.007(1.6) Example I.067: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.375(1.9);7.360(2.5); 7.355(2.6); 7.339(2.2); 7.217(1.5); 7.082(3.0); 7.047(2.2);7.040(2.3); 7.026(4.0); 7.019(4.0); 7.005(2.0); 6.998(1.9); 6.947(1.5);6.886(2.4); 6.881(2.3); 6.860(2.5); 6.855(2.2); 4.917(6.4); 4.046(0.5);4.028(0.5); 3.927(14.4); 3.892(1.3); 3.872(1.3); 3.822(0.4); 3.806(0.3);3.314(76.2); 2.907(1.8); 2.685(0.5); 2.681(0.9); 2.677(1.2); 2.672(0.9);2.668(0.4); 2.558(0.7); 2.530(2.7); 2.525(4.7); 2.517(64.7);2.512(132.7); 2.508(179.8); 2.503(125.8); 2.499(57.9); 2.458(0.7);2.344(0.4); 2.339(0.8); 2.335(1.2); 2.330(0.8); 1.995(2.2); 1.346(0.9);1.306(15.3); 1.290(3.3); 1.255(7.7); 1.200(1.0); 1.182(1.4); 1.164(0.9);1.149(0.4); 0.882(3.4); 0.866(11.8); 0.848(4.7); 0.798(16.0);0.748(0.9); 0.742(0.9); 0.707(0.6); 0.692(0.6); 0.675(0.5); 0.589(3.8);0.574(3.7); 0.499(4.3) Example I.068: ¹H-NMR(400.1 MHz, d₆-DMSO):7.405(1.5); 7.390(1.7); 7.384(1.7); 7.368(1.7); 7.264(1.4); 7.129(3.2);7.071(0.8); 7.064(0.9); 7.050(1.5); 7.043(1.4); 7.028(0.8); 7.022(0.7);6.994(1.6); 6.740(1.5); 6.733(1.4); 6.714(1.5); 6.707(1.3); 5.537(0.6);5.025(0.4); 4.063(1.2); 4.046(3.6); 4.028(3.6); 4.010(1.2); 3.836(10.3);3.805(0.3); 3.682(0.9); 3.314(24.1); 3.161(0.6); 3.149(0.9); 3.137(0.7);2.681(0.5); 2.676(0.7); 2.672(0.5); 2.530(1.4); 2.525(2.4); 2.517(40.2);2.512(83.5); 2.508(113.9); 2.503(80.2); 2.499(37.3); 2.463(0.6);2.459(0.6); 2.339(0.5); 2.334(0.7); 2.330(0.5); 1.995(16.0);1.313(16.0); 1.290(0.4); 1.200(4.3); 1.182(8.8); 1.164(4.3); 1.136(1.1);0.806(15.0); 0.759(2.1); 0.741(2.3); 0.712(1.4); 0.634(0.4) ExampleI.069: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.402(1.3); 7.387(1.5); 7.381(1.6);7.366(1.6); 7.244(1.3); 7.109(2.2); 7.070(0.8); 7.063(0.8); 7.049(1.5);7.042(1.5); 7.028(0.9); 7.021(0.8); 7.007(0.5); 6.975(1.4); 6.851(1.2);6.844(1.2); 6.825(1.2); 6.818(1.1); 5.577(0.8); 5.537(2.1); 5.495(2.1);5.454(0.8); 4.921(0.4); 4.064(0.7); 4.046(2.3); 4.028(2.4); 4.011(0.9);3.921(11.2); 3.873(0.3); 3.782(1.6); 3.315(13.8); 3.154(0.6);3.149(0.7); 3.137(1.1); 3.132(0.7); 3.123(0.9); 3.109(0.4); 2.677(0.4);2.673(0.3); 2.531(0.9); 2.526(1.3); 2.517(23.2); 2.513(50.5);2.508(72.3); 2.504(56.7); 2.499(33.4); 2.459(0.8); 2.340(0.3);2.335(0.5); 2.331(0.4); 1.996(10.0); 1.335(0.3); 1.319(14.6);1.285(0.4); 1.243(0.5); 1.200(2.7); 1.183(5.4); 1.165(2.8); 1.096(1.7);0.863(0.4); 0.850(0.3); 0.812(16.0); 0.733(0.3); 0.727(0.5); 0.714(0.6);0.703(1.3); 0.690(1.3); 0.672(3.5); 0.659(3.7); 0.636(0.9); 0.623(0.5)Example I.071: ¹H-NMR(499.9 MHz, CDCl₃): 7.256(2.3); 7.237(2.8);7.221(3.2); 7.000(1.9); 6.985(1.9); 6.938(2.9); 6.874(0.6); 5.009(1.4);3.826(3.5); 2.877(0.5); 2.286(16.0); 1.604(0.7); 1.320(4.8); 0.810(2.1);0.777(0.6); 0.747(2.2); 0.740(4.9); 0.728(1.6); 0.650(2.8); 0.000(2.0)Example I.072: ¹H-NMR(499.9 MHz, CDCl₃): 7.257(34.0); 7.232(1.9);7.217(2.2); 7.083(2.5); 7.045(0.5); 7.001(3.0); 6.986(2.6); 6.909(0.6);6.799(1.3); 6.690(0.7); 5.049(2.0); 4.779(0.4); 3.924(7.4); 3.813(0.6);2.907(1.1); 2.290(16.0); 2.039(0.5); 1.530(24.4); 1.336(7.5);1.304(1.3); 1.291(1.4); 1.279(1.6); 1.267(3.6); 1.257(1.5); 1.242(0.8);1.212(0.7); 0.896(2.6); 0.882(6.3); 0.868(3.2); 0.828(3.7); 0.789(0.8);0.748(4.2); 0.709(0.9); 0.612(2.7); 0.544(2.3); 0.533(2.1); 0.006(2.0);0.000(27.3); −0.007(0.9) Example I.073: ¹H-NMR(499.9 MHz, CDCl₃):7.263(3.0); 7.257(6.4); 7.247(3.4); 7.220(0.6); 7.204(0.5); 7.176(1.5);7.066(3.0); 7.021(2.3); 7.006(2.1); 6.956(1.5); 6.899(4.0); 6.659(0.4);5.043(0.8); 3.825(13.0); 3.698(0.3); 3.671(2.2); 3.080(0.8); 3.071(1.2);3.067(1.2); 3.063(1.0); 3.059(0.9); 2.317(2.6); 2.285(15.9);1.551(10.4); 1.346(16.0); 1.190(2.6); 1.027(0.4); 1.015(0.4);0.922(0.6); 0.915(0.6); 0.844(4.8); 0.804(0.9); 0.781(3.0); 0.770(1.4);0.763(2.3); 0.756(5.3); 0.745(1.9); 0.716(0.5); 0.697(1.5); 0.686(3.1);0.672(3.9); 0.000(4.8) Example I.074: ¹H-NMR(400.1 MHz, d₆-DMSO):7.234(3.2); 7.215(3.4); 7.171(0.5); 7.152(0.6); 7.137(0.4); 7.102(2.6);7.029(1.6); 7.013(1.4); 7.010(1.4); 7.004(0.8); 6.968(1.8); 6.945(2.8);6.834(0.5); 5.631(1.3); 5.591(1.9); 5.442(1.9); 5.403(1.4); 4.941(0.4);4.901(0.5); 4.001(0.7); 3.988(0.7); 3.985(0.4); 3.975(0.8); 3.922(13.1);3.893(0.4); 3.785(2.4); 3.314(20.0); 3.117(0.4); 3.103(0.9); 3.088(1.1);3.080(0.7); 3.076(0.7); 3.070(0.6); 3.059(0.3); 3.006(0.7); 2.995(0.3);2.992(0.7); 2.990(0.4); 2.979(0.7); 2.681(0.3); 2.677(0.5); 2.672(0.3);2.530(1.1); 2.525(1.9); 2.517(28.5); 2.512(59.3); 2.508(81.0);2.503(57.3); 2.499(26.8); 2.467(0.4); 2.463(0.5); 2.458(0.5);2.429(0.3); 2.339(0.4); 2.334(0.6); 2.330(0.4); 2.257(2.5); 2.233(13.7);1.363(1.6); 1.301(16.0); 1.251(1.9); 1.246(1.8); 1.107(2.5); 0.882(0.5);0.866(1.7); 0.858(0.6); 0.848(1.0); 0.777(8.1); 0.746(0.9); 0.737(0.7);0.728(1.2); 0.724(1.0); 0.714(1.0); 0.694(0.6); 0.680(0.8); 0.674(0.6);0.666(1.6); 0.660(1.8); 0.649(3.2); 0.643(2.2); 0.634(2.9); 0.629(2.9);0.597(0.4) Example I.075: ¹H-NMR(300.2 MHz, CDCl₃): 7.261(3.2);7.205(3.4); 7.179(4.3); 6.983(3.3); 6.957(3.1); 6.843(1.0); 6.741(0.4);5.024(1.2); 4.860(1.1); 3.836(1.9); 3.678(1.6); 2.266(16.0); 2.002(0.8);1.665(0.3); 1.388(2.4); 1.320(4.1); 0.905(2.8); 0.830(1.6); 0.741(8.1);0.515(1.1); 0.000(2.0) Example I.076: ¹H-NMR(300.2 MHz, CDCl₃):7.261(1.4); 7.244(2.3); 7.219(2.9); 7.037(1.9); 7.012(1.5); 6.966(1.1);6.937(2.3); 6.784(2.1); 6.602(1.0); 5.000(4.4); 3.804(8.6); 2.290(13.0);1.998(1.3); 1.646(1.0); 1.479(2.4); 1.413(0.5); 1.362(1.6); 1.345(3.3);1.314(1.2); 1.294(11.4); 0.770(16.0); 0.000(0.7) Example I.077:¹H-NMR(300.2 MHz, CDCl₃): 7.261(9.2); 7.187(2.6); 7.161(2.9);7.031(3.3); 6.985(3.7); 6.960(2.5); 6.824(1.1); 6.642(2.3); 6.460(1.1);5.065(0.9); 4.847(7.4); 3.933(1.5); 3.924(1.4); 3.778(12.3);2.286(16.0); 2.006(0.4); 1.623(3.5); 1.484(0.4); 1.462(0.4); 1.393(1.6);1.352(1.9); 1.303(12.3); 1.276(1.1); 1.256(0.6); 1.216(12.8);0.961(5.1); 0.842(0.8); 0.711(8.4); 0.685(6.7); 0.414(0.8); 0.000(6.2)Example I.078: ¹H-NMR(300.2 MHz, CDCl₃): 7.261(4.0); 7.230(3.3);7.205(4.2); 7.068(1.6); 7.038(3.6); 7.012(2.6); 6.878(0.6); 6.697(1.1);6.516(0.6); 4.934(1.6); 3.860(7.8); 2.312(16.0); 2.004(8.1); 1.613(2.3);1.549(1.3); 1.466(0.8); 1.393(4.5); 1.254(7.2); 0.752(9.1); 0.000(2.4)Example I.079: ¹H-NMR(300.2 MHz, CDCl₃): 7.672(2.3); 7.670(2.3);7.299(2.1); 7.272(2.9); 7.266(2.1); 7.185(3.1); 7.155(1.4); 7.123(1.4);7.118(1.4); 7.097(1.1); 7.093(1.0); 6.974(1.7); 6.972(1.7); 6.791(1.4);5.299(1.6); 3.777(9.1); 3.429(16.0); 2.367(12.1); 2.191(0.4);2.180(0.6); 2.168(0.9); 2.157(0.9); 2.145(0.7); 2.134(0.4); 2.007(3.4);1.356(0.4); 1.339(0.6); 1.332(0.5); 1.325(0.6); 1.321(0.6); 1.307(0.5);1.252(13.7); 0.826(0.9); 0.823(0.9); 0.803(2.0); 0.792(1.4); 0.775(2.3);0.705(0.4); 0.689(2.7); 0.673(1.9); 0.660(2.5); 0.650(1.2); 0.641(1.3);0.637(1.3); 0.609(0.4); 0.505(0.7); 0.495(0.3); 0.485(0.9); 0.474(0.6);0.462(0.5); 0.453(0.6); 0.415(0.4); 0.401(0.5); 0.396(0.5); 0.391(0.5);0.380(0.8); 0.366(0.6); 0.359(0.6); 0.347(0.4); 0.343(0.4); 0.000(1.3)Example I.080: ¹H-NMR(300.2 MHz, d₆-DMSO): 10.738(0.3); 7.328(0.6);7.301(14.5); 7.298(15.6); 7.190(2.6); 7.163(0.4); 7.114(5.8);7.011(5.7); 6.831(2.9); 6.707(2.1); 6.671(2.5); 6.648(2.8); 6.612(2.5);5.743(4.0); 5.687(3.4); 5.244(3.9); 5.205(4.1); 4.899(7.2); 4.665(0.3);3.875(0.5); 3.826(10.7); 3.589(0.3); 3.461(0.4); 3.423(0.4); 3.418(0.4);3.403(0.4); 3.393(1.4); 3.381(0.8); 3.364(1.1); 3.355(1.5); 3.345(2.9);3.327(400.0); 3.288(1.6); 3.277(1.2); 3.269(0.9); 3.242(0.3);3.213(0.4); 2.856(1.0); 2.729(0.4); 2.560(0.4); 2.541(0.8); 2.514(18.8);2.508(41.5); 2.502(58.6); 2.495(44.4); 2.490(22.3); 2.272(0.4);2.075(4.5); 1.367(0.5); 1.292(15.7); 0.776(16.0); 0.714(0.7);0.679(3.5); 0.662(3.5); 0.643(1.6); 0.611(0.7); 0.541(3.9); 0.474(0.4);0.011(1.0); 0.000(40.1); −0.011(2.1) Example I.081: ¹H-NMR(300.2 MHz,d₆-DMSO): 8.078(3.9); 8.053(4.2); 7.825(3.3); 7.799(3.6); 7.712(11.8);7.497(1.6); 7.471(8.7); 7.463(6.3); 7.431(4.3); 7.402(3.1); 7.383(2.7);7.358(2.8); 7.334(1.3); 7.312(6.0); 7.243(1.1); 7.193(0.5); 7.128(2.3);6.948(5.1); 6.769(2.5); 4.994(7.0); 4.467(0.7); 3.775(16.0);3.326(216.7); 2.975(1.1); 2.540(0.3); 2.507(20.6); 2.502(28.3);2.496(22.0); 2.075(1.0); 1.426(2.1); 1.368(13.5); 1.232(0.5);0.860(7.4); 0.841(9.0); 0.733(3.9); 0.715(4.0); 0.596(4.5); 0.448(0.4);0.252(0.4); 0.000(4.8) Example I.083: ¹H-NMR(400.1 MHz, d₆-DMSO):7.353(1.3); 7.348(1.3); 7.333(3.5); 7.328(3.8); 7.311(6.3); 7.291(2.2);7.170(4.0); 7.166(4.0); 7.132(2.0); 6.997(4.4); 6.863(2.2); 5.332(4.5);5.074(3.1); 5.070(4.4); 5.067(3.1); 4.916(5.0); 3.831(7.6); 3.328(34.0);2.886(0.7); 2.678(0.4); 2.531(1.4); 2.518(21.3); 2.513(43.8);2.509(60.0); 2.504(44.2); 2.500(22.5); 2.340(0.3); 2.336(0.4);2.331(0.3); 2.080(6.4); 2.068(16.0); 2.019(0.4); 1.355(0.4);1.303(10.7); 0.785(11.5); 0.707(0.8); 0.691(2.8); 0.677(2.9); 0.550(3.1)Example I.084: ¹H-NMR(300.2 MHz, CDCl₃): 7.261(17.6); 7.254(0.8);7.228(0.3); 7.145(0.4); 7.140(0.4); 7.113(0.4); 5.094(0.8); 3.814(1.6);2.010(0.6); 1.553(16.0); 1.332(2.2); 0.867(0.5); 0.811(0.4); 0.799(0.6);0.684(0.7); 0.667(1.0); 0.011(0.4); 0.000(12.2); −0.011(0.5) ExampleI.085: ¹H-NMR(300.2 MHz, CDCl₃): 7.367(1.2); 7.339(2.6); 7.291(2.9);7.262(24.3); 7.122(0.6); 6.940(1.3); 6.758(0.6); 5.170(4.3); 3.813(5.4);2.009(3.4); 1.553(16.0); 1.347(8.1); 0.905(1.7); 0.893(0.9); 0.881(0.5);0.846(0.4); 0.836(1.1); 0.823(2.2); 0.809(0.6); 0.801(0.6); 0.591(1.9);0.572(3.1); 0.011(0.6); 0.000(17.5); −0.011(0.7) Example I.086:¹H-NMR(300.2 MHz, CDCl₃): 7.262(22.9); 7.254(0.6); 7.251(0.4);7.250(0.4); 7.241(2.1); 7.215(3.3); 7.150(0.7); 7.140(2.4); 7.114(1.4);6.968(1.2); 6.786(0.6); 5.181(3.6); 3.811(8.6); 2.358(12.9); 2.009(2.1);1.564(16.0); 1.503(0.7); 1.338(12.2); 1.254(0.4); 0.879(2.4);0.867(1.2); 0.847(0.6); 0.818(0.4); 0.800(1.6); 0.788(3.3); 0.783(2.6);0.766(1.0); 0.550(2.7); 0.011(0.4); 0.000(15.6); −0.011(0.7) ExampleI.087: ¹H-NMR(300.2 MHz, CDCl₃): 7.272(0.3); 7.261(24.7); 7.255(0.7);7.254(0.5); 7.252(0.4); 7.251(0.3); 7.086(0.5); 7.060(4.5); 7.039(1.0);6.954(0.6); 5.086(1.4); 3.810(5.7); 2.226(5.7); 2.218(4.7); 2.009(1.3);1.554(16.0); 1.324(7.1); 1.255(0.3); 0.845(1.7); 0.819(0.5); 0.773(1.1);0.761(2.2); 0.748(0.7); 0.739(0.6); 0.657(1.9); 0.011(0.6); 0.000(19.3);−0.008(0.6); −0.009(0.6); −0.011(0.8) Example I.089: ¹H-NMR(300.2 MHz,CDCl₃): 7.269(0.3); 7.261(18.0); 7.206(0.5); 7.191(1.5); 7.183(1.4);7.176(0.9); 7.173(0.8); 6.951(0.5); 6.942(0.6); 6.919(0.3); 6.915(0.4);6.898(0.4); 5.301(1.3); 5.096(1.1); 3.806(3.5); 2.173(0.3); 1.550(16.0);1.342(4.7); 0.871(1.1); 0.860(0.5); 0.800(0.7); 0.788(1.4); 0.767(0.4);0.661(1.5); 0.011(0.4); 0.000(12.3); −0.009(0.3); −0.011(0.5) ExampleI.090: ¹H-NMR(400.1 MHz, d₆-DMSO): 10.728(0.4); 7.960(1.9); 7.384(4.9);7.363(8.6); 7.317(4.8); 7.311(4.7); 7.296(2.6); 7.291(2.7); 7.151(2.9);7.057(6.3); 7.052(5.8); 7.016(6.4); 6.881(3.2); 4.984(7.9); 4.353(0.4);4.341(0.7); 4.328(0.4); 3.838(12.3); 3.464(0.5); 3.451(0.5); 3.446(0.6);3.434(0.5); 3.317(78.9); 3.184(0.4); 3.170(0.4); 3.017(0.3);2.931(12.8); 2.898(16.0); 2.739(11.9); 2.738(11.7); 2.682(0.4);2.677(0.5); 2.673(0.4); 2.531(1.5); 2.517(29.8); 2.513(60.0);2.508(80.4); 2.504(56.8); 2.499(26.4); 2.458(0.4); 2.340(0.4);2.335(0.5); 2.330(0.4); 1.402(1.4); 1.386(2.2); 1.375(5.9); 1.370(6.2);1.360(2.7); 1.243(0.4); 1.205(2.8); 1.194(6.2); 1.189(6.0); 1.177(2.2);1.081(1.3); 1.064(2.5); 1.046(1.3); 0.717(1.0); 0.701(4.2); 0.687(4.2);0.671(1.4); 0.646(0.6); 0.627(0.4); 0.560(4.5) Example I.091:¹H-NMR(400.1 MHz, d₆-DMSO): 7.960(0.5); 7.382(2.7); 7.362(4.7);7.315(4.5); 7.310(4.7); 7.295(2.5); 7.289(2.6); 7.236(1.5); 7.179(4.8);7.102(3.1); 6.967(1.5); 4.996(6.7); 3.937(16.0); 3.896(0.5); 3.869(0.4);3.840(0.4); 3.822(0.4); 3.318(68.8); 2.951(6.4); 2.912(1.7); 2.898(5.2);2.845(0.3); 2.739(2.9); 2.677(0.4); 2.531(0.7); 2.517(24.1);2.513(49.8); 2.508(67.8); 2.504(48.4); 2.499(23.1); 2.465(0.4);2.340(0.4); 2.335(0.5); 2.331(0.3); 1.388(6.0); 1.338(0.4); 1.278(0.4);1.256(0.5); 1.206(5.7); 1.202(5.7); 1.178(1.0); 1.100(0.4); 1.081(0.4);1.064(0.6); 1.056(0.4); 1.046(0.4); 0.595(3.8); 0.579(3.8); 0.524(4.6)Example I.092: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.219(2.1); 7.200(2.6);7.147(1.5); 7.044(1.9); 7.024(1.6); 7.013(3.5); 6.896(3.3); 6.878(1.7);5.760(5.6); 4.968(2.5); 3.837(4.1); 3.320(73.9); 2.852(5.9); 2.530(0.7);2.517(12.3); 2.513(25.2); 2.508(34.4); 2.504(24.6); 2.499(11.7);2.265(16.0); 1.995(0.4); 1.330(2.7); 1.254(0.3); 1.135(2.6); 0.866(0.4);0.675(1.7); 0.661(1.7); 0.565(2.0) Example I.093: ¹H-NMR(400.1 MHz,d₆-DMSO): 7.218(2.3); 7.199(2.5); 7.105(0.5); 7.090(2.2); 7.043(2.2);7.017(4.0); 6.970(0.9); 6.955(1.2); 6.835(0.4); 5.760(6.5); 4.980(3.5);4.763(0.3); 3.936(11.0); 3.903(0.5); 3.873(2.9); 3.859(0.3); 3.813(0.5);3.372(0.3); 3.322(66.1); 2.872(5.6); 2.530(0.5); 2.517(12.3);2.512(25.2); 2.508(34.2); 2.503(24.4); 2.499(11.5); 2.269(16.0);1.346(3.9); 1.265(0.3); 1.243(0.7); 1.149(3.8); 1.144(3.8); 1.133(1.7);1.110(0.7); 1.098(0.6); 1.029(0.4); 1.013(0.6); 0.996(0.5); 0.866(0.4);0.559(2.6); 0.539(3.7); 0.527(3.8) Example I.094: ¹H-NMR(300.2 MHz,d₆-DMSO): 7.521(3.7); 7.499(1.7); 7.491(4.8); 7.320(1.0); 7.294(2.4);7.286(4.2); 7.264(9.3); 7.159(2.6); 7.144(2.0); 6.980(5.7); 6.968(1.0);6.801(2.8); 4.692(10.8); 4.041(0.5); 4.017(0.5); 3.823(6.1);3.799(16.0); 3.773(2.9); 3.323(95.8); 3.258(0.4); 2.649(0.8);2.640(0.8); 2.514(11.0); 2.508(23.6); 2.502(32.2); 2.496(23.5);2.490(11.3); 1.989(2.4); 1.813(2.2); 1.797(7.0); 1.787(7.1); 1.772(3.0);1.719(0.3); 1.550(0.4); 1.499(2.8); 1.482(6.9); 1.473(7.2); 1.455(2.3);1.247(2.5); 1.198(0.7); 1.175(1.3); 1.151(0.6); 1.083(0.7); 0.879(0.7);0.858(2.3); 0.835(0.8); 0.689(0.7); 0.664(3.1); 0.648(3.6); 0.628(2.4);0.608(2.2); 0.594(4.7); 0.555(0.8); 0.011(0.7); 0.000(24.3); −0.011(1.2)Example I.095: ¹H-NMR(300.2 MHz, d₆-DMSO): 7.521(3.3); 7.493(4.0);7.318(4.9); 7.311(6.2); 7.283(4.5); 7.275(3.0); 7.255(3.5); 7.247(2.7);7.208(1.5); 7.028(3.2); 6.849(1.6); 4.719(1.5); 4.065(0.4); 4.041(1.5);4.017(1.5); 3.993(0.5); 3.944(1.4); 3.897(16.0); 3.324(66.1);2.741(1.0); 2.514(8.1); 2.508(17.3); 2.502(23.7); 2.496(17.4);2.490(8.4); 1.989(6.3); 1.808(2.4); 1.791(7.9); 1.782(8.2); 1.767(3.4);1.714(0.4); 1.490(3.1); 1.473(7.7); 1.464(8.2); 1.446(2.6); 1.282(0.7);1.247(4.8); 1.198(1.9); 1.175(3.5); 1.151(1.8); 0.880(1.4); 0.873(1.1);0.858(4.6); 0.835(1.7); 0.657(0.4); 0.567(6.1); 0.011(0.6); 0.000(20.2);−0.011(0.9) Example I.096: ¹H-NMR(300.2 MHz, CDCl₃): 7.287(2.9);7.281(2.6); 7.278(2.3); 7.261(32.4); 7.237(1.0); 7.231(1.1); 7.213(2.9);7.207(2.9); 7.191(6.5); 7.187(6.7); 7.172(3.0); 7.166(3.5); 7.142(4.2);7.135(2.9); 7.113(1.8); 7.080(0.8); 6.897(1.5); 6.716(0.7); 5.026(4.2);3.834(11.3); 2.874(1.2); 2.007(1.1); 1.575(9.9); 0.848(7.4);0.824(16.0); 0.800(11.4); 0.770(7.2); 0.639(7.5); 0.627(7.6);0.082(0.4); 0.070(13.3); 0.058(0.6); 0.011(0.6); 0.000(19.4);−0.011(1.0) Example I.097: ¹H-NMR(300.2 MHz, CDCl₃): 7.271(4.0);7.261(52.9); 7.250(7.6); 7.240(7.7); 7.215(5.2); 7.194(6.5); 7.185(4.4);7.170(3.6); 7.163(2.5); 7.148(0.9); 7.140(1.0); 6.987(1.4); 6.910(0.3);6.805(2.8); 6.622(1.4); 5.064(4.2); 4.772(0.6); 3.926(16.0); 3.819(1.1);2.903(1.9); 2.891(1.5); 2.007(3.5); 1.643(0.4); 1.557(14.6); 1.348(0.4);1.329(0.3); 1.253(0.6); 0.853(5.9); 0.828(14.5); 0.806(8.7); 0.781(7.5);0.575(5.6); 0.536(4.2); 0.513(3.6); 0.081(0.8); 0.069(23.9); 0.057(1.1);0.011(1.6); 0.000(47.2); −0.011(2.1) Example I.098: ¹H-NMR(300.2 MHz,CDCl₃): 7.312(1.7); 7.299(1.8); 7.293(2.5); 7.282(3.5); 7.275(3.2);7.261(31.8); 7.238(1.6); 7.211(5.5); 7.199(4.5); 7.193(4.8); 7.181(5.5);7.168(0.9); 7.121(1.0); 7.108(2.4); 7.092(7.0); 7.078(1.5); 6.909(2.6);6.642(0.6); 5.673(0.5); 5.650(0.5); 5.047(1.1); 3.826(16.0); 3.670(2.7);3.134(0.4); 3.096(0.4); 3.087(0.6); 3.079(1.0); 3.065(1.4); 3.042(1.1);2.008(2.4); 1.612(0.4); 1.545(13.1); 1.035(0.5); 1.012(0.5); 0.921(0.7);0.908(0.7); 0.896(0.4); 0.873(6.2); 0.848(15.2); 0.824(6.8); 0.786(5.4);0.766(4.7); 0.756(5.3); 0.735(2.5); 0.720(1.7); 0.705(1.7); 0.680(3.9);0.656(4.1); 0.069(4.5); 0.011(1.0); 0.000(30.2); −0.011(1.7) ExampleI.099: ¹H-NMR(300.2 MHz, CDCl₃): 7.307(1.1); 7.301(1.2); 7.296(1.0);7.291(1.5); 7.284(1.6); 7.275(2.1); 7.262(10.5); 7.255(0.9); 7.247(0.8);7.240(0.6); 7.232(0.4); 7.224(1.8); 7.220(1.6); 7.217(1.2); 7.203(13.7);7.193(6.2); 7.187(3.4); 7.171(1.1); 7.161(0.9); 7.136(0.5); 7.102(2.4);6.919(3.4); 6.852(0.5); 6.736(2.4); 6.671(1.0); 6.490(0.5); 5.805(2.3);5.752(3.3); 5.525(3.5); 5.473(2.5); 5.030(0.6); 4.934(0.6); 3.912(16.0);3.776(4.8); 3.187(0.4); 3.141(0.4); 3.127(0.9); 3.117(1.0); 3.103(1.9);3.088(1.1); 3.078(1.0); 3.064(0.5); 2.005(4.5); 1.577(4.3); 1.101(0.3);1.096(0.4); 0.973(0.4); 0.968(0.4); 0.960(0.4); 0.948(0.5); 0.941(1.1);0.938(1.2); 0.924(1.1); 0.906(0.4); 0.875(5.6); 0.851(12.8); 0.826(5.6);0.797(3.2); 0.770(2.7); 0.755(3.0); 0.745(4.5); 0.741(4.5); 0.731(3.8);0.717(2.2); 0.681(0.8); 0.676(0.9); 0.660(0.7); 0.653(0.8); 0.637(0.7);0.622(1.3); 0.611(1.5); 0.605(3.1); 0.596(2.7); 0.587(1.6); 0.580(3.4);0.572(2.1); 0.557(0.7); 0.070(7.8); 0.058(0.3); 0.011(0.3); 0.000(10.0);−0.011(0.4) Example I.100: ¹H-NMR(300.2 MHz, CDCl₃): 7.512(4.4);7.478(2.0); 7.451(2.4); 7.269(1.5); 7.242(2.7); 7.215(2.2); 7.053(1.1);6.871(2.2); 6.689(1.1); 5.299(0.4); 5.047(4.4); 4.005(0.4); 3.843(11.1);2.902(1.0); 1.678(0.6); 1.551(0.6); 1.259(0.6); 0.902(0.4); 0.881(1.0);0.857(7.2); 0.841(15.4); 0.834(16.0); 0.809(5.4); 0.625(4.1); 0.000(1.7)Example I.101: ¹H-NMR(300.2 MHz, CDCl₃): 7.510(4.9); 7.494(3.0);7.466(3.4); 7.369(4.4); 7.342(3.0); 7.271(1.7); 7.248(0.4); 7.069(0.8);6.979(1.3); 6.889(0.5); 6.796(2.7); 6.613(1.3); 5.088(4.9); 3.933(14.7);3.888(0.8); 3.825(0.5); 2.963(0.4); 2.944(1.1); 2.927(1.6); 2.909(1.2);2.891(0.5); 1.696(0.4); 1.671(0.4); 1.645(0.4); 1.579(0.6); 1.557(0.6);1.330(0.5); 1.307(0.8); 1.267(4.6); 1.261(4.5); 0.903(1.9); 0.881(5.5);0.855(16.0); 0.838(12.2); 0.814(5.8); 0.753(1.1); 0.577(10.0);0.561(6.7); 0.000(1.8) Example I.102: ¹H-NMR(400.1 MHz, d₆-DMSO):7.303(2.8); 7.297(3.3); 7.282(3.2); 7.277(4.3); 7.255(8.1); 7.249(6.1);7.126(3.0); 7.088(5.9); 7.068(4.9); 6.991(6.5); 6.857(3.3); 4.851(8.0);3.815(13.6); 3.301(7.1); 2.832(1.1); 2.510(11.0); 2.506(21.4);2.501(28.2); 2.497(20.3); 2.492(9.9); 2.072(1.3); 1.500(0.9);0.792(13.1); 0.774(16.0); 0.756(6.2); 0.692(1.2); 0.675(4.4);0.661(4.4); 0.646(1.5); 0.623(0.4); 0.573(0.3); 0.525(4.7); 0.000(0.8)Example I.103: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.321(3.3); 7.316(3.6);7.300(4.3); 7.295(4.7); 7.253(6.0); 7.181(7.9); 7.160(5.5); 7.051(3.3);6.916(1.6); 4.872(4.2); 3.914(16.0); 3.867(0.9); 3.814(0.5); 3.303(6.0);2.853(2.3); 2.510(11.9); 2.506(23.0); 2.502(30.3); 2.497(22.0);2.073(13.3); 1.522(1.1); 0.799(15.6); 0.782(12.9); 0.765(6.8);0.715(1.4); 0.558(4.7); 0.545(4.6); 0.474(5.3); 0.000(0.4) ExampleI.104: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.279(0.3); 7.167(0.5); 7.147(0.8);7.132(1.9); 7.084(0.3); 7.059(3.7); 7.037(1.5); 7.016(2.7); 6.998(4.4);6.975(4.2); 6.955(2.3); 6.863(2.2); 5.760(8.4); 4.850(3.0); 3.829(4.9);3.821(6.1); 3.794(0.8); 3.775(2.3); 3.318(4.8); 2.801(0.6); 2.531(0.4);2.526(0.7); 2.517(12.5); 2.513(26.4); 2.508(36.4); 2.504(25.8);2.499(12.1); 2.268(16.0); 2.246(0.5); 1.505(0.5); 1.492(0.5);1.445(2.1); 1.293(0.3); 1.276(0.5); 1.244(0.4); 1.173(0.7); 1.155(1.3);1.137(0.7); 0.794(3.4); 0.776(7.3); 0.758(5.7); 0.733(3.8); 0.658(2.3);0.644(2.3); 0.525(2.4) Example I.105: ¹H-NMR(400.1 MHz, d₆-DMSO):7.503(0.4); 7.368(0.8); 7.233(0.4); 7.188(0.5); 7.078(0.7); 7.057(4.4);7.040(2.5); 7.021(0.9); 6.919(0.6); 5.760(16.0); 4.867(1.1); 3.920(5.6);3.873(0.8); 3.851(6.3); 3.325(0.5); 2.946(2.1); 2.929(2.1); 2.832(0.8);2.526(0.5); 2.517(10.0); 2.513(21.3); 2.508(29.4); 2.504(21.1);2.499(10.0); 2.269(8.5); 2.245(0.6); 1.244(0.3); 1.160(5.6);1.142(11.2); 1.124(5.6); 1.064(0.5); 0.801(2.0); 0.783(4.4); 0.766(3.1);0.748(2.9); 0.695(0.6); 0.668(0.6); 0.534(1.4); 0.518(1.5); 0.469(1.6)Example I.106: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.153(3.9); 7.138(3.6);7.133(4.1); 7.003(6.1); 6.868(3.1); 6.750(4.3); 6.722(4.3); 4.841(6.5);3.826(11.9); 3.309(6.7); 2.853(1.0); 2.530(0.4); 2.517(7.4);2.512(14.9); 2.508(20.1); 2.503(14.1); 2.499(6.5); 2.195(16.0);2.079(0.4); 1.483(0.7); 0.796(5.7); 0.777(12.2); 0.759(9.3); 0.739(6.1);0.689(1.1); 0.673(3.7); 0.659(3.6); 0.644(1.2); 0.620(0.3); 0.526(3.9)Example I.107: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.206(0.9); 7.149(2.1);7.129(2.2); 7.071(1.8); 6.936(0.9); 6.841(2.1); 6.813(2.2); 4.857(3.6);3.923(9.3); 3.308(20.2); 2.868(1.2); 2.677(0.4); 2.530(0.9);2.517(19.8); 2.512(40.1); 2.508(54.1); 2.503(38.0); 2.499(17.7);2.335(0.3); 2.197(13.2); 2.079(16.0); 1.498(0.5); 0.802(3.5);0.784(7.5); 0.767(5.6); 0.752(5.1); 0.564(2.5); 0.549(2.4); 0.474(2.8)Example I.108: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.583(2.5); 7.566(3.7);7.563(3.8); 7.492(5.5); 7.472(3.7); 7.341(5.8); 7.126(3.1); 6.991(7.1);6.857(3.6); 4.949(11.0); 3.832(15.8); 3.309(30.0); 2.863(1.2);2.677(0.4); 2.558(0.4); 2.531(0.9); 2.526(1.5); 2.517(20.5);2.513(43.3); 2.508(60.3); 2.504(44.4); 2.499(22.7); 2.463(1.2);2.459(1.0); 2.335(0.4); 2.079(12.5); 1.553(1.3); 0.857(5.7); 0.811(7.9);0.804(10.7); 0.786(16.0); 0.767(7.4); 0.729(0.7); 0.707(1.2);0.689(4.8); 0.676(4.9); 0.672(4.6); 0.659(1.9); 0.620(0.4); 0.525(4.9)Example I.109: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.583(2.6); 7.563(3.9);7.489(3.9); 7.468(5.9); 7.199(1.2); 7.064(2.4); 6.929(1.2); 4.967(2.7);3.961(0.5); 3.929(11.4); 3.309(9.8); 2.891(1.5); 2.530(0.6);2.517(13.7); 2.512(27.9); 2.508(37.6); 2.503(26.4); 2.499(12.3);2.079(16.0); 1.564(0.9); 1.486(0.4); 0.870(3.9); 0.824(5.4); 0.809(5.7);0.791(7.6); 0.773(4.1); 0.744(0.9); 0.726(0.7); 0.666(0.4); 0.590(3.1);0.576(3.0); 0.495(3.6) Example I.110: ¹H-NMR(400.1 MHz, d₆-DMSO):7.258(16.0); 7.255(15.5); 7.132(2.6); 7.038(7.0); 6.998(5.7);6.863(2.9); 4.873(8.7); 3.826(13.2); 3.303(6.6); 2.862(1.1);2.506(26.4); 2.501(34.7); 2.497(25.3); 2.073(14.3); 1.491(0.9);0.785(10.0); 0.767(13.2); 0.748(11.4); 0.700(1.3); 0.683(4.3);0.669(4.3); 0.654(1.5); 0.630(0.4); 0.528(4.6); 0.000(0.6) ExampleI.111: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.254(11.6); 7.203(1.2); 7.168(3.8);7.068(2.2); 6.934(1.1); 4.890(3.4); 3.923(11.0); 3.303(4.4); 2.876(1.5);2.506(21.1); 2.502(27.7); 2.497(20.2); 2.073(16.0); 1.505(0.8);0.792(5.9); 0.773(8.4); 0.757(8.1); 0.578(3.1); 0.564(3.0); 0.491(3.5);0.000(0.3) Example I.112: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.202(0.7);7.132(1.2); 7.112(1.6); 7.068(1.5); 7.005(4.4); 6.989(1.7); 6.933(0.8);5.760(16.0); 4.881(1.4); 3.928(7.2); 3.904(0.5); 3.891(0.4); 3.857(2.4);3.318(3.3); 2.913(0.7); 2.880(0.6); 2.862(0.8); 2.852(1.0); 2.531(0.6);2.526(1.0); 2.517(14.0); 2.513(29.0); 2.508(39.6); 2.504(27.9);2.499(13.0); 2.252(11.9); 1.486(0.4); 1.364(0.4); 1.143(1.9);1.125(3.5); 1.107(1.9); 0.794(2.5); 0.776(5.3); 0.758(3.6); 0.721(3.1);0.551(1.8); 0.535(1.9); 0.496(2.1) Example I.113: ¹H-NMR(499.9 MHz,CDCl₃): 7.259(4.5); 7.160(2.5); 7.144(2.9); 6.986(2.1); 6.971(1.7);6.939(2.9); 6.888(0.6); 5.001(1.5); 3.837(3.4); 2.876(0.5); 2.289(16.0);1.570(3.2); 1.189(0.8); 0.832(2.8); 0.818(5.1); 0.803(2.8); 0.774(2.1);0.739(2.6); 0.690(0.4); 0.630(2.8); 0.006(0.3); 0.000(5.1) ExampleI.114: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.292(1.1); 7.277(1.3); 7.272(2.3);7.258(2.4); 7.252(1.8); 7.238(1.7); 7.119(3.4); 7.116(4.0); 7.106(3.1);7.100(3.1); 7.097(3.2); 7.090(2.2); 7.087(1.9); 7.069(1.8); 7.067(1.7);7.061(2.1); 7.059(2.0); 7.041(1.6); 7.038(1.5); 6.972(5.6); 6.837(2.8);5.760(14.1); 4.981(7.1); 3.798(16.0); 3.755(2.6); 3.320(1.4);2.974(2.0); 2.958(2.0); 2.898(0.6); 2.872(1.6); 2.739(0.4); 2.677(0.4);2.673(0.4); 2.610(0.7); 2.531(0.7); 2.526(1.1); 2.517(13.7);2.513(28.1); 2.508(38.1); 2.504(26.7); 2.499(12.3); 2.458(0.3);1.691(0.4); 1.679(0.3); 1.616(0.3); 1.572(0.4); 1.555(0.5); 1.536(0.6);1.518(0.5); 1.506(0.5); 1.485(0.5); 1.444(2.1); 1.275(0.4); 1.243(1.0);1.169(5.4); 1.151(10.4); 1.133(5.1); 1.063(0.3); 0.868(0.6); 0.858(0.6);0.831(6.0); 0.812(1.5); 0.794(2.5); 0.781(3.2); 0.767(6.9); 0.748(12.2);0.730(5.3); 0.715(0.6); 0.697(0.7); 0.678(1.0); 0.660(3.4); 0.647(3.1);0.643(3.1); 0.632(1.3); 0.616(0.5); 0.610(0.6); 0.600(0.5); 0.592(0.5);0.560(3.4); 0.553(3.5) Example I.115: ¹H-NMR(400.1 MHz, d₆-DMSO):7.494(0.4); 7.359(0.8); 7.289(0.9); 7.271(2.1); 7.254(2.3); 7.236(1.3);7.225(0.6); 7.107(4.1); 7.089(3.2); 7.082(2.8); 7.060(2.2); 7.057(2.4);7.054(2.5); 7.033(1.8); 6.968(2.8); 6.834(1.4); 5.763(10.3);5.759(12.3); 5.030(0.4); 4.986(0.4); 4.913(0.4); 4.893(0.4); 4.873(0.4);4.867(0.4); 3.884(15.1); 3.853(6.1); 3.320(0.7); 2.974(4.1); 2.957(4.3);2.874(0.8); 2.871(0.9); 2.742(0.9); 2.511(31.9); 2.507(33.5);1.555(0.6); 1.535(0.7); 1.520(0.7); 1.241(0.4); 1.174(8.0); 1.156(16.0);1.138(8.5); 1.079(0.3); 1.066(0.3); 1.062(0.4); 0.838(3.6); 0.792(4.2);0.765(4.8); 0.747(7.1); 0.730(4.4); 0.614(0.7); 0.518(2.3); 0.421(1.5)Example I.116: ¹H-NMR(300.2 MHz, CDCl₃): 7.337(1.4); 7.332(1.7);7.308(8.5); 7.285(11.6); 7.273(1.3); 7.265(19.1); 7.257(1.0);7.256(0.9); 7.254(0.8); 7.253(0.7); 7.251(0.7); 7.250(0.7); 7.248(0.7);7.226(8.3); 7.204(7.0); 7.181(2.1); 7.176(1.7); 7.084(0.9); 6.901(1.8);6.720(0.9); 5.108(5.3); 3.832(11.6); 3.100(16.0); 2.958(1.5);2.885(2.6); 2.883(2.6); 2.007(13.0); 1.634(11.2); 1.136(7.1);1.063(0.4); 0.932(5.1); 0.637(7.4); 0.011(0.4); 0.000(11.3);−0.008(0.3); −0.011(0.5) Example I.117: ¹H-NMR(300.2 MHz, CDCl₃):7.325(6.3); 7.312(6.7); 7.283(3.6); 7.265(14.8); 7.239(0.9); 7.226(2.8);7.211(3.2); 7.200(2.4); 7.184(1.8); 7.172(1.0); 6.981(1.3); 6.798(2.6);6.615(1.3); 5.145(7.5); 4.851(0.7); 3.925(13.5); 3.821(1.1);3.114(16.0); 3.002(1.2); 2.957(1.5); 2.939(0.9); 2.929(1.1); 2.917(1.6);2.904(1.2); 2.893(1.0); 2.885(1.5); 2.883(1.5); 2.007(15.9);1.630(10.5); 1.170(1.2); 1.147(4.8); 1.131(2.2); 1.072(0.7); 1.057(0.7);1.024(0.4); 0.965(1.8); 0.948(4.7); 0.926(1.6); 0.811(0.9); 0.761(0.8);0.613(3.2); 0.600(3.4); 0.585(1.7); 0.562(0.7); 0.551(0.7); 0.536(1.6);0.518(2.8); 0.496(2.8); 0.473(0.7); 0.000(8.3); −0.011(0.4) ExampleI.118: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.378(3.3); 7.357(6.9); 7.327(4.4);7.322(4.4); 7.307(2.0); 7.301(2.1); 7.135(2.0); 7.119(5.1); 7.115(4.8);7.000(3.8); 6.865(1.9); 5.753(1.7); 4.924(6.4); 4.057(0.4); 4.039(1.1);4.021(1.2); 4.004(0.4); 3.824(10.9); 3.310(43.6); 3.007(16.0);2.855(1.2); 2.510(17.8); 2.506(35.6); 2.501(47.8); 2.497(34.6);2.493(16.9); 2.457(0.4); 2.453(0.4); 1.988(5.0); 1.247(0.7); 1.193(1.3);1.175(2.7); 1.158(1.4); 1.101(5.0); 0.912(5.4); 0.875(0.6); 0.858(1.1);0.841(0.5); 0.671(3.6); 0.657(3.7); 0.516(4.0); 0.000(5.5) ExampleI.119: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.377(2.1); 7.356(4.2); 7.324(4.5);7.319(4.8); 7.304(2.4); 7.299(2.5); 7.220(6.9); 7.085(2.7); 6.950(1.4);5.753(1.1); 4.944(6.8); 4.057(0.3); 4.039(0.9); 4.021(0.9); 4.003(0.3);3.925(14.5); 3.868(0.5); 3.806(0.4); 3.359(0.4); 3.309(75.8);3.258(0.3); 3.020(16.0); 2.968(0.4); 2.867(1.9); 2.859(2.3); 2.674(0.4);2.670(0.5); 2.666(0.4); 2.551(0.5); 2.546(0.5); 2.510(33.4);2.505(65.0); 2.501(85.9); 2.497(61.5); 2.492(29.5); 2.450(0.4);2.445(0.4); 2.332(0.4); 2.328(0.6); 2.323(0.4); 1.988(3.9); 1.247(0.7);1.193(1.1); 1.175(2.1); 1.157(1.2); 1.120(5.9); 1.063(0.3); 0.983(0.4);0.928(6.0); 0.875(0.6); 0.858(1.1); 0.841(0.6); 0.762(0.4); 0.564(3.7);0.549(3.6); 0.519(1.0); 0.476(4.4); 0.008(0.5); 0.000(10.5); −0.008(0.4)Example I.120: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.218(3.5); 7.199(4.2);7.139(1.5); 7.004(3.2); 6.970(2.9); 6.966(3.1); 6.951(2.5); 6.946(2.6);6.870(1.6); 6.799(4.3); 5.760(16.0); 4.906(4.0); 3.834(7.7); 3.361(0.6);3.311(100.1); 3.262(0.9); 2.991(11.3); 2.823(0.9); 2.683(0.6);2.678(0.8); 2.673(0.6); 2.564(0.6); 2.560(0.7); 2.555(0.3); 2.531(2.0);2.527(3.6); 2.518(44.0); 2.514(91.9); 2.509(127.9); 2.504(95.0);2.500(49.2); 2.460(2.5); 2.340(0.6); 2.336(0.8); 2.331(0.7); 1.996(1.3);1.910(0.5); 1.897(1.1); 1.889(1.3); 1.877(2.3); 1.864(1.5); 1.856(1.3);1.843(0.7); 1.202(0.4); 1.184(0.7); 1.166(0.3); 1.061(3.8); 0.984(1.8);0.973(4.7); 0.967(5.1); 0.963(2.8); 0.957(2.7); 0.952(5.0); 0.946(5.1);0.936(2.3); 0.920(0.7); 0.899(0.5); 0.859(4.3); 0.646(2.9); 0.638(4.3);0.628(7.6); 0.622(7.2); 0.615(6.3); 0.610(6.6); 0.599(2.5); 0.564(0.6);0.506(3.3) Example I.121: ¹H-NMR(400.1 MHz, CDCl₃): 7.259(31.5);7.213(1.5); 7.194(1.8); 7.069(1.6); 7.053(1.5); 7.034(1.2); 7.030(1.1);6.892(0.5); 5.297(2.4); 5.091(1.0); 3.833(2.3); 3.216(0.9); 3.094(3.2);2.912(0.3); 2.895(0.9); 2.877(1.3); 2.860(1.1); 2.843(0.5); 2.827(0.4);1.539(1.3); 1.255(0.4); 1.246(1.4); 1.241(4.8); 1.231(16.0);1.214(15.5); 1.106(1.8); 0.922(0.7); 0.904(1.3); 0.869(0.4); 0.641(1.4);0.601(0.8); 0.008(0.4); 0.000(10.7); −0.008(0.5) Example I.122:¹H-NMR(400.1 MHz, d₆-DMSO): 7.226(1.9); 7.207(2.3); 7.132(0.9);7.053(2.1); 7.034(1.7); 6.997(1.9); 6.957(3.4); 6.862(1.0); 5.753(1.6);4.910(2.4); 3.822(4.4); 3.309(25.6); 2.986(6.6); 2.814(0.7);2.505(25.0); 2.501(32.9); 2.496(24.4); 2.279(16.0); 1.060(2.5);0.859(2.8); 0.642(1.8); 0.630(1.9); 0.519(2.2); 0.000(3.6) ExampleI.123: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.225(2.0); 7.207(3.1); 7.073(2.5);7.060(4.5); 7.033(2.1); 6.939(1.0); 5.753(4.3); 4.930(4.1); 4.700(0.3);3.923(10.5); 3.803(0.5); 3.309(56.4); 3.259(0.3); 2.999(11.9);2.856(0.8); 2.838(1.2); 2.828(1.4); 2.670(0.4); 2.509(22.3);2.505(44.3); 2.501(59.4); 2.496(43.3); 2.455(0.5); 2.451(0.5);2.327(0.4); 2.323(0.4); 2.283(16.0); 1.988(0.5); 1.078(4.1); 0.932(0.4);0.875(4.2); 0.859(1.6); 0.761(0.3); 0.698(0.4); 0.637(0.3); 0.526(2.5);0.508(2.8); 0.483(3.7); 0.000(7.4); −0.008(0.4) Example I.124:¹H-NMR(300.2 MHz, CDCl₃): 7.744(0.4); 7.733(0.4); 7.725(0.4);7.714(0.5); 7.552(0.6); 7.541(0.5); 7.533(0.5); 7.522(0.4); 7.274(3.3);7.265(18.3); 7.250(10.5); 7.233(15.3); 7.208(2.4); 7.071(1.0);6.889(2.1); 6.707(1.0); 6.123(4.7); 5.300(1.1); 5.104(5.8); 4.330(4.7);4.321(11.4); 4.312(11.3); 4.303(4.6); 4.099(1.7); 4.077(1.8);3.938(7.5); 3.919(15.7); 3.901(8.1); 3.839(11.9); 3.107(16.0);2.924(1.6); 2.511(3.1); 2.502(4.6); 2.494(6.1); 2.488(6.1); 2.479(4.6);2.042(0.4); 2.020(0.3); 1.635(1.2); 1.327(0.5); 1.285(0.8); 1.256(3.8);1.221(0.4); 1.136(7.5); 1.063(0.5); 1.001(5.2); 0.978(5.0); 0.922(5.6);0.880(1.7); 0.856(1.2); 0.766(0.5); 0.631(7.8); 0.071(5.9); 0.011(0.5);0.000(11.0); −0.011(0.7) Example I.125: ¹H-NMR(400.1 MHz, CDCl₃):7.725(7.0); 7.722(8.7); 7.518(0.6); 7.468(7.3); 7.463(11.3); 7.459(7.0);7.359(0.5); 7.331(10.8); 7.312(9.0); 7.308(7.7); 7.297(9.5); 7.277(3.4);7.259(99.0); 7.209(0.9); 7.032(1.0); 6.995(0.6); 6.895(2.0); 6.759(1.0);6.686(7.8); 6.684(8.5); 6.682(8.4); 6.680(7.6); 5.125(4.2); 3.842(10.2);3.121(16.0); 2.936(1.5); 2.003(0.5); 1.542(19.2); 1.492(0.4);1.310(0.4); 1.255(1.9); 1.162(2.4); 1.145(7.8); 1.133(3.4); 0.935(5.1);0.881(0.9); 0.863(0.6); 0.654(5.1); 0.623(3.7); 0.078(1.0); 0.069(28.1);0.060(1.4); 0.050(0.7); 0.008(2.8); 0.000(77.2); −0.009(3.5);−0.050(0.7); −0.150(0.3) Example I.126: ¹H-NMR(300.2 MHz, CDCl₃):7.285(2.9); 7.262(23.5); 7.243(2.9); 7.216(0.7); 6.904(0.5); 6.187(1.5);5.301(1.4); 5.097(1.6); 4.158(1.1); 4.134(3.5); 4.111(3.5); 4.087(1.2);3.844(3.3); 3.100(5.1); 2.914(0.5); 2.704(0.8); 2.697(0.9); 2.673(1.6);2.654(1.1); 2.647(1.0); 2.550(0.8); 2.542(0.9); 2.525(1.5); 2.518(1.5);2.501(1.1); 2.493(1.0); 2.057(0.8); 2.047(16.0); 2.031(2.0); 2.007(2.4);1.981(1.5); 1.957(0.5); 1.573(9.9); 1.284(4.5); 1.260(8.8); 1.236(4.3);1.122(2.2); 0.914(1.6); 0.651(1.7); 0.070(4.1); 0.011(0.4); 0.000(15.3);−0.011(0.8) Example I.127: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.392(1.0);7.387(1.1); 7.372(2.0); 7.367(2.1); 7.333(3.0); 7.314(1.5); 7.259(2.6);7.131(0.8); 6.996(1.7); 6.861(0.8); 5.760(8.5); 5.394(3.0); 5.128(2.1);5.125(2.9); 5.121(1.9); 4.955(2.5); 4.047(0.4); 4.029(0.4); 3.917(2.6);3.830(4.9); 3.311(88.5); 3.261(0.6); 3.020(6.8); 2.869(0.5); 2.682(0.5);2.678(0.7); 2.673(0.5); 2.564(0.4); 2.531(2.0); 2.518(41.3);2.513(83.2); 2.509(112.2); 2.504(78.8); 2.500(36.6); 2.464(0.9);2.459(0.8); 2.455(0.5); 2.340(0.5); 2.335(0.7); 2.331(0.5); 2.097(10.5);1.996(1.7); 1.201(0.5); 1.183(0.9); 1.166(0.5); 1.099(2.3); 1.078(16.0);0.906(2.5); 0.867(0.5); 0.665(1.7); 0.651(1.7); 0.525(1.8) ExampleI.128: ¹H-NMR(300.2 MHz, CDCl₃): 7.266(11.4); 7.253(8.0); 7.246(9.5);7.191(3.6); 7.184(2.8); 7.164(5.2); 7.156(4.7); 7.061(7.9); 7.033(4.5);6.879(2.7); 6.697(1.4); 5.301(0.8); 4.974(5.8); 3.836(16.0); 2.849(1.4);1.624(2.6); 1.535(0.4); 1.511(0.4); 1.497(0.4); 1.481(0.4); 1.447(0.4);1.396(0.4); 1.267(4.4); 1.221(1.8); 0.903(0.8); 0.882(2.4); 0.850(7.7);0.826(15.4); 0.802(13.9); 0.618(7.0); 0.000(6.5) Example I.129:¹H-NMR(300.2 MHz, CDCl₃): 7.267(9.4); 7.243(6.3); 7.211(1.1);7.182(10.5); 7.177(15.6); 7.150(0.7); 6.971(1.5); 6.789(3.0);6.606(1.5); 5.012(4.8); 4.725(0.3); 3.925(16.0); 3.831(0.6); 2.892(1.3);2.878(1.8); 2.865(1.4); 2.844(0.6); 1.641(0.9); 1.538(0.3); 1.511(0.4);1.484(0.4); 1.459(0.4); 1.437(0.4); 1.267(5.4); 0.903(1.4); 0.881(4.2);0.851(6.6); 0.828(14.6); 0.806(11.3); 0.684(0.5); 0.672(0.6);0.547(8.8); 0.525(4.7); 0.000(6.2) Example I.130: ¹H-NMR(400.1 MHz,d₆-DMSO): 7.140(3.3); 7.120(3.3); 7.007(3.8); 6.999(2.0); 6.997(2.0);6.977(1.5); 6.879(3.4); 6.873(2.6); 4.873(2.8); 3.831(5.1); 3.311(1.7);2.820(0.5); 2.517(3.5); 2.512(7.0); 2.508(9.4); 2.503(6.6); 2.499(3.1);2.244(16.0); 2.078(5.2); 1.201(1.3); 1.183(1.3); 0.815(3.4); 0.797(6.6);0.779(3.2); 0.751(2.6); 0.719(2.3); 0.658(1.9); 0.644(1.9); 0.536(2.2)Example I.131: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.203(0.9); 7.136(1.8);7.118(2.3); 7.068(2.0); 6.998(5.1); 6.978(2.1); 6.933(1.1); 4.893(2.1);3.929(9.5); 3.807(0.3); 3.311(2.7); 2.856(0.9); 2.847(1.2); 2.517(4.5);2.512(9.2); 2.508(12.3); 2.503(8.7); 2.499(4.0); 2.249(16.0);2.078(11.6); 1.209(1.5); 1.192(1.5); 0.820(3.0); 0.802(5.7); 0.784(4.0);0.767(3.3); 0.731(3.2); 0.544(2.4); 0.528(2.6); 0.494(3.0) ExampleI.132: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.381(2.6); 7.361(3.0); 7.148(1.6);7.100(1.8); 7.080(1.6); 7.014(3.5); 6.949(3.4); 6.879(1.8); 4.992(3.0);3.834(4.5); 3.309(6.9); 2.866(0.6); 2.517(8.2); 2.512(16.8);2.508(22.7); 2.503(16.1); 2.499(7.6); 2.287(16.0); 2.079(9.2);1.519(0.8); 1.503(3.1); 1.341(1.2); 1.326(3.3); 1.309(0.9); 0.687(1.9);0.673(1.9); 0.579(2.2) Example I.133: ¹H-NMR(400.1 MHz, d₆-DMSO):7.379(1.7); 7.360(2.0); 7.222(0.8); 7.097(2.3); 7.087(2.3); 7.079(2.3);7.059(2.9); 6.953(0.8); 5.009(3.1); 3.935(8.6); 3.309(12.6); 2.900(0.8);2.891(1.1); 2.530(0.5); 2.517(11.2); 2.512(22.9); 2.508(30.9);2.503(21.8); 2.499(10.2); 2.292(14.7); 2.079(16.0); 1.523(3.4);1.339(3.3); 0.573(2.3); 0.553(3.1); 0.540(3.2) Example I.134:¹H-NMR(400.1 MHz, d₆-DMSO): 7.139(1.6); 7.119(2.5); 7.100(3.5);7.005(5.5); 6.986(1.5); 6.871(3.7); 4.924(2.9); 3.834(4.7); 3.310(7.7);2.859(0.5); 2.530(0.4); 2.517(6.0); 2.512(11.9); 2.508(16.0);2.503(11.3); 2.499(5.3); 2.250(16.0); 2.078(8.6); 1.095(0.7);0.693(4.7); 0.664(5.0); 0.614(0.4); 0.561(2.3); 0.342(0.7); 0.328(2.4);0.310(2.3); 0.308(2.3); 0.297(0.8); 0.073(2.6); 0.062(2.5) ExampleI.135: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.203(0.8); 7.116(1.5); 7.096(2.2);7.069(1.9); 7.003(5.0); 6.988(2.3); 6.934(1.0); 4.942(1.9); 3.931(8.4);3.810(0.4); 3.310(16.5); 2.889(0.8); 2.880(1.1); 2.530(0.5); 2.526(0.9);2.517(9.1); 2.513(18.6); 2.508(25.6); 2.504(18.7); 2.499(9.5);2.255(13.2); 2.079(16.0); 1.128(0.7); 1.115(1.0); 1.103(0.8);1.096(0.7); 1.082(0.4); 0.708(3.8); 0.677(4.2); 0.568(2.2); 0.552(2.5);0.522(3.1); 0.337(2.2); 0.317(2.3); 0.080(2.7); 0.069(2.7) ExampleI.136: ¹H-NMR(300.2 MHz, CDCl₃): 7.261(27.8); 7.176(2.0); 7.150(2.8);7.094(2.7); 7.047(0.5); 6.995(3.6); 6.970(2.0); 6.812(2.2); 6.630(1.1);5.001(1.2); 3.929(11.2); 3.818(1.1); 2.881(1.2); 2.866(0.8); 2.843(0.4);2.295(16.0); 2.174(0.9); 1.758(0.7); 1.735(1.0); 1.712(0.9); 1.690(0.4);1.566(8.3); 1.335(0.8); 1.306(0.9); 1.266(5.4); 0.975(0.5); 0.904(2.8);0.882(7.9); 0.858(7.3); 0.835(6.0); 0.783(2.8); 0.710(3.6); 0.583(2.3);0.540(2.9); 0.516(2.4); 0.011(0.7); 0.000(22.1); −0.011(0.9) ExampleI.137: ¹H-NMR(300.2 MHz, CDCl₃): 7.262(27.9); 7.254(0.7); 7.253(0.6);7.251(0.5); 7.179(2.5); 7.153(3.3); 7.076(0.4); 6.993(1.8); 6.967(1.4);6.936(2.8); 6.911(0.4); 6.894(0.8); 6.713(0.4); 4.974(1.9); 3.841(4.3);2.857(0.6); 2.290(16.0); 1.724(0.5); 1.564(14.8); 1.306(0.7);1.266(3.9); 0.904(1.9); 0.882(5.7); 0.858(4.1); 0.843(4.6); 0.825(4.6);0.756(0.8); 0.745(1.0); 0.696(2.3); 0.630(3.2); 0.011(0.5); 0.000(16.8);−0.011(0.7) Example I.138: ¹H-NMR(300.2 MHz, CDCl₃): 7.261(31.4);7.177(2.2); 7.163(0.8); 7.152(3.0); 7.128(4.0); 7.000(2.5); 6.987(1.7);6.975(2.0); 6.804(2.5); 6.621(1.2); 5.300(4.0); 5.139(6.9); 4.861(0.8);3.928(12.1); 3.892(1.9); 3.811(1.3); 3.347(1.1); 3.324(3.6); 3.301(3.9);3.278(1.6); 3.265(0.6); 3.241(0.4); 3.215(0.4); 3.192(0.4); 2.960(0.3);2.947(0.7); 2.937(0.9); 2.925(1.4); 2.912(1.0); 2.901(0.8); 2.888(0.4);2.351(1.3); 2.322(16.0); 2.046(0.5); 1.628(0.4); 1.604(0.4);1.564(23.3); 1.284(0.4); 1.254(1.8); 1.236(0.4); 1.152(1.1); 1.128(3.9);1.113(1.8); 1.085(4.2); 1.062(8.2); 1.038(4.2); 1.024(1.3); 1.012(1.2);1.000(0.9); 0.988(1.1); 0.977(0.9); 0.964(1.1); 0.928(1.7); 0.912(3.9);0.907(3.9); 0.889(1.5); 0.882(1.3); 0.846(0.9); 0.829(1.3); 0.823(1.3);0.741(0.7); 0.656(0.7); 0.630(2.7); 0.618(2.8); 0.603(1.2); 0.589(0.6);0.566(0.7); 0.538(1.0); 0.516(2.2); 0.497(2.4); 0.473(0.6); 0.069(3.1);0.011(0.9); 0.000(33.1); −0.011(1.5) Example I.139: ¹H-NMR(499.9 MHz,CDCl₃): 7.262(6.3); 7.171(1.6); 7.162(1.0); 7.155(2.1); 7.141(0.3);6.992(3.7); 6.979(3.1); 6.886(0.8); 6.776(0.4); 6.771(0.4); 5.112(2.3);3.842(3.8); 3.828(1.7); 3.803(1.6); 3.791(0.4); 3.308(1.6); 3.296(1.8);3.282(1.1); 3.267(0.6); 3.253(0.3); 2.923(0.8); 2.345(1.1); 2.315(16.0);1.612(8.3); 1.402(0.4); 1.388(0.4); 1.119(3.2); 1.087(0.7); 1.050(3.2);1.039(2.2); 1.021(1.1); 1.015(1.1); 1.007(1.0); 1.000(0.8); 0.993(0.6);0.987(0.5); 0.980(0.4); 0.973(0.4); 0.966(0.4); 0.900(2.2); 0.855(0.4);0.842(0.5); 0.829(0.7); 0.813(0.4); 0.804(0.4); 0.794(0.4); 0.791(0.4);0.780(0.4); 0.647(2.2); 0.606(1.6); 0.000(5.9) Example I.140:¹H-NMR(300.2 MHz, CDCl₃): 7.261(20.2); 7.123(0.5); 7.120(0.7);3.811(0.8); 2.350(1.6); 2.009(0.4); 1.545(16.0); 1.503(1.3); 0.011(0.5);0.000(15.0); −0.009(0.4); −0.011(0.6) Example I.142: ¹H-NMR(400.1 MHz,d₆-DMSO): 7.395(4.1); 7.391(4.5); 7.376(5.6); 7.373(6.2); 7.361(1.9);7.357(1.9); 7.342(5.0); 7.339(4.4); 7.323(4.0); 7.320(3.2); 7.290(3.8);7.286(4.1); 7.271(4.8); 7.268(4.9); 7.252(1.8); 7.249(1.7); 7.145(5.3);7.130(5.9); 6.996(9.7); 6.861(4.8); 5.988(1.7); 5.847(3.5); 5.758(1.3);5.706(1.8); 4.868(10.4); 3.823(16.0); 3.417(0.9); 3.368(2.1);3.318(373.4); 3.268(1.5); 2.860(1.3); 2.682(0.5); 2.678(0.7);2.673(0.5); 2.563(0.4); 2.558(0.7); 2.554(0.5); 2.531(2.1); 2.526(3.4);2.518(41.1); 2.513(84.4); 2.509(115.2); 2.504(82.0); 2.500(38.6);2.468(0.4); 2.463(0.6); 2.458(0.7); 2.454(0.6); 2.340(0.5); 2.336(0.7);2.331(0.5); 1.298(2.7); 1.283(9.0); 1.271(3.3); 1.232(0.4); 1.045(6.2);0.698(1.2); 0.681(5.7); 0.668(5.8); 0.651(1.8); 0.628(0.4); 0.578(0.3);0.529(6.0) Example I.143: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.390(3.3);7.371(5.4); 7.350(4.0); 7.331(3.0); 7.288(4.5); 7.269(5.4); 7.251(2.8);7.241(3.6); 7.223(2.8); 7.193(1.8); 7.058(3.3); 6.923(1.6); 6.002(1.2);5.861(2.4); 5.759(1.8); 5.719(1.3); 4.884(3.8); 3.921(16.0); 3.824(0.5);3.414(0.8); 3.364(2.1); 3.314(336.1); 3.264(2.0); 2.875(2.0);2.687(0.4); 2.682(0.7); 2.678(1.1); 2.673(0.7); 2.613(0.3); 2.609(0.4);2.568(0.4); 2.564(0.7); 2.559(0.9); 2.555(0.5); 2.531(2.9); 2.526(5.0);2.518(63.3); 2.513(130.5); 2.509(178.6); 2.504(127.4); 2.500(60.1);2.468(1.0); 2.463(1.2); 2.458(1.3); 2.454(0.9); 2.410(0.3); 2.340(0.8);2.335(1.1); 2.331(0.8); 1.296(6.4); 1.246(0.6); 1.058(5.3); 0.558(4.1);0.544(4.0); 0.474(4.7) Example I.144: ¹H-NMR(400.1 MHz, d₆-DMSO):7.230(0.7); 7.224(1.0); 7.210(1.6); 7.202(4.2); 7.194(1.9); 7.189(1.6);7.182(2.8); 7.175(3.6); 7.169(3.7); 7.153(2.7); 7.130(3.0); 6.995(5.1);6.860(2.5); 6.008(1.0); 5.867(2.1); 5.758(16.0); 5.726(1.1); 4.823(6.2);3.820(10.2); 3.421(0.5); 3.371(0.7); 3.321(278.6); 3.272(2.9);3.222(0.4); 2.849(0.8); 2.678(0.4); 2.532(1.4); 2.527(2.2); 2.518(22.3);2.514(46.3); 2.509(64.2); 2.505(47.0); 2.500(23.8); 2.464(1.4);2.460(1.3); 2.336(0.4); 2.331(0.3); 2.079(0.5); 1.309(1.4); 1.293(4.8);1.281(2.0); 1.098(3.4); 0.702(0.7); 0.684(3.2); 0.671(3.3); 0.667(3.0);0.655(1.2); 0.518(3.3) Example I.145: ¹H-NMR(400.1 MHz, d₆-DMSO):7.261(0.9); 7.238(5.9); 7.230(5.7); 7.225(5.6); 7.216(4.4); 7.211(4.4);7.192(5.3); 7.173(4.1); 7.055(3.5); 6.920(1.8); 6.020(1.2); 5.880(2.4);5.758(7.8); 5.738(1.3); 4.839(4.1); 3.917(16.0); 3.848(0.5); 3.806(0.4);3.421(1.7); 3.371(3.1); 3.321(865.2); 3.271(5.7); 3.256(0.3);3.221(0.8); 2.861(2.2); 2.682(0.9); 2.678(1.3); 2.673(0.9); 2.609(0.5);2.563(0.5); 2.559(0.7); 2.554(0.6); 2.531(3.8); 2.518(79.4);2.513(161.7); 2.509(219.1); 2.504(156.2); 2.500(73.9); 2.468(1.3);2.463(1.7); 2.459(1.9); 2.454(1.4); 2.406(0.4); 2.340(1.0); 2.336(1.3);2.331(1.0); 1.306(6.7); 1.111(5.5); 0.566(4.4); 0.553(4.4); 0.465(5.1)Example I.146: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.497(2.0); 7.492(2.1);7.477(2.6); 7.472(2.7); 7.340(4.9); 7.319(3.9); 7.238(4.0); 7.233(3.8);7.132(1.9); 6.997(4.3); 6.862(2.1); 5.975(1.0); 5.834(2.0); 5.758(16.0);5.694(1.1); 4.847(6.3); 3.832(9.5); 3.421(0.6); 3.371(2.7);3.321(341.9); 3.270(1.9); 3.221(0.5); 2.873(0.8); 2.682(0.3);2.678(0.5); 2.673(0.4); 2.563(0.5); 2.559(0.7); 2.554(0.6); 2.550(0.4);2.531(2.3); 2.526(3.4); 2.518(29.7); 2.513(60.2); 2.509(82.5);2.504(60.1); 2.500(30.5); 2.463(1.5); 2.458(1.4); 2.410(0.3);2.340(0.4); 2.336(0.6); 2.331(0.4); 2.079(0.5); 1.306(1.4); 1.291(4.5);1.278(1.9); 1.054(3.3); 0.710(0.6); 0.692(2.9); 0.679(3.0); 0.663(1.1);0.520(3.1) Example I.147: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.499(3.8);7.493(4.0); 7.478(4.8); 7.473(5.0); 7.377(4.1); 7.340(5.1); 7.319(4.0);7.204(1.4); 7.069(2.9); 6.934(1.4); 5.983(1.0); 5.842(2.1); 5.758(16.0);5.703(1.1); 4.864(3.0); 3.928(14.0); 3.421(1.3); 3.371(2.6);3.321(621.3); 3.271(3.0); 3.221(0.4); 2.878(1.7); 2.682(0.7);2.678(0.9); 2.673(0.6); 2.609(0.4); 2.564(0.5); 2.559(0.6); 2.555(0.4);2.531(2.6); 2.526(4.6); 2.518(54.7); 2.513(112.0); 2.509(152.5);2.504(108.1); 2.500(50.6); 2.464(0.9); 2.459(1.0); 2.455(0.7);2.340(0.7); 2.335(0.9); 2.331(0.7); 1.303(5.7); 1.064(4.5); 0.590(3.5);0.575(3.5); 0.490(4.1) Example I.148: ¹H-NMR(400.1 MHz, d₆-DMSO):7.411(3.4); 7.405(1.8); 7.401(1.6); 7.391(7.2); 7.362(6.7); 7.357(6.9);7.341(2.8); 7.336(3.1); 7.223(4.9); 7.074(3.3); 6.939(1.6); 5.986(1.2);5.846(2.5); 5.759(8.4); 5.705(1.3); 4.865(4.8); 3.927(16.0);3.310(32.5); 2.887(2.0); 2.682(0.4); 2.678(0.5); 2.673(0.4);2.517(29.6); 2.513(59.9); 2.509(81.3); 2.504(58.5); 2.500(28.1);2.463(0.7); 2.459(0.7); 2.454(0.5); 2.340(0.4); 2.335(0.5); 2.331(0.4);1.305(6.6); 1.245(0.8); 1.136(0.4); 1.132(0.4); 1.066(5.3); 0.974(0.3);0.589(4.1); 0.574(4.1); 0.542(0.9); 0.487(4.9) Example I.149:¹H-NMR(400.1 MHz, d₆-DMSO): 7.412(4.6); 7.392(9.9); 7.361(5.4);7.356(5.4); 7.340(2.6); 7.335(2.7); 7.134(3.2); 7.095(6.6); 7.090(6.3);7.000(7.1); 6.865(3.5); 5.978(1.6); 5.837(3.4); 5.759(8.4); 5.697(1.8);4.849(10.8); 3.831(16.0); 3.310(28.8); 2.886(1.3); 2.682(0.4);2.677(0.5); 2.673(0.4); 2.563(0.5); 2.558(0.7); 2.554(0.7); 2.531(2.1);2.517(26.6); 2.513(52.8); 2.508(71.0); 2.504(51.6); 2.499(26.2);2.339(0.4); 2.335(0.5); 2.331(0.4); 1.308(2.4); 1.292(7.8); 1.280(3.2);1.243(0.6); 1.057(5.6); 0.710(1.2); 0.693(4.9); 0.679(5.1); 0.663(1.8);0.623(0.3); 0.572(0.3); 0.523(5.3) Example I.150: ¹H-NMR(300.2 MHz,CDCl₃): 7.293(3.6); 7.262(46.0); 7.055(0.7); 6.945(1.9); 6.939(2.1);6.919(1.7); 6.913(1.9); 6.873(1.8); 6.857(2.9); 6.691(0.7); 5.802(0.4);5.612(0.9); 5.423(0.5); 5.302(16.0); 4.940(2.5); 3.844(6.2); 3.811(1.0);2.904(0.7); 2.047(0.3); 1.888(0.4); 1.871(0.8); 1.860(0.9); 1.843(1.6);1.826(0.9); 1.815(0.9); 1.798(0.4); 1.555(22.9); 1.260(2.1); 1.243(5.1);1.237(5.3); 1.222(2.3); 1.006(2.8); 0.975(1.7); 0.960(3.2); 0.953(3.4);0.938(2.1); 0.932(3.4); 0.925(3.1); 0.911(1.5); 0.889(0.4); 0.882(0.4);0.680(2.3); 0.664(5.6); 0.658(5.8); 0.648(6.5); 0.642(7.8); 0.627(4.9);0.069(5.4); 0.011(1.2); 0.000(35.3); −0.011(1.7) Example I.151:¹H-NMR(400.1 MHz, d₆-DMSO): 7.440(3.4); 7.425(3.7); 7.419(4.1);7.404(3.8); 7.138(5.3); 7.131(2.3); 7.117(3.6); 7.110(3.6); 7.096(1.9);7.089(1.8); 7.003(8.0); 6.868(4.2); 6.858(3.3); 6.851(3.1); 6.832(3.4);6.825(3.1); 5.969(1.6); 5.828(3.5); 5.759(12.5); 5.688(1.9);4.854(10.5); 3.828(16.0); 3.362(0.8); 3.312(141.7); 3.262(1.0);2.902(1.3); 2.683(0.3); 2.678(0.5); 2.674(0.4); 2.564(0.3); 2.559(0.4);2.531(1.5); 2.527(2.4); 2.518(28.6); 2.514(60.1); 2.509(83.7);2.504(61.0); 2.500(30.7); 2.459(1.4); 2.341(0.4); 2.336(0.6);2.331(0.4); 1.298(2.2); 1.282(7.5); 1.270(3.1); 1.246(0.6); 1.231(0.4);1.051(5.4); 0.708(1.1); 0.690(4.9); 0.677(5.0); 0.673(4.6); 0.661(1.8);0.639(0.5); 0.526(5.1) Example I.152: ¹H-NMR(400.1 MHz, d₆-DMSO):7.439(1.6); 7.423(2.0); 7.418(2.1); 7.403(1.8); 7.212(1.0); 7.139(1.6);7.132(1.6); 7.118(2.8); 7.111(2.9); 7.097(1.5); 7.090(1.6); 7.077(2.1);6.942(2.6); 6.920(1.7); 5.978(0.8); 5.837(1.6); 5.759(16.0); 5.697(0.8);4.870(4.5); 3.924(10.3); 3.362(0.4); 3.312(81.9); 3.262(0.4);2.905(1.3); 2.678(0.3); 2.531(0.8); 2.518(19.3); 2.513(39.7);2.509(54.2); 2.504(38.7); 2.500(18.3); 2.459(0.4); 2.336(0.3);2.079(1.3); 1.295(4.1); 1.244(0.3); 1.062(3.4); 0.583(2.6); 0.569(2.7);0.531(0.5); 0.477(3.2) Example I.153: ¹H-NMR(400.1 MHz, d₆-DMSO):7.258(2.8); 7.239(3.4); 7.126(1.6); 7.076(2.0); 7.057(1.6); 6.991(3.5);6.927(3.2); 6.856(1.8); 5.943(0.7); 5.801(1.4); 5.660(0.7); 4.824(3.8);3.820(5.9); 3.301(2.5); 2.836(0.5); 2.508(5.6); 2.504(11.0);2.500(14.7); 2.495(10.5); 2.491(5.0); 2.268(16.0); 2.070(12.8);1.257(1.2); 1.243(3.8); 1.231(1.4); 0.989(2.6); 0.663(2.1); 0.649(2.2);0.523(2.4); 0.000(0.4) Example I.154: ¹H-NMR(400.1 MHz, d₆-DMSO):7.255(2.0); 7.236(2.5); 7.189(1.0); 7.075(2.8); 7.055(5.1); 6.920(1.0);5.954(0.7); 5.812(1.4); 5.671(0.8); 4.839(2.1); 3.917(9.3); 3.300(6.2);2.851(1.2); 2.522(0.6); 2.508(13.1); 2.504(26.1); 2.499(35.0);2.495(25.1); 2.491(12.2); 2.454(0.3); 2.450(0.3); 2.273(16.0);2.070(2.2); 1.255(3.7); 1.204(0.4); 0.999(3.0); 0.550(2.3); 0.534(2.5);0.485(2.8); 0.000(0.8) Example I.155: ¹H-NMR(400.1 MHz, d₆-DMSO):7.622(2.7); 7.619(2.9); 7.603(3.1); 7.599(3.1); 7.420(2.4); 7.417(2.5);7.401(3.0); 7.398(2.9); 7.246(2.9); 7.226(4.7); 7.207(2.2); 7.080(1.7);6.945(3.9); 6.811(2.0); 6.114(1.2); 5.973(2.5); 5.831(1.4); 5.759(16.0);4.885(4.5); 3.799(14.3); 3.414(0.6); 3.364(1.3); 3.314(267.2);3.265(2.3); 2.904(0.5); 2.683(0.5); 2.678(0.8); 2.673(0.5); 2.564(0.4);2.559(0.6); 2.554(0.4); 2.531(2.1); 2.527(3.5); 2.518(44.8);2.513(94.7); 2.509(132.4); 2.504(97.4); 2.500(49.8); 2.464(2.2);2.460(2.0); 2.455(1.5); 2.410(0.3); 2.345(0.3); 2.340(0.6); 2.336(0.8);2.331(0.6); 2.327(0.4); 2.080(0.5); 1.282(3.9); 1.223(1.3); 0.653(0.6);0.635(3.1); 0.622(3.1); 0.618(2.8); 0.605(1.1); 0.474(3.1) ExampleI.156: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.641(2.2); 7.638(2.4); 7.621(2.6);7.618(2.5); 7.431(1.8); 7.428(1.8); 7.411(2.3); 7.409(2.2); 7.277(2.5);7.258(4.0); 7.238(1.8); 7.133(1.4); 6.998(3.1); 6.863(1.6); 6.071(0.4);5.929(0.9); 5.787(0.5); 5.758(10.7); 4.999(0.9); 3.886(16.0);3.365(0.8); 3.314(127.9); 3.265(0.6); 2.891(0.7); 2.678(0.4);2.531(1.0); 2.526(1.6); 2.518(21.1); 2.513(43.4); 2.509(59.1);2.504(42.0); 2.500(19.7); 2.459(0.3); 2.336(0.4); 2.079(0.4);1.288(3.2); 1.151(1.5); 0.394(1.5); 0.379(1.5); 0.152(1.5) ExampleI.157: ¹H-NMR(300.2 MHz, CDCl₃): 7.407(1.5); 7.305(2.3); 7.296(8.1);7.289(9.0); 7.267(8.9); 7.194(3.3); 7.186(2.8); 7.166(5.0); 7.159(4.5);7.065(7.3); 7.037(4.9); 6.875(2.9); 6.854(0.9); 6.692(1.5); 6.672(0.5);5.299(2.8); 4.973(5.7); 4.730(1.1); 3.834(16.0); 2.845(1.6); 1.638(0.6);1.466(0.4); 1.446(0.7); 1.424(1.4); 1.402(1.9); 1.380(1.7); 1.357(1.1);1.336(0.7); 1.306(0.8); 1.267(4.0); 0.936(2.7); 0.903(4.6); 0.881(9.3);0.858(6.9); 0.791(11.2); 0.724(2.0); 0.709(1.9); 0.615(7.1); 0.000(4.9)Example I.158: ¹H-NMR(300.2 MHz, CDCl₃): 7.287(6.5); 7.272(1.3);7.266(11.8); 7.214(0.6); 7.181(16.1); 7.155(0.7); 6.968(1.5);6.786(3.0); 6.758(0.4); 6.603(1.5); 5.299(2.0); 5.009(4.0); 3.924(16.0);3.829(0.6); 2.869(1.9); 2.852(1.5); 1.629(1.7); 1.455(0.6); 1.433(1.2);1.411(1.6); 1.389(1.5); 1.367(1.0); 1.353(0.7); 1.330(0.7); 1.306(1.1);1.267(5.7); 0.903(5.5); 0.881(11.0); 0.858(7.2); 0.796(9.9); 0.672(1.4);0.658(1.4); 0.636(1.3); 0.542(8.5); 0.522(5.1); 0.000(7.1) ExampleI.159: ¹H-NMR(300.2 MHz, CDCl₃): 7.262(2.8); 7.220(2.7); 7.194(3.3);7.075(0.4); 6.982(1.8); 6.956(1.6); 6.938(3.1); 6.893(0.9); 6.711(0.4);5.011(2.0); 3.838(4.5); 2.868(0.6); 2.287(16.0); 1.416(0.5); 1.394(0.6);1.372(0.6); 1.350(0.4); 1.323(0.4); 1.257(0.9); 0.903(1.5); 0.882(2.1);0.858(1.7); 0.735(4.0); 0.629(3.6); 0.000(1.7) Example I.160:¹H-NMR(300.2 MHz, CDCl₃): 7.262(3.9); 7.217(2.1); 7.191(2.7);7.092(2.7); 7.036(0.3); 6.985(2.7); 6.959(2.0); 6.811(2.1); 6.628(1.0);5.045(2.2); 3.927(10.7); 3.813(0.9); 2.910(0.6); 2.901(0.8); 2.889(1.2);2.875(0.9); 2.866(0.7); 2.851(0.4); 2.291(16.0); 1.668(0.4); 1.449(0.4);1.427(0.7); 1.404(0.9); 1.382(0.8); 1.360(0.6); 1.336(0.6); 1.307(0.5);1.267(2.1); 0.903(2.5); 0.882(4.2); 0.858(3.0); 0.828(2.2); 0.816(2.2);0.809(2.2); 0.743(4.8); 0.583(2.9); 0.532(2.7); 0.509(2.3); 0.000(2.4)Example I.161: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.499(4.1); 7.480(4.9);7.421(1.8); 7.418(1.9); 7.403(4.6); 7.399(4.2); 7.384(3.5); 7.380(3.0);7.342(3.2); 7.339(3.5); 7.323(4.5); 7.320(4.5); 7.304(1.8); 7.301(1.7);7.175(4.9); 7.157(4.1); 7.133(3.9); 6.998(8.6); 6.863(4.3); 5.758(14.7);4.872(3.8); 3.826(16.0); 3.360(0.5); 3.311(115.9); 3.261(0.6);2.863(1.2); 2.682(0.4); 2.677(0.5); 2.673(0.4); 2.558(0.4); 2.553(0.3);2.530(1.4); 2.517(28.7); 2.512(57.9); 2.508(78.2); 2.503(55.0);2.499(25.7); 2.463(0.4); 2.458(0.5); 2.339(0.4); 2.335(0.5); 2.330(0.4);1.516(3.4); 1.234(6.2); 0.681(5.2); 0.668(4.9); 0.665(4.9); 0.629(0.3);0.536(5.4) Example I.162: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.498(2.5);7.479(3.1); 7.429(1.2); 7.411(2.8); 7.393(2.0); 7.341(2.9); 7.326(3.7);7.323(3.9); 7.307(1.5); 7.304(1.5); 7.274(2.5); 7.254(2.1); 7.195(1.3);7.060(2.6); 6.925(1.3); 5.758(16.0); 4.885(1.6); 3.923(11.4);3.311(111.6); 3.261(0.9); 2.879(1.4); 2.682(0.3); 2.677(0.5);2.672(0.3); 2.530(1.1); 2.517(26.7); 2.513(54.3); 2.508(73.5);2.503(51.8); 2.499(24.2); 2.467(0.4); 2.463(0.6); 2.458(0.7);2.453(0.5); 2.339(0.4); 2.335(0.5); 2.330(0.3); 1.528(2.0); 1.246(3.8);0.561(2.9); 0.546(2.9); 0.482(3.2) Example I.163: ¹H-NMR(400.1 MHz,d₆-DMSO): 7.521(4.6); 7.500(6.4); 7.412(3.9); 7.406(3.8); 7.391(2.6);7.385(2.7); 7.128(3.0); 7.117(6.0); 7.112(5.6); 6.994(5.8); 6.859(2.9);4.845(3.2); 3.826(16.0); 3.300(15.5); 2.886(1.2); 2.674(0.4);2.669(0.5); 2.505(58.4); 2.500(76.5); 2.496(55.8); 2.455(0.8);2.450(0.9); 2.327(0.5); 2.323(0.4); 2.072(7.5); 1.515(3.5); 1.240(5.4);0.686(4.5); 0.672(4.5); 0.525(4.9); 0.000(0.9) Example I.164:¹H-NMR(400.1 MHz, d₆-DMSO): 7.603(0.7); 7.597(0.6); 7.520(4.4);7.499(6.2); 7.413(5.5); 7.408(5.6); 7.393(3.7); 7.387(3.8); 7.316(0.5);7.310(0.5); 7.295(0.4); 7.289(0.4); 7.247(4.6); 7.202(1.8); 7.068(3.5);6.933(1.7); 6.871(1.0); 6.621(0.6); 4.860(2.7); 3.921(16.0); 3.618(4.4);3.612(3.3); 3.608(4.5); 3.602(10.8); 3.596(4.6); 3.592(3.2); 3.585(4.5);3.300(25.9); 2.889(2.0); 2.674(0.5); 2.670(0.6); 2.665(0.5); 2.550(0.5);2.509(40.4); 2.505(78.9); 2.500(104.5); 2.496(75.4); 2.455(0.9);2.451(1.0); 2.446(0.8); 2.423(0.3); 2.332(0.5); 2.327(0.7); 2.323(0.5);2.184(1.7); 1.794(0.4); 1.777(4.5); 1.769(5.1); 1.760(12.8); 1.752(5.1);1.744(4.5); 1.727(0.6); 1.527(3.3); 1.434(0.9); 1.411(0.4); 1.394(0.4);1.357(12.2); 1.247(5.3); 1.196(1.0); 1.183(1.1); 1.166(0.7); 0.583(4.1);0.569(4.1); 0.490(4.9); 0.378(0.5); 0.373(0.7); 0.362(0.6); 0.357(0.6);0.276(0.7); 0.268(0.7); 0.262(0.5); 0.000(1.3) Example I.165:¹H-NMR(400.1 MHz, d₆-DMSO): 7.555(2.5); 7.540(2.8); 7.534(3.0);7.519(2.6); 7.188(1.6); 7.181(1.7); 7.167(2.9); 7.160(2.9); 7.146(1.5);7.139(1.6); 7.131(2.8); 6.997(5.8); 6.880(2.8); 6.874(2.7); 6.862(3.4);6.855(3.0); 6.848(2.5); 4.850(2.4); 3.823(16.0); 3.301(10.7);2.905(1.3); 2.670(0.4); 2.550(0.4); 2.545(0.4); 2.541(0.3); 2.505(42.6);2.501(55.6); 2.496(40.8); 2.455(0.5); 2.451(0.5); 2.327(0.4);2.072(14.3); 1.506(2.9); 1.234(5.4); 0.683(4.5); 0.669(4.5); 0.527(4.9);0.000(1.0) Example I.166: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.554(2.5);7.539(3.2); 7.534(3.3); 7.519(2.7); 7.207(1.8); 7.191(2.4); 7.184(2.4);7.170(4.1); 7.163(4.0); 7.149(2.1); 7.142(2.0); 7.072(3.5); 6.965(2.6);6.938(4.2); 6.872(1.2); 6.622(0.7); 4.864(2.6); 3.918(16.0); 3.867(0.7);3.849(0.4); 3.813(0.3); 3.618(4.1); 3.612(3.3); 3.608(4.5); 3.602(10.2);3.596(4.6); 3.585(4.3); 3.302(14.6); 2.906(2.1); 2.674(0.3); 2.670(0.4);2.665(0.3); 2.551(0.3); 2.505(49.1); 2.501(64.4); 2.496(47.5);2.456(0.6); 2.452(0.6); 2.328(0.4); 2.323(0.3); 2.184(1.8); 1.794(0.5);1.777(4.2); 1.769(5.0); 1.760(11.8); 1.752(5.1); 1.744(4.2); 1.727(0.6);1.516(2.9); 1.411(0.5); 1.394(0.4); 1.357(13.2); 1.242(5.5); 1.197(1.0);1.184(0.7); 1.166(0.8); 0.578(4.3); 0.565(4.3); 0.481(5.0); 0.000(0.9)Example I.167: ¹H-NMR(300.2 MHz, CDCl₃): 7.357(2.4); 7.331(3.0);7.262(14.2); 7.072(1.8); 7.046(2.2); 6.968(2.4); 6.864(1.6); 6.682(0.8);4.937(0.5); 3.842(5.2); 2.930(0.6); 2.314(16.0); 2.009(2.4); 1.576(3.5);1.458(2.9); 1.253(0.3); 1.108(1.9); 0.636(3.5); 0.000(9.8); −0.011(0.5)Example I.168: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.394(2.5); 7.391(2.3);7.371(0.8); 7.366(0.7); 7.350(2.9); 7.345(3.4); 7.337(5.0); 7.317(1.2);7.203(0.4); 7.156(1.4); 7.133(1.1); 7.098(2.9); 7.094(2.8); 7.021(2.9);6.995(0.8); 6.887(1.5); 6.861(0.4); 5.758(16.0); 4.934(0.4); 4.892(2.4);4.880(3.1); 4.839(0.8); 4.662(0.4); 4.637(0.7); 4.597(0.5); 3.844(7.8);3.824(2.3); 3.810(0.7); 3.307(33.3); 2.944(0.8); 2.681(0.5); 2.677(0.7);2.672(0.5); 2.562(0.5); 2.558(0.6); 2.553(0.4); 2.530(1.5); 2.517(40.4);2.512(82.7); 2.508(112.1); 2.503(79.1); 2.499(37.2); 2.467(0.5);2.462(0.6); 2.458(0.6); 2.453(0.5); 2.339(0.5); 2.334(0.7); 2.330(0.5);2.088(2.2); 2.069(2.8); 2.045(2.0); 1.917(3.1); 1.897(2.6); 1.637(11.4);1.613(3.6); 0.755(0.9); 0.741(1.7); 0.734(1.9); 0.726(1.7); 0.717(1.5);0.708(0.9); 0.696(0.6); 0.566(2.2); 0.556(2.2) Example I.169:¹H-NMR(400.1 MHz, d₆-DMSO): 7.243(0.6); 7.223(0.7); 7.152(2.5);7.132(2.7); 7.034(0.5); 7.029(0.5); 7.020(2.3); 7.010(0.4); 6.995(0.6);6.983(1.5); 6.978(1.5); 6.963(1.2); 6.959(1.2); 6.886(1.1); 6.860(0.4);6.801(0.6); 6.788(2.3); 6.785(2.1); 5.758(16.0); 4.863(2.9); 4.593(0.4);4.553(0.3); 3.846(4.7); 3.827(1.4); 3.307(19.4); 2.907(0.5); 2.681(0.4);2.677(0.5); 2.672(0.4); 2.558(0.4); 2.530(1.0); 2.517(28.1);2.512(57.5); 2.508(78.3); 2.503(54.6); 2.499(25.3); 2.462(0.4);2.458(0.5); 2.453(0.3); 2.339(0.4); 2.335(0.5); 2.330(0.4); 2.018(1.8);1.999(2.1); 1.951(0.7); 1.932(0.4); 1.888(0.6); 1.879(0.8); 1.867(1.3);1.852(2.9); 1.833(2.2); 1.612(6.8); 1.586(2.3); 0.966(2.2); 0.961(2.4);0.945(2.4); 0.940(2.5); 0.927(0.5); 0.710(1.3); 0.669(0.5); 0.649(0.5);0.624(1.4); 0.621(1.4); 0.616(1.5); 0.610(2.3); 0.597(1.3); 0.592(1.4);0.581(0.6); 0.574(0.5); 0.566(0.6); 0.547(1.6); 0.539(1.6) ExampleI.170: ¹H-NMR(300.2 MHz, CDCl₃): 7.429(0.3); 7.420(0.4); 7.401(0.4);7.265(5.7); 7.162(1.3); 7.143(1.6); 7.134(1.8); 7.115(1.8); 7.067(1.1);6.939(0.8); 6.930(1.1); 6.912(1.5); 6.903(3.2); 6.885(3.0); 6.876(1.7);6.866(1.6); 6.849(0.7); 6.703(1.1); 5.195(0.5); 5.140(0.6); 4.873(2.2);4.819(1.6); 4.714(0.4); 3.855(8.4); 3.840(2.7); 2.989(0.8); 2.007(0.9);1.921(2.5); 1.897(3.0); 1.814(1.2); 1.675(16.0); 1.657(4.4); 1.648(4.5);0.721(4.6); 0.707(4.0); 0.638(0.6); 0.072(1.8); 0.000(3.4) ExampleI.171: ¹H-NMR(300.2 MHz, CDCl₃): 7.607(0.3); 7.328(0.5); 7.261(59.4);7.250(1.0); 7.245(0.6); 7.157(0.9); 7.129(1.2); 7.110(1.1); 7.052(1.0);7.028(1.2); 7.005(0.5); 6.987(0.9); 6.940(1.1); 6.931(0.9); 6.913(1.6);6.904(1.4); 6.885(0.9); 6.876(0.7); 6.805(1.0); 6.623(0.6); 5.206(0.4);5.153(0.5); 4.902(0.6); 4.847(0.5); 3.941(5.7); 3.858(0.4); 3.492(0.4);3.009(0.7); 2.009(16.0); 1.926(1.0); 1.902(1.3); 1.829(0.7); 1.689(6.1);1.672(3.7); 1.649(1.8); 1.548(9.1); 0.665(2.1); 0.625(1.5); 0.605(1.4);0.588(1.1); 0.081(0.5); 0.069(15.5); 0.057(0.6); 0.011(1.7);0.000(56.6); −0.011(2.5) Example I.172: ¹H-NMR(300.2 MHz, d₆-DMSO):7.255(0.7); 7.229(1.0); 7.197(1.6); 7.169(2.3); 7.143(3.9); 7.124(0.7);7.084(2.5); 7.059(1.4); 7.018(3.3); 6.995(0.8); 6.932(3.7); 6.839(1.6);6.815(0.4); 5.758(0.4); 4.866(5.0); 4.811(0.5); 4.596(0.6); 4.545(0.4);4.041(0.4); 4.017(0.3); 3.835(7.9); 3.463(0.3); 3.333(315.3);2.894(1.0); 2.508(18.4); 2.502(24.3); 2.496(18.1); 2.269(16.0);2.225(0.9); 2.024(2.2); 1.999(3.2); 1.989(2.3); 1.953(0.9); 1.927(0.5);1.858(3.1); 1.833(2.5); 1.610(10.5); 1.585(3.6); 1.388(1.4); 1.247(4.7);1.198(0.6); 1.174(0.8); 1.151(0.4); 0.880(1.3); 0.858(3.7); 0.835(1.5);0.705(2.2); 0.694(2.1); 0.562(2.9); 0.553(3.1); 0.000(9.0) ExampleI.173: ¹H-NMR(499.9 MHz, CDCl₃): 7.475(1.9); 7.458(2.3); 7.429(0.8);7.413(0.9); 7.372(2.3); 7.355(2.6); 7.335(2.1); 7.318(1.7); 7.260(12.5);7.152(0.3); 7.135(0.3); 7.087(3.2); 7.070(2.9); 7.003(0.4); 6.987(0.8);6.979(1.4); 6.894(0.7); 6.877(1.7); 6.869(2.6); 6.785(0.4); 6.768(0.9);6.760(1.4); 5.589(0.3); 5.575(0.7); 5.562(0.3); 5.473(0.9); 5.240(1.0);5.015(0.5); 4.997(1.5); 4.986(2.2); 4.971(3.2); 4.942(0.6); 4.831(2.0);4.818(2.7); 4.787(1.9); 3.813(11.7); 3.799(9.4); 3.274(0.8); 3.261(0.8);3.058(0.4); 2.771(0.4); 2.048(0.7); 2.033(0.8); 1.999(2.5); 1.888(1.8);1.873(1.5); 1.815(16.0); 1.776(2.2); 1.761(2.9); 1.698(0.5); 1.685(3.5);1.670(11.9); 1.557(1.4); 1.281(0.8); 1.268(0.8); 1.257(0.4); 0.772(0.5);0.758(0.9); 0.744(1.1); 0.730(1.0); 0.721(1.0); 0.710(1.0); 0.700(1.1);0.691(1.1); 0.680(1.0); 0.669(1.3); 0.658(1.4); 0.650(2.0); 0.637(1.9);0.630(1.9); 0.625(1.7); 0.616(1.7); 0.585(1.8); 0.571(1.1); 0.539(0.8);0.501(0.7); 0.478(0.3); 0.000(7.6) Example I.174: ¹H-NMR(499.9 MHz,CDCl₃): 7.484(2.0); 7.467(2.5); 7.388(1.6); 7.371(1.7); 7.342(2.0);7.325(1.6); 7.259(2.5); 7.084(2.4); 7.067(2.1); 6.872(0.4); 6.856(0.6);6.762(0.7); 6.746(1.2); 6.652(0.4); 6.636(0.6); 5.075(0.4); 4.815(0.6);4.786(0.4); 3.896(16.0); 3.886(11.6); 2.856(0.4); 1.999(5.1);1.939(0.8); 1.924(0.7); 1.790(1.6); 1.776(6.8); 1.690(4.0); 1.676(3.2);1.659(3.8); 1.539(0.9); 0.521(1.3); 0.446(0.8); 0.270(0.8); 0.006(0.7);0.000(20.0); −0.007(0.8) Example I.175: ¹H-NMR(499.9 MHz, CDCl₃):7.388(0.9); 7.371(1.3); 7.356(1.0); 7.301(1.3); 7.285(2.1); 7.269(1.4);7.259(2.2); 7.210(1.2); 7.207(1.2); 7.193(1.0); 7.191(0.9); 6.958(2.4);6.955(2.3); 6.941(2.2); 6.939(2.0); 6.901(1.6); 6.856(0.6); 6.792(3.4);6.747(1.2); 6.682(1.7); 6.638(0.6); 3.900(16.0); 3.882(9.5); 1.999(7.5);1.926(0.6); 1.912(0.5); 1.815(7.4); 1.804(3.6); 1.789(3.4); 1.689(8.2);1.667(4.4); 1.653(3.5); 1.557(0.5); 0.673(1.2); 0.635(1.3); 0.529(0.8);0.006(0.8); 0.000(17.6); −0.007(0.6) Example I.176: ¹H-NMR(300.2 MHz,CDCl₃): 7.409(0.6); 7.381(1.0); 7.356(0.8); 7.310(1.1); 7.284(1.8);7.266(4.3); 7.258(1.4); 7.223(1.0); 7.218(1.0); 7.195(0.7); 7.190(0.7);7.092(1.2); 7.061(0.7); 6.969(1.8); 6.965(1.8); 6.941(1.6); 6.937(1.5);6.910(2.6); 6.879(1.4); 6.729(1.3); 6.698(0.7); 5.098(1.1); 5.045(2.2);5.025(0.5); 4.975(0.7); 4.949(1.9); 4.897(1.0); 4.785(1.0); 4.735(0.7);3.828(9.0); 3.806(4.7); 3.008(0.5); 2.008(3.2); 1.978(0.7); 1.898(1.4);1.873(1.0); 1.830(2.0); 1.802(16.0); 1.675(3.1); 1.656(8.4); 0.811(0.7);0.790(1.0); 0.773(1.1); 0.745(2.0); 0.729(2.4); 0.723(2.6); 0.707(2.0);0.699(1.8); 0.690(1.3); 0.683(1.1); 0.678(1.1); 0.662(0.9); 0.654(0.7);0.625(0.5); 0.611(0.5); 0.072(1.3); 0.000(2.0) Example I.177:¹H-NMR(300.2 MHz, CDCl₃): 7.608(0.4); 7.328(0.6); 7.303(0.9);7.277(3.7); 7.262(73.7); 7.238(0.6); 7.196(0.4); 7.175(1.6); 7.149(2.2);7.039(2.6); 7.013(1.9); 6.977(0.4); 6.949(0.6); 6.911(0.4); 6.796(0.7);6.766(1.2); 6.584(0.6); 5.097(0.6); 5.070(0.5); 4.789(0.7); 4.733(0.5);3.902(16.0); 3.892(11.8); 2.808(0.5); 2.394(8.6); 2.363(15.8);2.010(5.5); 1.957(0.5); 1.921(1.1); 1.899(0.7); 1.799(1.4); 1.766(4.9);1.668(4.4); 1.645(5.9); 1.559(20.5); 1.496(0.4); 0.457(1.9); 0.386(1.0);0.217(1.1); 0.081(1.1); 0.069(36.3); 0.057(1.7); 0.011(1.9);0.000(67.7); −0.011(3.2); −0.066(0.5) Example I.178: ¹H-NMR(300.2 MHz,CDCl₃): 7.607(0.4); 7.299(0.9); 7.272(9.3); 7.261(67.8); 7.231(0.8);7.159(1.4); 7.134(2.1); 7.103(1.5); 7.042(2.7); 7.016(1.8); 6.920(3.1);6.738(1.6); 5.118(1.5); 5.067(2.1); 4.997(3.7); 4.781(1.5); 4.731(1.1);3.818(9.7); 3.807(6.6); 2.992(0.4); 2.394(9.1); 2.356(12.6); 2.009(3.3);1.988(0.7); 1.870(1.7); 1.846(1.2); 1.806(13.9); 1.785(1.8); 1.761(2.4);1.662(11.0); 1.639(2.3); 1.552(16.0); 0.742(0.4); 0.693(1.0);0.673(1.1); 0.644(1.8); 0.629(2.1); 0.608(1.4); 0.584(1.7); 0.562(1.5);0.485(0.6); 0.069(15.8); 0.011(5.0); 0.000(45.0); −0.011(2.1) ExampleI.179: ¹H-NMR(499.9 MHz, CDCl₃): 7.259(15.9); 7.165(0.9); 7.149(3.0);7.133(0.6); 7.078(0.9); 7.062(1.9); 7.047(1.2); 7.035(0.9); 7.000(0.5);6.926(1.9); 6.887(2.7); 6.871(2.1); 6.817(0.9); 6.781(0.5); 5.159(1.6);5.128(1.9); 4.940(0.3); 4.860(0.9); 4.829(0.7); 4.802(1.3); 4.773(0.9);3.815(10.6); 3.796(5.6); 2.262(4.2); 2.258(4.7); 2.231(8.0); 2.227(8.3);1.999(2.9); 1.946(0.3); 1.933(0.4); 1.856(1.2); 1.841(0.9); 1.826(2.2);1.812(2.5); 1.777(16.0); 1.647(8.8); 1.629(3.5); 1.615(3.1); 1.557(1.4);0.744(1.1); 0.730(0.9); 0.716(0.6); 0.707(1.1); 0.698(1.4); 0.692(1.2);0.684(1.8); 0.676(1.5); 0.671(1.3); 0.665(1.5); 0.651(1.2); 0.638(1.1);0.626(0.4); 0.600(0.4); 0.591(0.5); 0.006(0.4); 0.000(10.2); −0.007(0.5)Example Ia.01: ¹H-NMR (300.2 MHz, CDCl₃): 7.262 (11.2); 7.121 (0.6);7.105 (4.4); 7.097 (3.0); 7.084 (2.8); 7.060 (1.0); 7.037 (1.9); 7.016(1.2); 7.007 (0.8); 6.773 (0.5); 4.576 (0.8); 3.906 (3.5); 2.992 (1.8);2.967 (3.5); 2.957 (3.5); 2.942 (2.1); 2.885 (2.3); 2.883 (2.4); 2.836(0.6); 2.053 (1.4); 2.028 (2.5); 2.006 (16.0); 1.597 (3.9); 1.375 (1.5);0.897 (3.7); 0.573 (2.3); 0.000 (8.6); −0.011 (0.3) Example Ia.02:¹H-NMR (300.2 MHz, CDCl₃): 7.262 (4.7); 7.123 (0.6); 7.097 (4.4); 7.074(2.8); 7.049 (1.3); 6.927 (1.4); 6.905 (1.2); 6.870 (0.7); 6.688 (0.4);4.550 (2.4); 3.819 (6.0); 2.993 (1.9); 2.968 (3.6); 2.955 (1.1); 2.943(2.1); 2.883 (0.5); 2.881 (0.5); 2.812 (0.6); 2.053 (2.4); 2.041 (0.4);2.028 (4.1); 2.016 (0.6); 2.014 (0.5); 2.012 (0.5); 2.003 (16.0); 1.987(0.3); 1.629 (0.7); 1.432 (1.2); 1.351 (2.1); 0.907 (1.6); 0.890 (4.1);0.887 (4.2); 0.869 (1.5); 0.621 (2.7); 0.000 (3.6) Example Ia.03: ¹H-NMR(300.2 MHz, CDCl₃): 7.262 (12.9); 7.130 (1.5); 7.106 (5.3); 7.082 (7.7);7.074 (4.5); 7.067 (5.9); 7.049 (2.0); 7.043 (1.3); 7.022 (3.7); 7.016(3.1); 6.998 (2.0); 6.992 (2.0); 6.893 (1.4); 6.711 (0.7); 5.298 (16.0);4.908 (5.3); 3.812 (13.6); 2.838 (3.8); 2.816 (7.9); 2.794 (4.2); 2.680(1.3); 2.045 (1.4); 1.839 (0.9); 1.816 (2.4); 1.798 (2.4); 1.791 (3.1);1.780 (2.3); 1.766 (3.0); 1.743 (1.3); 1.606 (11.7); 1.567 (3.6); 1.552(2.6); 1.540 (3.4); 1.516 (2.5); 1.283 (0.5); 1.259 (1.1); 1.235 (0.4);0.866 (4.3); 0.836 (10.3); 0.810 (1.3); 0.579 (6.9); 0.566 (6.7); 0.000(8.9); −0.011 (0.4) Example Ia.04: ¹H-NMR (300.2 MHz, CDCl₃): 7.262(8.7); 7.124 (3.2); 7.106 (3.1); 7.081 (1.1); 7.062 (3.0); 7.047 (1.6);7.033 (1.2); 6.962 (0.5); 6.779 (0.9); 6.596 (0.5); 5.298 (16.0); 5.290(0.4); 5.289 (0.4); 4.979 (1.6); 3.903 (6.0); 2.837 (1.5); 2.816 (3.1);2.794 (2.0); 2.724 (0.9); 2.171 (1.5); 1.811 (1.2); 1.786 (1.8); 1.764(1.7); 1.612 (7.9); 1.577 (1.4); 1.551 (1.7); 1.532 (1.2); 0.862 (5.0);0.707 (0.5); 0.521 (2.3); 0.477 (1.9); 0.000 (6.1) Example Ia.05: ¹H-NMR(400.1 MHz, d₆-DMSO): 7.123 (1.5); 6.988 (3.4); 6.889 (3.1); 6.853(1.8); 6.759 (2.4); 5.761 (15.5); 4.739 (5.3); 3.808 (6.3); 3.316(70.1); 2.747 (1.6); 2.731 (3.4); 2.714 (1.8); 2.682 (0.5); 2.677 (0.6);2.673 (0.5); 2.668 (0.4); 2.637 (0.6); 2.531 (1.2); 2.517 (28.7); 2.513(58.9); 2.508 (80.0); 2.504 (56.7); 2.499 (26.6); 2.463 (0.4); 2.340(0.4); 2.335 (0.5); 2.331 (0.4); 2.216 (16.0); 1.996 (0.6); 1.750 (0.4);1.733 (1.2); 1.715 (1.6); 1.697 (1.4); 1.680 (0.5); 1.494 (1.4); 1.474(1.7); 1.457 (1.1); 1.255 (0.9); 0.883 (0.4); 0.866 (1.3); 0.849 (0.6);0.795 (6.3); 0.580 (1.6); 0.567 (1.7); 0.535 (0.4); 0.488 (2.2) ExampleIa.06: ¹H-NMR (400.1 MHz, d₆-DMSO): 7.166 (0.4); 7.032 (0.9); 6.896(0.6); 6.875 (2.8); 6.853 (1.5); 5.758 (16.0); 4.784 (1.2); 3.908 (4.7);3.363 (0.7); 3.313 (138.0); 3.263 (0.6); 2.734 (2.1); 2.719 (1.6); 2.687(1.0); 2.682 (1.0); 2.677 (1.0); 2.562 (0.3); 2.558 (0.4); 2.553 (0.3);2.530 (1.0); 2.517 (24.8); 2.512 (49.9); 2.508 (67.2); 2.503 (48.0);2.499 (22.9); 2.463 (0.4); 2.458 (0.4); 2.340 (0.3); 2.335 (0.4); 2.330(0.3); 2.217 (14.2); 1.716 (1.3); 1.487 (1.4); 0.830 (6.1); 0.458 (2.4)Example Ia.07: ¹H-NMR (400.1 MHz, d₆-DMSO): 7.268 (1.1); 7.248 (10.4);7.236 (16.0); 7.137 (1.6); 7.059 (3.5); 7.003 (3.5); 6.868 (1.7); 5.752(8.4); 4.658 (2.4); 4.056 (1.1); 4.038 (3.3); 4.020 (3.4); 4.002 (1.2);3.889 (14.3); 3.362 (0.7); 3.311 (239.5); 3.263 (1.1); 3.028 (0.8);2.987 (2.0); 2.975 (1.9); 2.964 (1.9); 2.946 (1.6); 2.893 (2.2); 2.862(4.2); 2.843 (3.7); 2.824 (2.2); 2.805 (2.1); 2.669 (2.3); 2.645 (3.0);2.547 (1.4); 2.504 (120.5); 2.500 (161.8); 2.496 (122.3); 2.327 (1.1);2.279 (2.3); 2.263 (2.6); 2.247 (2.3); 2.231 (1.9); 2.085 (1.7); 1.987(14.0); 1.954 (10.1); 1.932 (9.5); 1.278 (0.5); 1.246 (2.4); 1.192(3.7); 1.174 (7.2); 1.157 (3.6); 0.874 (1.0); 0.858 (2.8); 0.840 (1.3);0.642 (0.3); 0.615 (0.4); 0.484 (7.1); 0.000 (13.2) Example Ia.08:¹H-NMR (400.1 MHz, d₆-DMSO): 7.250 (14.3); 7.240 (8.0); 7.237 (9.7);7.218 (1.1); 7.102 (3.1); 6.967 (9.0); 6.952 (4.4); 6.942 (2.7); 6.832(3.5); 5.760 (2.4); 4.672 (9.6); 4.047 (0.5); 4.029 (0.5); 3.807 (16.0);3.320 (158.9); 3.270 (1.1); 3.039 (0.7); 3.023 (1.0); 3.011 (1.1); 3.000(1.5); 2.984 (1.5); 2.972 (1.6); 2.955 (1.4); 2.870 (3.4); 2.852 (4.4);2.833 (3.3); 2.813 (2.2); 2.698 (1.8); 2.686 (2.4); 2.682 (2.7); 2.673(2.2); 2.548 (1.7); 2.518 (30.8); 2.513 (58.5); 2.509 (78.1); 2.504(58.0); 2.500 (31.3); 2.468 (3.0); 2.340 (0.4); 2.335 (0.6); 2.331(0.4); 2.290 (2.6); 2.274 (2.8); 2.257 (2.4); 2.241 (2.0); 2.093 (0.9);1.996 (2.3); 1.974 (6.5); 1.951 (6.2); 1.253 (0.4); 1.201 (0.6); 1.183(1.2); 1.165 (0.6); 0.866 (0.5); 0.607 (4.0); 0.591 (4.7); 0.554 (6.7)Example Ia.09: ¹H-NMR (300.2 MHz, CDCl₃): 7.263 (11.3); 7.235 (1.7);7.211 (5.8); 7.186 (7.5); 7.178 (4.3); 7.173 (5.3); 7.154 (1.8); 7.083(3.3); 7.078 (3.2); 7.058 (3.5); 6.877 (2.5); 6.695 (1.3); 4.820 (1.0);4.770 (3.1); 4.728 (3.9); 4.678 (1.2); 3.815 (16.0); 3.483 (0.9); 2.894(0.5); 2.873 (0.5); 2.847 (1.3); 2.825 (1.5); 2.805 (1.5); 2.780 (3.3);2.776 (2.8); 2.760 (2.7); 2.754 (2.4); 2.733 (1.0); 2.727 (1.0); 2.712(1.0); 2.706 (0.9); 2.667 (1.5); 2.659 (1.6); 2.649 (1.4); 2.329 (1.4);2.303 (1.6); 2.277 (0.8); 2.271 (0.9); 2.252 (1.1); 2.245 (1.0); 2.236(1.4); 2.230 (1.3); 2.220 (0.9); 2.213 (1.2); 2.200 (0.8); 2.195 (1.0);2.174 (1.6); 2.157 (0.4); 2.128 (1.4); 2.113 (1.0); 2.091 (1.2); 2.075(1.0); 2.006 (6.0); 1.999 (0.4); 1.989 (1.6); 1.977 (2.0); 1.955 (1.6);1.943 (2.3); 1.930 (1.4); 1.910 (0.8); 1.895 (0.9); 1.862 (7.0); 1.835(6.2); 1.614 (3.4); 1.598 (0.6); 1.577 (0.9); 1.561 (1.1); 1.540 (1.1);1.525 (0.8); 1.519 (1.0); 1.505 (0.7); 0.592 (8.5); 0.000 (8.7); −0.011(0.3) Example Ia.10: ¹H-NMR (300.2 MHz, CDCl₃): 7.266 (9.1); 7.239(2.0); 7.217 (2.9); 7.211 (3.7); 7.190 (9.6); 7.158 (9.5); 7.137 (4.0);6.941 (1.4); 6.759 (2.7); 6.576 (1.4); 4.914 (1.0); 4.726 (1.2); 4.682(1.0); 4.572 (0.4); 3.899 (16.0); 2.953 (1.9); 2.881 (2.1); 2.879 (2.1);2.849 (1.4); 2.827 (1.7); 2.805 (1.7); 2.770 (5.0); 2.752 (5.5); 2.727(2.9); 2.707 (1.8); 2.360 (2.4); 2.334 (2.8); 2.279 (0.7); 2.264 (1.0);2.244 (1.5); 2.228 (1.9); 2.194 (2.4); 2.153 (1.8); 2.115 (1.4); 2.101(1.2); 2.035 (0.4); 2.000 (8.9); 1.986 (2.2); 1.942 (5.7); 1.915 (4.6);1.684 (1.2); 1.593 (0.6); 1.556 (1.3); 1.535 (1.4); 1.514 (1.4); 1.483(0.8); 1.474 (0.6); 1.461 (0.6); 0.535 (9.3); 0.000 (6.7) Example Ia.11:¹H-NMR (400.1 MHz, d₆-DMSO): 7.295 (0.4); 7.282 (0.7); 7.280 (0.7);7.245 (0.4); 7.151 (1.3); 7.132 (3.8); 7.114 (4.6); 7.099 (5.7); 7.093(3.9); 7.084 (2.7); 7.062 (3.1); 7.043 (2.1); 6.958 (6.1); 6.823 (3.0);4.638 (0.5); 4.547 (6.3); 3.788 (16.0); 3.308 (21.6); 3.025 (0.5); 2.803(0.5); 2.781 (11.0); 2.674 (0.4); 2.669 (0.5); 2.665 (0.5); 2.605 (1.0);2.555 (0.3); 2.550 (0.4); 2.523 (1.6); 2.510 (22.0); 2.505 (44.7); 2.501(61.1); 2.496 (44.8); 2.492 (23.1); 2.332 (0.3); 2.327 (0.4); 2.323(0.3); 1.988 (1.0); 1.955 (0.3); 1.722 (0.3); 1.700 (1.2); 1.678 (2.9);1.643 (5.3); 1.635 (6.3); 1.614 (4.8); 1.544 (3.0); 1.526 (4.5); 1.509(3.3); 1.441 (1.4); 1.365 (0.5); 1.339 (0.4); 1.329 (0.4); 1.298 (0.4);1.281 (1.2); 1.245 (2.8); 1.193 (0.4); 1.175 (0.5); 1.157 (0.3); 1.124(2.0); 0.875 (1.2); 0.858 (3.9); 0.841 (1.6); 0.669 (0.9); 0.652 (3.7);0.639 (3.9); 0.635 (3.8); 0.622 (1.9); 0.600 (0.6); 0.583 (0.7); 0.535(4.3); 0.000 (3.7) Example Ia.12: ¹H-NMR (400.1 MHz, d₆-DMSO): 7.295(0.6); 7.284 (0.9); 7.165 (0.4); 7.151 (1.0); 7.131 (2.8); 7.117 (5.0);7.103 (7.2); 7.084 (2.1); 6.996 (0.6); 6.968 (3.7); 6.834 (1.9); 5.753(6.4); 4.540 (1.1); 4.410 (0.4); 3.915 (0.4); 3.908 (0.6); 3.869 (16.0);3.308 (16.9); 3.026 (0.4); 2.831 (4.3); 2.670 (0.4); 2.579 (1.1); 2.505(38.3); 2.501 (50.7); 2.496 (36.9); 2.450 (0.4); 2.327 (0.4); 1.988(0.5); 1.702 (1.2); 1.680 (3.1); 1.639 (6.9); 1.617 (5.1); 1.527 (4.9);1.509 (3.5); 1.464 (1.5); 1.448 (1.5); 1.385 (0.5); 1.373 (0.5); 1.341(0.4); 1.284 (0.4); 1.269 (0.4); 1.236 (0.9); 1.128 (1.8); 0.858 (0.4);0.522 (4.4); 0.000 (3.4) Example Ia.13: ¹H-NMR (300.2 MHz, d₆-DMSO):7.228 (0.4); 7.217 (0.5); 7.209 (0.6); 7.196 (1.6); 7.187 (1.7); 7.175(0.9); 7.152 (1.8); 7.138 (1.6); 7.130 (2.5); 7.104 (1.1); 7.015 (1.2);6.977 (0.6); 6.953 (0.3); 6.837 (0.8); 5.758 (4.3); 5.469 (0.9); 5.421(1.1); 5.049 (1.1); 5.001 (0.9); 4.607 (0.5); 4.581 (0.5); 4.041 (0.7);4.017 (0.8); 3.868 (6.4); 3.817 (2.3); 3.326 (16.0); 2.876 (3.8); 2.793(0.7); 2.780 (0.5); 2.771 (0.5); 2.757 (0.9); 2.751 (0.8); 2.733 (0.5);2.513 (3.1); 2.508 (6.5); 2.502 (9.0); 2.496 (6.7); 2.490 (3.4); 2.300(1.3); 1.989 (3.3); 1.649 (2.6); 1.530 (1.5); 1.297 (0.4); 1.236 (0.3);1.198 (0.9); 1.174 (1.8); 1.151 (0.9); 1.127 (0.6); 0.926 (0.4); 0.912(0.4); 0.902 (0.5); 0.891 (0.4); 0.850 (0.4); 0.838 (0.6); 0.774 (0.4);0.755 (0.5); 0.740 (0.5); 0.682 (0.4); 0.675 (0.5); 0.668 (0.5); 0.662(0.5); 0.643 (0.6); 0.635 (0.6); 0.625 (0.7); 0.615 (1.5); 0.601 (0.7);0.590 (1.3); 0.570 (0.4); 0.000 (4.5) Example II.01: 1H-NMR (400.1 MHz,d6-DMSO): 7.417 (1.3); 7.413 (1.5); 7.398 (1.5); 7.395 (1.7); 7.252(1.4); 7.248 (1.4); 7.235 (2.1); 7.230 (2.1); 7.176 (0.6); 7.172 (0.8);7.158 (1.8); 7.154 (1.8); 7.140 (2.0); 7.137 (2.3); 7.132 (2.1); 7.119(1.7); 7.115 (1.5); 7.100 (0.6); 7.097 (0.5); 3.956 (5.1); 3.943 (0.9);3.311 (3.2); 2.508 (3.3); 2.504 (6.0); 2.500 (7.8); 2.495 (5.6); 2.144(0.4); 2.135 (0.7); 2.127 (1.0); 2.118 (1.4); 2.110 (1.0); 2.102 (0.8);2.093 (0.4); 1.271 (16.0); 1.263 (1.7); 0.757 (0.8); 0.739 (4.3); 0.734(3.2); 0.710 (3.4); 0.708 (3.4); 0.703 (4.9); 0.700 (3.7); 0.685 (1.0);0.393 (0.7); 0.381 (2.0); 0.376 (3.1); 0.365 (2.3); 0.359 (2.6); 0.351(1.2); 0.328 (0.4); 0.314 (0.3); 0.300 (1.2); 0.291 (3.6); 0.286 (2.4);0.282 (3.5); 0.277 (2.1); 0.265 (0.8); 0.000 (1.2) Example II.02: 1H-NMR(300.2 MHz, CDCl3): 7.259 (5.2); 7.185 (0.3); 7.160 (1.3); 7.144 (2.3);7.141 (2.7); 7.136 (2.8); 7.133 (2.2); 7.126 (3.4); 7.116 (0.6); 6.915(0.8); 6.907 (0.9); 6.892 (0.7); 6.881 (1.0); 6.866 (1.1); 6.849 (0.7);4.074 (6.4); 2.246 (0.4); 2.233 (0.7); 2.225 (0.9); 2.212 (1.4); 2.204(0.6); 2.200 (0.9); 2.191 (0.8); 2.178 (0.5); 1.792 (0.4); 1.432 (1.7);1.329 (16.0); 1.315 (1.1); 1.306 (0.6); 1.260 (0.6); 0.928 (0.4); 0.915(0.5); 0.904 (0.7); 0.897 (0.5); 0.892 (0.7); 0.884 (0.6); 0.879 (0.6);0.868 (0.4); 0.860 (0.3); 0.852 (0.4); 0.821 (3.7); 0.817 (3.8); 0.801(4.2); 0.798 (4.5); 0.771 (0.5); 0.498 (0.4); 0.477 (1.7); 0.473 (1.8);0.471 (2.0); 0.467 (1.6); 0.462 (1.6); 0.455 (1.6); 0.452 (1.8); 0.448(2.6); 0.441 (2.0); 0.438 (1.9); 0.433 (1.8); 0.428 (2.4); 0.426 (3.0);0.424 (2.8); 0.419 (3.1); 0.414 (2.0); 0.411 (1.8); 0.402 (0.7); 0.389(0.6); 0.074 (0.3); 0.000 (3.9) Example II.03: 1H-NMR (300.2 MHz,CDCl3): 7.261 (11.7); 6.825 (2.1); 6.798 (3.0); 6.683 (3.8); 6.656(2.6); 5.995 (0.4); 5.942 (16.0); 3.977 (8.6); 3.749 (0.5); 2.242 (0.4);2.229 (0.7); 2.220 (0.8); 2.208 (1.4); 2.200 (0.6); 2.195 (0.8); 2.187(0.8); 2.174 (0.5); 2.084 (0.4); 2.079 (0.4); 2.076 (0.4); 1.621 (0.9);1.332 (13.5); 1.318 (1.0); 1.255 (0.5); 0.870 (0.8); 0.849 (3.3); 0.836(1.6); 0.803 (0.5); 0.787 (0.4); 0.754 (1.9); 0.742 (3.5); 0.736 (2.8);0.731 (1.8); 0.720 (1.2); 0.468 (1.6); 0.462 (1.9); 0.458 (1.6); 0.453(1.6); 0.446 (1.6); 0.443 (1.7); 0.438 (2.6); 0.431 (2.3); 0.425 (1.8);0.421 (2.4); 0.416 (2.9); 0.410 (3.0); 0.403 (1.7); 0.394 (0.7); 0.381(0.5); 0.000 (8.0); −0.011 (0.4) Example II.04: 1H-NMR (300.2 MHz,CDCl3): 7.517 (0.3); 7.327 (0.5); 7.315 (2.2); 7.305 (3.3); 7.297 (3.7);7.287 (3.3); 7.260 (5.8); 7.168 (2.2); 7.161 (2.0); 7.141 (1.5); 7.133(1.4); 4.040 (9.8); 3.852 (0.6); 2.238 (0.5); 2.225 (0.9); 2.216 (1.1);2.204 (1.6); 2.197 (0.7); 2.192 (1.0); 2.183 (1.0); 2.170 (0.5); 2.046(1.4); 1.722 (0.8); 1.432 (0.9); 1.339 (0.3); 1.331 (1.3); 1.317 (16.0);1.300 (0.6); 1.294 (0.6); 1.283 (0.6); 1.259 (0.9); 1.235 (0.9); 0.826(1.0); 0.802 (4.1); 0.792 (3.8); 0.755 (4.1); 0.745 (4.3); 0.741 (3.4);0.722 (1.3); 0.493 (0.4); 0.472 (2.0); 0.469 (2.1); 0.467 (2.3); 0.460(1.7); 0.456 (1.8); 0.451 (1.9); 0.448 (2.1); 0.445 (2.5); 0.441 (2.0);0.436 (1.8); 0.427 (1.8); 0.424 (1.7); 0.415 (3.4); 0.409 (3.1); 0.407(2.8); 0.403 (2.2); 0.399 (2.0); 0.392 (0.9); 0.385 (0.5); 0.379 (0.6);0.000 (4.0) Example II.05: 1H-NMR (300.2 MHz, CDCl3): 7.256 (5.1); 7.251(2.5); 7.225 (2.8); 7.148 (2.4); 7.144 (2.6); 7.022 (1.4); 7.017 (1.4);6.996 (1.2); 6.992 (1.1); 4.049 (9.3); 2.300 (13.7); 2.251 (0.5); 2.238(0.8); 2.230 (1.0); 2.227 (0.8); 2.217 (1.8); 2.209 (0.8); 2.204 (0.9);2.197 (0.9); 2.184 (0.6); 2.045 (0.6); 1.720 (1.8); 1.320 (16.0); 1.259(0.4); 0.819 (0.9); 0.810 (1.2); 0.797 (4.0); 0.786 (2.0); 0.770 (1.0);0.739 (0.7); 0.724 (2.4); 0.712 (4.5); 0.707 (3.5); 0.699 (1.6); 0.691(1.4); 0.466 (1.7); 0.458 (3.1); 0.452 (2.0); 0.444 (1.9); 0.437 (5.2);0.431 (4.9); 0.427 (2.8); 0.423 (3.8); 0.418 (3.9); 0.415 (2.2); 0.412(1.9); 0.402 (0.6); 0.388 (0.4); 0.000 (3.3) Example II.06: 1H-NMR(300.2 MHz, d6-DMSO): 7.136 (2.1); 7.008 (2.4); 6.992 (2.4); 6.975(0.7); 6.963 (1.1); 6.956 (1.2); 6.887 (1.2); 3.971 (0.6); 3.870 (4.4);3.661 (3.9); 3.655 (2.3); 3.328 (1.1); 3.252 (0.4); 2.514 (1.6); 2.508(3.2); 2.501 (4.4); 2.495 (3.2); 2.489 (1.6); 2.320 (2.8); 2.286 (0.3);2.271 (0.5); 2.209 (1.4); 2.191 (5.9); 2.159 (4.3); 2.142 (16.0); 2.120(1.6); 2.110 (6.9); 2.099 (1.7); 2.094 (1.4); 2.087 (1.2); 2.077 (1.0);2.072 (1.1); 2.064 (0.8); 2.060 (0.7); 2.051 (0.6); 2.039 (0.6); 1.981(0.5); 1.743 (0.4); 1.617 (7.4); 1.356 (0.6); 1.328 (6.7); 1.318 (1.2);1.305 (0.4); 1.263 (1.2); 1.236 (8.5); 1.227 (1.5); 1.220 (2.9); 1.177(0.5); 0.772 (0.7); 0.751 (1.8); 0.741 (1.0); 0.728 (0.6); 0.720 (0.9);0.710 (1.1); 0.704 (1.3); 0.689 (2.9); 0.682 (1.9); 0.674 (2.0); 0.663(5.0); 0.656 (5.6); 0.641 (1.4); 0.631 (0.8); 0.392 (0.5); 0.385 (0.6);0.376 (1.7); 0.370 (2.6); 0.365 (2.4); 0.354 (2.5); 0.349 (2.6); 0.343(2.0); 0.337 (1.2); 0.332 (1.0); 0.321 (0.6); 0.311 (0.7); 0.304 (0.5);0.294 (0.9); 0.283 (2.0); 0.276 (1.4); 0.271 (1.8); 0.265 (1.4); 0.257(1.9); 0.250 (1.8); 0.245 (1.9); 0.239 (1.5); 0.223 (0.6); 0.059 (0.5);0.000 (4.5); −0.236 (0.4) Example II.07: 1H-NMR (300.2 MHz, CDCl3):7.510 (5.0); 7.418 (6.6); 7.300 (4.8); 4.215 (13.5); 4.059 (10.1); 3.830(0.4); 3.525 (0.7); 2.278 (0.4); 2.266 (0.9); 2.257 (1.0); 2.244 (1.5);2.238 (0.8); 2.232 (1.0); 2.223 (0.9); 2.211 (0.5); 1.686 (4.4); 1.339(16.0); 0.845 (0.5); 0.817 (5.0); 0.798 (3.7); 0.792 (5.6); 0.764 (0.7);0.542 (0.6); 0.521 (1.9); 0.516 (2.2); 0.506 (2.3); 0.500 (2.0); 0.496(2.1); 0.493 (2.4); 0.488 (1.7); 0.484 (1.7); 0.468 (2.3); 0.456 (3.5);0.453 (3.3); 0.448 (2.6); 0.441 (2.0); 0.433 (1.0); 0.420 (0.6); 0.413(0.4); 0.037 (4.6) Example II.08: 1H-NMR (400.1 MHz, d6-DMSO): 7.134(1.1); 6.999 (2.5); 6.861 (5.2); 6.595 (3.4); 4.831 (2.8); 3.812 (5.7);3.749 (16.0); 3.670 (15.2); 3.308 (30.9); 2.826 (0.4); 2.523 (0.8);2.509 (144); 2.505 (28.9); 2.500 (38.8); 2.496 (27.4); 2.491 (12.8);1.988 (0.5); 1.278 (6.8); 1.248 (0.4); 0.859 (0.4); 0.794 (0.6); 0.777(2.5); 0.742 (2.0); 0.735 (2.8); 0.719 (0.7); 0.663 (1.5); 0.649 (1.5);0.524 (1.7); 0.000 (4.6) Example II.09: 1H-NMR (300.2 MHz, CDCl3): 7.522(2.6); 7.515 (2.7); 7.289 (1.1); 7.282 (1.0); 7.260 (5.5); 7.255 (2.2);7.196 (4.2); 7.169 (2.3); 4.056 (10.2); 2.253 (0.4); 2.241 (0.8); 2.232(1.0); 2.219 (1.5); 2.212 (0.7); 2.207 (0.9); 2.198 (0.9); 2.186 (0.5);1.725 (0.9); 1.640 (0.6); 1.491 (4.8); 1.300 (16.0); 0.794 (0.6); 0.767(4.7); 0.743 (3.4); 0.737 (5.2); 0.710 (0.9); 0.575 (0.3); 0.504 (0.4);0.483 (1.9); 0.478 (2.2); 0.472 (1.6); 0.468 (1.7); 0.462 (1.8); 0.455(2.5); 0.447 (1.8); 0.440 (1.8); 0.437 (1.7); 0.428 (3.4); 0.423 (3.1);0.413 (2.0); 0.405 (0.8); 0.397 (0.3); 0.392 (0.5); 0.000 (4.9) ExampleII.10: 1H-NMR (300.2 MHz, d6-DMSO): 7.478 (2.7); 7.471 (2.7); 7.268(2.3); 7.240 (4.2); 7.184 (2.1); 7.176 (2.0); 7.156 (1.1); 7.148 (1.1);3.943 (7.5); 3.323 (7.5); 2.810 (0.3); 2.514 (2.5); 2.508 (5.4); 2.502(7.4); 2.496 (5.5); 2.490 (2.7); 2.127 (0.4); 2.114 (0.8); 2.104 (1.0);2.093 (1.5); 2.081 (1.0); 2.071 (0.9); 2.059 (0.5); 1.742 (0.6); 1.359(0.3); 1.252 (16.0); 0.723 (14.1); 0.403 (0.5); 0.394 (0.6); 0.386(1.7); 0.380 (2.8); 0.365 (2.0); 0.358 (2.5); 0.347 (1.4); 0.336 (0.7);0.321 (0.5); 0.302 (1.5); 0.291 (3.3); 0.284 (2.3); 0.280 (2.8); 0.273(2.1); 0.262 (0.8); 0.256 (0.8); 0.000 (7.5); −0.011 (0.4) ExampleII.11: 1H-NMR (300.2 MHz, d6-DMSO): 7.285 (1.6); 7.264 (1.9); 7.257(3.1); 7.248 (1.5); 7.236 (1.9); 7.222 (1.3); 7.212 (1.3); 6.956 (0.9);6.946 (0.8); 6.928 (1.5); 6.918 (1.4); 6.899 (0.7); 6.890 (0.7); 3.951(7.4); 3.322 (8.0); 2.788 (0.3); 2.514 (2.6); 2.508 (5.6); 2.502 (7.8);2.495 (5.8); 2.489 (2.8); 2.131 (0.4); 2.119 (0.8); 2.109 (1.0); 2.097(1.5); 2.090 (0.7); 2.085 (1.0); 2.076 (0.9); 2.063 (0.5); 1.349 (0.3);1.304 (0.4); 1.250 (16.0); 0.717 (6.6); 0.713 (6.8); 0.710 (7.4); 0.680(0.5); 0.401 (0.5); 0.392 (0.6); 0.384 (1.8); 0.378 (2.7); 0.366 (1.7);0.362 (2.1); 0.355 (2.6); 0.345 (1.4); 0.336 (0.8); 0.319 (0.6); 0.302(1.4); 0.291 (3.3); 0.285 (2.3); 0.280 (2.8); 0.273 (2.1); 0.262 (0.8);0.256 (0.8); 0.000 (10.4); −0.011 (0.5) Example II.12: 1H-NMR (300.2MHz, d6-DMSO): 7.211 (2.9); 7.128 (2.6); 7.102 (3.3); 6.935 (1.7); 6.909(1.4); 3.913 (7.0); 3.322 (12.7); 2.507 (10.3); 2.501 (13.7); 2.495(10.4); 2.233 (14.8); 2.148 (0.4); 2.136 (0.8); 2.126 (1.1); 2.114(1.5); 2.103 (1.0); 2.093 (0.9); 2.081 (0.5); 1.243 (16.0); 0.723 (0.4);0.695 (5.9); 0.673 (6.7); 0.646 (0.9); 0.402 (0.5); 0.380 (3.0); 0.365(2.2); 0.358 (2.7); 0.347 (1.4); 0.338 (0.6); 0.320 (0.5); 0.303 (1.5);0.292 (3.6); 0.280 (3.2); 0.257 (0.8); 0.000 (12.5) Example II.13:1H-NMR (400.1 MHz, d6-DMSO): 7.161 (2.5); 7.158 (2.6); 7.124 (2.7);7.113 (0.3); 7.105 (3.3); 7.097 (0.6); 7.082 (0.4); 6.932 (1.4); 6.928(1.5); 6.912 (1.2); 6.909 (1.2); 3.893 (5.4); 3.318 (3.7); 2.518 (3.6);2.513 (7.7); 2.509 (10.8); 2.504 (8.1); 2.500 (4.2); 2.252 (0.9); 2.229(14.4); 1.930 (0.4); 1.366 (0.3); 1.350 (0.9); 1.300 (15.4); 1.260(16.0); 1.235 (0.4); 0.732 (0.9); 0.714 (4.1); 0.708 (3.6); 0.692 (0.4);0.682 (3.4); 0.675 (4.5); 0.671 (3.6); 0.658 (1.3); 0.570 (1.1); 0.560(3.7); 0.555 (4.0); 0.546 (1.6); 0.360 (1.8); 0.351 (5.4); 0.346 (5.6);0.336 (1.6) Example II.14: 1H-NMR (400.1 MHz, d6-DMSO): 7.158 (2.8);7.138 (6.6); 7.097 (0.4); 6.977 (1.6); 6.975 (1.5); 6.958 (1.3); 6.955(1.3); 4.030 (0.4); 4.019 (4.7); 4.002 (5.0); 3.548 (0.9); 3.531 (1.7);3.514 (0.8); 3.319 (1.9); 2.873 (0.7); 2.518 (2.9); 2.513 (5.9); 2.509(8.1); 2.504 (5.8); 2.500 (2.8); 2.253 (1.0); 2.236 (14.8); 1.996 (1.0);1.367 (0.4); 1.350 (0.8); 1.266 (16.0); 1.246 (0.5); 1.226 (1.5); 1.213(4.1); 1.206 (4.4); 1.195 (1.9); 1.184 (0.7); 1.167 (0.4); 1.131 (0.7);1.119 (2.2); 1.112 (2.1); 1.101 (0.9); 1.024 (2.2); 1.012 (4.5); 1.005(4.4); 0.993 (1.6); 0.892 (0.9); 0.881 (2.2); 0.874 (2.2); 0.862 (0.7);0.752 (0.8); 0.734 (4.4); 0.717 (0.5); 0.707 (3.3); 0.701 (4.8); 0.683(0.9) Example II.15: 1H-NMR (300.2 MHz, CDCl3): 7.290 (1.2); 7.285(1.3); 7.264 (1.6); 7.260 (2.0); 7.257 (2.1); 7.240 (1.2); 7.235 (1.3);7.214 (2.1); 7.209 (1.7); 7.134 (2.2); 7.109 (2.6); 7.083 (1.1); 4.098(4.0); 4.090 (4.3); 4.044 (0.4); 2.236 (0.4); 2.223 (0.7); 2.215 (0.9);2.202 (1.4); 2.196 (0.6); 2.190 (0.8); 2.181 (0.8); 2.169 (0.5); 1.765(0.9); 1.347 (16.0); 1.266 (0.4); 0.901 (0.4); 0.892 (0.8); 0.875(10.6); 0.869 (4.3); 0.862 (3.3); 0.851 (1.1); 0.844 (0.7); 0.837 (0.4);0.495 (0.4); 0.474 (1.6); 0.470 (2.3); 0.466 (1.6); 0.463 (1.5); 0.459(1.8); 0.455 (1.3); 0.452 (1.4); 0.448 (2.3); 0.444 (2.3); 0.439 (1.9);0.434 (1.8); 0.430 (1.4); 0.424 (2.5); 0.420 (3.2); 0.416 (2.7); 0.414(2.6); 0.407 (1.6); 0.398 (0.7); 0.385 (0.5); 0.000 (1.7) Example II.20:1H-NMR (400.0 MHz, d6-DMSO): 9.514 (0.5); 9.445 (1.5); 7.953 (0.6);7.654 (9.4); 7.648 (9.9); 7.585 (9.7); 7.564 (13.3); 7.459 (6.7); 7.453(6.3); 7.438 (5.0); 7.432 (4.7); 4.337 (16.0); 3.329 (65.0); 2.890(4.5); 2.747 (1.8); 2.737 (2.4); 2.730 (6.5); 2.720 (2.4); 2.712 (1.7);2.675 (1.5); 2.671 (1.9); 2.666 (1.5); 2.524 (8.4); 2.511 (120.3); 2.506(235.6); 2.502 (305.6); 2.497 (219.4); 2.493 (107.0); 2.333 (1.3); 2.328(1.8); 2.324 (1.3); 1.842 (4.3); 1.829 (13.8); 1.822 (13.7); 1.810(5.5); 1.771 (0.6); 1.649 (0.6); 1.610 (5.5); 1.598 (13.2); 1.591(13.8); 1.577 (4.2); 1.269 (0.5); 1.253 (0.7); 1.236 (1.1); 0.900 (1.7);0.878 (7.4); 0.873 (7.0); 0.861 (2.6); 0.824 (0.8); 0.806 (0.7); 0.784(2.5); 0.767 (7.1); 0.752 (7.2); 0.735 (1.5); 0.697 (0.4); 0.683 (0.6);0.008 (1.0); 0.000 (26.4); −0.009 (1.0); −0.081 (0.4) Example II.22:1H-NMR (300.2 MHz, CDCl3): 7.304 (1.7); 7.300 (5.7); 7.278 (1.8); 7.203(1.4); 7.050 (0.8); 7.046 (0.7); 7.024 (0.7); 7.020 (0.6); 4.142 (2.3);4.042 (5.8); 3.428 (6.4); 3.298 (0.6); 3.278 (16.0); 3.264 (0.5); 2.806(0.4); 2.346 (8.1); 2.328 (0.6); 2.281 (0.5); 2.273 (0.6); 2.260 (1.0);2.252 (0.5); 2.247 (0.6); 2.239 (0.6); 2.226 (0.3); 2.069 (0.4); 2.055(0.6); 1.749 (0.6); 1.675 (0.3); 1.424 (0.4); 1.399 (0.4); 1.390 (0.4);1.364 (0.7); 1.352 (0.6); 1.340 (0.7); 1.323 (0.6); 1.317 (0.6); 1.300(0.9); 1.272 (0.4); 1.258 (0.4); 1.250 (0.3); 1.101 (0.4); 1.092 (0.4);1.079 (0.5); 1.069 (0.5); 1.050 (0.4); 1.043 (0.4); 1.020 (0.4); 0.988(0.7); 0.965 (1.7); 0.956 (1.5); 0.943 (4.0); 0.931 (3.1); 0.923 (1.6);0.918 (1.8); 0.910 (2.3); 0.885 (1.1); 0.880 (2.3); 0.873 (1.6); 0.861(2.4); 0.846 (0.8); 0.838 (0.8); 0.824 (0.4); 0.536 (0.4); 0.515 (1.1);0.509 (1.5); 0.501 (1.3); 0.493 (1.2); 0.490 (1.3); 0.486 (2.0); 0.479(2.2); 0.470 (1.8); 0.465 (2.1); 0.460 (2.2); 0.452 (1.3); 0.443 (0.7);0.434 (0.6); 0.430 (0.6); 0.422 (0.7); 0.410 (0.4); 0.406 (0.4); 0.377(0.4); 0.359 (0.4); 0.038 (5.0) Example II.23: 1H-NMR (300.2 MHz,d6-DMSO): 7.433 (1.3); 7.408 (1.4); 7.402 (1.4); 7.222 (0.3); 7.216(0.4); 7.199 (0.5); 7.193 (1.0); 7.186 (0.7); 7.179 (0.9); 7.172 (1.6);7.165 (1.9); 7.155 (2.4); 7.149 (2.5); 7.144 (2.5); 7.135 (2.0); 7.129(2.0); 7.113 (0.9); 7.108 (1.0); 7.087 (0.4); 7.082 (0.4); 7.056 (0.4);7.051 (0.4); 7.032 (0.4); 5.168 (0.5); 5.162 (0.5); 4.843 (0.4); 4.839(0.4); 4.836 (0.4); 3.932 (6.0); 3.888 (0.3); 3.682 (1.5); 3.327 (1.7);2.848 (0.7); 2.514 (1.4); 2.508 (2.7); 2.502 (3.6); 2.495 (2.7); 2.489(1.5); 2.334 (0.5); 2.309 (0.5); 2.305 (0.4); 2.138 (0.3); 2.126 (0.7);2.116 (0.9); 2.104 (1.3); 2.092 (0.9); 2.082 (0.8); 2.070 (0.5); 2.035(0.4); 1.604 (0.6); 1.489 (0.8); 1.472 (0.8); 1.005 (1.0); 0.980 (2.0);0.955 (1.0); 0.881 (0.4); 0.760 (3.5); 0.736 (7.5); 0.711 (3.6); 0.698(16.0); 0.650 (0.5); 0.583 (0.5); 0.392 (0.6); 0.384 (0.6); 0.376 (1.5);0.370 (2.3); 0.358 (1.5); 0.354 (1.8); 0.347 (2.3); 0.337 (1.7); 0.325(0.9); 0.315 (0.6); 0.310 (0.6); 0.304 (0.4); 0.291 (1.4); 0.280 (2.8);0.273 (2.0); 0.268 (2.4); 0.261 (1.8); 0.252 (0.8); 0.245 (0.7); 0.238(0.5); 0.226 (0.8); 0.219 (0.5); 0.215 (0.7); 0.207 (0.5); 0.000 (4.0)Example II.24: 1H-NMR (300.2 MHz, CDCl3): 7.532 (1.0); 7.506 (1.9);7.480 (2.2); 7.455 (1.5); 7.428 (0.8); 7.261 (2.6); 4.114 (5.5); 2.237(0.6); 2.228 (0.8); 2.216 (1.2); 2.208 (0.6); 2.203 (0.7); 2.194 (0.7);2.182 (0.4); 1.942 (0.5); 1.906 (0.7); 1.523 (0.7); 0.830 (3.6); 0.805(7.4); 0.786 (16.0); 0.504 (0.3); 0.483 (1.4); 0.478 (1.7); 0.472 (1.2);0.468 (1.4); 0.455 (2.0); 0.447 (1.4); 0.441 (1.4); 0.437 (1.3); 0.428(2.5); 0.422 (2.4); 0.405 (0.6); 0.392 (0.4); 0.000 (3.2) Example II.25:1H-NMR (400.1 MHz, d6-DMSO): 7.428 (2.1); 7.407 (2.5); 7.197 (1.7);7.192 (1.8); 7.177 (1.4); 7.171 (1.7); 7.132 (0.3); 7.126 (3.4); 7.120(2.9); 7.108 (0.5); 7.102 (0.4); 5.707 (11.0); 3.864 (6.3); 3.853 (1.1);3.813 (0.4); 3.265 (0.3); 2.470 (1.6); 2.466 (3.1); 2.461 (4.3); 2.457(3.2); 2.452 (1.7); 2.120 (0.5); 2.071 (0.4); 2.062 (0.8); 2.054 (0.9);2.045 (1.5); 2.037 (1.0); 2.029 (0.8); 2.020 (0.4); 1.438 (0.8); 0.719(3.8); 0.711 (1.1); 0.701 (8.2); 0.692 (2.6); 0.683 (16.0); 0.663 (2.6);0.633 (0.4); 0.338 (0.6); 0.327 (1.7); 0.322 (2.6); 0.311 (2.0); 0.305(2.2); 0.296 (1.1); 0.275 (0.4); 0.267 (0.3); 0.238 (1.1); 0.229 (3.0);0.224 (2.2); 0.221 (3.0); 0.215 (2.0); 0.213 (1.7); 0.204 (0.8) ExampleII.26: 1H-NMR (400.1 MHz, d6-DMSO): 7.304 (2.2); 7.284 (2.4); 6.984(7.0); 6.966 (1.9); 3.891 (8.8); 2.517 (2.4); 2.513 (4.9); 2.508 (6.7);2.504 (4.8); 2.499 (2.3); 2.422 (0.7); 2.402 (0.4); 2.245 (16.0); 2.124(0.5); 2.115 (1.1); 2.107 (1.3); 2.098 (2.1); 2.089 (1.3); 2.082 (1.1);2.073 (0.6); 1.474 (1.0); 0.763 (5.1); 0.744 (10.8); 0.734 (1.0); 0.726(4.8); 0.686 (14.5); 0.382 (0.8); 0.370 (2.4); 0.365 (3.8); 0.354 (2.8);0.349 (3.1); 0.340 (1.4); 0.324 (0.4); 0.318 (0.4); 0.314 (0.4); 0.303(0.4); 0.286 (1.5); 0.277 (4.3); 0.272 (3.0); 0.268 (4.1); 0.263 (2.6);0.251 (0.9) Example II.27: 1H-NMR (300.2 MHz, CDCl3): 7.261 (14.1);7.049 (4.8); 7.016 (5.1); 4.048 (0.7); 4.030 (11.6); 2.254 (2.0); 2.240(2.1); 2.234 (2.3); 2.230 (2.3); 2.217 (13.6); 2.212 (14.0); 2.200(2.8); 2.186 (1.3); 2.166 (0.5); 2.160 (0.5); 1.483 (1.2); 1.460 (1.2);1.292 (0.9); 1.253 (0.7); 0.858 (0.4); 0.850 (0.3); 0.822 (7.6); 0.797(16.0); 0.773 (7.0); 0.747 (0.9); 0.719 (9.4); 0.705 (7.6); 0.676 (1.1);0.509 (0.5); 0.483 (3.0); 0.479 (4.8); 0.473 (3.0); 0.461 (5.7); 0.456(8.2); 0.447 (6.1); 0.443 (6.0); 0.439 (3.3); 0.425 (1.0); 0.411 (0.5);0.000 (10.5); −0.011 (0.5) Example II.28: 1H-NMR (400.1 MHz, d6-DMSO):7.912 (1.0); 7.849 (0.6); 7.807 (2.6); 7.722 (1.1); 7.482 (2.0); 7.463(3.1); 7.391 (3.8); 7.371 (3.3); 7.350 (0.7); 4.060 (0.3); 4.042 (0.9);4.024 (1.0); 4.001 (7.9); 3.988 (3.4); 3.957 (3.3); 3.948 (1.3); 3.932(1.7); 3.905 (0.4); 3.505 (0.5); 3.489 (1.0); 3.473 (0.5); 3.386 (0.6);3.370 (1.2); 3.354 (0.7); 3.307 (0.4); 2.632 (0.6); 2.615 (1.1); 2.597(0.7); 2.586 (1.0); 2.578 (0.5); 2.568 (1.3); 2.565 (1.2); 2.549 (1.4);2.529 (0.9); 2.513 (7.6); 2.509 (14.0); 2.504 (18.3); 2.500 (13.1);2.496 (6.6); 2.476 (0.5); 2.459 (0.4); 2.454 (0.4); 2.333 (0.3); 2.205(0.3); 2.199 (0.8); 2.123 (0.5); 2.114 (0.9); 2.107 (1.2); 2.098 (1.8);2.089 (1.2); 2.082 (1.0); 2.073 (0.5); 1.990 (3.9); 1.919 (0.4); 1.914(0.5); 1.906 (0.7); 1.897 (0.6); 1.889 (0.5); 1.880 (0.3); 1.664 (0.8);1.645 (1.0); 1.636 (0.9); 1.627 (1.1); 1.620 (1.0); 1.610 (0.8); 1.603(0.9); 1.588 (0.6); 1.567 (0.6); 1.510 (1.9); 1.360 (0.5); 1.196 (1.1);1.178 (2.1); 1.160 (1.0); 1.051 (0.9); 1.035 (0.9); 0.812 (0.5); 0.773(5.9); 0.764 (8.1); 0.758 (8.6); 0.746 (16.0); 0.740 (13.0); 0.727(8.6); 0.722 (7.2); 0.440 (0.4); 0.424 (1.5); 0.412 (1.4); 0.407 (1.3);0.393 (0.9); 0.381 (2.1); 0.376 (3.2); 0.365 (2.4); 0.359 (2.7); 0.350(1.3); 0.340 (0.4); 0.335 (0.5); 0.329 (0.6); 0.325 (0.7); 0.314 (0.6);0.309 (0.4); 0.297 (1.4); 0.288 (3.9); 0.283 (2.9); 0.279 (4.0); 0.274(3.0); 0.270 (3.0); 0.262 (2.3); 0.254 (1.3); 0.244 (0.5); 0.113 (0.5);0.107 (0.4); 0.104 (0.4); 0.098 (0.4); 0.000 (1.7) Example II.29: 1H-NMR(400.1 MHz, d6-DMSO): 9.751 (2.1); 7.912 (5.8); 7.906 (6.0); 7.378(2.6); 7.373 (2.7); 7.358 (4.2); 7.352 (4.3); 7.302 (8.0); 7.282 (4.7);4.432 (8.3); 3.317 (12.3); 2.806 (0.5); 2.796 (1.0); 2.788 (1.5); 2.779(1.9); 2.769 (1.5); 2.761 (1.1); 2.751 (0.5); 2.510 (10.9); 2.506(21.6); 2.501 (28.8); 2.497 (20.7); 2.493 (10.0); 1.450 (1.1); 1.259(1.1); 1.091 (0.4); 1.045 (1.2); 1.028 (4.7); 1.023 (4.9); 1.018 (4.6);1.006 (1.5); 0.859 (0.3); 0.839 (0.7); 0.818 (2.1); 0.799 (16.0); 0.790(12.1); 0.762 (7.6); 0.743 (15.0); 0.725 (6.5); 0.000 (4.2) ExampleII.30: 1H-NMR (400.1 MHz, CDCl3): 7.284 (0.5); 7.240 (2.8); 7.238 (2.9);7.204 (3.0); 7.184 (3.7); 7.023 (1.6); 7.020 (1.6); 7.004 (1.4); 7.001(1.3); 4.100 (9.6); 2.365 (16.0); 2.312 (0.5); 2.303 (1.0); 2.296 (1.2);2.287 (1.9); 2.281 (0.8); 2.277 (1.1); 2.271 (1.0); 2.261 (0.6); 1.818(0.8); 1.563 (0.9); 1.558 (0.9); 0.948 (0.4); 0.885 (5.6); 0.866 (11.4);0.848 (5.1); 0.816 (0.9); 0.800 (4.6); 0.793 (3.4); 0.765 (3.0); 0.758(3.9); 0.741 (1.0); 0.545 (0.5); 0.530 (2.2); 0.525 (2.6); 0.519 (2.0);0.514 (2.0); 0.508 (3.3); 0.502 (3.0); 0.495 (3.0); 0.492 (3.6); 0.487(3.7); 0.481 (2.0); 0.475 (0.6); 0.465 (0.5); 0.065 (0.5) Example II.31:1H-NMR (400.1 MHz, d6-DMSO): 7.185 (1.1); 7.169 (1.3); 7.165 (2.4);7.150 (2.3); 7.145 (1.8); 7.130 (1.6); 7.009 (2.8); 7.006 (3.7); 6.989(3.7); 6.987 (3.0); 6.972 (1.6); 6.967 (2.0); 6.964 (1.6); 6.946 (1.3);6.943 (1.2); 3.931 (8.8); 3.929 (9.0); 3.272 (1.9); 2.828 (1.2); 2.472(3.5); 2.468 (7.3); 2.463 (10.0); 2.459 (7.1); 2.454 (3.3); 2.142 (0.8);2.133 (1.6); 2.125 (2.3); 2.117 (3.1); 2.109 (2.1); 2.101 (1.5); 2.092(0.8); 1.509 (0.7); 1.490 (1.2); 1.473 (1.2); 0.750 (0.4); 0.737 (1.1);0.721 (5.7); 0.713 (3.5); 0.704 (7.0); 0.686 (16.0); 0.676 (5.7); 0.668(7.4); 0.659 (1.9); 0.377 (1.0); 0.366 (3.1); 0.361 (4.6); 0.350 (4.0);0.344 (3.7); 0.335 (1.6); 0.313 (0.3); 0.248 (1.5); 0.239 (5.0); 0.230(4.5); 0.224 (3.4); 0.213 (1.1) Example II.32: 1H-NMR (300.2 MHz,CDCl3): 7.324 (4.2); 7.297 (5.9); 7.261 (15.9); 7.221 (5.8); 7.214(7.5); 7.171 (4.5); 7.164 (3.6); 7.144 (3.2); 7.137 (2.7); 4.025 (14.9);2.230 (0.8); 2.217 (1.7); 2.208 (2.0); 2.196 (3.0); 2.189 (1.4); 2.184(1.9); 2.175 (1.8); 2.162 (1.0); 1.692 (0.9); 1.440 (1.2); 1.317 (0.4);1.296 (0.7); 1.272 (2.1); 1.247 (3.1); 1.222 (2.8); 1.195 (1.7); 1.170(0.6); 0.836 (7.9); 0.812 (16.0); 0.788 (6.7); 0.761 (9.9); 0.743 (9.2);0.715 (0.9); 0.493 (0.4); 0.488 (0.9); 0.478 (0.3); 0.467 (3.6); 0.462(4.1); 0.455 (3.2); 0.452 (3.4); 0.446 (3.4); 0.443 (3.6); 0.439 (4.5);0.436 (3.5); 0.431 (3.2); 0.421 (3.4); 0.418 (3.2); 0.409 (6.3); 0.404(5.8); 0.401 (4.9); 0.397 (3.9); 0.393 (3.4); 0.386 (1.3); 0.380 (0.7);0.373 (0.9); 0.011 (0.4); 0.000 (10.7); −0.011 (0.4) Example II.33:1H-NMR (499.9 MHz, d6-DMSO): 9.738 (1.1); 7.646 (4.1); 7.170 (2.4);7.154 (3.8); 7.103 (2.6); 7.088 (1.7); 4.388 (3.8); 3.338 (1.1); 2.741(1.3); 2.502 (1.6); 2.274 (16.0); 1.164 (1.8); 1.150 (1.8); 1.049 (1.0);1.036 (3.7); 1.032 (3.8); 1.019 (1.1); 0.795 (5.2); 0.781 (11.0); 0.769(12.3); 0.750 (4.0); 0.000 (0.6) Example II.34: 1H-NMR (400.1 MHz,d6-DMSO): 9.855 (1.4); 7.713 (3.3); 7.422 (3.2); 7.402 (3.8); 7.213(1.9); 7.211 (1.9); 7.194 (1.6); 7.192 (1.6); 4.508 (4.1); 2.810 (1.0);2.802 (0.8); 2.612 (0.5); 2.530 (0.4); 2.517 (6.1); 2.513 (12.4); 2.508(17.0); 2.504 (12.6); 2.499 (6.5); 2.322 (16.0); 2.294 (0.5); 2.278(0.3); 2.244 (0.4); 1.527 (0.9); 1.507 (4.0); 1.495 (3.9); 1.471 (3.8);1.458 (4.3); 1.438 (1.1); 1.087 (0.7); 1.074 (2.6); 1.071 (2.8); 1.065(3.0); 1.061 (2.9); 1.049 (1.1); 0.831 (0.8); 0.830 (0.8); 0.817 (2.6);0.813 (3.2); 0.799 (3.0); 0.796 (2.9); 0.782 (0.9); 0.780 (0.9); 0.761(0.3); 0.750 (0.3); 0.744 (0.3); 0.741 (0.3); 0.738 (0.3) Example II.35:1H-NMR (400.1 MHz, d6-DMSO): 9.657 (1.6); 7.593 (3.3); 7.132 (1.9);7.113 (4.8); 7.091 (2.5); 7.088 (2.5); 7.071 (1.0); 7.068 (1.0); 4.402(3.8); 3.306 (0.6); 2.751 (0.9); 2.481 (4.4); 2.477 (8.9); 2.472 (12.0);2.468 (8.6); 2.463 (4.2); 2.253 (16.0); 1.018 (0.8); 1.002 (3.5); 0.995(3.5); 0.981 (2.3); 0.968 (1.0); 0.961 (0.9); 0.948 (0.6); 0.789 (0.8);0.775 (2.6); 0.772 (3.0); 0.758 (2.9); 0.755 (2.7); 0.741 (0.7); 0.712(1.0); 0.695 (4.7); 0.688 (3.2); 0.662 (3.2); 0.656 (4.7); 0.638 (0.9);0.295 (0.9); 0.284 (2.8); 0.280 (2.9); 0.275 (1.4); 0.270 (1.4); 0.263(2.8); 0.260 (2.8); 0.249 (1.0); 0.014 (1.1); 0.003 (3.2); 0.000 (3.7);−0.011 (3.3); −0.013 (3.3); −0.025 (0.9) Example II.36: 1H-NMR (300.2MHz, CDCl3): 7.454 (4.2); 7.449 (2.7); 7.435 (3.7); 7.429 (6.4); 7.425(4.2); 7.371 (1.6); 7.365 (1.8); 7.346 (3.7); 7.341 (3.1); 7.321 (2.2);7.316 (2.0); 7.306 (2.9); 7.300 (3.8); 7.281 (3.2); 7.276 (2.9); 7.257(1.1); 7.252 (1.0); 6.177 (3.2); 5.983 (6.6); 5.789 (3.3); 4.071 (16.0);2.313 (0.8); 2.301 (1.6); 2.292 (1.9); 2.280 (2.7); 2.275 (1.7); 2.267(1.8); 2.258 (1.7); 2.246 (0.9); 1.788 (2.0); 1.335 (2.6); 1.319 (7.9);1.313 (7.9); 1.298 (3.5); 1.246 (0.4); 1.063 (0.9); 1.055 (1.9); 1.048(3.1); 1.040 (5.5); 1.033 (5.6); 1.026 (3.1); 1.017 (1.7); 1.009 (0.9);0.551 (1.0); 0.546 (0.9); 0.532 (3.2); 0.528 (4.6); 0.514 (3.0); 0.510(3.6); 0.507 (4.1); 0.505 (4.1); 0.493 (3.3); 0.471 (1.5); 0.464 (2.5);0.453 (6.8); 0.447 (3.7); 0.441 (4.2); 0.434 (3.7); 0.429 (1.6); 0.417(1.4); 0.068 (1.1) Example II.37: 1H-NMR (300.2 MHz, CDCl3): 7.562(4.8); 7.555 (5.2); 7.359 (2.3); 7.352 (2.1); 7.332 (3.8); 7.325 (3.7);7.258 (2.8); 7.250 (6.6); 7.223 (3.9); 5.996 (3.0); 5.803 (6.1); 5.611(3.1); 3.972 (16.0); 2.236 (0.7); 2.224 (1.5); 2.214 (1.9); 2.202 (2.6);2.195 (1.2); 2.190 (1.8); 2.181 (1.7); 2.169 (0.9); 1.696 (2.8); 1.268(2.5); 1.252 (7.3); 1.246 (7.4); 1.230 (3.3); 1.179 (0.4); 0.978 (0.9);0.969 (1.8); 0.961 (2.9); 0.954 (4.9); 0.948 (5.1); 0.940 (2.9); 0.931(1.6); 0.923 (0.8); 0.494 (0.9); 0.486 (1.1); 0.476 (3.0); 0.471 (4.2);0.455 (3.2); 0.448 (3.7); 0.443 (1.8); 0.436 (2.2); 0.428 (1.3); 0.411(1.0); 0.395 (2.3); 0.392 (1.8); 0.383 (5.5); 0.378 (3.5); 0.372 (4.1);0.370 (4.0); 0.366 (3.4); 0.360 (1.6); 0.354 (1.2); 0.348 (1.1); 0.000(2.7) Example II.39: 1H-NMR (400.1 MHz, d6-DMSO): 7.347 (6.0); 7.332(6.5); 7.325 (7.2); 7.310 (7.6); 7.306 (6.6); 7.299 (6.4); 7.280 (6.0);7.273 (6.0); 7.049 (3.8); 7.042 (3.6); 7.028 (6.9); 7.021 (6.4); 7.007(3.5); 7.000 (3.1); 6.034 (5.2); 5.892 (11.0); 5.749 (5.8); 4.038 (0.4);3.895 (9.0); 3.882 (9.5); 3.428 (1.5); 3.378 (4.3); 3.371 (0.5); 3.328(713.8); 3.278 (5.6); 3.228 (0.9); 3.197 (0.3); 2.682 (3.7); 2.558(0.5); 2.554 (0.3); 2.531 (1.9); 2.526 (2.9); 2.518 (31.7); 2.513(65.8); 2.509 (91.2); 2.504 (65.9); 2.499 (33.1); 2.463 (1.6); 2.459(1.6); 2.454 (1.2); 2.340 (0.5); 2.335 (0.7); 2.331 (0.6); 2.110 (2.1);2.102 (3.0); 2.093 (4.8); 2.086 (3.2); 2.078 (2.4); 1.212 (4.9); 1.200(15.3); 1.196 (16.0); 1.185 (6.9); 1.146 (0.8); 1.039 (0.4); 0.990(10.2); 0.985 (10.5); 0.965 (2.1); 0.397 (2.7); 0.386 (8.3); 0.381(13.0); 0.370 (10.4); 0.364 (10.8); 0.355 (5.0); 0.333 (1.1); 0.320(1.1); 0.317 (1.1); 0.310 (0.9); 0.281 (4.6); 0.272 (14.2); 0.267(10.3); 0.264 (12.8); 0.258 (9.6); 0.256 (8.8); 0.247 (3.6); 0.220(0.6); 0.211 (0.6) Example II.41: 1H-NMR (300.2 MHz, CDCl3): 7.528(3.5); 7.523 (3.5); 7.501 (4.0); 7.497 (3.9); 7.361 (3.0); 7.357 (2.8);7.335 (3.7); 7.331 (3.4); 7.256 (2.9); 7.111 (4.1); 7.085 (6.5); 7.059(3.1); 6.230 (3.0); 6.037 (6.1); 5.844 (3.1); 4.098 (16.0); 2.288 (0.7);2.276 (1.5); 2.266 (1.9); 2.254 (2.7); 2.247 (1.3); 2.242 (1.7); 2.233(1.6); 2.221 (0.8); 1.999 (1.5); 1.296 (1.8); 1.280 (7.2); 1.274 (8.2);1.260 (3.3); 1.082 (0.9); 1.074 (1.8); 1.059 (5.0); 1.052 (4.9); 1.045(2.6); 1.036 (1.4); 1.028 (0.8); 0.904 (0.4); 0.882 (1.3); 0.858 (0.5);0.517 (1.0); 0.508 (1.3); 0.499 (3.4); 0.495 (4.6); 0.478 (3.6); 0.473(3.7); 0.471 (3.9); 0.464 (1.7); 0.460 (2.3); 0.449 (1.2); 0.433 (0.9);0.415 (2.7); 0.403 (5.8); 0.398 (3.9); 0.392 (4.6); 0.390 (4.6); 0.386(3.4); 0.380 (1.7); 0.375 (1.3); 0.368 (1.1); 0.000 (3.4) Example II.42:1H-NMR (300.2 MHz, CDCl3): 7.521 (2.7); 7.330 (7.1); 7.303 (9.8); 7.283(3.8); 7.274 (0.5); 7.272 (0.5); 7.258 (20.6); 7.250 (12.1); 7.229(0.4); 7.173 (7.1); 7.165 (6.0); 7.157 (1.0); 7.145 (5.2); 7.138 (4.4);7.102 (0.4); 7.074 (0.5); 7.065 (0.4); 6.781 (0.6); 6.752 (0.5); 4.026(16.0); 3.885 (0.4); 3.853 (5.1); 2.227 (1.4); 2.215 (2.8); 2.206 (3.3);2.193 (5.1); 2.186 (2.3); 2.181 (3.1); 2.172 (3.1); 2.160 (1.7); 2.150(0.4); 2.137 (0.6); 2.128 (0.7); 2.116 (0.9); 2.110 (0.5); 2.104 (0.6);2.095 (0.6); 2.082 (0.4); 1.749 (2.6); 1.607 (0.3); 1.513 (0.4); 1.492(0.4); 1.469 (0.5); 1.460 (0.6); 1.451 (0.6); 1.439 (0.7); 1.416 (1.7);1.394 (3.0); 1.372 (3.8); 1.350 (3.3); 1.337 (1.2); 1.328 (2.0); 1.316(0.8); 1.306 (0.9); 1.284 (0.4); 1.255 (0.5); 1.222 (0.4); 1.046 (0.4);1.032 (0.4); 1.013 (0.4); 0.923 (1.3); 0.901 (2.2); 0.890 (5.7); 0.869(13.5); 0.851 (14.8); 0.786 (7.8); 0.736 (14.8); 0.675 (0.7); 0.658(0.6); 0.644 (0.6); 0.491 (0.8); 0.485 (1.5); 0.464 (6.6); 0.458 (7.9);0.452 (6.2); 0.449 (6.5); 0.443 (6.4); 0.439 (7.0); 0.436 (8.3); 0.428(5.6); 0.419 (6.4); 0.416 (5.6); 0.407 (11.8); 0.401 (10.5); 0.399(9.5); 0.391 (6.5); 0.384 (2.6); 0.377 (1.3); 0.371 (1.7); 0.358 (0.7);0.000 (8.5); −0.011 (0.4) Example II.43: 1H-NMR (300.2 MHz, CDCl3):7.254 (4.7); 7.204 (0.4); 7.193 (2.6); 7.168 (4.2); 6.960 (1.5); 6.934(1.2); 6.930 (1.2); 4.061 (1.0); 4.041 (5.6); 2.304 (16.0); 2.278 (1.1);2.259 (0.6); 2.246 (0.9); 2.238 (1.1); 2.225 (1.8); 2.217 (0.8); 2.213(1.0); 2.204 (0.9); 2.191 (0.5); 1.728 (1.1); 1.409 (0.5); 1.387 (1.0);1.365 (1.2); 1.343 (1.0); 1.320 (0.7); 1.313 (1.6); 0.922 (0.3); 0.883(1.6); 0.862 (3.5); 0.850 (3.8); 0.839 (3.7); 0.779 (1.5); 0.766 (1.6);0.718 (1.0); 0.692 (4.6); 0.497 (0.4); 0.475 (2.0); 0.468 (2.9); 0.461(2.0); 0.453 (2.2); 0.446 (4.4); 0.439 (3.8); 0.431 (3.9); 0.426 (3.8);0.409 (0.6); 0.395 (0.3); 0.000 (3.6) Example II.44: 1H-NMR (400.1 MHz,d6-DMSO): 7.611 (13.2); 7.606 (13.9); 7.427 (9.9); 7.406 (14.5); 7.377(0.3); 7.322 (9.5); 7.316 (9.3); 7.301 (6.7); 7.295 (6.5); 7.273 (0.3);3.894 (7.7); 3.309 (17.4); 2.779 (4.3); 2.530 (1.2); 2.526 (1.7); 2.517(16.3); 2.513 (33.3); 2.508 (45.6); 2.503 (32.9); 2.499 (16.4); 2.463(0.9); 2.458 (0.8); 2.110 (1.2); 2.101 (2.5); 2.094 (3.5); 2.085 (4.6);2.077 (3.6); 2.070 (2.7); 2.061 (1.5); 1.440 (13.8); 1.192 (11.1); 0.397(3.1); 0.385 (9.1); 0.380 (143); 0.369 (10.9); 0.364 (11.8); 0.355(5.5); 0.332 (2.0); 0.323 (1.4); 0.317 (1.4); 0.294 (5.4); 0.285 (16.0);0.280 (11.2); 0.276 (15.2); 0.271 (10.2); 0.268 (8.7); 0.259 (3.8);0.234 (0.6); 0.226 (0.5) Example II.45: 1H-NMR (300.2 MHz, d6-DMSO):7.547 (6.3); 7.543 (6.6); 7.521 (8.5); 7.518 (8.4); 7.402 (6.2); 7.377(8.8); 7.365 (4.8); 7.360 (4.6); 7.340 (9.6); 7.335 (7.7); 7.315 (6.1);7.310 (4.7); 7.263 (6.4); 7.258 (6.5); 7.239 (8.1); 7.234 (7.8); 7.214(3.2); 7.209 (2.9); 3.897 (10.5); 3.337 (3.7); 2.592 (5.6); 2.514 (1.3);2.508 (2.7); 2.502 (3.7); 2.496 (2.7); 2.490 (1.3); 2.133 (1.5); 2.121(3.3); 2.111 (4.3); 2.099 (6.3); 2.088 (4.1); 2.078 (3.6); 2.066 (1.8);1.413 (14.3); 1.196 (10.3); 0.399 (2.9); 0.389 (3.6); 0.383 (8.7); 0.377(13.5); 0.369 (4.7); 0.364 (8.3); 0.361 (9.6); 0.354 (11.4); 0.343(6.4); 0.327 (2.3); 0.316 (1.9); 0.292 (6.0); 0.281 (16.0); 0.274(10.8); 0.269 (14.0); 0.262 (9.5); 0.259 (5.7); 0.254 (3.9); 0.246(3.3); 0.217 (0.4); 0.205 (0.3); 0.000 (6.4) Example II.46: 1H-NMR(400.1 MHz, d6-DMSO): 7.458 (5.6); 7.443 (6.1); 7.437 (6.5); 7.422(6.2); 7.380 (6.3); 7.373 (6.5); 7.353 (6.4); 7.346 (6.4); 7.098 (4.0);7.091 (3.8); 7.077 (7.2); 7.070 (6.6); 7.056 (3.6); 7.049 (3.2); 3.901(6.3); 3.309 (23.4); 2.765 (4.0); 2.677 (0.4); 2.530 (0.9); 2.517(22.7); 2.512 (46.2); 2.508 (62.5); 2.503 (43.9); 2.499 (20.5); 2.462(0.3); 2.458 (0.4); 2.453 (0.4); 2.335 (0.4); 2.096 (3.2); 2.088 (4.1);1.431 (12.9); 1.182 (10.7); 0.395 (3.0); 0.383 (9.0); 0.378 (14.1);0.367 (10.6); 0.362 (11.4); 0.353 (4.9); 0.331 (1.8); 0.322 (1.2); 0.315(1.2); 0.293 (5.2); 0.284 (16.0); 0.279 (11.1); 0.276 (15.2); 0.270(9.7); 0.267 (8.1); 0.258 (3.1) Example IV.01: 1H-NMR (400.1 MHz,d6-DMSO): 10.696 (4.5); 10.694 (4.7); 7.786 (1.4); 7.783 (1.5); 7.767(1.6); 7.764 (1.7); 7.630 (0.8); 7.626 (0.8); 7.611 (1.7); 7.607 (1.7);7.592 (1.4); 7.589 (1.4); 7.523 (1.9); 7.521 (2.2); 7.504 (1.4); 7.502(1.5); 7.436 (0.8); 7.434 (1.0); 7.433 (1.0); 7.431 (0.8); 7.415 (1.7);7.398 (0.7); 7.396 (0.8); 7.394 (0.7); 3.318 (1.1); 2.517 (1.9); 2.512(3.8); 2.508 (5.1); 2.503 (3.9); 2.499 (2.1); 1.406 (16.0); 1.383 (0.4);0.868 (14.3); 0.842 (0.4) Example IV.02: 1H-NMR (400.1 MHz, CDCl3):10.732 (14.3); 10.730 (14.4); 10.349 (1.5); 9.635 (0.4); 8.056 (1.2);7.829 (9.3); 7.817 (0.3); 7.808 (10.1); 7.460 (9.7); 7.455 (10.3); 7.433(1.3); 7.323 (4.0); 7.321 (4.2); 7.318 (3.9); 7.316 (3.8); 7.302 (3.7);7.301 (3.8); 7.297 (3.6); 7.295 (3.5); 7.274 (0.5); 7.262 (10.9); 1.575(11.9); 1.457 (46.5); 1.439 (0.6); 1.432 (2.6); 1.375 (3.4); 1.296(0.4); 1.279 (1.5); 1.265 (1.1); 0.946 (0.5); 0.939 (1.2); 0.917 (13.4);0.914 (9.2); 0.905 (10.9); 0.901 (16.0); 0.897 (11.4); 0.882 (2.2);0.879 (2.4); 0.872 (3.1); 0.864 (1.1); 0.857 (0.4); 0.830 (0.5); 0.794(0.3); 0.000 (7.7) Example IV.03: 1H-NMR (300.2 MHz, d6-DMSO): 10.595(4.9); 10.098 (1.2); 7.981 (0.7); 7.958 (0.7); 7.881 (1.5); 7.860 (1.6);7.852 (1.8); 7.832 (1.7); 7.480 (0.7); 7.443 (0.7); 7.339 (1.5); 7.330(1.9); 7.306 (1.5); 7.297 (1.9); 7.285 (0.8); 7.283 (0.8); 7.277 (0.6);7.257 (1.5); 7.255 (1.4); 7.248 (1.1); 7.228 (0.7); 7.226 (0.7); 7.220(0.6); 3.321 (13.8); 2.514 (3.1); 2.508 (6.5); 2.502 (9.0); 2.496 (6.5);2.490 (3.1); 1.421 (0.5); 1.405 (16.0); 1.355 (0.3); 1.340 (3.6); 0.926(0.4); 0.896 (5.1); 0.881 (4.1); 0.876 (6.0); 0.859 (3.8); 0.847 (0.8);0.011 (0.4); 0.000 (11.2); −0.011 (0.5) Example IV.04: 1H-NMR (300.2MHz, CDCl3): 10.745 (4.9); 10.743 (5.1); 7.798 (2.6); 7.771 (2.8); 7.266(2.9); 7.261 (12.1); 7.155 (1.5); 7.152 (1.5); 7.149 (1.3); 7.128 (1.3);7.126 (1.3); 7.123 (1.3); 2.958 (2.0); 2.886 (1.7); 2.884 (1.7); 2.390(14.4); 2.331 (0.8); 2.289 (0.8); 2.276 (1.1); 1.568 (2.6); 1.444(16.0); 1.392 (1.0); 1.341 (1.2); 1.291 (0.5); 1.281 (0.8); 1.254 (0.6);0.920 (0.6); 0.896 (3.8); 0.894 (3.9); 0.892 (3.8); 0.886 (2.8); 0.865(3.4); 0.859 (3.8); 0.856 (4.2); 0.853 (3.9); 0.831 (1.0); 0.818 (0.5);0.806 (0.4); 0.772 (0.4); 0.761 (0.4); 0.697 (0.4); 0.071 (0.4); 0.000(8.8); −0.011 (0.4) Example IV.05: 1H-NMR (300.2 MHz, d6-DMSO): 10.518(3.8); 7.780 (1.6); 7.778 (1.3); 7.753 (1.5); 7.750 (1.6); 6.978 (1.3);6.972 (4.5); 6.945 (1.1); 6.943 (1.1); 6.937 (0.7); 6.935 (0.7); 6.734(0.4); 6.730 (0.4); 3.852 (16.0); 3.729 (1.8); 3.699 (0.5); 3.324 (7.0);2.891 (0.4); 2.732 (0.4); 2.730 (0.4); 2.514 (1.4); 2.508 (3.0); 2.502(4.1); 2.496 (3.0); 2.490 (1.4); 1.989 (0.5); 1.395 (10.9); 1.356 (1.5);1.244 (0.4); 0.865 (3.6); 0.853 (3.1); 0.848 (4.2); 0.819 (0.6); 0.726(0.3); 0.698 (0.4); 0.000 (5.2) Example IV.06: 1H-NMR (300.2 MHz,d6-DMSO): 10.579 (0.9); 10.568 (0.9); 10.210 (1.0); 10.208 (1.0); 10.204(1.0); 10.202 (0.9); 10.158 (3.9); 7.845 (0.7); 7.817 (0.8); 7.808(0.7); 7.780 (0.7); 7.757 (0.4); 7.729 (0.4); 7.721 (0.4); 7.692 (0.4);7.651 (0.8); 7.642 (0.9); 7.626 (0.9); 7.618 (1.1); 7.611 (0.8); 7.602(0.9); 7.594 (0.5); 7.586 (0.8); 7.581 (0.6); 7.577 (0.9); 7.556 (0.4);7.510 (1.0); 7.505 (1.1); 7.502 (1.0); 7.496 (1.0); 7.491 (1.1); 7.486(1.1); 7.483 (1.0); 7.478 (0.9); 5.758 (0.5); 3.331 (4.9); 2.515 (2.9);2.509 (6.4); 2.502 (8.8); 2.496 (6.4); 2.490 (3.0); 2.132 (0.3); 1.399(16.0); 1.358 (0.6); 1.335 (6.9); 1.246 (1.0); 0.938 (0.7); 0.929 (0.9);0.914 (3.3); 0.903 (2.5); 0.888 (1.2); 0.881 (1.2); 0.875 (1.5); 0.853(4.8); 0.843 (3.7); 0.831 (3.9); 0.825 (3.0); 0.816 (1.3); 0.808 (1.2);0.011 (0.4); 0.000 (11.8); −0.011 (0.5) Example IV.07: 1H-NMR (300.2MHz, d6-DMSO): 10.825 (1.1); 10.600 (8.1); 10.258 (6.6); 10.246 (2.0);9.896 (0.5); 7.599 (0.6); 7.573 (0.8); 7.533 (3.5); 7.512 (2.0); 7.505(2.1); 7.323 (2.5); 7.297 (0.9); 7.276 (3.7); 7.220 (0.4); 3.327 (6.2);2.534 (4.4); 2.516 (1.3); 2.510 (2.7); 2.504 (3.7); 2.498 (2.8); 2.492(1.4); 2.473 (12.0); 2.427 (0.4); 2.413 (0.9); 2.397 (4.4); 2.338 (1.8);2.310 (0.9); 2.285 (11.0); 2.270 (13.1); 2.235 (13.2); 1.386 (12.6);1.369 (16.0); 1.357 (1.5); 1.338 (2.3); 1.268 (4.9); 0.865 (0.8); 0.857(0.9); 0.843 (3.1); 0.819 (11.9); 0.802 (2.1); 0.791 (2.2); 0.786 (2.2);0.773 (2.7); 0.762 (3.8); 0.756 (3.7); 0.746 (2.3); 0.740 (2.3); 0.720(0.5); 0.000 (4.2) Example IV.08: 1H-NMR (300.2 MHz, d6-DMSO): 10.567(6.9); 7.254 (5.3); 7.000 (4.9); 3.879 (15.7); 3.841 (0.3); 3.800 (0.9);3.780 (16.0); 3.721 (0.7); 3.326 (7.1); 2.515 (1.0); 2.509 (2.2); 2.503(3.1); 2.497 (2.3); 2.491 (1.1); 1.401 (11.7); 1.372 (0.3); 1.171 (0.5);0.908 (0.4); 0.882 (3.3); 0.854 (2.4); 0.846 (3.5); 0.820 (0.6); 0.000(3.1) Example IV.10: 1H-NMR (499.9 MHz, CDCl3): 10.750 (5.3); 7.825(2.3); 7.821 (2.4); 7.468 (0.9); 7.464 (0.9); 7.452 (2.0); 7.447 (2.0);7.424 (3.1); 7.407 (1.4); 7.268 (0.5); 1.647 (0.4); 1.444 (12.6); 1.433(0.5); 1.410 (0.5); 1.096 (0.3); 0.892 (16.0); 0.000 (0.6) ExampleIV.11: 1H-NMR (300.2 MHz, d6-DMSO): 10.657 (2.5); 10.647 (2.5); 7.592(0.5); 7.587 (0.4); 7.574 (0.6); 7.567 (0.9); 7.562 (0.9); 7.558 (0.5);7.551 (0.5); 7.544 (0.9); 7.487 (2.8); 7.482 (1.0); 7.458 (2.8); 7.452(1.1); 7.435 (0.7); 7.425 (0.3); 3.906 (1.1); 3.332 (3.8); 2.516 (0.6);2.510 (1.4); 2.504 (1.9); 2.498 (1.4); 2.492 (0.7); 1.392 (11.9); 1.330(0.3); 0.867 (16.0); 0.000 (1.8) Example IV.12: 1H-NMR (300.2 MHz,d6-DMSO): 10.658 (7.8); 7.572 (2.3); 7.569 (2.6); 7.436 (0.4); 7.408(2.7); 7.399 (4.9); 7.373 (0.7); 3.324 (7.9); 2.514 (1.8); 2.508 (3.9);2.502 (5.3); 2.496 (3.8); 2.490 (1.9); 2.327 (14.5); 1.375 (16.0); 1.246(0.6); 0.866 (0.5); 0.858 (0.7); 0.836 (7.0); 0.832 (5.7); 0.824 (6.0);0.794 (0.4); 0.000 (6.1) Example IV.14: 1H-NMR (300.2 MHz, CDCl3):10.759 (5.1); 10.757 (5.2); 9.119 (0.4); 7.680 (1.3); 7.678 (1.4); 7.675(1.4); 7.673 (1.3); 7.653 (1.7); 7.650 (1.7); 7.648 (1.6); 7.352 (0.5);7.349 (0.5); 7.335 (0.5); 7.332 (0.5); 7.324 (1.2); 7.322 (1.0); 7.307(1.2); 7.305 (1.1); 7.299 (1.0); 7.297 (1.0); 7.282 (0.9); 7.280 (0.9);7.271 (1.7); 7.264 (6.0); 7.244 (1.0); 7.238 (2.3); 7.233 (1.7); 7.221(0.3); 7.211 (1.0); 7.206 (0.9); 2.958 (0.4); 2.886 (0.3); 2.885 (0.3);1.468 (16.0); 1.433 (2.5); 1.417 (0.6); 1.404 (0.7); 1.398 (0.7); 1.381(2.6); 1.368 (1.8); 1.350 (1.1); 1.335 (0.8); 1.326 (0.8); 1.316 (1.0);1.298 (0.6); 1.290 (0.6); 1.284 (0.5); 1.274 (0.4); 1.260 (0.6); 1.255(0.6); 1.222 (0.3); 0.967 (1.1); 0.963 (0.8); 0.946 (3.9); 0.931 (3.9);0.917 (1.4); 0.906 (1.9); 0.893 (2.2); 0.890 (2.8); 0.886 (2.5); 0.875(3.8); 0.854 (1.3); 0.821 (1.3); 0.802 (0.7); 0.776 (0.3); 0.075 (0.4);0.000 (4.0) Example IV.15: 1H-NMR (400.0 MHz, d6-DMSO): 10.312 (6.2);10.297 (0.5); 10.274 (16.0); 7.942 (7.7); 7.936 (8.4); 7.845 (8.8);7.839 (7.6); 7.826 (0.7); 7.813 (3.0); 7.807 (3.1); 7.672 (1.9); 7.651(3.9); 7.618 (2.3); 7.611 (2.2); 7.596 (1.2); 7.590 (1.2); 7.562 (0.4);7.528 (0.4); 7.516 (0.4); 7.502 (0.4); 7.409 (0.4); 7.405 (0.5); 7.383(0.6); 7.372 (0.4); 7.351 (0.8); 7.330 (1.2); 7.314 (0.4); 7.277 (1.0);7.267 (0.5); 7.257 (0.5); 7.232 (0.5); 7.227 (0.5); 7.204 (0.4); 7.142(0.4); 4.181 (0.4); 3.551 (0.4); 3.503 (0.4); 3.466 (0.4); 3.444 (0.4);3.429 (0.5); 3.390 (0.6); 3.381 (0.6); 3.323 (370.9); 2.892 (0.4); 2.887(0.4); 2.802 (0.3); 2.735 (0.4); 2.731 (0.6); 2.712 (0.4); 2.675 (4.0);2.671 (5.2); 2.666 (3.9); 2.641 (0.7); 2.614 (0.9); 2.592 (0.9); 2.524(20.2); 2.506 (630.5); 2.502 (802.6); 2.497 (575.5); 2.332 (3.5); 2.328(4.8); 2.324 (3.4); 2.009 (0.5); 1.988 (0.6); 1.860 (3.0); 1.847 (8.8);1.839 (10.1); 1.827 (4.4); 1.788 (0.9); 1.770 (0.6); 1.758 (0.8); 1.751(0.7); 1.738 (0.9); 1.700 (4.4); 1.688 (8.7); 1.681 (8.7); 1.667 (2.9);1.652 (0.4); 1.622 (1.6); 1.608 (3.5); 1.601 (3.8); 1.588 (1.4); 1.552(0.5); 1.538 (0.4); 1.513 (0.5); 1.505 (0.5); 1.487 (0.9); 1.478 (0.8);1.468 (0.6); 1.458 (0.6); 1.443 (0.8); 1.435 (0.9); 1.424 (0.5); 1.413(0.4); 1.384 (0.4); 1.371 (0.4); 1.334 (0.5); 1.297 (1.9); 1.258 (2.9);1.236 (4.2); 1.195 (0.5); 1.187 (0.5); 1.170 (0.4); 1.063 (0.4); 0.860(0.8); 0.855 (1.1); 0.837 (0.6); 0.149 (0.4); 0.008 (3.4); 0.000 (81.4);−0.008 (3.3); −0.046 (0.4); −0.085 (0.8); −0.149 (0.4); −0.874 (0.3)Example IV.16: 1H-NMR (601.6 MHz, d6-DMSO): 10.395 (8.7); 7.764 (2.5);7.763 (2.7); 7.761 (2.5); 7.527 (0.5); 7.524 (0.4); 7.514 (2.6); 7.513(2.7); 7.5111 (3.0); 7.5106 (3.0); 7.508 (4.9); 7.495 (0.7); 3.902(1.0); 3.316 (92.4); 2.616 (0.6); 2.613 (0.9); 2.610 (0.6); 2.522 (1.6);2.519 (2.1); 2.516 (2.0); 2.507 (44.9); 2.504 (97.6); 2.501 (134.0);2.498 (97.4); 2.495 (44.4); 2.399 (16.0); 2.391 (0.4); 2.388 (0.7);2.385 (0.9); 2.382 (0.6); 2.344 (0.3); 2.300 (0.9); 1.908 (0.4); 1.758(1.7); 1.749 (4.4); 1.745 (4.7); 1.737 (2.0); 1.438 (1.8); 1.429 (4.4);1.425 (4.6); 1.416 (1.6); 0.994 (0.5); 0.000 (0.3) Example IV.17: 1H-NMR(300.2 MHz, CDCl3): 10.827 (7.8); 10.826 (7.8); 9.367 (0.4); 8.006(2.7); 7.979 (3.1); 7.662 (4.5); 7.615 (2.4); 7.587 (2.1); 7.262 (8.3);1.699 (1.3); 1.675 (3.9); 1.650 (4.2); 1.626 (1.6); 1.560 (6.7); 0.975(0.8); 0.946 (7.7); 0.941 (5.8); 0.920 (8.4); 0.896 (1.4); 0.884 (8.2);0.872 (1.2); 0.859 (16.0); 0.835 (7.2); 0.011 (0.4); 0.000 (10.7);−0.011 (0.6) Example IV.18: 1H-NMR (300.2 MHz, d6-DMSO): 10.667 (10.5);7.605 (2.4); 7.603 (2.4); 7.600 (2.5); 7.598 (2.6); 7.449 (1.1); 7.447(1.1); 7.442 (1.0); 7.440 (0.9); 7.423 (1.8); 7.421 (1.9); 7.418 (1.5);7.416 (1.9); 7.414 (1.7); 7.356 (4.2); 7.330 (2.4); 7.138 (0.7); 7.104(0.5); 3.351 (4.3); 2.537 (0.5); 2.531 (1.0); 2.525 (1.4); 2.518 (1.0);2.512 (0.5); 2.352 (16.0); 2.270 (1.5); 1.613 (0.8); 1.588 (2.6); 1.564(3.0); 1.539 (1.3); 0.882 (0.8); 0.857 (4.2); 0.848 (3.0); 0.819 (4.0);0.813 (5.3); 0.806 (6.9); 0.789 (2.6); 0.781 (12.1); 0.764 (1.2); 0.757(4.9); 0.696 (0.4); 0.691 (0.5); 0.686 (0.4); 0.682 (0.4); 0.656 (0.4);0.652 (0.4); 0.648 (0.5); 0.642 (0.4); 0.018 (1.1) Example IV.19: 1H-NMR(300.2 MHz, CDCl3): 10.727 (6.0); 10.724 (5.9); 10.352 (0.7); 8.061(0.6); 7.846 (3.6); 7.818 (4.0); 7.395 (3.7); 7.389 (4.3); 7.347 (0.6);7.331 (1.8); 7.328 (1.9); 7.324 (1.6); 7.321 (1.5); 7.303 (1.6); 7.301(1.7); 7.296 (1.5); 7.294 (1.4); 7.266 (3.6); 7.130 (0.4); 5.605 (0.4);1.605 (1.2); 1.591 (1.0); 1.566 (1.4); 1.553 (1.1); 1.538 (1.3); 1.458(0.5); 1.332 (0.5); 1.308 (1.5); 1.284 (1.9); 1.255 (1.7); 1.229 (1.3);1.205 (0.5); 0.924 (0.4); 0.895 (16.0); 0.867 (1.1); 0.856 (5.6); 0.843(1.6); 0.832 (12.0); 0.818 (0.9); 0.808 (4.8); 0.796 (0.6); 0.774 (0.3);0.766 (0.5); 0.000 (2.6) Example IV.22: 1H-NMR (300.2 MHz, CDCl3):10.738 (3.7); 10.735 (3.9); 10.350 (1.1); 8.061 (0.9); 7.851 (2.4);7.823 (2.7); 7.449 (1.4); 7.421 (1.8); 7.417 (2.6); 7.410 (2.8); 7.388(1.0); 7.333 (1.1); 7.331 (1.2); 7.326 (1.1); 7.324 (1.0); 7.305 (1.1);7.303 (1.2); 7.299 (1.1); 7.296 (1.3); 7.294 (1.3); 7.287 (3.1); 7.283(1.8); 7.280 (2.7); 7.259 (4.5); 7.202 (2.3); 7.199 (1.8); 7.198 (1.8);7.189 (2.0); 7.184 (3.7); 7.182 (2.6); 7.173 (0.5); 7.168 (0.5); 7.164(0.7); 7.159 (0.7); 7.157 (0.9); 7.152 (1.5); 7.145 (1.3); 7.139 (0.8);7.134 (0.8); 7.130 (1.0); 7.121 (0.6); 7.114 (0.5); 7.059 (1.0); 7.050(0.9); 7.031 (0.8); 7.022 (0.8); 5.533 (0.4); 1.553 (1.7); 1.504 (0.5);1.494 (0.7); 1.489 (0.7); 1.471 (3.2); 1.464 (3.8); 1.451 (1.1); 1.446(1.1); 1.432 (2.9); 1.426 (1.2); 1.404 (1.2); 1.390 (0.8); 1.381 (1.0);1.368 (0.7); 1.359 (0.6); 1.346 (0.6); 1.332 (0.4); 1.324 (0.4); 1.264(0.9); 1.259 (0.9); 0.968 (0.4); 0.962 (0.5); 0.928 (1.8); 0.892 (5.6);0.871 (8.6); 0.865 (16.0); 0.844 (11.9); 0.813 (2.6); 0.798 (5.3); 0.793(4.8); 0.778 (2.1); 0.749 (1.3); 0.727 (1.2); 0.721 (0.6); 0.671 (1.9);0.658 (3.1); 0.653 (2.6); 0.637 (1.2); 0.000 (5.1) Example IV.23: 1H-NMR(300.2 MHz, CDCl3): 10.792 (7.7); 7.701 (2.1); 7.699 (2.2); 7.696 (2.0);7.347 (1.5); 7.332 (0.4); 7.320 (4.1); 7.310 (2.5); 7.305 (2.3); 7.283(0.5); 7.278 (0.5); 7.256 (4.1); 7.223 (0.7); 7.217 (0.3); 7.205 (0.9);7.196 (1.1); 7.179 (1.0); 7.141 (0.4); 7.089 (1.4); 7.063 (1.1); 7.049(0.3); 7.016 (0.5); 7.012 (0.5); 6.990 (0.4); 6.982 (0.5); 6.691 (0.5);5.532 (0.9); 2.361 (16.0); 2.310 (3.6); 2.300 (0.9); 2.281 (7.8); 1.568(0.8); 1.563 (1.0); 1.492 (0.3); 1.479 (0.3); 1.455 (1.4); 1.448 (1.3);1.436 (3.0); 1.432 (4.4); 1.404 (1.1); 1.382 (2.2); 1.360 (1.2); 1.335(1.7); 1.311 (1.1); 0.977 (0.6); 0.955 (0.6); 0.945 (0.4); 0.884 (5.9);0.862 (10.7); 0.840 (10.6); 0.803 (1.3); 0.792 (1.2); 0.785 (1.2); 0.763(3.0); 0.759 (2.8); 0.752 (2.3); 0.746 (1.6); 0.704 (0.4); 0.692 (0.4);0.686 (0.4); 0.659 (0.3); 0.653 (0.4); 0.622 (0.6); 0.610 (1.0); 0.604(0.9); 0.589 (0.4); 0.000 (4.4)

The following examples illustrate in a non-limiting manner thepreparation and efficacy of the compounds of formula (I) according tothe invention.

Preparation Example 1: Preparation ofN-[5-chloro-2-(1-methylcyclopropyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide(compound I.060) Step 1: Preparation of2-bromo-4-chloro-1-(prop-1-en-2-yl)benzene

To a cooled suspension of 7.34 g (20.56 mmol) ofmethyltriphenylphosphonium bromide in 25 mL of tetrahydrofuran areslowly added 20.56 ml (20.56 mmol) of a 1M solution of potassiumtert-butoxide in tetrahydrofuran. The reaction mixture is stirred for 20min at 0° C. A solution of 4 g (17.13 mmol) of1-(2-bromo-4-chlorophenyl)ethanone in 20 mL of tetrahydrofuran is addedat 0° C. and the reaction mixture is further stirred at room temperaturefor 15 h. The reaction mixture is diluted by an aqueous saturatedsolution of NH₄Cl and extracted by ethyl acetate. The organic phase iswashed by water, dried over magnesium sulfate, concentrated under vacuumand purified by column chromatography on silica gel (gradientn-heptane/ethyl acetate) to yield 3.54 g (84% yield) of2-bromo-4-chloro-1-(prop-1-en-2-yl)benzene as an oil (M=230 by GC-mass).Log P=4.91.

Step 2: Preparation of 2-bromo-4-chloro-1-(1-methylcyclopropyl)benzene

To 21.94 ml (21.94 mmol) of a 1M solution of diethyl zinc in hexanesunder argon, is slowly added at 0° C., a solution of 2.5 g (21.94 mmol)of trifluoroacetic acid in 10 mL of dichloromethane. The reactionmixture is stirred at 0° C. for 20 min. A solution of 5.87 g (21.94mmol) of diiodomethane in 10 mL of dichloromethane is then added and thereaction mixture further stirred at 0° C. for 20 min. A solution of 2.54g (10.97 mmol) of 2-bromo-4-chloro-1-(prop-1-en-2-yl)benzene in 10 mL ofdichloromethane is finally added and the reaction mixture is stirred atroom temperature for 2 h. The reaction mixture is diluted by 70 mL of a1N aqueous solution of HCl and extracted by 3×70 mL of ethyl acetate.The organic phase is washed by a saturated aqueous solution of NaCl,dried over magnesium sulfate, concentrated under vacuum and purified bycolumn chromatography on silica gel (n-heptane) to yield 2.65 g (93%yield) of 2-bromo-4-chloro-1-(1-methylcyclopropyl)benzene as a colorlessoil (M=244 by GC-mass). Log P=4.93.

Step 3: Preparation of 5-chloro-2-(1-methylcyclopropyl)benzaldehyde(Compound IV.10)

To a solution of 1 g (4.07 mmol) of2-bromo-4-chloro-1-(1-methylcyclopropyl)benzene in 10 mL of drytetrahydrofuran is slowly added at −78° C. under argon, 1.8 mL (4.48mmol) of a 1.6 M solution of BuLi in hexanes. The reaction mixture isstirred at −78° C. for 45 min then quenched by 0.38 mL (4.89 mmol) ofdry DMF and left at −78° C. for another 3 h. The reaction mixture ispoured over a 1N aqueous solution of HCl and extracted by ethyl acetate.The organic phase is washed by water, dried over magnesium sulfate,concentrated under vacuum and purified by column chromatography onsilica gel (gradient n-heptane/ethyl acetate) to yield 0.46 g (55%yield) of 5-chloro-2-(1-methylcyclopropyl)benzaldehyde as a colorlessoil (M-CHO=166 by GC-mass).

Step 4: Preparation ofN-[5-chloro-2-(1-methylcyclopropyl)benzyl]cyclopropanamine (CompoundII.10)

To a cooled solution of 0.47 g (8.22 mmol) of cyclopropylamine and 2 gof 3 Å molecular sieves in 15 mL of methanol, is slowly added of 0.62 g(10.3 mmol) of acetic acid followed by 0.80 g (4.11 mmol) of5-chloro-2-(1-methylcyclopropyl)benzaldehyde. The reaction mixture isstirred for 3 h at 80° C. The reaction mixture is then cooled to roomtemperature and 0.39 g (6.17 mmol) of sodium cyanoborohydride is slowlyadded. The reaction mixture is further stirred for 2 h at 80° C. Thecooled reaction mixture is then filtered over a cake of diatomaceousearth and the cake washed by methanol. Concentration leaves a yellowishsolid residue that is dissolved by ethyl acetate, washed by a 1N aqueoussolution of sodium hydroxide followed by a saturated aqueous solution ofNaCl. The organic phase is dried and concentrated under vacuum to yield0.85 g (83% yield) ofN-[5-chloro-2-(1-methylcyclopropyl)benzyl]cyclopropanamine as a yellowoil (M+H=236).

Step 5: Preparation ofN-[5-chloro-2-(1-methylcyclopropyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide

In a dried Radleys™ vial, a solution of 234 mg (1.10 mmol) of3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carbonyl chloride in2 mL of dry tetrahydrofuran is added to a mixture of 236 mg (1 mmol) ofN-[5-chloro-2-(1-methylcyclopropyl)benzyl]cyclopropanamine and 0.167 mL(1.21 mmol) of triethylamine in 3 mL of dry tetrahydrofuran. Thereaction mixture is heated at reflux for 120 min. After cooling, a fewmL of water are added and the reaction mixture is extracted by ethylacetate. The organic phase is washed by a saturated aqueous solution ofNaCl, dried over a ChemElut™ cartridge, concentrated and purified bycolumn chromatography on silica gel (gradient n-heptane/ethyl acetate)to yield 334 mg (77% yield) ofN-[5-chloro-2-(1-methylcyclopropyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamideas a colorless oil (M+H=412).

Preparation Example 2: Preparation ofN-cyclopropyl-3-(difluoromethyl)-N-{2-[1-(difluoromethyl)-cyclopropyl]-5-fluorobenzyl}-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide(Compound I.151) Step 1: Preparation ofN-{2-[1-(difluoromethyl)cyclopropyl]-5-fluorobenzyl}cyclopropanamine(Compound II.39)

In a Radleys™ vial, 1 g (3.22 mmol) of2-(bromomethyl)-1-[1-(difluoromethyl)cyclopropyl]-4-fluorobenzene isadded to 3.5 mL of cyclopropylamine and stirred for 2 hours at roomtemperature. The excess of cyclopropylamine is removed under vacuum. 2mL of water are added to the residue and the reaction mixture isextracted by 3×2 mL of dichloromethane. The organic extracts are driedand concentrated under vacuum to yield 690 mg of crude material.Purification by column chromatography on silica gel (gradientn-heptane/ethyl acetate) gives 450 mg (52% yield) ofN-{2-[1-(difluoromethyl)cyclopropyl]-5-fluorobenzyl}cyclopropanamine asan oil (M+H=256). Log P=1.08.

Step 2: Preparation ofN-cyclopropyl-3-(difluoromethyl)-N-{2-[1-(difluoromethyl)-cyclopropyl]-5-fluorobenzyl}-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide

In a dried Radleys™ vial, a solution of 87 mg (0.41 mmol) of3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carbonyl chloride in2 mL of dry tetrahydrofuran is added to a mixture of 100 mg (0.39 mmol)of N-{2-[1-(difluoromethyl)cyclopropyl]-5-fluorobenzyl}cyclopropanamineand 0.06 mL (0.43 mmol) of triethylamine in 3 mL of dry tetrahydrofuran.The reaction mixture is stirred overnight at room temperature. Thereaction mixture is filtered over an alumina basic cartridge and washedseveral time by a few mL of tetrahydrofuran. Concentration under vacuumand purification of the residue by preparative HPLC (gradientacetonitrile/water+0.1% HCO₂H) gives 144 mg (81% yield) ofN-cyclopropyl-3-(difluoromethyl)-N-{2-[1-(difluoromethyl)-cyclopropyl]-5-fluorobenzyl}-5-fluoro-1-methyl-1H-pyrazole-4-carboxamideas an oil (M+H=432). Log P=3.39.

General Preparation Example 3: Thionation of Amide of Formula (I) onChemspeed™ Apparatus

In a 13 mL Chemspeed™ vial is weighted 0.27 mmol of phosphorouspentasulfide (P₂S₅). 3 mL of a 0.18 M solution of the amide (I) (0.54mmol) in dioxane is added and the mixture is heated at reflux for twohours. The temperature is then cooled to 80° C. and 2.5 mL of water areadded. The mixture is heated at 80° C. for one more hour. 2 mL of waterare then added and the reaction mixture is extracted twice by 4 mL ofdichloromethane. The organic phase is deposited on a basic aluminacartridge (2 g) and eluted twice by 8 mL of dichloromethane. Thesolvents are removed and the crude thioamide derivative is analyzed byLCMS and NMR. Insufficiently pure compounds are further purified bypreparative LC.

Example A: In Vivo Preventive Test on Puccinia recondita (Brown Rust onWheat)

Solvent: 5% by volume of Dimethyl sulfoxide

-   -   10% by volume of Acetone

Emulsifier: 1 μL of Tween® 80 per mg of active ingredient

The active ingredients are made soluble and homogenized in a mixture ofDimethyl sulfoxide/Acetone/Tween® 80 and then diluted in water to thedesired concentration.

The young plants of wheat are treated by spraying the active ingredientprepared as described above. Control plants are treated only with anaqueous solution of Acetone/Dimethyl sulfoxide/Tween® 80. After 24hours, the plants are contaminated by spraying the leaves with anaqueous suspension of Puccinia recondita spores. The contaminated wheatplants are incubated for 24 hours at 20° C. and at 100% relativehumidity and then for 10 days at 20° C. and at 70-80% relative humidity.

The test is evaluated 11 days after the inoculation. 0% means anefficacy which corresponds to that of the control plants while anefficacy of 100% means that no disease is observed.

In this test the following compounds according to the invention showedefficacy between 70% and 79% at a concentration of 100 ppm of activeingredient: I.126

In this test the following compounds according to the invention showedefficacy between 80% and 89% at a concentration of 100 ppm of activeingredient: I.017; I.034; I.036; I.037; I.044; I.045; I.047; I.094;I.095; I.129; I.140; I.141; I.171; I.173; I.175; I.177; I.178; Ia.04;Ia.08; Ia.09 In this test the following compounds according to theinvention showed efficacy between 90% and 100% at a concentration of 100ppm of active ingredient: I.001; I.002; I.003; I.004; I.007; I.008;I.009; I.010; I.011; I.012; I.014; I.016; I.018; I.019; I.020; I.021;I.022; I.023; I.024; I.025; I.026; I.027; I.028; I.029; I.030; I.031;I.032; I.033; I.035; I.038; I.039; I.040; I.041; I.042; I.043; I.048;I.049; I.050; I.051; I.052; I.053; I.054; I.055; I.056; I.057; I.058;I.059; I.060; I.061; I.062; I.063; I.064; I.066; I.067; I.068; I.069;I.070; I.071; I.072; I.073; I.074; I.079; I.080; I.083; I.084; I.085;I.086; I.087; I.088; I.089; I.090; I.091; I.092; I.093; I.096; I.097;I.098; I.099; Ia.01; I.100; I.101; I.102; I.103; I.104; I.105; I.106;I.107; I.108; I.109; I.110; I.111; I.112; I.113; I.114; I.115; I.116;I.117; I.118; I.119; I.120; I.121; I.122; I.123; I.125; I.127; I.128;I.130; I.131; I.132; I.133; I.134; I.135; I.136; I.137; I.148; I.149;I.150; I.151; I.152; I.153; I.154; I.157; I.158; I.159; I.160; I.161;I.162; I.163; I.164; I.165; I.166; I.167; I.168; I.169; I.170; I.172;I.176; I.179; Ia.02; Ia.03; Ia.05; Ia.06 Under the same conditions,excellent (at least 90%) protection to total protection is observed at adose of 100 and 10 ppm of active ingredient with compound of exampleI.067, whereas total to average (less than 40%) protection is observedwith the compound of example I.8 (oxa analogue) disclosed in patentapplication WO-2013/156559 as in table A1:

TABLE A1 Example dose (ppm) Efficacy I.067 from this patent 100 100 1098 I.8 from WO-2013/156559 100 94 10 38

Compound I.8 disclosed in international patent WO-2013/156559corresponds to5-chloro-N-cyclopropyl-3-(difluoromethyl)-N-[5-fluoro-2-(1-methylcyclopropyl)benzyl]-1-methyl-1H-pyrazole-4-carboxamide.These results show that the compounds according to the invention have amuch better biological activity than the structurally closest compoundsdisclosed in WO-2013/156559.

Example B: In Vivo Preventive Test on Uromyces appendiculatus (BeanRust)

Solvent: 5% by volume of Dimethyl sulfoxide

-   -   10% by volume of Acetone

Emulsifier: 1 μL of Tween® 80 per mg of active ingredient

The active ingredients are made soluble and homogenized in a mixture ofDimethyl sulfoxide/Acetone/Tween® 80 and then diluted in water to thedesired concentration.

The young plants of bean are treated by spraying the active ingredientprepared as described above. Control plants are treated only with anaqueous solution of Acetone/Dimethyl sulfoxide/Tween® 80.

After 24 hours, the plants are contaminated by spraying the leaves withan aqueous suspension of Uromyces appendiculatus spores. Thecontaminated bean plants are incubated for 24 hours at 20° C. and at100% relative humidity and then for 10 days at 20° C. and at 70-80%relative humidity.

The test is evaluated 11 days after the inoculation. 0% means anefficacy which corresponds to that of the control plants while anefficacy of 100% means that no disease is observed.

In this test the following compounds according to the invention showedefficacy between 70% and 79% at a concentration of 100 ppm of activeingredient: Ia.04 In this test the following compounds according to theinvention showed efficacy between 80% and 89% at a concentration of 100ppm of active ingredient: I.016; I.037; I.038; I.044; I.045; I.079;Ia.07 In this test the following compounds according to the inventionshowed efficacy between 90% and 100% at a concentration of 100 ppm ofactive ingredient: I.002; I.003; I.004; I.005; I.006; I.007; I.008;I.009; I.010; I.011; I.012; I.014; I.018; I.019; I.020; I.021; I.022;I.023; I.024; I.025; I.026; I.027; I.028; I.029; I.030; I.031; I.032;I.033; I.034; I.035; I.036; I.039; I.040; I.041; I.042; I.043; I.046;I.047; I.048; I.049; I.050; I.051; I.052; I.053; I.054; I.055; I.056;I.057; I.058; I.059; I.060; I.061; I.062; I.063; I.064; I.065; I.066;I.067; I.068; I.069; I.070; I.071; I.072; I.073; I.074; I.080; I.083;I.084; I.085; I.086; I.087; I.088; I.089; I.090; I.091; I.092; I.093;I.094; I.096; I.097; I.098; I.099; I.100; I.101; I.102; I.103; I.104;I.105; I.106; I.107; I.108; I.109; I.110; I.111; I.112; I.113; I.114;I.115; I.118; I.119; I.120; I.121; I.122; I.123; I.125; I.127; I.128;I.129; I.130; I.131; I.132; I.133; I.134; I.135; I.136; I.137; I.138;I.139; I.140; I.148; I.149; I.150; I.151; I.152; I.153; I.154; I.157;I.158; I.159; I.160; I.161; I.163; I.164; I.165; I.166; I.167; I.168;I.169; I.170; I.172; I.176; I.178; I.179; Ia.02; Ia.03; Ia.05; Ia.06;Ia.08

Under the same conditions, total protection is observed at a dose of 100and 10 ppm of active ingredient with compounds of examples I.066 andI.151, whereas total to poor (less than 30%) protection is observed withthe compound of example 54 (unsubstituted cyclopropyl analogue)disclosed in patent application WO-2010/130767 as in table B1:

TABLE B1 Example dose (ppm) Efficacy I.066 from this patent 100 100 10100 I.151 from this patent 100 100 10 100 54 from WO-2010/130767 100 10010 29

Compound 54 disclosed in international patent WO-2010/130767 correspondstoN-cyclopropyl-N-(6-cyclopropyl-2,3-difluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide.These results show that the compounds according to the invention have amuch better biological activity than the structurally closest compoundsdisclosed in WO-2010/130767.

Under the same conditions, excellent (at least 90%) protection to totalprotection is observed at a dose of 100 and 10 ppm of active ingredientwith compound of example I.067, whereas total to poor (less than 20%)protection is observed with the compound of example I.8 (oxa analogue)disclosed in patent application WO-2013/156559 as in table B2:

TABLE B2 Example dose (ppm) Efficacy I.067 from this patent 100 100 1093 I.8 from WO-2013/156559 100 95 10 14

Compound I.8 disclosed in international patent WO-2013/156559corresponds to5-chloro-N-cyclopropyl-3-(difluoromethyl)-N-[5-fluoro-2-(1-methylcyclopropyl)benzyl]-1-methyl-1H-pyrazole-4-carboxamide.

These results show that the compounds according to the invention have amuch better biological activity than the structurally closest compoundsdisclosed in WO-2013/156559.

Example C: In Vivo Preventive Test on Phakopsora pachyrhizi (SoybeanRust)

Solvent: 24.5 parts by weight of acetone

-   -   24.5 parts by weight of N,N-dimethylacetamide

Emulsifier: 1 part by weight of alkylaryl polyglycol ether

To produce a suitable preparation of active compound, 1 part by weightof active compound is mixed with the stated amounts of solvent andemulsifier, and the concentrate is diluted with water to the desiredconcentration.

To test for preventive activity, young plants are sprayed with thepreparation of active compound at the stated rate of application. Afterthe spray coating has dried on, the plants are inoculated with anaqueous spore suspension of the causal agent of soybean rust (Phakopsorapachyrhizi) and stay for 24 h without light in an incubation cabinet atapproximately 24° C. and a relative atmospheric humidity of 95%.

The plants remain in the incubation cabinet at approximately 24° C. anda relative atmospheric humidity of approximately 80% and a day/nightinterval of 12 h.

The test is evaluated 7 days after the inoculation. 0% means an efficacywhich corresponds to that of the untreated control, while an efficacy of100% means that no disease is observed.

In this test the following compounds according to the invention showedefficacy between 70% and 79% at a concentration of 10 ppm of activeingredient: I.018; I.041; I.065; I.074; I.087; I.112; I.114; I.133;I.159

In this test the following compounds according to the invention showedefficacy between 80% and 89% at a concentration of 10 ppm of activeingredient: I.066; I.072; I.108; I.111 In this test the followingcompounds according to the invention showed efficacy between 90% and100% at a concentration of 10 ppm of active ingredient: I.026; I.068;I.071; I.073; I.089; I.092; I.096; I.102; I.104; I.106; I.110; I.113;I.122; I.130; I.131; I.132; I.134; I.153 Under the same conditions,excellent (at least 90%) protection is observed at a dose of 10 ppm ofactive ingredient with compound of example I.071, whereas no protectionis observed with the compound of example 12 (trifluoromethyl analogue)disclosed in patent application WO-2010/130767 as in table C1:

TABLE C1 Example dose (ppm) Efficacy I.071 from this patent 10 99 12from WO-2010/130767 10 0

Compound 12 disclosed in international patent WO-2010/130767 correspondstoN-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-1H-pyrazole-4-carboxamide.These results show that the compounds according to the invention have amuch better biological activity than the structurally closest compoundsdisclosed in WO-2010/130767.

Under the same conditions, excellent (at least 90%) protection isobserved at a dose of 10 ppm of active ingredient with compound ofexample I.110, whereas no protection is observed with the compound ofexample 41 (unsubstituted cyclopropyl analogue) disclosed in patentapplication WO-2010/130767 as in table C2:

TABLE C2 Example dose (ppm) Efficacy I.110 from this patent 10 98 41from WO-2010/130767 10 0

Compound 41 disclosed in international patent WO-2010/130767 correspondstoN-(5-chloro-2-cyclopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide.

These results show that the compounds according to the invention have amuch better biological activity than the structurally closest compoundsdisclosed in WO-2010/130767.

Under the same conditions, high (at least 80%) protection to totalprotection is observed at a dose of 10 ppm of active ingredient withcompounds of examples I.066 and I.106, whereas no protection is observedwith the compound of example 123 (unsubstituted cyclopropyl analogue)disclosed in patent application WO-2010/130767 as in table C3:

TABLE C3 Example dose (ppm) Efficacy I.066 from this patent 10 89 I.106from this patent 10 100/98 123 from WO-2010/130767 10 0

Compound 123 disclosed in international patent WO-2010/130767corresponds toN-cyclopropyl-N-(2-cyclopropyl-5-fluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide.

These results show that the compounds according to the invention have amuch better biological activity than the structurally closest compoundsdisclosed in WO-2010/130767.

The invention claimed is:
 1. A compound of formula (II) or a saltthereof:

wherein n is 0, 1, 2, 3 or 4; m is 0, 1, 2, 3, 4, 5 or 6; p is 1, 2, 3,4 or 5; Z¹ is a non-substituted C₃-C₇-cycloalkyl or a C₃-C₇-cycloalkylsubstituted by up to 10 atoms or groups that can be the same ordifferent and that are selected from the group consisting of halogenatoms, cyano, C₁-C₈-alkyl, C₁-C₈-halogenoalkyl comprising up to 9halogen atoms that can be the same or different, C₁-C₈-alkoxy,C₁-C₈-halogenoalkoxy comprising up to 9 halogen atoms that can be thesame or different, C₁-C₈-alkoxycarbonyl, C₁-C₈-halogenoalkoxycarbonylcomprising up to 9 halogen atoms that can be the same or different,C₁-C₈-alkylaminocarbonyl and di-C₁-C₈-alkylaminocarbonyl; Z² and Z³ areindependently a hydrogen atom; substituted or non-substitutedC₁-C₈-alkyl; substituted or non-substituted C₂-C₈-alkenyl substituted ornon-substituted C₂-C₈-alkynyl cyano; isonitrile; nitro; a halogen atom;substituted or non-substituted C₁-C₈-alkoxy; substituted ornon-substituted C₂-C₈-alkenyloxy; substituted or non-substitutedC₂-C₈-alkynyloxy; substituted or non-substituted C₃-C₇-cycloalkyl;substituted or non-substituted C₁-C₈-alkylsulfanyl; substituted ornon-substituted C₁-C₈-alkylsulfonyl substituted or non-substitutedC₁-C₈-alkylsulfinyl; amino; substituted or non-substitutedC₁-C₈-alkylamino; substituted or non-substituted di-C₁-C₈-alkylamino;substituted or non-substituted C₁-C₈-alkoxycarbonyl; substituted ornon-substituted C₁-C₈-alkylcarbamoyl; substituted or non-substituteddi-C₁-C₈-alkylcarbamoyl or substituted or non-substitutedN—C₁-C₈-alkyl-C₁-C₈-alkoxy-carbamoyl; or Z² and Z³ together with thecarbon atom to which they are linked form a substituted ornon-substituted C₃-C₇-cycloalkyl; Z⁴ is a halogen atom; hydroxy; cyano;substituted or non-substituted C₁-C₈-alkyl; C₁-C₈-halogenoalkyl having 1to 5 halogen atoms; substituted or non-substituted C₂-C₈-alkenylC₂-C₈-halogenoalkenyl having 1 to 5 halogen atoms; substituted ornon-substituted C₂-C₈-alkynyl; C₂-C₈-halogenoalkynyl having 1 to 5halogen atoms; substituted or non-substituted C₁-C₈-alkoxy;C₁-C₈-halogenoalkoxy having 1 to 5 halogen atoms; substituted ornon-substituted C₁-C₈-alkylsulfanyl; formyl; substituted ornon-substituted C₁-C₈-alkylcarbonyl; carboxy; or substituted ornon-substituted C₁-C₈-alkoxycarbonyl; each W is independently a halogenatom; nitro; cyano; isonitrile; hydroxy; amino; sulfanyl;pentafluoro-λ⁶-sulfanyl; formyl; formyloxy; formylamino; substituted ornon-substituted (hydroxyimino)-C₁-C₈-alkyl; substituted ornon-substituted (C₁-C₈-alkoxyimino)-C₁-C₈-alkyl; substituted ornon-substituted (C₂-C₈-alkenyloxyimino)-C₁-C₈-alkyl; substituted ornon-substituted (C₂-C₈-alkynyloxyimino)-C₁-C₈-alkyl; substituted ornon-substituted (benzyloxyimino)-C₁-C₈-alkyl; carboxy; carbamoyl;N-hydroxycarbamoyl; carbamate; substituted or non-substitutedC₁-C₈-alkyl; C₁-C₈-halogenoalkyl having 1 to 9 halogen atoms;substituted or non-substituted C₂-C₈-alkenyl; C₂-C₈-halogenoalkenylhaving 1 to 9 halogen atoms; substituted or non-substitutedC₂-C₈-alkynyl; C₂-C₈-halogenoalkynyl having 1 to 9 halogen atoms;substituted or non-substituted C₁-C₈-alkoxy; C₁-C₈-halogenoalkoxy having1 to 9 halogen atoms; substituted or non-substitutedC₁-C₈-alkylsulfanyl; C₁-C₈-halogenoalkylsulfanyl having 1 to 9 halogenatoms; substituted or non-substituted C₁-C₈-alkylsulfinylC₁-C₈-halogenoalkylsulfinyl having 1 to 9 halogen atoms; substituted ornon-substituted C₁-C₈-alkylsulfonyl; C₁-C₈-halogenoalkylsulfonyl having1 to 9 halogen atoms; substituted or non-substituted C₁-C₈-alkylamino;substituted or non-substituted di-C₁-C₈-alkylamino; substituted ornon-substituted C₂-C₈-alkenyloxy; C₂-C₈-halogenoalkenyloxy having 1 to 9halogen atoms; substituted or non-substituted C₁-C₈-alkynyloxy; C₇-C₈halogenoalkynyloxy having 1 to 9 halogen atoms; substituted ornon-substituted C₃-C₇-cycloalkyl; C₃-C₇-halogenocycloalkyl having 1 to 9halogen atoms; substituted or non-substituted(C₃-C₇-cycloalkyl)-C₁-C₈-alkyl; substituted or non-substitutedC₄-C₇-cycloalkenyl; C₄-C₇-halogenocycloalkenyl having 1 to 9 halogenatoms; substituted or non-substituted (C₃-C₇-cycloalkyl)-C₂-C₈-alkenyl;substituted or non-substituted (C₃-C₇-cycloalkyl)-C₂-C₈-alkynyl;substituted or non-substituted bicyclo[2.2.1]heptanyl substituted ornon-substituted bicyclo[2.2.1]heptenyl; substituted or non-substitutedtri(C₁-C₈)alkylsilyl; substituted or non-substitutedtri(C₁-C₈)alkylsilyl-C₁-C₈-alkyl; substituted or non-substitutedC₁-C₈-alkylcarbonyl; C₁-C₈-halogenoalkylcarbonyl having 1 to 9 halogenatoms; substituted or non-substituted C₁-C₈-alkylcarbonyloxy;C₁-C₈-halogenoalkylcarbonyloxy having 1 to 9 halogen atoms; substitutedor non-substituted C₁-C₈-alkylcarbonylamino;C₁-C₈-halogenoalkylcarbonylamino having 1 to 9 halogen atoms;substituted or non-substituted C₁-C₈-alkoxycarbonyl;C₁-C₈-halogenoalkoxycarbonyl having 1 to 9 halogen atoms; substituted ornon-substituted C₁-C₈-alkyloxycarbonyloxy;C₁-C₈-halogenoalkoxycarbonyloxy having 1 to 9 halogen atoms; substitutedor non-substituted C₁-C₈-alkylcarbamoyl; substituted or non-substituteddi-C₁-C₈-alkylcarbamoyl; substituted or non-substitutedC₁-C₈-alkylaminocarbonyloxy; substituted or non-substituteddi-C₁-C₈-alkylaminocarbonyloxy; substituted or non-substitutedN—(C₁-C₈-alkyl)hydroxy carbamoyl; substituted or non-substitutedC₁-C₈-alkoxycarbamoyl; substituted or non-substitutedN—(C₁-C₈-alkyl)-C₁-C₈-alkoxycarbamoyl; aryl that can be substituted byup to 6 groups Q which can be the same or different; C₁-C₈-arylalkylthat can be substituted by up to 6 groups Q which can be the same ordifferent; C₁-C₈-arylalkenyl that can be substituted by up to 6 groups Qwhich can be the same or different; C₂-C₈-arylalkynyl that can besubstituted by up to 6 groups Q which can be the same or different;aryloxy that can be substituted by up to 6 groups Q which can be thesame or different; arylsulfanyl that can be substituted by up to 6groups Q which can be the same or different; arylamino that can besubstituted by up to 6 groups Q which can be the same or different;C₁-C₈-arylalkyloxy that can be substituted by up to 6 groups Q which canbe the same or different; C₁-C₈-arylalkylsulfanyl that can besubstituted by up to 6 groups Q which can be the same or different;C₁-C₈-arylalkylamino that can be substituted by up to 6 groups Q whichcan be the same or different; C₁-C₈-heteroarylalkyl that can besubstituted by up to 6 groups Q which can be the same or different;heteroaryl which can be substituted by up to 4 groups Q; orheteroaryloxy which can be substituted by up to 4 groups Q; or Z⁴ andits vicinal substituent W, together with the carbon atom to which theyare linked, form a substituted or non-substituted C₄-C₇-cycloalkyl; eachY is independently a halogen atom; C₁-C₈-alkyl; C₁-C₈-halogenoalkylhaving 1 to 9 halogen atoms; substituted or non-substitutedC₁-C₈-alkoxy; C₁-C₈-halogenoalkoxy having 1 to 9 halogen atoms;substituted or non-substituted C₁-C₈-alkylsulfanyl;C₁-C₈-halogenoalkylsulfanyl having 1 to 9 halogen atoms; or substitutedor non-substituted C₁-C₈-alkoxycarbonyl; and each Q is independently ahalogen atom; cyano; nitro; substituted or non-substituted C₁-C₈-alkyl;C₁-C₈-halogenoalkyl comprising up to 9 halogen atoms that can be thesame or different; substituted or non-substituted C₁-C₈-alkoxy;C₁-C₈-halogenoalkoxy comprising up to 9 halogen atoms that can be thesame or different; substituted or non-substituted C₁-C₈-alkylsulfanyl;C₁-C₈-halogenoalkylsulfanyl comprising up to 9 halogen atoms that can bethe same or different; substituted or non-substitutedtri(C₁-C₈)alkylsilyl; substituted or non-substitutedtri(C₁-C₈)alkylsilyl-C₁-C₈-alkyl; substituted or non-substituted(C₁-C₈-alkoxyimino)-C₁-C₈-alkyl; or substituted or non-substituted(benzyloxyimino)-C₁-C₈-alkyl.